2021	PMC7836272	cep57	depletion	We recently reported that the Cep57–PCNT interaction is crucial for the maintenance of centriole engagement during mitosis and that depletion of Cep57 causes precocious centriole disengagement in mitosis, but not in interphase (mitosis, 42.2 ± 5.1%; interphase, 0%;  n  = 30 and 50, respectively, from three independent experiments;  Fig. 1, A and B ;  Watanabe et al., 2019 ).	 We recently reported that the Cep57–PCNT interaction is crucial for the maintenance of centriole engagement during mitosis and that [EXPE] of [GENE] causes precocious centriole disengagement in mitosis but not in interphase  mitosis 422 ± 51%; interphase 0%;  n  = 30 and 50 respectively from three independent experiments;  Fig 1 A and B ;  Watanabe et al 2019   
2021	PMC7836272	cep57l1	depletion	We found that depletion of Cep57L1 did not affect centriole engagement in either interphase or mitosis ( Fig. 1 E ).	 We found that [EXPE] of [GENE] did not affect centriole engagement in either interphase or mitosis   Fig 1 E   
2021	PMC7836272	cep57	sirnas	We accordingly tested codepletion of two of the three proteins Cep57, Cep57L1, and PCNT by treating human cells with two distinct siRNAs, and we observed the centrosome and centriole behaviors.	 We accordingly tested codepletion of two of the three proteins [GENE] Cep57L1 and PCNT by treating human cells with two distinct [EXPE] and we observed the centrosome and centriole behaviors 
2021	PMC7836272	cep57l1	sirnas	We accordingly tested codepletion of two of the three proteins Cep57, Cep57L1, and PCNT by treating human cells with two distinct siRNAs, and we observed the centrosome and centriole behaviors.	 We accordingly tested codepletion of two of the three proteins Cep57 [GENE] and PCNT by treating human cells with two distinct [EXPE] and we observed the centrosome and centriole behaviors 
2021	PMC7836272	pcnt	sirnas	We accordingly tested codepletion of two of the three proteins Cep57, Cep57L1, and PCNT by treating human cells with two distinct siRNAs, and we observed the centrosome and centriole behaviors.	 We accordingly tested codepletion of two of the three proteins Cep57 Cep57L1 and [GENE] by treating human cells with two distinct [EXPE] and we observed the centrosome and centriole behaviors 
2021	PMC7836272	cep57	sirnas	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the [EXPE] was validated by quantifying mRNAs using quantitative RT-PCR  RT-qPCR  and also by measuring the signal intensities of [GENE] and Cep57L1 at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57	rt-pcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative [EXPE]  RT-qPCR  and also by measuring the signal intensities of [GENE] and Cep57L1 at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57	rt-qpcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR  [EXPE]  and also by measuring the signal intensities of [GENE] and Cep57L1 at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57l1	sirnas	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the [EXPE] was validated by quantifying mRNAs using quantitative RT-PCR  RT-qPCR  and also by measuring the signal intensities of Cep57 and [GENE] at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57l1	rt-pcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative [EXPE]  RT-qPCR  and also by measuring the signal intensities of Cep57 and [GENE] at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57l1	rt-qpcr	The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR (RT-qPCR) and also by measuring the signal intensities of Cep57 and Cep57L1 at old mother centrioles ( Fig. S1, C and D ).	 The efficiency of the siRNAs was validated by quantifying mRNAs using quantitative RT-PCR  [EXPE]  and also by measuring the signal intensities of Cep57 and [GENE] at old mother centrioles   Fig S1 C and D   
2021	PMC7836272	cep57	sirna	The phenotypes provoked by codepletion of Cep57 and Cep57L1 were also confirmed by using a different siRNA and other human cell lines ( Fig. S1, E and F ).	 The phenotypes provoked by codepletion of [GENE] and Cep57L1 were also confirmed by using a different [EXPE] and other human cell lines   Fig S1 E and F   
2021	PMC7836272	cep57l1	sirna	The phenotypes provoked by codepletion of Cep57 and Cep57L1 were also confirmed by using a different siRNA and other human cell lines ( Fig. S1, E and F ).	 The phenotypes provoked by codepletion of Cep57 and [GENE] were also confirmed by using a different [EXPE] and other human cell lines   Fig S1 E and F   
2021	PMC7836272	cep57	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant [GENE] or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] [GENE] or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant Cep57 or [GENE] construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] Cep57 or [GENE] construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + [GENE] expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + [GENE] expression 100 ± 33%; siCep57/Cep57L1 + Cep57L1 expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rescued	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were [EXPE] by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + [GENE] expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57l1	rnai-resistant	As expected, the phenotypes were rescued by expressing a synthetic RNAi-resistant Cep57 or Cep57L1 construct (siControl, 2.2 ± 1.9%; siCep57/Cep57L1, 33.2 ± 2.9%; siCep57/Cep57L1 + Cep57 expression, 10.0 ± 3.3%; siCep57/Cep57L1 + Cep57L1 expression, 6.7 ± 3.3%;  n  = 30; from three independent experiments;  Fig. 1, G and H ).	 As expected the phenotypes were rescued by expressing a synthetic [EXPE] Cep57 or Cep57L1 construct  siControl 22 ± 19%; siCep57/Cep57L1 332 ± 29%; siCep57/Cep57L1 + Cep57 expression 100 ± 33%; siCep57/Cep57L1 + [GENE] expression 67 ± 33%;  n  = 30; from three independent experiments;  Fig 1 G and H   
2021	PMC7836272	cep57	depletion	The efficiency of the CRISPR/Cas9-mediated depletion was validated by measuring the signal intensities of Cep57 and Cep57L1 at the centrosomes ( Fig. S1, I and J ).	 The efficiency of the CRISPR/Cas9-mediated [EXPE] was validated by measuring the signal intensities of [GENE] and Cep57L1 at the centrosomes   Fig S1 I and J   
2021	PMC7836272	cep57l1	depletion	The efficiency of the CRISPR/Cas9-mediated depletion was validated by measuring the signal intensities of Cep57 and Cep57L1 at the centrosomes ( Fig. S1, I and J ).	 The efficiency of the CRISPR/Cas9-mediated [EXPE] was validated by measuring the signal intensities of Cep57 and [GENE] at the centrosomes   Fig S1 I and J   
2021	PMC7836272	cep57	depletion	  (A)  Depletion of Cep57 induced precocious centriole disengagement in mitosis, but not in interphase.	    A   [EXPE] of [GENE] induced precocious centriole disengagement in mitosis but not in interphase 
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against [GENE]  green  and Cep192  red  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against CP110  green  and [GENE]  red  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  and Cep192  red  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against CP110 (green) and Cep192 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against CP110  green  and [GENE]  red  
2021	PMC7836272	cep57	rescued	 (G)  Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was rescued by exogenous expression of Cep57 or Cep57L1.	   G   Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was [EXPE] by exogenous expression of [GENE] or Cep57L1 
2021	PMC7836272	cep57l1	rescued	 (G)  Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was rescued by exogenous expression of Cep57 or Cep57L1.	   G   Precocious centriole disengagement in interphase induced by Cep57/Cep57L1 codepletion was [EXPE] by exogenous expression of Cep57 or [GENE] 
2021	PMC7836272	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), CENP-F (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against FLAG  green  CENP-F  red  and [GENE]  cyan  
2021	PMC7836272	cep57	depletion	Double depletion of Cep57 and Cep57L1 causes precocious centriole disengagement in interphase.	 Double [EXPE] of [GENE] and Cep57L1 causes precocious centriole disengagement in interphase 
2021	PMC7836272	cep57l1	depletion	Double depletion of Cep57 and Cep57L1 causes precocious centriole disengagement in interphase.	 Double [EXPE] of Cep57 and [GENE] causes precocious centriole disengagement in interphase 
2021	PMC7836272	cep57l1	alignments	  (A)  Alignments of full-length  H. sapiens  Cep57L1 and Cep57.	    A   [EXPE] of full-length  H sapiens  [GENE] and Cep57 
2021	PMC7836272	cep57	alignments	  (A)  Alignments of full-length  H. sapiens  Cep57L1 and Cep57.	    A   [EXPE] of full-length  H sapiens  Cep57L1 and [GENE] 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against centrin (green), Cep192 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  [GENE]  red  and PCNA  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against centrin (green), Cep192 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  Cep192  red  and [GENE]  cyan  
2021	PMC7836272	cep57	rt-qpcr	 (D)  Expression levels of Cep57 and Cep57L1 were quantified by RT-qPCR in control and Cep57/Cep57L1-depleted cells.	   D   Expression levels of [GENE] and Cep57L1 were quantified by [EXPE] in control and Cep57/Cep57L1-depleted cells 
2021	PMC7836272	cep57l1	rt-qpcr	 (D)  Expression levels of Cep57 and Cep57L1 were quantified by RT-qPCR in control and Cep57/Cep57L1-depleted cells.	   D   Expression levels of Cep57 and [GENE] were quantified by [EXPE] in control and Cep57/Cep57L1-depleted cells 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57 and siCep57L1 no. 2 and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siCep57 and siCep57L1 no 2 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep192	immunostained	U2OS cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and Cep192 (red).	 U2OS cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting [GENE] and Cep57L1  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and [GENE]  sgCep57/Cep57L1  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting [GENE] and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting [GENE] and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and [GENE]  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and [GENE]  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	sgrna	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control [EXPE]  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep192	sgrnas	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or [EXPE] targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and immunostained with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells stably expressing Cas9 were treated with control sgRNA (sgControl) or sgRNAs targeting Cep57 and Cep57L1 (sgCep57/Cep57L1) and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells stably expressing Cas9 were treated with control sgRNA  sgControl  or sgRNAs targeting Cep57 and Cep57L1  sgCep57/Cep57L1  and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep57	immunostained	To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase, we immunostained HeLa cells with an antibody against outer dense fiber protein 2 (ODF2), a marker of old mother centrioles ( Fig. S2, A and B ).	 To investigate whether the phenotype seen with codepletion of [GENE] and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase we [EXPE] HeLa cells with an antibody against outer dense fiber protein 2  ODF2  a marker of old mother centrioles   Fig S2 A and B   
2021	PMC7836272	cep57l1	immunostained	To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase, we immunostained HeLa cells with an antibody against outer dense fiber protein 2 (ODF2), a marker of old mother centrioles ( Fig. S2, A and B ).	 To investigate whether the phenotype seen with codepletion of Cep57 and [GENE] is due to a failure of cytokinesis or to precocious centriole disengagement during interphase we [EXPE] HeLa cells with an antibody against outer dense fiber protein 2  ODF2  a marker of old mother centrioles   Fig S2 A and B   
2021	PMC7836272	odf2	immunostained	To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase, we immunostained HeLa cells with an antibody against outer dense fiber protein 2 (ODF2), a marker of old mother centrioles ( Fig. S2, A and B ).	 To investigate whether the phenotype seen with codepletion of Cep57 and Cep57L1 is due to a failure of cytokinesis or to precocious centriole disengagement during interphase we [EXPE] HeLa cells with an antibody against outer dense fiber protein 2  [GENE]  a marker of old mother centrioles   Fig S2 A and B   
2021	PMC7836272	cep57	suppress	Taken together, these data suggest that Cep57 and Cep57L1 cooperatively regulate the maintenance of centriole engagement during interphase and thus suppress centriole reduplication within the same cell cycle.	 Taken together these data suggest that [GENE] and Cep57L1 cooperatively regulate the maintenance of centriole engagement during interphase and thus [EXPE] centriole reduplication within the same cell cycle 
2021	PMC7836272	cep57l1	suppress	Taken together, these data suggest that Cep57 and Cep57L1 cooperatively regulate the maintenance of centriole engagement during interphase and thus suppress centriole reduplication within the same cell cycle.	 Taken together these data suggest that Cep57 and [GENE] cooperatively regulate the maintenance of centriole engagement during interphase and thus [EXPE] centriole reduplication within the same cell cycle 
2021	PMC7836272	odf2	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and ODF2 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep295	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and Cep295 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	pcnt	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against PCNT (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  CP110  red  and PCNA  cyan  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against PCNT (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against PCNT  green  [GENE]  red  and PCNA  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were treated with siCep57/Cep57L1 and immunostained with antibodies against PCNT (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against PCNT  green  CP110  red  and [GENE]  cyan  
2021	PMC7836272	pcnt	immunostained	HeLa cells were immunostained with antibodies against PCNT (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against [GENE]  green  and CP110  red  
2021	PMC7836272	cp110	immunostained	HeLa cells were immunostained with antibodies against PCNT (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against PCNT  green  and [GENE]  red  
2021	PMC7836272	cp110	immunostaining	HeLa cells were treated with siControl or siCep57/Cep57L1 and followed by nocodazole treatment (10 µM) for 3 h. After nocodazole treatment, the cells were cold treated for 1 h, followed by 1-min incubation at 37°C and immunostaining with antibodies against EB1 (green) and CP110 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and followed by nocodazole treatment  10 µM  for 3 h After nocodazole treatment the cells were cold treated for 1 h followed by 1-min incubation at 37°C and [EXPE] with antibodies against EB1  green  and [GENE]  red  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 for 36 h in the presence of EdU (S phase marker; cyan) for the last 30 min before fixation and immunostained with antibodies against CP110 (red) and CENP-F (green).	 HeLa cells were treated with siControl or siCep57/Cep57L1 for 36 h in the presence of EdU  S phase marker; cyan  for the last 30 min before fixation and [EXPE] with antibodies against [GENE]  red  and CENP-F  green  
2021	PMC7836272	cdk1	inhibitor	Previous studies have reported that the G 2  phase cell cycle arrest induced by treatment with a Cdk1 inhibitor or DNA-damaging reagents caused precocious centriole disengagement ( Prosser et al., 2012 ;  Douthwright and Sluder, 2014 ).	 Previous studies have reported that the G 2  phase cell cycle arrest induced by treatment with a [GENE] [EXPE] or DNA-damaging reagents caused precocious centriole disengagement   Prosser et al 2012 ;  Douthwright and Sluder 2014   
2021	PMC7836272	cep57	live-cell	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of [GENE] and Cep57L1 induces cell cycle arrest in interphase we performed a [EXPE] imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	cep57	imaging	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of [GENE] and Cep57L1 induces cell cycle arrest in interphase we performed a live-cell [EXPE] analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	cep57l1	live-cell	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of Cep57 and [GENE] induces cell cycle arrest in interphase we performed a [EXPE] imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	cep57l1	imaging	To examine whether codepletion of Cep57 and Cep57L1 induces cell cycle arrest in interphase, we performed a live-cell imaging analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis.	 To examine whether codepletion of Cep57 and [GENE] induces cell cycle arrest in interphase we performed a live-cell [EXPE] analysis and measured the duration of the period from anaphase onset to cell roundup in the next mitosis 
2021	PMC7836272	poc5	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and POC5 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	pcnt	immunostained	HeLa-GFP-centrin1 cells were treated with siCep57/Cep57L1 and immunostained with antibodies against GFP (green), PCNT (red), and CENP-F (cyan).	 HeLa-GFP-centrin1 cells were treated with siCep57/Cep57L1 and [EXPE] with antibodies against GFP  green  [GENE]  red  and CENP-F  cyan  
2021	PMC7836272	plk1	inhibition	Previous studies have reported that canonical centriole disengagement requires Plk1 activity and that the inhibition of Plk1 perturbs centriole disengagement at the end of mitosis ( Tsou et al., 2009 ).	 Previous studies have reported that canonical centriole disengagement requires [GENE] activity and that the [EXPE] of Plk1 perturbs centriole disengagement at the end of mitosis   Tsou et al 2009   
2021	PMC7836272	plk1	inhibition	Previous studies have reported that canonical centriole disengagement requires Plk1 activity and that the inhibition of Plk1 perturbs centriole disengagement at the end of mitosis ( Tsou et al., 2009 ).	 Previous studies have reported that canonical centriole disengagement requires Plk1 activity and that the [EXPE] of [GENE] perturbs centriole disengagement at the end of mitosis   Tsou et al 2009   
2021	PMC7836272	plk1	inhibition	Precocious centriole disengagement in G 2 /M phase-arrested cells was also suppressed by Plk1 inhibition ( Prosser et al., 2012 ).	 Precocious centriole disengagement in G 2 /M phase-arrested cells was also suppressed by [GENE] [EXPE]   Prosser et al 2012   
2021	PMC7836272	plk1	inhibitor	To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires Plk1 activity, we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule inhibitor of Plk1 (BI2536).	 To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires [GENE] activity we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule [EXPE] of Plk1  BI2536  
2021	PMC7836272	plk1	inhibitor	To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires Plk1 activity, we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule inhibitor of Plk1 (BI2536).	 To determine whether the precocious centriole disengagement in Cep57/Cep57L1-depleted cells also requires Plk1 activity we treated G 2  phase-arrested cells or Cep57/Cep57L1-depleted cells with a small-molecule [EXPE] of [GENE]  BI2536  
2021	PMC7836272	plk1	inhibition	Inhibition of Plk1 prevents disengaged daughter centrioles from acquiring PCM but does not suppress precocious centriole disengagement.	 [EXPE] of [GENE] prevents disengaged daughter centrioles from acquiring PCM but does not suppress precocious centriole disengagement 
2021	PMC7836272	plk1	suppress	Inhibition of Plk1 prevents disengaged daughter centrioles from acquiring PCM but does not suppress precocious centriole disengagement.	 Inhibition of [GENE] prevents disengaged daughter centrioles from acquiring PCM but does not [EXPE] precocious centriole disengagement 
2021	PMC7836272	cdk1	immunostained	HeLa cells were synchronized in the G 1 /S phase by aphidicolin (1.2 µg/ml) for 17 h, then released into fresh medium for 4 h. Next, the cells were treated with DMSO (control), RO3306 (Cdk1 inhibitor; 10 µM), or both of RO3306 and BI2536 (100 nM) for 24 h. HeLa cells were immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were synchronized in the G 1 /S phase by aphidicolin  12 µg/ml  for 17 h then released into fresh medium for 4 h Next the cells were treated with DMSO  control  RO3306  [GENE] inhibitor; 10 µM  or both of RO3306 and BI2536  100 nM  for 24 h HeLa cells were [EXPE] with antibodies against centrin  green  and Cep192  red  
2021	PMC7836272	cep192	immunostained	HeLa cells were synchronized in the G 1 /S phase by aphidicolin (1.2 µg/ml) for 17 h, then released into fresh medium for 4 h. Next, the cells were treated with DMSO (control), RO3306 (Cdk1 inhibitor; 10 µM), or both of RO3306 and BI2536 (100 nM) for 24 h. HeLa cells were immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were synchronized in the G 1 /S phase by aphidicolin  12 µg/ml  for 17 h then released into fresh medium for 4 h Next the cells were treated with DMSO  control  RO3306  Cdk1 inhibitor; 10 µM  or both of RO3306 and BI2536  100 nM  for 24 h HeLa cells were [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	pcnt	immunostained	HeLa-GFP-centrin1 cells were treated as in C and immunostained with antibodies against GFP (green), CENP-F (red), and PCNT (cyan).	 HeLa-GFP-centrin1 cells were treated as in C and [EXPE] with antibodies against GFP  green  CENP-F  red  and [GENE]  cyan  
2021	PMC7836272	cep57l1	immunostained	To do this, we immunostained HeLa cells with an antibody against Cep57L1 and found that endogenous Cep57L1 localized at mother centrioles ( Fig. 5 A ).	 To do this we [EXPE] HeLa cells with an antibody against [GENE] and found that endogenous Cep57L1 localized at mother centrioles   Fig 5 A   
2021	PMC7836272	cep57l1	immunostained	To do this, we immunostained HeLa cells with an antibody against Cep57L1 and found that endogenous Cep57L1 localized at mother centrioles ( Fig. 5 A ).	 To do this we [EXPE] HeLa cells with an antibody against Cep57L1 and found that endogenous [GENE] localized at mother centrioles   Fig 5 A   
2021	PMC7836272	cep57l1	depletion	Moreover, stimulated emission depletion (STED) analysis showed that Cep57L1 formed a ring-like structure around the mother centriole ( Fig. 5 B ).	 Moreover stimulated emission [EXPE]  STED  analysis showed that [GENE] formed a ring-like structure around the mother centriole   Fig 5 B   
2021	PMC7836272	cep57l1	sted	Moreover, stimulated emission depletion (STED) analysis showed that Cep57L1 formed a ring-like structure around the mother centriole ( Fig. 5 B ).	 Moreover stimulated emission depletion  [EXPE]  analysis showed that [GENE] formed a ring-like structure around the mother centriole   Fig 5 B   
2021	PMC7836272	cep57	sted	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 [EXPE] microscopy also revealed the colocalization of [GENE] and Cep57L1 around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57	microscopy	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 STED [EXPE] also revealed the colocalization of [GENE] and Cep57L1 around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57l1	sted	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 [EXPE] microscopy also revealed the colocalization of Cep57 and [GENE] around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57l1	microscopy	STED microscopy also revealed the colocalization of Cep57 and Cep57L1 around the mother centriole ( Fig. S3 E ).	 STED [EXPE] also revealed the colocalization of Cep57 and [GENE] around the mother centriole   Fig S3 E   
2021	PMC7836272	cep57l1	sirna	The specificity of the antibody was validated using siRNA against Cep57L1 ( Fig. 5 C ).	 The specificity of the antibody was validated using [EXPE] against [GENE]   Fig 5 C   
2021	PMC7836272	cep57	sted	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using [EXPE] microscopy we observed the localization pattern of [GENE] and Cep57L1 at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57	microscopy	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED [EXPE] we observed the localization pattern of [GENE] and Cep57L1 at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57	sirna	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED microscopy we observed the localization pattern of [GENE] and Cep57L1 at centrioles upon reciprocal [EXPE] treatment 
2021	PMC7836272	cep57l1	sted	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using [EXPE] microscopy we observed the localization pattern of Cep57 and [GENE] at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57l1	microscopy	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED [EXPE] we observed the localization pattern of Cep57 and [GENE] at centrioles upon reciprocal siRNA treatment 
2021	PMC7836272	cep57l1	sirna	To examine the mutual dependency on centriole localization, using STED microscopy, we observed the localization pattern of Cep57 and Cep57L1 at centrioles upon reciprocal siRNA treatment.	 To examine the mutual dependency on centriole localization using STED microscopy we observed the localization pattern of Cep57 and [GENE] at centrioles upon reciprocal [EXPE] treatment 
2021	PMC7836272	cep57	depletion	Depletion of Cep57 or Cep57L1 did not significantly affect each other’s localization pattern at centrioles ( Fig. 5 C ;  Fig. S3, F and G ).	 [EXPE] of [GENE] or Cep57L1 did not significantly affect each other’s localization pattern at centrioles   Fig 5 C ;  Fig S3 F and G   
2021	PMC7836272	cep57l1	depletion	Depletion of Cep57 or Cep57L1 did not significantly affect each other’s localization pattern at centrioles ( Fig. 5 C ;  Fig. S3, F and G ).	 [EXPE] of Cep57 or [GENE] did not significantly affect each other’s localization pattern at centrioles   Fig 5 C ;  Fig S3 F and G   
2021	PMC7836272	cep57l1	immunostained	HeLa cells were immunostained with antibodies against Cep57L1 (red) and centrin (green).	 HeLa cells were [EXPE] with antibodies against [GENE]  red  and centrin  green  
2021	PMC7836272	pcnt	sted	 (B)  STED images representing top view of Cep57/Cep57L1 (red) and PCNT (green) at mother centrioles.	   B   [EXPE] images representing top view of Cep57/Cep57L1  red  and [GENE]  green  at mother centrioles 
2021	PMC7836272	cep57	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against [GENE]  green  Cep57  red  and Cep192  cyan  
2021	PMC7836272	cep57	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  Cep57  red  and [GENE]  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were immunostained with antibodies against PCNA (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were [EXPE] with antibodies against PCNA  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	cep57l1	sted	 (E)  STED images representing top view of Cep57L1 (red) and Cep57 (green) at mother centrioles.	   E   [EXPE] images representing top view of [GENE]  red  and Cep57  green  at mother centrioles 
2021	PMC7836272	cep57	sted	 (E)  STED images representing top view of Cep57L1 (red) and Cep57 (green) at mother centrioles.	   E   [EXPE] images representing top view of Cep57L1  red  and [GENE]  green  at mother centrioles 
2021	PMC7836272	cep57	sted	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   [EXPE] images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon siRNA treatment against Cep57L1 
2021	PMC7836272	cep57	sirna	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   STED images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against Cep57L1 
2021	PMC7836272	pcnt	sted	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   [EXPE] images representing top view of Cep57  red  and [GENE]  green  at mother centrioles upon siRNA treatment against Cep57L1 
2021	PMC7836272	pcnt	sirna	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   STED images representing top view of Cep57  red  and [GENE]  green  at mother centrioles upon [EXPE] treatment against Cep57L1 
2021	PMC7836272	cep57l1	sted	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   [EXPE] images representing top view of Cep57  red  and PCNT  green  at mother centrioles upon siRNA treatment against [GENE] 
2021	PMC7836272	cep57l1	sirna	 (F)  STED images representing top view of Cep57 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57L1.	   F   STED images representing top view of Cep57  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against [GENE] 
2021	PMC7836272	cep57l1	sted	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   [EXPE] images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon siRNA treatment against Cep57 
2021	PMC7836272	cep57l1	sirna	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   STED images representing top view of [GENE]  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against Cep57 
2021	PMC7836272	pcnt	sted	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   [EXPE] images representing top view of Cep57L1  red  and [GENE]  green  at mother centrioles upon siRNA treatment against Cep57 
2021	PMC7836272	pcnt	sirna	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   STED images representing top view of Cep57L1  red  and [GENE]  green  at mother centrioles upon [EXPE] treatment against Cep57 
2021	PMC7836272	cep57	sted	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   [EXPE] images representing top view of Cep57L1  red  and PCNT  green  at mother centrioles upon siRNA treatment against [GENE] 
2021	PMC7836272	cep57	sirna	 (G)  STED images representing top view of Cep57L1 (red) and PCNT (green) at mother centrioles upon siRNA treatment against Cep57.	   G   STED images representing top view of Cep57L1  red  and PCNT  green  at mother centrioles upon [EXPE] treatment against [GENE] 
2021	PMC7836272	cep57	depletion	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by [GENE] [EXPE] was not rescued by exogenous expression of Cep57L1 
2021	PMC7836272	cep57	rescued	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by [GENE] depletion was not [EXPE] by exogenous expression of Cep57L1 
2021	PMC7836272	cep57l1	depletion	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by Cep57 [EXPE] was not rescued by exogenous expression of [GENE] 
2021	PMC7836272	cep57l1	rescued	Scale bar, 500 nm in E–G.  (H)  Precocious centriole disengagement in mitosis induced by Cep57 depletion was not rescued by exogenous expression of Cep57L1.	 Scale bar 500 nm in E–G   H   Precocious centriole disengagement in mitosis induced by Cep57 depletion was not [EXPE] by exogenous expression of [GENE] 
2021	PMC7836272	cep57l1	coimmunoprecipitation	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and [EXPE]  co-IP  analyses with the mutant revealed that the PINC motif of [GENE] was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the PCNT C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	cep57l1	co-ip	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and coimmunoprecipitation  [EXPE]  analyses with the mutant revealed that the PINC motif of [GENE] was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the PCNT C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	pcnt	coimmunoprecipitation	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and [EXPE]  co-IP  analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the [GENE] C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	pcnt	co-ip	Unexpectedly, IF and coimmunoprecipitation (co-IP) analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization ( Fig. S4 A ) and for the binding to the PCNT C-terminal region, including the PACT domain ( Fig. S4 B ).	 Unexpectedly IF and coimmunoprecipitation  [EXPE]  analyses with the mutant revealed that the PINC motif of Cep57L1 was dispensable for the centrosomal localization   Fig S4 A   and for the binding to the [GENE] C-terminal region including the PACT domain   Fig S4 B   
2021	PMC7836272	cep57	pfam	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the [EXPE] protein family database predicted the presence of microtubule-binding domains in both [GENE] and Cep57L1   Fig S1 A   
2021	PMC7836272	cep57	database	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the Pfam protein family [EXPE] predicted the presence of microtubule-binding domains in both [GENE] and Cep57L1   Fig S1 A   
2021	PMC7836272	cep57l1	pfam	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the [EXPE] protein family database predicted the presence of microtubule-binding domains in both Cep57 and [GENE]   Fig S1 A   
2021	PMC7836272	cep57l1	database	In addition to the PINC motif, the Pfam protein family database predicted the presence of microtubule-binding domains in both Cep57 and Cep57L1 ( Fig. S1 A ).	 In addition to the PINC motif the Pfam protein family [EXPE] predicted the presence of microtubule-binding domains in both Cep57 and [GENE]   Fig S1 A   
2021	PMC7836272	cep57	overexpressed	As previously reported, overexpressed Cep57 was occasionally localized on the microtubule network via its microtubule-binding domain ( Fig. S4 C ;  Momotani et al., 2008 ).	 As previously reported [EXPE] [GENE] was occasionally localized on the microtubule network via its microtubule-binding domain   Fig S4 C ;  Momotani et al 2008   
2021	PMC7836272	cep57l1	overexpressed	In contrast, overexpressed Cep57L1 did not show such a localization pattern, but instead aggregated in the cytoplasm ( Fig. S4 C ).	 In contrast [EXPE] [GENE] did not show such a localization pattern but instead aggregated in the cytoplasm   Fig S4 C   
2021	PMC7836272	cep57	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of [GENE] and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of [GENE] and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of Cep57 and [GENE] proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of Cep57 and [GENE] proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of [GENE] but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57l1	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of [GENE] but not of Cep57   Fig S4 D   
2021	PMC7836272	cep57	co-ip	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore [EXPE] assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of [GENE]   Fig S4 D   
2021	PMC7836272	cep57	assays	Furthermore, co-IP assays of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of Cep57 ( Fig. S4 D ).	 Furthermore co-IP [EXPE] of Cep57 and Cep57L1 proteins in HEK293T cells detected self-interaction of Cep57L1 but not of [GENE]   Fig S4 D   
2021	PMC7836272	cep192	immunostained	HeLa cells expressing FLAG-Cep57L1 or FLAG-Cep57L1 mutant lacking the PINC motif (Δ52–86 aa) were immunostained with antibodies against FLAG (green) and Cep192 (red).	 HeLa cells expressing FLAG-Cep57L1 or FLAG-Cep57L1 mutant lacking the PINC motif  Δ52–86 aa  were [EXPE] with antibodies against FLAG  green  and [GENE]  red  
2021	PMC7836272	cep57	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   [EXPE] [GENE] was accumulated on the microtubules but overexpressed Cep57L1 aggregated in the cytoplasm 
2021	PMC7836272	cep57	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   Overexpressed [GENE] was accumulated on the microtubules but [EXPE] Cep57L1 aggregated in the cytoplasm 
2021	PMC7836272	cep57l1	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   [EXPE] Cep57 was accumulated on the microtubules but overexpressed [GENE] aggregated in the cytoplasm 
2021	PMC7836272	cep57l1	overexpressed	 (C)  Overexpressed Cep57 was accumulated on the microtubules, but overexpressed Cep57L1 aggregated in the cytoplasm.	   C   Overexpressed Cep57 was accumulated on the microtubules but [EXPE] [GENE] aggregated in the cytoplasm 
2021	PMC7836272	cep152	depletion	 (E)  Depletion of Cep152 has a modest effect on centriole duplication.	   E   [EXPE] of [GENE] has a modest effect on centriole duplication 
2021	PMC7836272	cep152	sirnas	 (F)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   F   Beeswarm plots piled on boxplots represent the normalized signal intensity of [GENE] at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  [GENE]  red  and PCNA  cyan  
2021	PMC7836272	pcna	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green), CP110 (red), and PCNA (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  CP110  red  and [GENE]  cyan  
2021	PMC7836272	cep63	depletion	Consistent with previous studies ( Aziz et al., 2018 ;  Lukinavičius et al., 2013 ), we confirmed that Cep63 (median, 30.6% compared with siControl;  n  > 50) or Cep152 depletion (19.3%) significantly decreased the signal intensity of Cep57 at the centrosomes ( Fig. 6, A and D ).	 Consistent with previous studies   Aziz et al 2018 ;  Lukinavičius et al 2013   we confirmed that [GENE]  median 306% compared with siControl;  n  > 50  or Cep152 [EXPE]  193%  significantly decreased the signal intensity of Cep57 at the centrosomes   Fig 6 A and D   
2021	PMC7836272	cep152	depletion	Consistent with previous studies ( Aziz et al., 2018 ;  Lukinavičius et al., 2013 ), we confirmed that Cep63 (median, 30.6% compared with siControl;  n  > 50) or Cep152 depletion (19.3%) significantly decreased the signal intensity of Cep57 at the centrosomes ( Fig. 6, A and D ).	 Consistent with previous studies   Aziz et al 2018 ;  Lukinavičius et al 2013   we confirmed that Cep63  median 306% compared with siControl;  n  > 50  or [GENE] [EXPE]  193%  significantly decreased the signal intensity of Cep57 at the centrosomes   Fig 6 A and D   
2021	PMC7836272	cep57	depletion	Consistent with previous studies ( Aziz et al., 2018 ;  Lukinavičius et al., 2013 ), we confirmed that Cep63 (median, 30.6% compared with siControl;  n  > 50) or Cep152 depletion (19.3%) significantly decreased the signal intensity of Cep57 at the centrosomes ( Fig. 6, A and D ).	 Consistent with previous studies   Aziz et al 2018 ;  Lukinavičius et al 2013   we confirmed that Cep63  median 306% compared with siControl;  n  > 50  or Cep152 [EXPE]  193%  significantly decreased the signal intensity of [GENE] at the centrosomes   Fig 6 A and D   
2021	PMC7836272	cep63	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of [GENE]  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep152	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or [GENE]  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep57l1	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of [GENE] at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep57	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both [GENE] and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep57l1	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and [GENE] localization at the centrosomes was partially dependent on Cep63 and Cep152   Fig 6 A and D   
2021	PMC7836272	cep63	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on [GENE] and Cep152   Fig 6 A and D   
2021	PMC7836272	cep152	depletion	As expected, depletion of Cep63 (24.8%) or Cep152 (45.8%) reduced the signal intensity of Cep57L1 at the centrosomes, indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and Cep152 ( Fig. 6, A and D ).	 As expected [EXPE] of Cep63  248%  or Cep152  458%  reduced the signal intensity of Cep57L1 at the centrosomes indicating that both Cep57 and Cep57L1 localization at the centrosomes was partially dependent on Cep63 and [GENE]   Fig 6 A and D   
2021	PMC7836272	cep63	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of [GENE] and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and [GENE] at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of [GENE]  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep63	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  [GENE] 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; [GENE] 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57l1	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or [GENE]  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep63	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  [GENE] 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; [GENE] 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of [GENE] and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep57l1	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and [GENE] reduced the signal intensity of Cep152 at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	On the other hand, the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by depletion of Cep57 (Cep63, 81.0%; Cep152, 80.2%) or Cep57L1 (Cep63, 70.6%; Cep152, 81.0%), whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of Cep152 at the centrosomes more drastically (31.1%;  Fig. 6, B–D ).	 On the other hand the signal intensity of Cep63 and Cep152 at the centrosomes was only slightly affected by [EXPE] of Cep57  Cep63 810%; Cep152 802%  or Cep57L1  Cep63 706%; Cep152 810%  whereas codepletion of Cep57 and Cep57L1 reduced the signal intensity of [GENE] at the centrosomes more drastically  311%;  Fig 6 B–D   
2021	PMC7836272	cep152	depletion	Moreover, as reported in previous studies ( Lukinavičius et al., 2013 ;  Kim et al., 2019 ;  Brown et al., 2013 ), the signal intensity of Cep152 was attenuated by Cep63 depletion (25.8%) and vice versa (66.4%;  Fig. 6 D ).	 Moreover as reported in previous studies   Lukinavičius et al 2013 ;  Kim et al 2019 ;  Brown et al 2013   the signal intensity of [GENE] was attenuated by Cep63 [EXPE]  258%  and vice versa  664%;  Fig 6 D   
2021	PMC7836272	cep63	depletion	Moreover, as reported in previous studies ( Lukinavičius et al., 2013 ;  Kim et al., 2019 ;  Brown et al., 2013 ), the signal intensity of Cep152 was attenuated by Cep63 depletion (25.8%) and vice versa (66.4%;  Fig. 6 D ).	 Moreover as reported in previous studies   Lukinavičius et al 2013 ;  Kim et al 2019 ;  Brown et al 2013   the signal intensity of Cep152 was attenuated by [GENE] [EXPE]  258%  and vice versa  664%;  Fig 6 D   
2021	PMC7836272	cep57	immunostained	HeLa cells were treated with siControl, siCep63, or siCep152 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep63 or siCep152 and [EXPE] with antibodies against [GENE]  green  Cep57L1  red  and Cep192  cyan  
2021	PMC7836272	cep57l1	immunostained	HeLa cells were treated with siControl, siCep63, or siCep152 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep63 or siCep152 and [EXPE] with antibodies against Cep57  green  [GENE]  red  and Cep192  cyan  
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl, siCep63, or siCep152 and immunostained with antibodies against Cep57 (green), Cep57L1 (red), and Cep192 (cyan).	 HeLa cells were treated with siControl siCep63 or siCep152 and [EXPE] with antibodies against Cep57  green  Cep57L1  red  and [GENE]  cyan  
2021	PMC7836272	odf2	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against ODF2 (green), Cep63 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against [GENE]  green  Cep63  red  and GT335  cyan  
2021	PMC7836272	cep63	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against ODF2 (green), Cep63 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against ODF2  green  [GENE]  red  and GT335  cyan  
2021	PMC7836272	gt335	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against ODF2 (green), Cep63 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against ODF2  green  Cep63  red  and [GENE]  cyan  
2021	PMC7836272	odf2	immunostained	HeLa cells were treated with siControl or siCep57/Cep5L1 and immunostained with antibodies against ODF2 (green), Cep152 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep5L1 and [EXPE] with antibodies against [GENE]  green  Cep152  red  and GT335  cyan  
2021	PMC7836272	cep152	immunostained	HeLa cells were treated with siControl or siCep57/Cep5L1 and immunostained with antibodies against ODF2 (green), Cep152 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep5L1 and [EXPE] with antibodies against ODF2  green  [GENE]  red  and GT335  cyan  
2021	PMC7836272	gt335	immunostained	HeLa cells were treated with siControl or siCep57/Cep5L1 and immunostained with antibodies against ODF2 (green), Cep152 (red), and GT335 (cyan).	 HeLa cells were treated with siControl or siCep57/Cep5L1 and [EXPE] with antibodies against ODF2  green  Cep152  red  and [GENE]  cyan  
2021	PMC7836272	cep57	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of [GENE] Cep57L1 Cep63 and Cep152 at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep57l1	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57 [GENE] Cep63 and Cep152 at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep63	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57 Cep57L1 [GENE] and Cep152 at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep152	sirnas	 (D)  Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57, Cep57L1, Cep63, and Cep152 at the old mother centrioles upon the indicated siRNAs ( n  = 50).	   D   Beeswarm plots piled on boxplots represent the normalized signal intensity of Cep57 Cep57L1 Cep63 and [GENE] at the old mother centrioles upon the indicated [EXPE]   n  = 50  
2021	PMC7836272	cep57	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of [GENE] and Cep57L1 did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep57l1	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of Cep57 and [GENE] did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57/Cep57L1 for 96 h and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siCep57/Cep57L1 for 96 h and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57l1	depletion	Note that depletion of Cep57L1 for 96 h slightly reduced the number of centrioles.	 Note that [EXPE] of [GENE] for 96 h slightly reduced the number of centrioles 
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green) and CP110 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  and [GENE]  red  
2021	PMC7836272	cep57	depletion	Single depletion of Cep57 caused precocious centriole disengagement only in mitosis, but not in interphase (pattern 2;  Fig. 8, A and B ).	 Single [EXPE] of [GENE] caused precocious centriole disengagement only in mitosis but not in interphase  pattern 2;  Fig 8 A and B   
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siControl, siCep57, siCep57L1, or siCep57/Cep57L1 and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siControl siCep57 siCep57L1 or siCep57/Cep57L1 and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of [GENE] and Cep57L1 did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep57l1	suppress	This result suggests that codepletion of Cep57 and Cep57L1 did not suppress the initial recruitment of HsSAS-6 to the centriole.	 This result suggests that codepletion of Cep57 and [GENE] did not [EXPE] the initial recruitment of HsSAS-6 to the centriole 
2021	PMC7836272	cep192	immunostained	HeLa cells were treated with siCep57/Cep57L1 for 96 h and immunostained with antibodies against centrin (green) and Cep192 (red).	 HeLa cells were treated with siCep57/Cep57L1 for 96 h and [EXPE] with antibodies against centrin  green  and [GENE]  red  
2021	PMC7836272	cep57l1	depletion	Note that depletion of Cep57L1 for 96 h slightly reduced the number of centrioles.	 Note that [EXPE] of [GENE] for 96 h slightly reduced the number of centrioles 
2021	PMC7836272	cp110	immunostained	HeLa cells were treated with siControl or siCep57/Cep57L1 and immunostained with antibodies against HsSAS-6 (green) and CP110 (red).	 HeLa cells were treated with siControl or siCep57/Cep57L1 and [EXPE] with antibodies against HsSAS-6  green  and [GENE]  red  
2019	PMC6389942	cep57	blast	To determine whether Cep57 is a conserved factor across species, we first performed BLAST analysis.	 To determine whether [GENE] is a conserved factor across species we first performed [EXPE] analysis 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were [EXPE] with antibodies against [GENE]  red  and GT335  green  and observed by STED microscopy 
2019	PMC6389942	cep57	sted	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against [GENE]  red  and GT335  green  and observed by [EXPE] microscopy 
2019	PMC6389942	cep57	microscopy	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against [GENE]  red  and GT335  green  and observed by STED [EXPE] 
2019	PMC6389942	gt335	immunostained	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were [EXPE] with antibodies against Cep57  red  and [GENE]  green  and observed by STED microscopy 
2019	PMC6389942	gt335	sted	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against Cep57  red  and [GENE]  green  and observed by [EXPE] microscopy 
2019	PMC6389942	gt335	microscopy	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against Cep57  red  and [GENE]  green  and observed by STED [EXPE] 
2019	PMC6389942	cep57	sted	 d  STED images representing top views of Cep57 and Cep192 at mother centrioles.	  d  [EXPE] images representing top views of [GENE] and Cep192 at mother centrioles 
2019	PMC6389942	cep192	sted	 d  STED images representing top views of Cep57 and Cep192 at mother centrioles.	  d  [EXPE] images representing top views of Cep57 and [GENE] at mother centrioles 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 and centrin-2.	 HeLa cells were [EXPE] with antibodies against [GENE] and centrin-2 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 and PCNT.	 HeLa cells were [EXPE] with antibodies against [GENE] and PCNT 
2019	PMC6389942	pcnt	immunostained	HeLa cells were immunostained with antibodies against Cep57 and PCNT.	 HeLa cells were [EXPE] with antibodies against Cep57 and [GENE] 
2019	PMC6389942	cep192	transfection	 i  HeLa cells co-expressing HA empty (control), HA-Cep57, or the indicated HA-Cep57 deletion mutants (1 μg) and Histone 2B-RFP (transfection control, 10 ng) were immunostained with antibodies against HA (green), Cep192 (cyan) and RFP (red).	  i  HeLa cells co-expressing HA empty  control  HA-Cep57 or the indicated HA-Cep57 deletion mutants  1 μg  and Histone 2B-RFP  [EXPE] control 10 ng  were immunostained with antibodies against HA  green  [GENE]  cyan  and RFP  red  
2019	PMC6389942	cep192	immunostained	 i  HeLa cells co-expressing HA empty (control), HA-Cep57, or the indicated HA-Cep57 deletion mutants (1 μg) and Histone 2B-RFP (transfection control, 10 ng) were immunostained with antibodies against HA (green), Cep192 (cyan) and RFP (red).	  i  HeLa cells co-expressing HA empty  control  HA-Cep57 or the indicated HA-Cep57 deletion mutants  1 μg  and Histone 2B-RFP  transfection control 10 ng  were [EXPE] with antibodies against HA  green  [GENE]  cyan  and RFP  red  
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were [EXPE] with antibodies against [GENE]  red  and GT335  green  and observed by STED microscopy 
2019	PMC6389942	cep57	sted	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against [GENE]  red  and GT335  green  and observed by [EXPE] microscopy 
2019	PMC6389942	cep57	microscopy	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against [GENE]  red  and GT335  green  and observed by STED [EXPE] 
2019	PMC6389942	gt335	immunostained	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were [EXPE] with antibodies against Cep57  red  and [GENE]  green  and observed by STED microscopy 
2019	PMC6389942	gt335	sted	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against Cep57  red  and [GENE]  green  and observed by [EXPE] microscopy 
2019	PMC6389942	gt335	microscopy	HeLa cells were immunostained with antibodies against Cep57 (red) and GT335 (green) and observed by STED microscopy.	 HeLa cells were immunostained with antibodies against Cep57  red  and [GENE]  green  and observed by STED [EXPE] 
2019	PMC6389942	cep57	sted	 d  STED images representing top views of Cep57 and Cep192 at mother centrioles.	  d  [EXPE] images representing top views of [GENE] and Cep192 at mother centrioles 
2019	PMC6389942	cep192	sted	 d  STED images representing top views of Cep57 and Cep192 at mother centrioles.	  d  [EXPE] images representing top views of Cep57 and [GENE] at mother centrioles 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 and centrin-2.	 HeLa cells were [EXPE] with antibodies against [GENE] and centrin-2 
2019	PMC6389942	cep57	immunostained	HeLa cells were immunostained with antibodies against Cep57 and PCNT.	 HeLa cells were [EXPE] with antibodies against [GENE] and PCNT 
2019	PMC6389942	pcnt	immunostained	HeLa cells were immunostained with antibodies against Cep57 and PCNT.	 HeLa cells were [EXPE] with antibodies against Cep57 and [GENE] 
2019	PMC6389942	cep192	transfection	 i  HeLa cells co-expressing HA empty (control), HA-Cep57, or the indicated HA-Cep57 deletion mutants (1 μg) and Histone 2B-RFP (transfection control, 10 ng) were immunostained with antibodies against HA (green), Cep192 (cyan) and RFP (red).	  i  HeLa cells co-expressing HA empty  control  HA-Cep57 or the indicated HA-Cep57 deletion mutants  1 μg  and Histone 2B-RFP  [EXPE] control 10 ng  were immunostained with antibodies against HA  green  [GENE]  cyan  and RFP  red  
2019	PMC6389942	cep192	immunostained	 i  HeLa cells co-expressing HA empty (control), HA-Cep57, or the indicated HA-Cep57 deletion mutants (1 μg) and Histone 2B-RFP (transfection control, 10 ng) were immunostained with antibodies against HA (green), Cep192 (cyan) and RFP (red).	  i  HeLa cells co-expressing HA empty  control  HA-Cep57 or the indicated HA-Cep57 deletion mutants  1 μg  and Histone 2B-RFP  transfection control 10 ng  were [EXPE] with antibodies against HA  green  [GENE]  cyan  and RFP  red  
2019	PMC6389942	cep57	immunofluorescence	Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an [EXPE] analysis with HeLa cells by using stimulated emission depletion  STED  microscopy 
2019	PMC6389942	cep57	depletion	Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an immunofluorescence analysis with HeLa cells by using stimulated emission [EXPE]  STED  microscopy 
2019	PMC6389942	cep57	sted	Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion  [EXPE]  microscopy 
2019	PMC6389942	cep57	microscopy	Next, to investigate the precise distribution of Cep57 at centrosomes across the cell cycle, we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion (STED) microscopy.	 Next to investigate the precise distribution of [GENE] at centrosomes across the cell cycle we performed an immunofluorescence analysis with HeLa cells by using stimulated emission depletion  STED  [EXPE] 
2019	PMC6389942	cep57	sted	STED analysis revealed that Cep57 formed ring-like structures around the proximal end of the mother centriole wall across the cell cycle (Fig.  1c ).	 [EXPE] analysis revealed that [GENE] formed ring-like structures around the proximal end of the mother centriole wall across the cell cycle  Fig  1c   
2019	PMC6389942	cep57	overexpressed	We also noted that overexpressed Cep57 occasionally localized to the filamentous microtubule network around the nucleus, which is consistent with previous reports 23 , 24  (Supplementary Fig.  1e ).	 We also noted that [EXPE] [GENE] occasionally localized to the filamentous microtubule network around the nucleus which is consistent with previous reports 23  24   Supplementary Fig  1e   
2019	PMC6389942	cep57	depleted	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of [GENE] we next [EXPE] endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	interfering	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of [GENE] we next depleted endogenous Cep57 using short [EXPE] RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	sirnas	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of [GENE] we next depleted endogenous Cep57 using short interfering RNAs  [EXPE]  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	depletion	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of [GENE] we next depleted endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that [EXPE] of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	depleted	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next [EXPE] endogenous [GENE] using short interfering RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	interfering	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next depleted endogenous [GENE] using short [EXPE] RNAs  siRNAs  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	sirnas	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next depleted endogenous [GENE] using short interfering RNAs  [EXPE]  in HeLa cells and found that depletion of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	depletion	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next depleted endogenous [GENE] using short interfering RNAs  siRNAs  in HeLa cells and found that [EXPE] of Cep57 caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	depleted	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next [EXPE] endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that depletion of [GENE] caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	interfering	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next depleted endogenous Cep57 using short [EXPE] RNAs  siRNAs  in HeLa cells and found that depletion of [GENE] caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	sirnas	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next depleted endogenous Cep57 using short interfering RNAs  [EXPE]  in HeLa cells and found that depletion of [GENE] caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	depletion	To investigate the function of Cep57, we next depleted endogenous Cep57 using short interfering RNAs (siRNAs) in HeLa cells, and found that depletion of Cep57 caused PCM disorganization (74.7 ± 3.8%, from three experiments) and precocious centriole disengagement (68.7 ± 2.5%, from three experiments) in mitotic cells (Fig.  2a–c ).	 To investigate the function of Cep57 we next depleted endogenous Cep57 using short interfering RNAs  siRNAs  in HeLa cells and found that [EXPE] of [GENE] caused PCM disorganization  747 ± 38% from three experiments  and precocious centriole disengagement  687 ± 25% from three experiments  in mitotic cells  Fig  2a–c   
2019	PMC6389942	cep57	depletion	In contrast, depletion of Cep57 did not lead to any defects in centriolar recruitment of Cep152, centriole duplication, and PCM organization in interphase cells (Supplementary Fig.  2a–c ).	 In contrast [EXPE] of [GENE] did not lead to any defects in centriolar recruitment of Cep152 centriole duplication and PCM organization in interphase cells  Supplementary Fig  2a–c   
2019	PMC6389942	cep152	depletion	In contrast, depletion of Cep57 did not lead to any defects in centriolar recruitment of Cep152, centriole duplication, and PCM organization in interphase cells (Supplementary Fig.  2a–c ).	 In contrast [EXPE] of Cep57 did not lead to any defects in centriolar recruitment of [GENE] centriole duplication and PCM organization in interphase cells  Supplementary Fig  2a–c   
2019	PMC6389942	odf2	staining	To ensure the two centrioles seen at the poles are the mother and daughter centriole pair, we tested ODF2 staining which marks mother centrioles and found a single ODF2-positive focus out of two separate centrioles at a spindle pole in Cep57-depleted cells (Supplementary Fig.  2d ).	 To ensure the two centrioles seen at the poles are the mother and daughter centriole pair we tested [GENE] [EXPE] which marks mother centrioles and found a single ODF2-positive focus out of two separate centrioles at a spindle pole in Cep57-depleted cells  Supplementary Fig  2d   
2019	PMC6389942	cep57	sirnas	The same mitotic defects were observed in different human cell lines (Supplementary Fig.  2e ) or when using siRNAs targeting different sequences of Cep57 ORF (Supplementary Fig.  2f ).	 The same mitotic defects were observed in different human cell lines  Supplementary Fig  2e   or when using [EXPE] targeting different sequences of [GENE] ORF  Supplementary Fig  2f   
2019	PMC6389942	cep57	sirna	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig.  2g ).	 The efficacy of [GENE] [EXPE] was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57  Supplementary Fig  2g   
2019	PMC6389942	cep57	immunofluorescence	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig.  2g ).	 The efficacy of [GENE] siRNA was confirmed using [EXPE] analysis with specific antibodies against endogenous Cep57  Supplementary Fig  2g   
2019	PMC6389942	cep57	sirna	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig.  2g ).	 The efficacy of Cep57 [EXPE] was confirmed using immunofluorescence analysis with specific antibodies against endogenous [GENE]  Supplementary Fig  2g   
2019	PMC6389942	cep57	immunofluorescence	The efficacy of Cep57 siRNA was confirmed using immunofluorescence analysis with specific antibodies against endogenous Cep57 (Supplementary Fig.  2g ).	 The efficacy of Cep57 siRNA was confirmed using [EXPE] analysis with specific antibodies against endogenous [GENE]  Supplementary Fig  2g   
2019	PMC6389942	cep57	rescued	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig.  3a, b ).	 Furthermore these defects were [EXPE] by expressing RNAi-resistant full-length [GENE] constructs indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA  Supplementary Fig  3a b   
2019	PMC6389942	cep57	rnai-resistant	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig.  3a, b ).	 Furthermore these defects were rescued by expressing [EXPE] full-length [GENE] constructs indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA  Supplementary Fig  3a b   
2019	PMC6389942	cep57	sirna	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig.  3a, b ).	 Furthermore these defects were rescued by expressing RNAi-resistant full-length [GENE] constructs indicating that the phenotypes observed were not due to the off-target effects of Cep57 [EXPE]  Supplementary Fig  3a b   
2019	PMC6389942	cep57	rescued	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig.  3a, b ).	 Furthermore these defects were [EXPE] by expressing RNAi-resistant full-length Cep57 constructs indicating that the phenotypes observed were not due to the off-target effects of [GENE] siRNA  Supplementary Fig  3a b   
2019	PMC6389942	cep57	rnai-resistant	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig.  3a, b ).	 Furthermore these defects were rescued by expressing [EXPE] full-length Cep57 constructs indicating that the phenotypes observed were not due to the off-target effects of [GENE] siRNA  Supplementary Fig  3a b   
2019	PMC6389942	cep57	sirna	Furthermore, these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs, indicating that the phenotypes observed were not due to the off-target effects of Cep57 siRNA (Supplementary Fig.  3a, b ).	 Furthermore these defects were rescued by expressing RNAi-resistant full-length Cep57 constructs indicating that the phenotypes observed were not due to the off-target effects of [GENE] [EXPE]  Supplementary Fig  3a b   
2019	PMC6389942	cep57	depletion	To further confirm the phenotypes upon depletion of Cep57, we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1.	 To further confirm the phenotypes upon [EXPE] of [GENE] we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1 
2019	PMC6389942	cep57	live imaging	To further confirm the phenotypes upon depletion of Cep57, we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1.	 To further confirm the phenotypes upon depletion of [GENE] we also performed a [EXPE] of HeLa cells stably expressing GFP-centrin-1 
2019	PMC6389942	cep57	imaging	To further confirm the phenotypes upon depletion of Cep57, we also performed a live imaging of HeLa cells stably expressing GFP-centrin-1.	 To further confirm the phenotypes upon depletion of [GENE] we also performed a live [EXPE] of HeLa cells stably expressing GFP-centrin-1 
2019	PMC6389942	cep57	depletion	These data suggest that Cep57 is critical for PCM integrity and centriole engagement, and also that ectopic MTOC activity of disengaged daughter centrioles, provoked by Cep57 depletion, may be deleterious to cells.	 These data suggest that [GENE] is critical for PCM integrity and centriole engagement and also that ectopic MTOC activity of disengaged daughter centrioles provoked by Cep57 [EXPE] may be deleterious to cells 
2019	PMC6389942	cep57	depletion	These data suggest that Cep57 is critical for PCM integrity and centriole engagement, and also that ectopic MTOC activity of disengaged daughter centrioles, provoked by Cep57 depletion, may be deleterious to cells.	 These data suggest that Cep57 is critical for PCM integrity and centriole engagement and also that ectopic MTOC activity of disengaged daughter centrioles provoked by [GENE] [EXPE] may be deleterious to cells 
2019	PMC6389942	cep192	immunostained	 a  HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against centrin-2 (green) and Cep192 (red).	  a  HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against centrin-2  green  and [GENE]  red  
2019	PMC6389942	cep57	knockdown	 b  Schematic model of the phenotype of Cep57 knockdown observed in  a .	  b  Schematic model of the phenotype of [GENE] [EXPE] observed in  a  
2019	PMC6389942	cep57	depletion	Depletion of Cep57 led to PCM disorganization and precocious centriole disengagement.	 [EXPE] of [GENE] led to PCM disorganization and precocious centriole disengagement 
2019	PMC6389942	cep57	time-lapse	 d  Time-lapse observation of cells upon Cep57 depletion.	  d  [EXPE] observation of cells upon [GENE] depletion 
2019	PMC6389942	cep57	depletion	 d  Time-lapse observation of cells upon Cep57 depletion.	  d  Time-lapse observation of cells upon [GENE] [EXPE] 
2019	PMC6389942	cp110	immunostained	HeLa cells were immunostained with antibodies against α-Tubulin (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against α-Tubulin  green  and [GENE]  red  
2019	PMC6389942	cep57	knockdown	 i  Schematic illustration of the phenotype of Cep57 knockdown observed in  g  and  h .	  i  Schematic illustration of the phenotype of [GENE] [EXPE] observed in  g  and  h  
2019	PMC6389942	cep192	immunostained	 a  HeLa cells were treated with siControl or siCep57 and immunostained with antibodies against centrin-2 (green) and Cep192 (red).	  a  HeLa cells were treated with siControl or siCep57 and [EXPE] with antibodies against centrin-2  green  and [GENE]  red  
2019	PMC6389942	cep57	knockdown	 b  Schematic model of the phenotype of Cep57 knockdown observed in  a .	  b  Schematic model of the phenotype of [GENE] [EXPE] observed in  a  
2019	PMC6389942	cep57	depletion	Depletion of Cep57 led to PCM disorganization and precocious centriole disengagement.	 [EXPE] of [GENE] led to PCM disorganization and precocious centriole disengagement 
2019	PMC6389942	cep57	time-lapse	 d  Time-lapse observation of cells upon Cep57 depletion.	  d  [EXPE] observation of cells upon [GENE] depletion 
2019	PMC6389942	cep57	depletion	 d  Time-lapse observation of cells upon Cep57 depletion.	  d  Time-lapse observation of cells upon [GENE] [EXPE] 
2019	PMC6389942	cp110	immunostained	HeLa cells were immunostained with antibodies against α-Tubulin (green) and CP110 (red).	 HeLa cells were [EXPE] with antibodies against α-Tubulin  green  and [GENE]  red  
2019	PMC6389942	cep57	knockdown	 i  Schematic illustration of the phenotype of Cep57 knockdown observed in  g  and  h .	  i  Schematic illustration of the phenotype of [GENE] [EXPE] observed in  g  and  h  
2019	PMC6389942	cep57	depletion	Given the above, we next examined the impact of Cep57 depletion on chromosome segregation in HeLa cells.	 Given the above we next examined the impact of [GENE] [EXPE] on chromosome segregation in HeLa cells 
2019	PMC6389942	cep57	depletion	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig.  4c ).	 Moreover chromosome misalignment one of the major defects provoked by [GENE] [EXPE] was efficiently rescued by the expression of Cep57  Supplementary Fig  4c   
2019	PMC6389942	cep57	rescued	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig.  4c ).	 Moreover chromosome misalignment one of the major defects provoked by [GENE] depletion was efficiently [EXPE] by the expression of Cep57  Supplementary Fig  4c   
2019	PMC6389942	cep57	depletion	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig.  4c ).	 Moreover chromosome misalignment one of the major defects provoked by Cep57 [EXPE] was efficiently rescued by the expression of [GENE]  Supplementary Fig  4c   
2019	PMC6389942	cep57	rescued	Moreover, chromosome misalignment, one of the major defects provoked by Cep57 depletion, was efficiently rescued by the expression of Cep57 (Supplementary Fig.  4c ).	 Moreover chromosome misalignment one of the major defects provoked by Cep57 depletion was efficiently [EXPE] by the expression of [GENE]  Supplementary Fig  4c   
2019	PMC6389942	cep57	depletion	Fig. 3 Depletion of Cep57 or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy.	 Fig 3 [EXPE] of [GENE] or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Fig. 3 Depletion of Cep57 or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy.	 Fig 3 [EXPE] of Cep57 or  [GENE]  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy 
2019	PMC6389942	cep192	immunostained	MVA patients’ lymphoblastoid cell lines (LCLs) and their mother’s LCL (unaffected control) were immunostained with antibodies against centrin-2 (green) and Cep192 (red).	 MVA patients’ lymphoblastoid cell lines  LCLs  and their mother’s LCL  unaffected control  were [EXPE] with antibodies against centrin-2  green  and [GENE]  red  
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy.	 [EXPE] of [GENE] or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy.	 [EXPE] of Cep57 or  [GENE]  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy.	 [EXPE] of [GENE] or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy.	 [EXPE] of Cep57 or  [GENE]  mutations in MVA disease patients cause chromosome segregation errors and aneuploidy 
2019	PMC6389942	cep192	immunostained	MVA patients’ lymphoblastoid cell lines (LCLs) and their mother’s LCL (unaffected control) were immunostained with antibodies against centrin-2 (green) and Cep192 (red).	 MVA patients’ lymphoblastoid cell lines  LCLs  and their mother’s LCL  unaffected control  were [EXPE] with antibodies against centrin-2  green  and [GENE]  red  
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy.	 [EXPE] of [GENE] or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	Depletion of Cep57 or  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy.	 [EXPE] of Cep57 or  [GENE]  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement and thereby result in chromosomal segregation errors and aneuploidy 
2019	PMC6389942	cep57	depletion	A previous report showed that kinetochore-localized Cep57 is involved in spindle assembly checkpoint (SAC) and also that depletion of Cep57 causes an impairment of SAC function, and resulting premature onset of anaphase 21 .	 A previous report showed that kinetochore-localized [GENE] is involved in spindle assembly checkpoint  SAC  and also that [EXPE] of Cep57 causes an impairment of SAC function and resulting premature onset of anaphase 21  
2019	PMC6389942	cep57	depletion	A previous report showed that kinetochore-localized Cep57 is involved in spindle assembly checkpoint (SAC) and also that depletion of Cep57 causes an impairment of SAC function, and resulting premature onset of anaphase 21 .	 A previous report showed that kinetochore-localized Cep57 is involved in spindle assembly checkpoint  SAC  and also that [EXPE] of [GENE] causes an impairment of SAC function and resulting premature onset of anaphase 21  
2019	PMC6389942	cep57	depletion	To judge whether such SAC impairment could cause chromosomal segregation errors, we quantified the time from nuclear envelope breakdown to anaphase onset (AO) upon depletion of Cep57.	 To judge whether such SAC impairment could cause chromosomal segregation errors we quantified the time from nuclear envelope breakdown to anaphase onset  AO  upon [EXPE] of [GENE] 
2019	PMC6389942	cep57	depletion	We found that depletion of Cep57 did not decrease mitotic duration, compared to the control cells, whereas depletion of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration (Supplementary Fig.  4f ).	 We found that [EXPE] of [GENE] did not decrease mitotic duration compared to the control cells whereas depletion of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration  Supplementary Fig  4f   
2019	PMC6389942	cep57	depletion	We found that depletion of Cep57 did not decrease mitotic duration, compared to the control cells, whereas depletion of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration (Supplementary Fig.  4f ).	 We found that depletion of [GENE] did not decrease mitotic duration compared to the control cells whereas [EXPE] of Mad2 bypassed the SAC pathway and significantly shortened mitotic duration  Supplementary Fig  4f   
2019	PMC6389942	cep57	depletion	Moreover, depletion of Cep57 did not reduce the kinetochore signal of Mad1 in HeLa cells treated with nocodazole and MG132 (Supplementary Fig.  4g, h ).	 Moreover [EXPE] of [GENE] did not reduce the kinetochore signal of Mad1 in HeLa cells treated with nocodazole and MG132  Supplementary Fig  4g h   
2019	PMC6389942	cep57	depletion	We therefore reasoned that chromosomal segregation errors caused by Cep57 depletion in this condition are due to precocious centriole disengagement and PCM disorganization, rather than reduced SAC signaling.	 We therefore reasoned that chromosomal segregation errors caused by [GENE] [EXPE] in this condition are due to precocious centriole disengagement and PCM disorganization rather than reduced SAC signaling 
2019	PMC6389942	cep57	depletion	Overall, these findings strongly suggest that both Cep57 depletion and  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis, which results in chromosomal segregation errors and aneuploidy (Fig.  3i ).	 Overall these findings strongly suggest that both [GENE] [EXPE] and  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis which results in chromosomal segregation errors and aneuploidy  Fig  3i   
2019	PMC6389942	cep57	depletion	Overall, these findings strongly suggest that both Cep57 depletion and  cep57  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis, which results in chromosomal segregation errors and aneuploidy (Fig.  3i ).	 Overall these findings strongly suggest that both Cep57 [EXPE] and  [GENE]  mutations in MVA patients cause PCM disorganization and precocious centriole disengagement in mitosis which results in chromosomal segregation errors and aneuploidy  Fig  3i   
2019	PMC6389942	pcnt	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig.  6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of [GENE] a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig  6a b   we examined whether Cep57 physically interacts with PCNT 
2019	PMC6389942	separase	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig.  6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by [GENE] is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig  6a b   we examined whether Cep57 physically interacts with PCNT 
2019	PMC6389942	pcnt	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig.  6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of [GENE] only caused precocious centriole disengagement in early mitosis  Supplementary Fig  6a b   we examined whether Cep57 physically interacts with PCNT 
2019	PMC6389942	cep57	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig.  6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig  6a b   we examined whether [GENE] physically interacts with PCNT 
2019	PMC6389942	pcnt	depletion	Given that the cleavage of PCNT, a major PCM component, by separase is required for mitotic centriole disengagement 9 , 10 , and also the fact that, among major PCM components that we tested, depletion of PCNT only caused precocious centriole disengagement in early mitosis (Supplementary Fig.  6a, b ), we examined whether Cep57 physically interacts with PCNT.	 Given that the cleavage of PCNT a major PCM component by separase is required for mitotic centriole disengagement 9  10  and also the fact that among major PCM components that we tested [EXPE] of PCNT only caused precocious centriole disengagement in early mitosis  Supplementary Fig  6a b   we examined whether Cep57 physically interacts with [GENE] 
2019	PMC6389942	cep57	co-ip	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using [EXPE] assay with deletion constructs of [GENE] we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	cep57	assay	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using co-IP [EXPE] with deletion constructs of [GENE] we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	cep57	co-ip	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using [EXPE] assay with deletion constructs of Cep57 we narrowed down the [GENE] region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	cep57	assay	Using co-IP assay with deletion constructs of Cep57, we narrowed down the Cep57 region required for PCNT-binding to the short stretch spanning a.a.	 Using co-IP [EXPE] with deletion constructs of Cep57 we narrowed down the [GENE] region required for PCNT-binding to the short stretch spanning aa 
2019	PMC6389942	pcnt	co-ip	First, by using co-IP analyses with PCNT truncate mutants, we found	 First by using [EXPE] analyses with [GENE] truncate mutants we found 
2019	PMC6389942	akap9	co-ip	Co-IP analysis with the AKAP9 C-terminus (a.a.	 [EXPE] analysis with the [GENE] C-terminus  aa 
2019	PMC6389942	cep57	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially [EXPE] recombinant proteins we purified [GENE] and PCNT fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	cep57	recombinant	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified [EXPE] proteins we purified [GENE] and PCNT fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	cep57	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we [EXPE] [GENE] and PCNT fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	cep57	co-ip	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we purified [GENE] and PCNT fragments containing the interaction regions that were identified by [EXPE] experiments 
2019	PMC6389942	pcnt	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially [EXPE] recombinant proteins we purified Cep57 and [GENE] fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	pcnt	recombinant	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified [EXPE] proteins we purified Cep57 and [GENE] fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	pcnt	purified	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we [EXPE] Cep57 and [GENE] fragments containing the interaction regions that were identified by co-IP experiments 
2019	PMC6389942	pcnt	co-ip	Second, to confirm the interaction in vitro with the bacterially purified recombinant proteins, we purified Cep57 and PCNT fragments containing the interaction regions that were identified by co-IP experiments.	 Second to confirm the interaction in vitro with the bacterially purified recombinant proteins we purified Cep57 and [GENE] fragments containing the interaction regions that were identified by [EXPE] experiments 
2019	PMC6389942	cep57	pull-down	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig.  4f , Supplementary Fig.  6d ).	 We demonstrated that the two proteins interacted with each other by [EXPE] assays suggesting the physical association between [GENE] and PCNT  Fig  4f  Supplementary Fig  6d   
2019	PMC6389942	cep57	assays	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig.  4f , Supplementary Fig.  6d ).	 We demonstrated that the two proteins interacted with each other by pull-down [EXPE] suggesting the physical association between [GENE] and PCNT  Fig  4f  Supplementary Fig  6d   
2019	PMC6389942	pcnt	pull-down	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig.  4f , Supplementary Fig.  6d ).	 We demonstrated that the two proteins interacted with each other by [EXPE] assays suggesting the physical association between Cep57 and [GENE]  Fig  4f  Supplementary Fig  6d   
2019	PMC6389942	pcnt	assays	We demonstrated that the two proteins interacted with each other by pull-down assays, suggesting the physical association between Cep57 and PCNT (Fig.  4f , Supplementary Fig.  6d ).	 We demonstrated that the two proteins interacted with each other by pull-down [EXPE] suggesting the physical association between Cep57 and [GENE]  Fig  4f  Supplementary Fig  6d   
2019	PMC6389942	pcnt	recombinant	We noted that the C-terminus PCNT recombinant protein lacking the region of a.a.	 We noted that the C-terminus [GENE] [EXPE] protein lacking the region of aa 
2019	PMC6389942	cep57	pull-down	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig.  6e ).	 [EXPE] assays also showed the direct interaction between [GENE] and AKAP9  Supplementary Fig  6e   
2019	PMC6389942	cep57	assays	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig.  6e ).	 Pull-down [EXPE] also showed the direct interaction between [GENE] and AKAP9  Supplementary Fig  6e   
2019	PMC6389942	akap9	pull-down	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig.  6e ).	 [EXPE] assays also showed the direct interaction between Cep57 and [GENE]  Supplementary Fig  6e   
2019	PMC6389942	akap9	assays	Pull-down assays also showed the direct interaction between Cep57 and AKAP9 (Supplementary Fig.  6e ).	 Pull-down [EXPE] also showed the direct interaction between Cep57 and [GENE]  Supplementary Fig  6e   
2019	PMC6389942	cep57	co-expressed	Third, to test whether Cep57 is a target of the PACT domain, we co-expressed HA-Cep57 and the GFP-PCNT C-terminus (a.a. 3113–3336) containing the PACT domain in human cells.	 Third to test whether [GENE] is a target of the PACT domain we [EXPE] HA-Cep57 and the GFP-PCNT C-terminus  aa 3113–3336  containing the PACT domain in human cells 
2019	PMC6389942	cep57	co-expressed	In contrast, when the GFP-PCNT C-terminus was co-expressed with HA-Cep57, GFP-PCNT C-terminus co-localized with overexpressed Cep57 on microtubules as well as at centrioles (Fig.  4g ).	 In contrast when the GFP-PCNT C-terminus was [EXPE] with HA-Cep57 GFP-PCNT C-terminus co-localized with overexpressed [GENE] on microtubules as well as at centrioles  Fig  4g   
2019	PMC6389942	cep57	overexpressed	In contrast, when the GFP-PCNT C-terminus was co-expressed with HA-Cep57, GFP-PCNT C-terminus co-localized with overexpressed Cep57 on microtubules as well as at centrioles (Fig.  4g ).	 In contrast when the GFP-PCNT C-terminus was co-expressed with HA-Cep57 GFP-PCNT C-terminus co-localized with [EXPE] [GENE] on microtubules as well as at centrioles  Fig  4g   
2019	PMC6389942	pcnt	overexpressed	These data suggest that the PCNT PACT domain is loaded onto microtubules due to its binding to overexpressed Cep57 that ectopically localizes to the microtubule network.	 These data suggest that the [GENE] PACT domain is loaded onto microtubules due to its binding to [EXPE] Cep57 that ectopically localizes to the microtubule network 
2019	PMC6389942	cep57	overexpressed	These data suggest that the PCNT PACT domain is loaded onto microtubules due to its binding to overexpressed Cep57 that ectopically localizes to the microtubule network.	 These data suggest that the PCNT PACT domain is loaded onto microtubules due to its binding to [EXPE] [GENE] that ectopically localizes to the microtubule network 
2019	PMC6389942	cep57	overexpressed	3643–3907) also co-localized with overexpressed Cep57 on microtubules (Fig.  4g ).	 3643–3907  also co-localized with [EXPE] [GENE] on microtubules  Fig  4g   
2019	PMC6389942	cep57	sted	Finally, we performed STED analysis to precisely test the co-localization of Cep57 and PCNT around centrioles.	 Finally we performed [EXPE] analysis to precisely test the co-localization of [GENE] and PCNT around centrioles 
2019	PMC6389942	pcnt	sted	Finally, we performed STED analysis to precisely test the co-localization of Cep57 and PCNT around centrioles.	 Finally we performed [EXPE] analysis to precisely test the co-localization of Cep57 and [GENE] around centrioles 
2019	PMC6389942	pcnt	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig.  6g ).	 [EXPE] analysis with N- and C-terminal [GENE] antibodies showed that Cep57 co-localized with the C-terminus of PCNT but not with the N-terminus of PCNT in interphase  Supplementary Fig  6g   
2019	PMC6389942	cep57	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig.  6g ).	 [EXPE] analysis with N- and C-terminal PCNT antibodies showed that [GENE] co-localized with the C-terminus of PCNT but not with the N-terminus of PCNT in interphase  Supplementary Fig  6g   
2019	PMC6389942	pcnt	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig.  6g ).	 [EXPE] analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of [GENE] but not with the N-terminus of PCNT in interphase  Supplementary Fig  6g   
2019	PMC6389942	pcnt	sted	STED analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT, but not with the N-terminus of PCNT in interphase (Supplementary Fig.  6g ).	 [EXPE] analysis with N- and C-terminal PCNT antibodies showed that Cep57 co-localized with the C-terminus of PCNT but not with the N-terminus of [GENE] in interphase  Supplementary Fig  6g   
2019	PMC6389942	cep57	co-ip	 a  Schematic of Cep57 and the deletion mutants used for co-IP assays.	  a  Schematic of [GENE] and the deletion mutants used for [EXPE] assays 
2019	PMC6389942	cep57	assays	 a  Schematic of Cep57 and the deletion mutants used for co-IP assays.	  a  Schematic of [GENE] and the deletion mutants used for co-IP [EXPE] 
2019	PMC6389942	pcnt	co-ip	 d  Schematic of PCNT and the deletion mutants used for co-IP assays.	  d  Schematic of [GENE] and the deletion mutants used for [EXPE] assays 
2019	PMC6389942	pcnt	assays	 d  Schematic of PCNT and the deletion mutants used for co-IP assays.	  d  Schematic of [GENE] and the deletion mutants used for co-IP [EXPE] 
2019	PMC6389942	cep57	pull-down	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP [EXPE] assay showing the interaction between [GENE] and PCNT fragments in vitro 
2019	PMC6389942	cep57	assay	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP pull-down [EXPE] showing the interaction between [GENE] and PCNT fragments in vitro 
2019	PMC6389942	pcnt	pull-down	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP [EXPE] assay showing the interaction between Cep57 and [GENE] fragments in vitro 
2019	PMC6389942	pcnt	assay	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP pull-down [EXPE] showing the interaction between Cep57 and [GENE] fragments in vitro 
2019	PMC6389942	cep57	immunostained	The cells were immunostained with antibodies against GFP (green), Cep57 (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against GFP  green  [GENE]  red  and Cep192  cyan  
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against GFP (green), Cep57 (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against GFP  green  Cep57  red  and [GENE]  cyan  
2019	PMC6389942	pcnt	co-ip	 a  Schematic of PCNT and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP assays.	  a  Schematic of [GENE] and the ΔPACT mutant or MOPD2 disease-related mutants used for [EXPE] assays 
2019	PMC6389942	pcnt	assays	 a  Schematic of PCNT and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP assays.	  a  Schematic of [GENE] and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP [EXPE] 
2019	PMC6389942	pcnt	transfection	 d  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant (RNAi-R) PCNT or the indicated mutants.	  d  HeLa cells were treated with siControl or siPCNT followed by [EXPE] with FLAG empty  control  RNAi-resistant  RNAi-R  [GENE] or the indicated mutants 
2019	PMC6389942	pcnt	rnai-resistant	 d  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant (RNAi-R) PCNT or the indicated mutants.	  d  HeLa cells were treated with siControl or siPCNT followed by transfection with FLAG empty  control  [EXPE]  RNAi-R  [GENE] or the indicated mutants 
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan) and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  [GENE]  cyan  and CP110  red  
2019	PMC6389942	cp110	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan) and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  Cep192  cyan  and [GENE]  red  
2019	PMC6389942	pcnt	knockdown	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of [GENE] and the PCNT-Cep57 chimera mutant used for PCNT [EXPE] and rescue experiments 
2019	PMC6389942	pcnt	rescue	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of [GENE] and the PCNT-Cep57 chimera mutant used for PCNT knockdown and [EXPE] experiments 
2019	PMC6389942	pcnt	knockdown	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for [GENE] [EXPE] and rescue experiments 
2019	PMC6389942	pcnt	rescue	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for [GENE] knockdown and [EXPE] experiments 
2019	PMC6389942	pcnt	transfection	 g  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant PCNT, or the PCNT-Cep57 chimera mutant.	  g  HeLa cells were treated with siControl or siPCNT followed by [EXPE] with FLAG empty  control  RNAi-resistant [GENE] or the PCNT-Cep57 chimera mutant 
2019	PMC6389942	pcnt	rnai-resistant	 g  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant PCNT, or the PCNT-Cep57 chimera mutant.	  g  HeLa cells were treated with siControl or siPCNT followed by transfection with FLAG empty  control  [EXPE] [GENE] or the PCNT-Cep57 chimera mutant 
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan), and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  [GENE]  cyan  and CP110  red  
2019	PMC6389942	cp110	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan), and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  Cep192  cyan  and [GENE]  red  
2019	PMC6389942	cep57	co-ip	 a  Schematic of Cep57 and the deletion mutants used for co-IP assays.	  a  Schematic of [GENE] and the deletion mutants used for [EXPE] assays 
2019	PMC6389942	cep57	assays	 a  Schematic of Cep57 and the deletion mutants used for co-IP assays.	  a  Schematic of [GENE] and the deletion mutants used for co-IP [EXPE] 
2019	PMC6389942	pcnt	co-ip	 d  Schematic of PCNT and the deletion mutants used for co-IP assays.	  d  Schematic of [GENE] and the deletion mutants used for [EXPE] assays 
2019	PMC6389942	pcnt	assays	 d  Schematic of PCNT and the deletion mutants used for co-IP assays.	  d  Schematic of [GENE] and the deletion mutants used for co-IP [EXPE] 
2019	PMC6389942	cep57	pull-down	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP [EXPE] assay showing the interaction between [GENE] and PCNT fragments in vitro 
2019	PMC6389942	cep57	assay	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP pull-down [EXPE] showing the interaction between [GENE] and PCNT fragments in vitro 
2019	PMC6389942	pcnt	pull-down	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP [EXPE] assay showing the interaction between Cep57 and [GENE] fragments in vitro 
2019	PMC6389942	pcnt	assay	 f  MBP pull-down assay showing the interaction between Cep57 and PCNT fragments in vitro.	  f  MBP pull-down [EXPE] showing the interaction between Cep57 and [GENE] fragments in vitro 
2019	PMC6389942	cep57	immunostained	The cells were immunostained with antibodies against GFP (green), Cep57 (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against GFP  green  [GENE]  red  and Cep192  cyan  
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against GFP (green), Cep57 (red), and Cep192 (cyan).	 The cells were [EXPE] with antibodies against GFP  green  Cep57  red  and [GENE]  cyan  
2019	PMC6389942	pcnt	co-ip	 a  Schematic of PCNT and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP assays.	  a  Schematic of [GENE] and the ΔPACT mutant or MOPD2 disease-related mutants used for [EXPE] assays 
2019	PMC6389942	pcnt	assays	 a  Schematic of PCNT and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP assays.	  a  Schematic of [GENE] and the ΔPACT mutant or MOPD2 disease-related mutants used for co-IP [EXPE] 
2019	PMC6389942	pcnt	transfection	 d  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant (RNAi-R) PCNT or the indicated mutants.	  d  HeLa cells were treated with siControl or siPCNT followed by [EXPE] with FLAG empty  control  RNAi-resistant  RNAi-R  [GENE] or the indicated mutants 
2019	PMC6389942	pcnt	rnai-resistant	 d  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant (RNAi-R) PCNT or the indicated mutants.	  d  HeLa cells were treated with siControl or siPCNT followed by transfection with FLAG empty  control  [EXPE]  RNAi-R  [GENE] or the indicated mutants 
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan) and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  [GENE]  cyan  and CP110  red  
2019	PMC6389942	cp110	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan) and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  Cep192  cyan  and [GENE]  red  
2019	PMC6389942	pcnt	knockdown	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of [GENE] and the PCNT-Cep57 chimera mutant used for PCNT [EXPE] and rescue experiments 
2019	PMC6389942	pcnt	rescue	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of [GENE] and the PCNT-Cep57 chimera mutant used for PCNT knockdown and [EXPE] experiments 
2019	PMC6389942	pcnt	knockdown	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for [GENE] [EXPE] and rescue experiments 
2019	PMC6389942	pcnt	rescue	 f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for PCNT knockdown and rescue experiments.	  f  Schematic of PCNT and the PCNT-Cep57 chimera mutant used for [GENE] knockdown and [EXPE] experiments 
2019	PMC6389942	pcnt	transfection	 g  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant PCNT, or the PCNT-Cep57 chimera mutant.	  g  HeLa cells were treated with siControl or siPCNT followed by [EXPE] with FLAG empty  control  RNAi-resistant [GENE] or the PCNT-Cep57 chimera mutant 
2019	PMC6389942	pcnt	rnai-resistant	 g  HeLa cells were treated with siControl or siPCNT, followed by transfection with FLAG empty (control), RNAi-resistant PCNT, or the PCNT-Cep57 chimera mutant.	  g  HeLa cells were treated with siControl or siPCNT followed by transfection with FLAG empty  control  [EXPE] [GENE] or the PCNT-Cep57 chimera mutant 
2019	PMC6389942	cep192	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan), and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  [GENE]  cyan  and CP110  red  
2019	PMC6389942	cp110	immunostained	The cells were immunostained with antibodies against FLAG (green), Cep192 (cyan), and CP110 (red).	 The cells were [EXPE] with antibodies against FLAG  green  Cep192  cyan  and [GENE]  red  
2019	PMC6389942	cep57	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig.  8a, b ).	 Although we show that [GENE] is the direct interactor of the PACT domain of PCNT Cep57 [EXPE] slightly affected the loading of PCNT in interphase  Supplementary Fig  8a b   
2019	PMC6389942	pcnt	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig.  8a, b ).	 Although we show that Cep57 is the direct interactor of the PACT domain of [GENE] Cep57 [EXPE] slightly affected the loading of PCNT in interphase  Supplementary Fig  8a b   
2019	PMC6389942	cep57	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig.  8a, b ).	 Although we show that Cep57 is the direct interactor of the PACT domain of PCNT [GENE] [EXPE] slightly affected the loading of PCNT in interphase  Supplementary Fig  8a b   
2019	PMC6389942	pcnt	depletion	Although we show that Cep57 is the direct interactor of the PACT domain of PCNT, Cep57 depletion slightly affected the loading of PCNT in interphase (Supplementary Fig.  8a, b ).	 Although we show that Cep57 is the direct interactor of the PACT domain of PCNT Cep57 [EXPE] slightly affected the loading of [GENE] in interphase  Supplementary Fig  8a b   
2019	PMC6389942	cep152	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig.  8d–f ).	 Importantly we found that [GENE] interacted with the C-terminus of PCNT  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase  Supplementary Fig  8d–f   
2019	PMC6389942	pcnt	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig.  8d–f ).	 Importantly we found that Cep152 interacted with the C-terminus of [GENE]  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase  Supplementary Fig  8d–f   
2019	PMC6389942	cep152	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig.  8d–f ).	 Importantly we found that Cep152 interacted with the C-terminus of PCNT  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of [GENE] significantly decreased the centriolar signal intensity of PCNT in interphase  Supplementary Fig  8d–f   
2019	PMC6389942	pcnt	depletion	Importantly, we found that Cep152 interacted with the C-terminus of PCNT (but not with the PACT domain) and also that CRISPR/Cas9-mediated depletion of Cep152 significantly decreased the centriolar signal intensity of PCNT in interphase (Supplementary Fig.  8d–f ).	 Importantly we found that Cep152 interacted with the C-terminus of PCNT  but not with the PACT domain  and also that CRISPR/Cas9-mediated [EXPE] of Cep152 significantly decreased the centriolar signal intensity of [GENE] in interphase  Supplementary Fig  8d–f   
2019	PMC6389942	pcnt	overexpression	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig.  8e, f ).	 [EXPE] of CRISPR/Cas9-resistant GFP-Cep152 restored the [GENE] signal at centrioles in the same condition confirming the specificity of Cep152 guideRNA  Supplementary Fig  8e f   
2019	PMC6389942	pcnt	restored	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig.  8e, f ).	 Overexpression of CRISPR/Cas9-resistant GFP-Cep152 [EXPE] the [GENE] signal at centrioles in the same condition confirming the specificity of Cep152 guideRNA  Supplementary Fig  8e f   
2019	PMC6389942	cep152	overexpression	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig.  8e, f ).	 [EXPE] of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition confirming the specificity of [GENE] guideRNA  Supplementary Fig  8e f   
2019	PMC6389942	cep152	restored	Overexpression of CRISPR/Cas9-resistant GFP-Cep152 restored the PCNT signal at centrioles in the same condition, confirming the specificity of Cep152 guideRNA (Supplementary Fig.  8e, f ).	 Overexpression of CRISPR/Cas9-resistant GFP-Cep152 [EXPE] the PCNT signal at centrioles in the same condition confirming the specificity of [GENE] guideRNA  Supplementary Fig  8e f   
2019	PMC6389942	pcnt	depleted	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we [EXPE] endogenous [GENE] using siRNA and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  PCNT ΔPACT or K3154del  
2019	PMC6389942	pcnt	sirna	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous [GENE] using [EXPE] and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  PCNT ΔPACT or K3154del  
2019	PMC6389942	pcnt	rnai-resistant	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous [GENE] using siRNA and expressed [EXPE]  RNAi-R  full-length or Cep57-binding-deficient mutants  PCNT ΔPACT or K3154del  
2019	PMC6389942	pcnt	depleted	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we [EXPE] endogenous PCNT using siRNA and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  [GENE] ΔPACT or K3154del  
2019	PMC6389942	pcnt	sirna	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous PCNT using [EXPE] and expressed RNAi-resistant  RNAi-R  full-length or Cep57-binding-deficient mutants  [GENE] ΔPACT or K3154del  
2019	PMC6389942	pcnt	rnai-resistant	To this end, we depleted endogenous PCNT using siRNA and expressed RNAi-resistant (RNAi-R) full-length or Cep57-binding-deficient mutants (PCNT ΔPACT or K3154del).	 To this end we depleted endogenous PCNT using siRNA and expressed [EXPE]  RNAi-R  full-length or Cep57-binding-deficient mutants  [GENE] ΔPACT or K3154del  
2019	PMC6389942	pcnt	depletion	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig.  5d, e ).	 Whereas [EXPE] of endogenous [GENE] caused precocious centriole disengagement in mitosis expression of the full-length PCNT functionally rescued this phenotype  Fig  5d e   
2019	PMC6389942	pcnt	rescued	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig.  5d, e ).	 Whereas depletion of endogenous [GENE] caused precocious centriole disengagement in mitosis expression of the full-length PCNT functionally [EXPE] this phenotype  Fig  5d e   
2019	PMC6389942	pcnt	depletion	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig.  5d, e ).	 Whereas [EXPE] of endogenous PCNT caused precocious centriole disengagement in mitosis expression of the full-length [GENE] functionally rescued this phenotype  Fig  5d e   
2019	PMC6389942	pcnt	rescued	Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis, expression of the full-length PCNT functionally rescued this phenotype (Fig.  5d, e ).	 Whereas depletion of endogenous PCNT caused precocious centriole disengagement in mitosis expression of the full-length [GENE] functionally [EXPE] this phenotype  Fig  5d e   
2019	PMC6389942	pcnt	rescue	In contrast, the two binding-deficient mutants failed to rescue the phenotype provoked by depletion of endogenous PCNT (Fig.  5d, e ).	 In contrast the two binding-deficient mutants failed to [EXPE] the phenotype provoked by depletion of endogenous [GENE]  Fig  5d e   
2019	PMC6389942	pcnt	depletion	In contrast, the two binding-deficient mutants failed to rescue the phenotype provoked by depletion of endogenous PCNT (Fig.  5d, e ).	 In contrast the two binding-deficient mutants failed to rescue the phenotype provoked by [EXPE] of endogenous [GENE]  Fig  5d e   
2019	PMC6389942	cep57	depletion	In line with this notion, we established that depletion of Cep57 caused PCNT dispersion (Supplementary Fig.  9b ) and significantly shortened the height of PCNT that binds along the side of centriolar wall (Supplementary Fig.  9c, d ).	 In line with this notion we established that [EXPE] of [GENE] caused PCNT dispersion  Supplementary Fig  9b   and significantly shortened the height of PCNT that binds along the side of centriolar wall  Supplementary Fig  9c d   
2019	PMC6389942	pcnt	depletion	In line with this notion, we established that depletion of Cep57 caused PCNT dispersion (Supplementary Fig.  9b ) and significantly shortened the height of PCNT that binds along the side of centriolar wall (Supplementary Fig.  9c, d ).	 In line with this notion we established that [EXPE] of Cep57 caused [GENE] dispersion  Supplementary Fig  9b   and significantly shortened the height of PCNT that binds along the side of centriolar wall  Supplementary Fig  9c d   
2019	PMC6389942	pcnt	depletion	In line with this notion, we established that depletion of Cep57 caused PCNT dispersion (Supplementary Fig.  9b ) and significantly shortened the height of PCNT that binds along the side of centriolar wall (Supplementary Fig.  9c, d ).	 In line with this notion we established that [EXPE] of Cep57 caused PCNT dispersion  Supplementary Fig  9b   and significantly shortened the height of [GENE] that binds along the side of centriolar wall  Supplementary Fig  9c d   
2019	PMC6389942	cep57	rescue	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig.  9e ).	 As expected we demonstrated that expression of the [GENE] mutant did not [EXPE] the phenotype provoked by Cep57 depletion  Supplementary Fig  9e   
2019	PMC6389942	cep57	depletion	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig.  9e ).	 As expected we demonstrated that expression of the [GENE] mutant did not rescue the phenotype provoked by Cep57 [EXPE]  Supplementary Fig  9e   
2019	PMC6389942	cep57	rescue	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig.  9e ).	 As expected we demonstrated that expression of the Cep57 mutant did not [EXPE] the phenotype provoked by [GENE] depletion  Supplementary Fig  9e   
2019	PMC6389942	cep57	depletion	As expected, we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by Cep57 depletion (Supplementary Fig.  9e ).	 As expected we demonstrated that expression of the Cep57 mutant did not rescue the phenotype provoked by [GENE] [EXPE]  Supplementary Fig  9e   
2019	PMC6389942	pcnt	rescued	Interestingly, this chimera mutant efficiently rescued the disengagement phenotype of PCNT depletion (Fig.  5g, h ).	 Interestingly this chimera mutant efficiently [EXPE] the disengagement phenotype of [GENE] depletion  Fig  5g h   
2019	PMC6389942	pcnt	depletion	Interestingly, this chimera mutant efficiently rescued the disengagement phenotype of PCNT depletion (Fig.  5g, h ).	 Interestingly this chimera mutant efficiently rescued the disengagement phenotype of [GENE] [EXPE]  Fig  5g h   
2019	PMC6472344	plk4	purified	While performing in vitro biochemical experiments, we unexpectedly found that a kinase-dead (KD) mutant of a purified Plk4 fragment (Kinase + Linker 1) was highly insoluble compared with wild-type (WT) (Fig.  1a, b , Supplementary Fig.  1a ).	 While performing in vitro biochemical experiments we unexpectedly found that a kinase-dead  KD  mutant of a [EXPE] [GENE] fragment  Kinase + Linker 1  was highly insoluble compared with wild-type  WT   Fig  1a b  Supplementary Fig  1a   
2019	PMC6472344	plk4	purified	To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig.  1d , Supplementary Fig.  1c  and  1d ).	 To assess the solubility of [EXPE] [GENE] fragments in vitro we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig  1d  Supplementary Fig  1c  and  1d   
2019	PMC6472344	plk4	assay	To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig.  1d , Supplementary Fig.  1c  and  1d ).	 To assess the solubility of purified [GENE] fragments in vitro we performed a spin-down [EXPE] and showed that Plk4 WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig  1d  Supplementary Fig  1c  and  1d   
2019	PMC6472344	plk4	purified	To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig.  1d , Supplementary Fig.  1c  and  1d ).	 To assess the solubility of [EXPE] Plk4 fragments in vitro we performed a spin-down assay and showed that [GENE] WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig  1d  Supplementary Fig  1c  and  1d   
2019	PMC6472344	plk4	assay	To assess the solubility of purified Plk4 fragments in vitro, we performed a spin-down assay and showed that Plk4 WT fragments were mostly soluble, whereas the KD mutant was largely insoluble (Fig.  1d , Supplementary Fig.  1c  and  1d ).	 To assess the solubility of purified Plk4 fragments in vitro we performed a spin-down [EXPE] and showed that [GENE] WT fragments were mostly soluble whereas the KD mutant was largely insoluble  Fig  1d  Supplementary Fig  1c  and  1d   
2019	PMC6472344	plk4	visualized	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase + L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize [GENE] self-assembly further we [EXPE] purified Plk4 fragments  Kinase + L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	purified	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase + L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize [GENE] self-assembly further we visualized [EXPE] Plk4 fragments  Kinase + L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	visualized	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase + L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we [EXPE] purified [GENE] fragments  Kinase + L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	purified	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase + L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we visualized [EXPE] [GENE] fragments  Kinase + L1  and full-length Plk4 by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	visualized	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase + L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we [EXPE] purified Plk4 fragments  Kinase + L1  and full-length [GENE] by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	purified	To characterize Plk4 self-assembly further, we visualized purified Plk4 fragments (Kinase + L1) and full-length Plk4 by labeling with GFP and mScarlet I, respectively.	 To characterize Plk4 self-assembly further we visualized [EXPE] Plk4 fragments  Kinase + L1  and full-length [GENE] by labeling with GFP and mScarlet I respectively 
2019	PMC6472344	plk4	overexpressed	We overexpressed the Plk4 (Kinase + L1) fragments in HeLa cells and found that depending on the degree of its expression level, the Plk4 fragments self-assemble into spherical structures (Fig.  2c , Supplementary Fig.  3a ).	 We [EXPE] the [GENE]  Kinase + L1  fragments in HeLa cells and found that depending on the degree of its expression level the Plk4 fragments self-assemble into spherical structures  Fig  2c  Supplementary Fig  3a   
2019	PMC6472344	plk4	overexpressed	We overexpressed the Plk4 (Kinase + L1) fragments in HeLa cells and found that depending on the degree of its expression level, the Plk4 fragments self-assemble into spherical structures (Fig.  2c , Supplementary Fig.  3a ).	 We [EXPE] the Plk4  Kinase + L1  fragments in HeLa cells and found that depending on the degree of its expression level the [GENE] fragments self-assemble into spherical structures  Fig  2c  Supplementary Fig  3a   
2019	PMC6472344	plk4	purified	Importantly, consistent with in vitro observation of the purified Plk4 proteins, expression of the kinase domain alone did not induce such structures, demonstrating the dependency on the L1 domain for self-condensation (Fig.  2c , Supplementary Fig.  3a ).	 Importantly consistent with in vitro observation of the [EXPE] [GENE] proteins expression of the kinase domain alone did not induce such structures demonstrating the dependency on the L1 domain for self-condensation  Fig  2c  Supplementary Fig  3a   
2019	PMC6472344	plk4	photobleaching	To reveal the significance of autophosphorylation for Plk4 condensation in cells, we performed fluorescence recovery after photobleaching (FRAP) analysis with HeLa cells expressing GFP-Plk4.	 To reveal the significance of autophosphorylation for [GENE] condensation in cells we performed fluorescence recovery after [EXPE]  FRAP  analysis with HeLa cells expressing GFP-Plk4 
2019	PMC6472344	plk4	frap	To reveal the significance of autophosphorylation for Plk4 condensation in cells, we performed fluorescence recovery after photobleaching (FRAP) analysis with HeLa cells expressing GFP-Plk4.	 To reveal the significance of autophosphorylation for [GENE] condensation in cells we performed fluorescence recovery after photobleaching  [EXPE]  analysis with HeLa cells expressing GFP-Plk4 
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that [EXPE] of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not [EXPE] of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an [EXPE] of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an [EXPE] of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitors	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of [GENE] kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these [EXPE] similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that [EXPE] of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not [EXPE] of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an [EXPE] of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an [EXPE] of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitors	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the [GENE] turnover  Fig  2e   although all of these [EXPE] similarly increased the amount of endogenous Plk4 at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that [EXPE] of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibition	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not [EXPE] of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an [EXPE] of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an [EXPE] of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these inhibitors similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitors	Intriguingly, we found that inhibition of Plk4 kinase activity with centrinone, but not inhibition of its protein degradation by MG132 (an inhibitor of proteasomes) or MLN4924 (an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase) treatment, significantly impaired the Plk4 turnover (Fig.  2e ), although all of these inhibitors similarly increased the amount of endogenous Plk4 at centrioles (Supplementary Fig.  4a ).	 Intriguingly we found that inhibition of Plk4 kinase activity with centrinone but not inhibition of its protein degradation by MG132  an inhibitor of proteasomes  or MLN4924  an inhibitor of the NEDD8-activating enzyme that activates SCF-cullin-RING ubiquitin ligase  treatment significantly impaired the Plk4 turnover  Fig  2e   although all of these [EXPE] similarly increased the amount of endogenous [GENE] at centrioles  Supplementary Fig  4a   
2019	PMC6472344	plk4	inhibitor	Consistent with the effects of the inhibitor treatment, KD, 10A, and 13A mutations, but not 2A mutation (in the DSG phospho degron motif 16 , 20 ), attenuated Plk4 turnover both in the cytoplasmic condensates and at centrioles (Fig.  2g–i , Supplementary Fig.  4b  and  4c ).	 Consistent with the effects of the [EXPE] treatment KD 10A and 13A mutations but not 2A mutation  in the DSG phospho degron motif 16  20   attenuated [GENE] turnover both in the cytoplasmic condensates and at centrioles  Fig  2g–i  Supplementary Fig  4b  and  4c   
2019	PMC6472344	plk4	assay	We also confirmed the differences of condensation properties between Plk4 mutants using the plasma membrane tethering assay (Supplementary Fig.  5a–c ).	 We also confirmed the differences of condensation properties between [GENE] mutants using the plasma membrane tethering [EXPE]  Supplementary Fig  5a–c   
2019	PMC6472344	plk4	overexpression	In human cells, exogenous overexpression of Plk4 under a strong promoter such as CMV (cytomegalovirus) induces centriole overduplication 5 , 16 .	 In human cells exogenous [EXPE] of [GENE] under a strong promoter such as CMV  cytomegalovirus  induces centriole overduplication 5  16  
2019	PMC6472344	plk4	microscopy	Strikingly, structural illumination microscopy (SIM) revealed that even in cells with a ring-like distribution of Plk4, Plk4pS305 appeared as a single focus around mother centrioles (Fig.  4b ).	 Strikingly structural illumination [EXPE]  SIM  revealed that even in cells with a ring-like distribution of [GENE] Plk4pS305 appeared as a single focus around mother centrioles  Fig  4b   
2019	PMC6472344	plk4	sim	Strikingly, structural illumination microscopy (SIM) revealed that even in cells with a ring-like distribution of Plk4, Plk4pS305 appeared as a single focus around mother centrioles (Fig.  4b ).	 Strikingly structural illumination microscopy  [EXPE]  revealed that even in cells with a ring-like distribution of [GENE] Plk4pS305 appeared as a single focus around mother centrioles  Fig  4b   
2019	PMC6472344	stil	depleted	Furthermore, even in cells depleted of STIL and HsSAS6 (siSTIL and siHsSAS6-treated), the Plk4pS305 signal was localized as a single focus around mother centrioles (Supplementary Fig.  10b–e ), further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4.	 Furthermore even in cells [EXPE] of [GENE] and HsSAS6  siSTIL and siHsSAS6-treated  the Plk4pS305 signal was localized as a single focus around mother centrioles  Supplementary Fig  10b–e   further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4 
2019	PMC6472344	plk4	depleted	Furthermore, even in cells depleted of STIL and HsSAS6 (siSTIL and siHsSAS6-treated), the Plk4pS305 signal was localized as a single focus around mother centrioles (Supplementary Fig.  10b–e ), further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4.	 Furthermore even in cells [EXPE] of STIL and HsSAS6  siSTIL and siHsSAS6-treated  the Plk4pS305 signal was localized as a single focus around mother centrioles  Supplementary Fig  10b–e   further confirming that the occurrence of [GENE] phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4 
2019	PMC6472344	plk4	depleted	Furthermore, even in cells depleted of STIL and HsSAS6 (siSTIL and siHsSAS6-treated), the Plk4pS305 signal was localized as a single focus around mother centrioles (Supplementary Fig.  10b–e ), further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of Plk4.	 Furthermore even in cells [EXPE] of STIL and HsSAS6  siSTIL and siHsSAS6-treated  the Plk4pS305 signal was localized as a single focus around mother centrioles  Supplementary Fig  10b–e   further confirming that the occurrence of Plk4 phosphorylation is independent of the presence of STIL-HsSAS6 and is likely dependent on the intrinsic properties of [GENE] 
2019	PMC6472344	cep152	costained	Cep152 was costained and used for a marker of mother centriole wall.	 [GENE] was [EXPE] and used for a marker of mother centriole wall 
2019	PMC6472344	cep152	3d-sim	 d  3D-SIM images of centrioles immunostained with antibodies against HsSAS6, Plk4pS305, and Cep152 in HeLa cells.	  d  [EXPE] images of centrioles immunostained with antibodies against HsSAS6 Plk4pS305 and [GENE] in HeLa cells 
2019	PMC6472344	cep152	immunostained	 d  3D-SIM images of centrioles immunostained with antibodies against HsSAS6, Plk4pS305, and Cep152 in HeLa cells.	  d  3D-SIM images of centrioles [EXPE] with antibodies against HsSAS6 Plk4pS305 and [GENE] in HeLa cells 
2019	PMC6472344	cep152	costained	Cep152 was costained and used for a marker of mother centriole wall.	 [GENE] was [EXPE] and used for a marker of mother centriole wall 
2019	PMC6472344	cep152	3d-sim	 d  3D-SIM images of centrioles immunostained with antibodies against HsSAS6, Plk4pS305, and Cep152 in HeLa cells.	  d  [EXPE] images of centrioles immunostained with antibodies against HsSAS6 Plk4pS305 and [GENE] in HeLa cells 
2019	PMC6472344	cep152	immunostained	 d  3D-SIM images of centrioles immunostained with antibodies against HsSAS6, Plk4pS305, and Cep152 in HeLa cells.	  d  3D-SIM images of centrioles [EXPE] with antibodies against HsSAS6 Plk4pS305 and [GENE] in HeLa cells 
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig.  10e ).	 We also found that [EXPE] of [GENE] WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall  Supplementary Fig  10e   
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig.  10e ).	 We also found that overexpression of [GENE] WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that Plk4 over-condensation induced by its [EXPE] promoted autonomous activation on the mother centriole wall  Supplementary Fig  10e   
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig.  10e ).	 We also found that [EXPE] of Plk4 WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that [GENE] over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall  Supplementary Fig  10e   
2019	PMC6472344	plk4	overexpression	We also found that overexpression of Plk4 WT (under CMV promoter) induced a uniform ring-like structure of Plk4pS305 around the mother centriole, suggesting that Plk4 over-condensation induced by its overexpression promoted autonomous activation on the mother centriole wall (Supplementary Fig.  10e ).	 We also found that overexpression of Plk4 WT  under CMV promoter  induced a uniform ring-like structure of Plk4pS305 around the mother centriole suggesting that [GENE] over-condensation induced by its [EXPE] promoted autonomous activation on the mother centriole wall  Supplementary Fig  10e   
2019	PMC6472344	plk4	inhibited	We first inhibited the kinase activity of Plk4 by centrinone treatment in G1-arrested HeLa cells and subsequently released the inhibition by washout of centrinone (Fig.  5a ).	 We first [EXPE] the kinase activity of [GENE] by centrinone treatment in G1-arrested HeLa cells and subsequently released the inhibition by washout of centrinone  Fig  5a   
2019	PMC6472344	plk4	inhibition	We first inhibited the kinase activity of Plk4 by centrinone treatment in G1-arrested HeLa cells and subsequently released the inhibition by washout of centrinone (Fig.  5a ).	 We first inhibited the kinase activity of [GENE] by centrinone treatment in G1-arrested HeLa cells and subsequently released the [EXPE] by washout of centrinone  Fig  5a   
2019	PMC6472344	stil	depletion	In contrast, as reported previously 31 , depletion of HsSAS6 suppressed centriolar loading of STIL (Fig.  5c ).	 In contrast as reported previously 31  [EXPE] of HsSAS6 suppressed centriolar loading of [GENE]  Fig  5c   
2019	PMC6472344	stil	immunostained	 b ,  c  Representative images of immunostained HsSAS6 and Plk4pS305 ( b ), STIL and Plk4 ( c ) in the indicated condition.	  b   c  Representative images of [EXPE] HsSAS6 and Plk4pS305   b   [GENE] and Plk4   c   in the indicated condition 
2019	PMC6472344	plk4	immunostained	 b ,  c  Representative images of immunostained HsSAS6 and Plk4pS305 ( b ), STIL and Plk4 ( c ) in the indicated condition.	  b   c  Representative images of [EXPE] HsSAS6 and Plk4pS305   b   STIL and [GENE]   c   in the indicated condition 
2019	PMC6472344	stil	immunostained	 b ,  c  Representative images of immunostained HsSAS6 and Plk4pS305 ( b ), STIL and Plk4 ( c ) in the indicated condition.	  b   c  Representative images of [EXPE] HsSAS6 and Plk4pS305   b   [GENE] and Plk4   c   in the indicated condition 
2019	PMC6472344	plk4	immunostained	 b ,  c  Representative images of immunostained HsSAS6 and Plk4pS305 ( b ), STIL and Plk4 ( c ) in the indicated condition.	  b   c  Representative images of [EXPE] HsSAS6 and Plk4pS305   b   STIL and [GENE]   c   in the indicated condition 
2021	PMC7812875	cep192	depleted	To understand the functions of PCM in bipolar spindle formation, we depleted the main components of PCM, such as CEP192, pericentrin, and CDK5RAP2, and observed bipolar spindle assembly in HeLa, A549, and RPE1 cells.	 To understand the functions of PCM in bipolar spindle formation we [EXPE] the main components of PCM such as [GENE] pericentrin and CDK5RAP2 and observed bipolar spindle assembly in HeLa A549 and RPE1 cells 
2021	PMC7812875	pericentrin	depleted	To understand the functions of PCM in bipolar spindle formation, we depleted the main components of PCM, such as CEP192, pericentrin, and CDK5RAP2, and observed bipolar spindle assembly in HeLa, A549, and RPE1 cells.	 To understand the functions of PCM in bipolar spindle formation we [EXPE] the main components of PCM such as CEP192 [GENE] and CDK5RAP2 and observed bipolar spindle assembly in HeLa A549 and RPE1 cells 
2021	PMC7812875	cdk5rap2	depleted	To understand the functions of PCM in bipolar spindle formation, we depleted the main components of PCM, such as CEP192, pericentrin, and CDK5RAP2, and observed bipolar spindle assembly in HeLa, A549, and RPE1 cells.	 To understand the functions of PCM in bipolar spindle formation we [EXPE] the main components of PCM such as CEP192 pericentrin and [GENE] and observed bipolar spindle assembly in HeLa A549 and RPE1 cells 
2021	PMC7812875	cep192	depletion	As previously described, the depletion of CEP192 caused severe defects in bipolar spindle formation and prolonged mitotic duration ( Fig. 1, A and B ;  Fig. S3 ;  Videos 1  and  2 ).	 As previously described the [EXPE] of [GENE] caused severe defects in bipolar spindle formation and prolonged mitotic duration   Fig 1 A and B ;  Fig S3 ;  Videos 1  and  2   
2021	PMC7812875	pericentrin	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double [EXPE] of [GENE] and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	pericentrin	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double depletion of [GENE] and CDK5RAP2 or their individual [EXPE] had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double [EXPE] of pericentrin and [GENE] or their individual depletion had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	On the other hand, double depletion of pericentrin and CDK5RAP2 or their individual depletion had a limited effect on mitotic duration in HeLa cells ( Fig. 1, A and B ;  Fig. 2 C ;  Fig. S1 G ;  Videos 1 ,  3 ,  15 ,  17 , and  18 ) and bipolar spindle assembly in RPE1 and A549 cells ( Fig. S3, A–D ).	 On the other hand double depletion of pericentrin and [GENE] or their individual [EXPE] had a limited effect on mitotic duration in HeLa cells   Fig 1 A and B ;  Fig 2 C ;  Fig S1 G ;  Videos 1   3   15   17  and  18   and bipolar spindle assembly in RPE1 and A549 cells   Fig S3 A–D   
2021	PMC7812875	cep192	depletion	Therefore, we observed the amount and localization of CEP192 at centrosomes upon depletion of pericentrin and CDK5RAP2.	 Therefore we observed the amount and localization of [GENE] at centrosomes upon [EXPE] of pericentrin and CDK5RAP2 
2021	PMC7812875	pericentrin	depletion	Therefore, we observed the amount and localization of CEP192 at centrosomes upon depletion of pericentrin and CDK5RAP2.	 Therefore we observed the amount and localization of CEP192 at centrosomes upon [EXPE] of [GENE] and CDK5RAP2 
2021	PMC7812875	cdk5rap2	depletion	Therefore, we observed the amount and localization of CEP192 at centrosomes upon depletion of pericentrin and CDK5RAP2.	 Therefore we observed the amount and localization of CEP192 at centrosomes upon [EXPE] of pericentrin and [GENE] 
2021	PMC7812875	cep192	depletion	To further understand this mechanism, we used gated stimulated emission depletion (STED) microscopy to analyze the detailed localization pattern of CEP192 at centrosomes in pericentrin/CDK5RAP2 double-depleted cells ( Fig. 1, E–G ).	 To further understand this mechanism we used gated stimulated emission [EXPE]  STED  microscopy to analyze the detailed localization pattern of [GENE] at centrosomes in pericentrin/CDK5RAP2 double-depleted cells   Fig 1 E–G   
2021	PMC7812875	cep192	sted	To further understand this mechanism, we used gated stimulated emission depletion (STED) microscopy to analyze the detailed localization pattern of CEP192 at centrosomes in pericentrin/CDK5RAP2 double-depleted cells ( Fig. 1, E–G ).	 To further understand this mechanism we used gated stimulated emission depletion  [EXPE]  microscopy to analyze the detailed localization pattern of [GENE] at centrosomes in pericentrin/CDK5RAP2 double-depleted cells   Fig 1 E–G   
2021	PMC7812875	cep192	microscopy	To further understand this mechanism, we used gated stimulated emission depletion (STED) microscopy to analyze the detailed localization pattern of CEP192 at centrosomes in pericentrin/CDK5RAP2 double-depleted cells ( Fig. 1, E–G ).	 To further understand this mechanism we used gated stimulated emission depletion  STED  [EXPE] to analyze the detailed localization pattern of [GENE] at centrosomes in pericentrin/CDK5RAP2 double-depleted cells   Fig 1 E–G   
2021	PMC7812875	cep192	sted	STED images showing centriolar distribution of CEP192 in pericentrin/CDK5RAP2 double-depleted cells.	 [EXPE] images showing centriolar distribution of [GENE] in pericentrin/CDK5RAP2 double-depleted cells 
2021	PMC7812875	cep192	western blot	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   [EXPE] analysis of the efficiency of protein depletion of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cep192	depletion	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein [EXPE] of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cep192	sirna	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of [EXPE] transfection in HeLa cells 
2021	PMC7812875	cep192	transfection	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of [GENE]  A  CDK5RAP2  B  and pericentrin  C  after 48 h of siRNA [EXPE] in HeLa cells 
2021	PMC7812875	cdk5rap2	western blot	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   [EXPE] analysis of the efficiency of protein depletion of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cdk5rap2	depletion	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein [EXPE] of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	cdk5rap2	sirna	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of [EXPE] transfection in HeLa cells 
2021	PMC7812875	cdk5rap2	transfection	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  [GENE]  B  and pericentrin  C  after 48 h of siRNA [EXPE] in HeLa cells 
2021	PMC7812875	pericentrin	western blot	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   [EXPE] analysis of the efficiency of protein depletion of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	pericentrin	depletion	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein [EXPE] of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of siRNA transfection in HeLa cells 
2021	PMC7812875	pericentrin	sirna	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of [EXPE] transfection in HeLa cells 
2021	PMC7812875	pericentrin	transfection	(A–C)  Western blot analysis of the efficiency of protein depletion of CEP192 (A), CDK5RAP2 (B), and pericentrin (C) after 48 h of siRNA transfection in HeLa cells.	  A–C   Western blot analysis of the efficiency of protein depletion of CEP192  A  CDK5RAP2  B  and [GENE]  C  after 48 h of siRNA [EXPE] in HeLa cells 
2021	PMC7812875	cep192	depleted	 (D–F)  Quantification of depleted centrosomal CEP192 (D), CDK5RAP2 (E), and pericentrin (F).	   D–F   Quantification of [EXPE] centrosomal [GENE]  D  CDK5RAP2  E  and pericentrin  F  
2021	PMC7812875	cdk5rap2	depleted	 (D–F)  Quantification of depleted centrosomal CEP192 (D), CDK5RAP2 (E), and pericentrin (F).	   D–F   Quantification of [EXPE] centrosomal CEP192  D  [GENE]  E  and pericentrin  F  
2021	PMC7812875	pericentrin	depleted	 (D–F)  Quantification of depleted centrosomal CEP192 (D), CDK5RAP2 (E), and pericentrin (F).	   D–F   Quantification of [EXPE] centrosomal CEP192  D  CDK5RAP2  E  and [GENE]  F  
2021	PMC7812875	plk4	inhibitors	To understand the functions of PCM independently of centrioles in human cells, we next induced the formation of mitotic spindles with one or zero centrosomes by treating HeLa cells with the PLK4 inhibitors centrinone or centrinone B ( Fig. 2, A and B ).	 To understand the functions of PCM independently of centrioles in human cells we next induced the formation of mitotic spindles with one or zero centrosomes by treating HeLa cells with the [GENE] [EXPE] centrinone or centrinone B   Fig 2 A and B   
2021	PMC7812875	cep192	depleted	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We [EXPE] PCM components [GENE] pericentrin and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging 
2021	PMC7812875	cep192	live-cell	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components [GENE] pericentrin and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using [EXPE] imaging 
2021	PMC7812875	cep192	imaging	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components [GENE] pericentrin and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell [EXPE] 
2021	PMC7812875	pericentrin	depleted	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We [EXPE] PCM components CEP192 [GENE] and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging 
2021	PMC7812875	pericentrin	live-cell	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 [GENE] and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using [EXPE] imaging 
2021	PMC7812875	pericentrin	imaging	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 [GENE] and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell [EXPE] 
2021	PMC7812875	cdk5rap2	depleted	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We [EXPE] PCM components CEP192 pericentrin and [GENE] in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging 
2021	PMC7812875	cdk5rap2	live-cell	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 pericentrin and [GENE] in one- or zero-centrosome cells and observed their mitotic progression using [EXPE] imaging 
2021	PMC7812875	cdk5rap2	imaging	We depleted PCM components CEP192, pericentrin, and CDK5RAP2 in one- or zero-centrosome cells and observed their mitotic progression using live-cell imaging.	 We depleted PCM components CEP192 pericentrin and [GENE] in one- or zero-centrosome cells and observed their mitotic progression using live-cell [EXPE] 
2021	PMC7812875	cep192	depletion	As described above, the depletion of CEP192, but not pericentrin or CDK5RAP2, prolonged mitosis in cells with two centrosomes ( Fig. 2 C ;  Fig. S1 A–G ;  Videos 15 ,  16 ,  17 , and  18 ).	 As described above the [EXPE] of [GENE] but not pericentrin or CDK5RAP2 prolonged mitosis in cells with two centrosomes   Fig 2 C ;  Fig S1 A–G ;  Videos 15   16   17  and  18   
2021	PMC7812875	pericentrin	depletion	As described above, the depletion of CEP192, but not pericentrin or CDK5RAP2, prolonged mitosis in cells with two centrosomes ( Fig. 2 C ;  Fig. S1 A–G ;  Videos 15 ,  16 ,  17 , and  18 ).	 As described above the [EXPE] of CEP192 but not [GENE] or CDK5RAP2 prolonged mitosis in cells with two centrosomes   Fig 2 C ;  Fig S1 A–G ;  Videos 15   16   17  and  18   
2021	PMC7812875	cdk5rap2	depletion	As described above, the depletion of CEP192, but not pericentrin or CDK5RAP2, prolonged mitosis in cells with two centrosomes ( Fig. 2 C ;  Fig. S1 A–G ;  Videos 15 ,  16 ,  17 , and  18 ).	 As described above the [EXPE] of CEP192 but not pericentrin or [GENE] prolonged mitosis in cells with two centrosomes   Fig 2 C ;  Fig S1 A–G ;  Videos 15   16   17  and  18   
2021	PMC7812875	pericentrin	depletion	On the other hand, interestingly, we found that depletion of pericentrin or CDK5RAP2, as well as CEP192, significantly prolonged mitotic duration in one-centrosome cells ( Fig. 2 D ;  Fig. S1 H ;  Videos 19 ,  20 ,  21 , and  22 ).	 On the other hand interestingly we found that [EXPE] of [GENE] or CDK5RAP2 as well as CEP192 significantly prolonged mitotic duration in one-centrosome cells   Fig 2 D ;  Fig S1 H ;  Videos 19   20   21  and  22   
2021	PMC7812875	cdk5rap2	depletion	On the other hand, interestingly, we found that depletion of pericentrin or CDK5RAP2, as well as CEP192, significantly prolonged mitotic duration in one-centrosome cells ( Fig. 2 D ;  Fig. S1 H ;  Videos 19 ,  20 ,  21 , and  22 ).	 On the other hand interestingly we found that [EXPE] of pericentrin or [GENE] as well as CEP192 significantly prolonged mitotic duration in one-centrosome cells   Fig 2 D ;  Fig S1 H ;  Videos 19   20   21  and  22   
2021	PMC7812875	cep192	depletion	On the other hand, interestingly, we found that depletion of pericentrin or CDK5RAP2, as well as CEP192, significantly prolonged mitotic duration in one-centrosome cells ( Fig. 2 D ;  Fig. S1 H ;  Videos 19 ,  20 ,  21 , and  22 ).	 On the other hand interestingly we found that [EXPE] of pericentrin or CDK5RAP2 as well as [GENE] significantly prolonged mitotic duration in one-centrosome cells   Fig 2 D ;  Fig S1 H ;  Videos 19   20   21  and  22   
2021	PMC7812875	pericentrin	depletion	In contrast, we found that depletion of pericentrin, CDK5RAP2, or CEP192 had a limited effect on mitotic progression in zero-centrosome cells ( Fig. 2 E ;  Fig. S1 I ;  Videos 23 ,  24 ,  25 , and  26 ).	 In contrast we found that [EXPE] of [GENE] CDK5RAP2 or CEP192 had a limited effect on mitotic progression in zero-centrosome cells   Fig 2 E ;  Fig S1 I ;  Videos 23   24   25  and  26   
2021	PMC7812875	cdk5rap2	depletion	In contrast, we found that depletion of pericentrin, CDK5RAP2, or CEP192 had a limited effect on mitotic progression in zero-centrosome cells ( Fig. 2 E ;  Fig. S1 I ;  Videos 23 ,  24 ,  25 , and  26 ).	 In contrast we found that [EXPE] of pericentrin [GENE] or CEP192 had a limited effect on mitotic progression in zero-centrosome cells   Fig 2 E ;  Fig S1 I ;  Videos 23   24   25  and  26   
2021	PMC7812875	cep192	depletion	In contrast, we found that depletion of pericentrin, CDK5RAP2, or CEP192 had a limited effect on mitotic progression in zero-centrosome cells ( Fig. 2 E ;  Fig. S1 I ;  Videos 23 ,  24 ,  25 , and  26 ).	 In contrast we found that [EXPE] of pericentrin CDK5RAP2 or [GENE] had a limited effect on mitotic progression in zero-centrosome cells   Fig 2 E ;  Fig S1 I ;  Videos 23   24   25  and  26   
2021	PMC7812875	sas6	depletion	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by [GENE] [EXPE] using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of PLK4 inhibition 
2021	PMC7812875	sas6	inhibition	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by [GENE] depletion using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of PLK4 [EXPE] 
2021	PMC7812875	plk4	depletion	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by SAS6 [EXPE] using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of [GENE] inhibition 
2021	PMC7812875	plk4	inhibition	Furthermore, the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron (AID) system ( Fig. S2, C and D ;  Yoshiba et al., 2019 ), suggesting that this phenotype was not a specific result of PLK4 inhibition.	 Furthermore the PCM pole was similarly observed in one-centrosome cells induced by SAS6 depletion using the auxin-inducible degron  AID  system   Fig S2 C and D ;  Yoshiba et al 2019   suggesting that this phenotype was not a specific result of [GENE] [EXPE] 
2021	PMC7812875	sas6	depletion	 (C)  PCM poles were observed in one-centrosome spindles induced by SAS6 depletion.	   C   PCM poles were observed in one-centrosome spindles induced by [GENE] [EXPE] 
2021	PMC7812875	pericentrin	time-lapse	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used [EXPE] fluorescence microscopy to track the dynamics of endogenous [GENE] or CDK5RAP2 tagged with mCherry as markers of PCM 
2021	PMC7812875	pericentrin	microscopy	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used time-lapse fluorescence [EXPE] to track the dynamics of endogenous [GENE] or CDK5RAP2 tagged with mCherry as markers of PCM 
2021	PMC7812875	cdk5rap2	time-lapse	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used [EXPE] fluorescence microscopy to track the dynamics of endogenous pericentrin or [GENE] tagged with mCherry as markers of PCM 
2021	PMC7812875	cdk5rap2	microscopy	To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells, we used time-lapse fluorescence microscopy to track the dynamics of endogenous pericentrin or CDK5RAP2 tagged with mCherry as markers of PCM.	 To understand the mechanism of PCM recruitment to the acentriolar pole in one-centrosome cells we used time-lapse fluorescence [EXPE] to track the dynamics of endogenous pericentrin or [GENE] tagged with mCherry as markers of PCM 
2021	PMC7812875	cdk5rap2	depletion	On the other hand, depletion of the PCM scaffold proteins CDK5RAP2 and pericentrin are known to have little effect on spindle formation in two- or zero-centrosome cells ( Fig. 2, C–E ;  Fig. S1, G–I ;  Videos 15 ,  17 ,  18 ,  23 ,  25 , and  26 ).	 On the other hand [EXPE] of the PCM scaffold proteins [GENE] and pericentrin are known to have little effect on spindle formation in two- or zero-centrosome cells   Fig 2 C–E ;  Fig S1 G–I ;  Videos 15   17   18   23   25  and  26   
2021	PMC7812875	pericentrin	depletion	On the other hand, depletion of the PCM scaffold proteins CDK5RAP2 and pericentrin are known to have little effect on spindle formation in two- or zero-centrosome cells ( Fig. 2, C–E ;  Fig. S1, G–I ;  Videos 15 ,  17 ,  18 ,  23 ,  25 , and  26 ).	 On the other hand [EXPE] of the PCM scaffold proteins CDK5RAP2 and [GENE] are known to have little effect on spindle formation in two- or zero-centrosome cells   Fig 2 C–E ;  Fig S1 G–I ;  Videos 15   17   18   23   25  and  26   
2021	PMC7812875	cdk5rap2	depletion	We found that depletion of CDK5RAP2 or pericentrin caused arrest of one-centrosome cells in mitosis with monopolar spindles; however, this effect was not observed in two-centrosome cells ( Fig. 4, A and B ).	 We found that [EXPE] of [GENE] or pericentrin caused arrest of one-centrosome cells in mitosis with monopolar spindles; however this effect was not observed in two-centrosome cells   Fig 4 A and B   
2021	PMC7812875	pericentrin	depletion	We found that depletion of CDK5RAP2 or pericentrin caused arrest of one-centrosome cells in mitosis with monopolar spindles; however, this effect was not observed in two-centrosome cells ( Fig. 4, A and B ).	 We found that [EXPE] of CDK5RAP2 or [GENE] caused arrest of one-centrosome cells in mitosis with monopolar spindles; however this effect was not observed in two-centrosome cells   Fig 4 A and B   
2021	PMC7812875	cdk5rap2	depletion	Upon depletion of CDK5RAP2 or pericentrin, the separation of two NuMA foci was normally detectable in early mitosis ( Fig. 4, C and D ;  Videos 8 ,  9 , and  10 ), while the time from nuclear envelope breakdown (NEBD) to cytokinesis was prolonged ( Fig. 4, C, E, and F ;  Videos 8 ,  9 , and  10 ).	 Upon [EXPE] of [GENE] or pericentrin the separation of two NuMA foci was normally detectable in early mitosis   Fig 4 C and D ;  Videos 8   9  and  10   while the time from nuclear envelope breakdown  NEBD  to cytokinesis was prolonged   Fig 4 C E and F ;  Videos 8   9  and  10   
2021	PMC7812875	pericentrin	depletion	Upon depletion of CDK5RAP2 or pericentrin, the separation of two NuMA foci was normally detectable in early mitosis ( Fig. 4, C and D ;  Videos 8 ,  9 , and  10 ), while the time from nuclear envelope breakdown (NEBD) to cytokinesis was prolonged ( Fig. 4, C, E, and F ;  Videos 8 ,  9 , and  10 ).	 Upon [EXPE] of CDK5RAP2 or [GENE] the separation of two NuMA foci was normally detectable in early mitosis   Fig 4 C and D ;  Videos 8   9  and  10   while the time from nuclear envelope breakdown  NEBD  to cytokinesis was prolonged   Fig 4 C E and F ;  Videos 8   9  and  10   
2021	PMC7812875	pericentrin	inhibitor	Next, by using proTAME (APC/C inhibitor) treatment, we arrested pericentrin or CDK5RAP2-depleted HeLa cells with one centrosome in metaphase to artificially induce bipolar spindle formation.	 Next by using proTAME  APC/C [EXPE]  treatment we arrested [GENE] or CDK5RAP2-depleted HeLa cells with one centrosome in metaphase to artificially induce bipolar spindle formation 
2021	PMC7812875	cep192	immunofluorescence	Immunofluorescence analysis revealed that in these HeLa cells, the degree of CEP192 localization at the acentrosomal spindle poles was significantly reduced compared with that in control cells ( Fig. 4, G–I ).	 [EXPE] analysis revealed that in these HeLa cells the degree of [GENE] localization at the acentrosomal spindle poles was significantly reduced compared with that in control cells   Fig 4 G–I   
2021	PMC7812875	gt335	sirna	  (A)  Mitotic spindle structures upon siRNA treatment with or without 500 nM centrinone B. Green, red, and blue represent GT335, α-tubulin, and DNA, respectively.	    A   Mitotic spindle structures upon [EXPE] treatment with or without 500 nM centrinone B Green red and blue represent [GENE] α-tubulin and DNA respectively 
2021	PMC7812875	cep192	assay	 (I)  The signal intensity of CEP192 on acentrosomal spindle poles in G. Line and error bars represent the mean and SD ( n  = 3, triplicates,  n  ≥ 20 cells for each assay).	   I   The signal intensity of [GENE] on acentrosomal spindle poles in G Line and error bars represent the mean and SD   n  = 3 triplicates  n  ≥ 20 cells for each [EXPE]  
2021	PMC7812875	pericentrin	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether [GENE] and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of pericentrin or CDK5RAP2 
2021	PMC7812875	cdk5rap2	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether pericentrin and [GENE] are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of pericentrin or CDK5RAP2 
2021	PMC7812875	pericentrin	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of [GENE] or CDK5RAP2 
2021	PMC7812875	cdk5rap2	depletion	To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome, we observed the spindle structure of RPE1 and A549 cells upon depletion of pericentrin or CDK5RAP2.	 To verify whether pericentrin and CDK5RAP2 are important for bipolar spindle formation in other human cell lines with one centrosome we observed the spindle structure of RPE1 and A549 cells upon [EXPE] of pericentrin or [GENE] 
2021	PMC7812875	pericentrin	immunostaining	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through [EXPE] we found that in cells with one centrosome depletion of [GENE] or CDK5RAP2 induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	pericentrin	depletion	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through immunostaining we found that in cells with one centrosome [EXPE] of [GENE] or CDK5RAP2 induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	immunostaining	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through [EXPE] we found that in cells with one centrosome depletion of pericentrin or [GENE] induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	Through immunostaining, we found that in cells with one centrosome, depletion of pericentrin or CDK5RAP2 induced the formation of monopolar spindles ( Fig. S3, A–D ).	 Through immunostaining we found that in cells with one centrosome [EXPE] of pericentrin or [GENE] induced the formation of monopolar spindles   Fig S3 A–D   
2021	PMC7812875	cdk5rap2	depletion	Since siRNA-mediated depletion reduces the total expression level of CDK5RAP2 and pericentrin, it is difficult to analyze the function of the PCM components specifically at PCM poles ( Fig. 4 ).	 Since siRNA-mediated [EXPE] reduces the total expression level of [GENE] and pericentrin it is difficult to analyze the function of the PCM components specifically at PCM poles   Fig 4   
2021	PMC7812875	pericentrin	depletion	Since siRNA-mediated depletion reduces the total expression level of CDK5RAP2 and pericentrin, it is difficult to analyze the function of the PCM components specifically at PCM poles ( Fig. 4 ).	 Since siRNA-mediated [EXPE] reduces the total expression level of CDK5RAP2 and [GENE] it is difficult to analyze the function of the PCM components specifically at PCM poles   Fig 4   
2021	PMC7812875	cep57	depletion	CEP57 provides a critical interface between the centriole and PCM, and depletion of CEP57 induces the fragmentation of PCM proteins in early mitosis of human cells ( Watanabe et al., 2019 ).	 [GENE] provides a critical interface between the centriole and PCM and [EXPE] of CEP57 induces the fragmentation of PCM proteins in early mitosis of human cells   Watanabe et al 2019   
2021	PMC7812875	cep57	depletion	CEP57 provides a critical interface between the centriole and PCM, and depletion of CEP57 induces the fragmentation of PCM proteins in early mitosis of human cells ( Watanabe et al., 2019 ).	 CEP57 provides a critical interface between the centriole and PCM and [EXPE] of [GENE] induces the fragmentation of PCM proteins in early mitosis of human cells   Watanabe et al 2019   
2021	PMC7812875	cep57	depletion	Given that 38.5% of one-centrosome cells assembled PCM poles by splitting PCM from the centrosome ( Fig. 3, A and D ;  Video 4 ), we hypothesized that upon CEP57 depletion, the PCM that is dissociated from the centrosome could be incorporated into the acentriolar pole in one-centrosome cells.	 Given that 385% of one-centrosome cells assembled PCM poles by splitting PCM from the centrosome   Fig 3 A and D ;  Video 4   we hypothesized that upon [GENE] [EXPE] the PCM that is dissociated from the centrosome could be incorporated into the acentriolar pole in one-centrosome cells 
2021	PMC7812875	pericentrin	depletion	As expected, the amount of pericentrin at PCM poles was significantly increased, presumably due to the increased PCM fragmentation at centriolar poles after CEP57 depletion ( Fig. 5, A–C ).	 As expected the amount of [GENE] at PCM poles was significantly increased presumably due to the increased PCM fragmentation at centriolar poles after CEP57 [EXPE]   Fig 5 A–C   
2021	PMC7812875	cep57	depletion	As expected, the amount of pericentrin at PCM poles was significantly increased, presumably due to the increased PCM fragmentation at centriolar poles after CEP57 depletion ( Fig. 5, A–C ).	 As expected the amount of pericentrin at PCM poles was significantly increased presumably due to the increased PCM fragmentation at centriolar poles after [GENE] [EXPE]   Fig 5 A–C   
2021	PMC7812875	cep57	depletion	Subsequently, to analyze the effect of CEP57 depletion on the mitotic processes of one-centrosome cells, we performed time-lapse imaging of NuMA and microtubules.	 Subsequently to analyze the effect of [GENE] [EXPE] on the mitotic processes of one-centrosome cells we performed time-lapse imaging of NuMA and microtubules 
2021	PMC7812875	cep57	time-lapse	Subsequently, to analyze the effect of CEP57 depletion on the mitotic processes of one-centrosome cells, we performed time-lapse imaging of NuMA and microtubules.	 Subsequently to analyze the effect of [GENE] depletion on the mitotic processes of one-centrosome cells we performed [EXPE] imaging of NuMA and microtubules 
2021	PMC7812875	cep57	imaging	Subsequently, to analyze the effect of CEP57 depletion on the mitotic processes of one-centrosome cells, we performed time-lapse imaging of NuMA and microtubules.	 Subsequently to analyze the effect of [GENE] depletion on the mitotic processes of one-centrosome cells we performed time-lapse [EXPE] of NuMA and microtubules 
2021	PMC7812875	cep57	depletion	We found that depletion of CEP57 promoted bipolar spindle formation more efficiently than in control cells and thereby shortened the mitotic duration ( Fig. 5, D–F ;  Videos 11  and  12 ).	 We found that [EXPE] of [GENE] promoted bipolar spindle formation more efficiently than in control cells and thereby shortened the mitotic duration   Fig 5 D–F ;  Videos 11  and  12   
2021	PMC7812875	cep57	depletion	CEP57 depletion leads to an increase of PCM at the acentriolar pole and facilitates spindle bipolarization in one-centrosome cells.	 [GENE] [EXPE] leads to an increase of PCM at the acentriolar pole and facilitates spindle bipolarization in one-centrosome cells 
2021	PMC7812875	cep57	depletion	  (A)  Mitotic spindle pole structures of one-centrosome cells upon CEP57 depletion.	    A   Mitotic spindle pole structures of one-centrosome cells upon [GENE] [EXPE] 
2021	PMC7812875	cep57	time-lapse	 (D)  Time-lapse observation of NuMA structures and microtubules upon CEP57 depletion.	   D   [EXPE] observation of NuMA structures and microtubules upon [GENE] depletion 
2021	PMC7812875	cep57	depletion	 (D)  Time-lapse observation of NuMA structures and microtubules upon CEP57 depletion.	   D   Time-lapse observation of NuMA structures and microtubules upon [GENE] [EXPE] 
2021	PMC7812875	cep57	depletion	*, P < 0.0001.  (G)  Frequency of mitotic spindle structures upon CEP57 depletion.	 * P < 00001   G   Frequency of mitotic spindle structures upon [GENE] [EXPE] 
2021	PMC7812875	plk1	inhibitor	To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation, we treated cells with a low dose of the PLK1 inhibitor BI 2536 (1 nM) and observed the amount of pericentrin at the centriolar pole and the spindle structure.	 To determine if [GENE] was required for PCM pole assembly and subsequent bipolar spindle formation we treated cells with a low dose of the PLK1 [EXPE] BI 2536  1 nM  and observed the amount of pericentrin at the centriolar pole and the spindle structure 
2021	PMC7812875	plk1	inhibitor	To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation, we treated cells with a low dose of the PLK1 inhibitor BI 2536 (1 nM) and observed the amount of pericentrin at the centriolar pole and the spindle structure.	 To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation we treated cells with a low dose of the [GENE] [EXPE] BI 2536  1 nM  and observed the amount of pericentrin at the centriolar pole and the spindle structure 
2021	PMC7812875	pericentrin	inhibitor	To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation, we treated cells with a low dose of the PLK1 inhibitor BI 2536 (1 nM) and observed the amount of pericentrin at the centriolar pole and the spindle structure.	 To determine if PLK1 was required for PCM pole assembly and subsequent bipolar spindle formation we treated cells with a low dose of the PLK1 [EXPE] BI 2536  1 nM  and observed the amount of [GENE] at the centriolar pole and the spindle structure 
2021	PMC7812875	plk1	inhibitor	Treatment of two-centrosome cells with a low dose of the PLK1 inhibitor caused chromosome congression errors and a slight reduction of pericentrin at centrosomes but did not affect bipolar spindle formation ( Fig. 6, E–G ).	 Treatment of two-centrosome cells with a low dose of the [GENE] [EXPE] caused chromosome congression errors and a slight reduction of pericentrin at centrosomes but did not affect bipolar spindle formation   Fig 6 E–G   
2021	PMC7812875	pericentrin	inhibitor	Treatment of two-centrosome cells with a low dose of the PLK1 inhibitor caused chromosome congression errors and a slight reduction of pericentrin at centrosomes but did not affect bipolar spindle formation ( Fig. 6, E–G ).	 Treatment of two-centrosome cells with a low dose of the PLK1 [EXPE] caused chromosome congression errors and a slight reduction of [GENE] at centrosomes but did not affect bipolar spindle formation   Fig 6 E–G   
2021	PMC7812875	plk1	inhibition	In contrast, in one-centrosome cells, PLK1 inhibition prevented PCM pole formation and led to the formation of monopolar spindles ( Fig. 6, E and F ).	 In contrast in one-centrosome cells [GENE] [EXPE] prevented PCM pole formation and led to the formation of monopolar spindles   Fig 6 E and F   
2021	PMC7812875	plk1	inhibition	In addition, PLK1 inhibition greatly reduced the level of pericentrin at the centriolar pole compared with the level recorded in two-centrosome cells ( Fig. 6 G ).	 In addition [GENE] [EXPE] greatly reduced the level of pericentrin at the centriolar pole compared with the level recorded in two-centrosome cells   Fig 6 G   
2021	PMC7812875	pericentrin	inhibition	In addition, PLK1 inhibition greatly reduced the level of pericentrin at the centriolar pole compared with the level recorded in two-centrosome cells ( Fig. 6 G ).	 In addition PLK1 [EXPE] greatly reduced the level of [GENE] at the centriolar pole compared with the level recorded in two-centrosome cells   Fig 6 G   
2021	PMC7812875	plk1	assay	 (D)  Frequency of localization of phosphorylated PLK1 in C ( n  = 6, triplicates, two independent experiments, at least 20 cells in each assay).	   D   Frequency of localization of phosphorylated [GENE] in C   n  = 6 triplicates two independent experiments at least 20 cells in each [EXPE]  
2021	PMC7812875	plk1	inhibition	 (E)  Mitotic spindle structures upon PLK1 inhibition (1 nM of BI 2536) with or without 100 nM of centrinone.	   E   Mitotic spindle structures upon [GENE] [EXPE]  1 nM of BI 2536  with or without 100 nM of centrinone 
2021	PMC7812875	pericentrin	depletion	We subsequently analyzed the spindle length upon depletion of pericentrin or CDK5RAP2 in HeLa cells.	 We subsequently analyzed the spindle length upon [EXPE] of [GENE] or CDK5RAP2 in HeLa cells 
2021	PMC7812875	cdk5rap2	depletion	We subsequently analyzed the spindle length upon depletion of pericentrin or CDK5RAP2 in HeLa cells.	 We subsequently analyzed the spindle length upon [EXPE] of pericentrin or [GENE] in HeLa cells 
2021	PMC7812875	pericentrin	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that [EXPE] of [GENE] significantly reduced the spindle length compared with that of control cells whereas depletion of CDK5RAP2 had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	pericentrin	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that depletion of [GENE] significantly reduced the spindle length compared with that of control cells whereas [EXPE] of CDK5RAP2 had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	cdk5rap2	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that [EXPE] of pericentrin significantly reduced the spindle length compared with that of control cells whereas depletion of [GENE] had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	cdk5rap2	depletion	We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells, whereas depletion of CDK5RAP2 had a limited effect on the spindle length ( Fig. 7, A and B ).	 We found that depletion of pericentrin significantly reduced the spindle length compared with that of control cells whereas [EXPE] of [GENE] had a limited effect on the spindle length   Fig 7 A and B   
2021	PMC7812875	pericentrin	depletion	To further investigate this defect upon depletion of pericentrin, we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells.	 To further investigate this defect upon [EXPE] of [GENE] we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells 
2021	PMC7812875	pericentrin	live-cell	To further investigate this defect upon depletion of pericentrin, we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells.	 To further investigate this defect upon depletion of [GENE] we performed [EXPE] imaging of mitotic spindle formation in HeLa and HCT116 cells 
2021	PMC7812875	pericentrin	imaging	To further investigate this defect upon depletion of pericentrin, we performed live-cell imaging of mitotic spindle formation in HeLa and HCT116 cells.	 To further investigate this defect upon depletion of [GENE] we performed live-cell [EXPE] of mitotic spindle formation in HeLa and HCT116 cells 
2021	PMC7812875	pericentrin	depletion	Depletion of pericentrin delayed the elongation of two spindle poles ( Fig. 7, E and F ;  Fig. S4, A and B ;  Videos 13 ,  14 ,  27 , and  28 ).	 [EXPE] of [GENE] delayed the elongation of two spindle poles   Fig 7 E and F ;  Fig S4 A and B ;  Videos 13   14   27  and  28   
2021	PMC7812875	pericentrin	time-lapse	 (E)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin in two-centrosome HeLa cells were observed with a 40× objective.	   E   [EXPE] observation of the structure of microtubules upon depletion of [GENE] in two-centrosome HeLa cells were observed with a 40× objective 
2021	PMC7812875	pericentrin	depletion	 (E)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin in two-centrosome HeLa cells were observed with a 40× objective.	   E   Time-lapse observation of the structure of microtubules upon [EXPE] of [GENE] in two-centrosome HeLa cells were observed with a 40× objective 
2021	PMC7812875	pericentrin	depletion	The spindle length of A549 (H) and U2OS (I) cells upon depletion of pericentrin ( n  > 40 from two independent experiments).	 The spindle length of A549  H  and U2OS  I  cells upon [EXPE] of [GENE]   n  > 40 from two independent experiments  
2021	PMC7812875	pericentrin	time-lapse	  (A)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin.	    A   [EXPE] observation of the structure of microtubules upon depletion of [GENE] 
2021	PMC7812875	pericentrin	depletion	  (A)  Time-lapse observation of the structure of microtubules upon depletion of pericentrin.	    A   Time-lapse observation of the structure of microtubules upon [EXPE] of [GENE] 
2021	PMC7812875	pericentrin	depletion	Furthermore, we tested the effect of depletion of pericentrin on the spindle elongation of various cell types.	 Furthermore we tested the effect of [EXPE] of [GENE] on the spindle elongation of various cell types 
2021	PMC7812875	pericentrin	depletion	On the other hand, in some cell types (RPE1, GI1, and SKOV3), the spindle length upon depletion of pericentrin was not altered compared with that observed in control cells ( Fig. S4, C–F ).	 On the other hand in some cell types  RPE1 GI1 and SKOV3  the spindle length upon [EXPE] of [GENE] was not altered compared with that observed in control cells   Fig S4 C–F   
2021	PMC7938805	foxj1	immunostaining	(C) Immunostaining of FoxJ1 in differentiated E1 cells cultured in ALI for 21 days.	  C  [EXPE] of [GENE] in differentiated E1 cells cultured in ALI for 21 days 
2021	PMC7938805	foxj1	immunostaining	(C) Immunostaining of FoxJ1 in differentiated E1 cells cultured in ALI for 21 days.	  C  [EXPE] of [GENE] in differentiated E1 cells cultured in ALI for 21 days 
2021	PMC7938805	deup1	doxycycline-inducible	Through lenti-virus-mediated gene transfer, we generated E1 cells that expressed Deup1 and Centrin2 tagged with mScarlet I and GFP, respectively, with a doxycycline-inducible expression promoter ( Fig. S1F,G ).	 Through lenti-virus-mediated gene transfer we generated E1 cells that expressed [GENE] and Centrin2 tagged with mScarlet I and GFP respectively with a [EXPE] expression promoter   Fig S1FG   
2021	PMC7938805	deup1	frap	We performed FRAP analysis of mScarlet I-Deup1 in undifferentiated E1 cells to further characterize the properties of Deup1 assemblies.	 We performed [EXPE] analysis of mScarlet I-Deup1 in undifferentiated E1 cells to further characterize the properties of [GENE] assemblies 
2021	PMC7938805	deup1	photobleaching	We found that, even in the undifferentiated cells, mScarlet I-Deup1 showed a slow turnover within the Deup1 assemblies (recovery: 6±3% at 290 s after photobleaching) ( Fig. 2 B).	 We found that even in the undifferentiated cells mScarlet I-Deup1 showed a slow turnover within the [GENE] assemblies  recovery: 6±3% at 290 s after [EXPE]    Fig 2 B  
2021	PMC7938805	deup1	frap	We performed FRAP analysis of mScarlet I-Deup1 to investigate the biophysical properties of the Deup1 assemblies formed  in vitro .	 We performed [EXPE] analysis of mScarlet I-Deup1 to investigate the biophysical properties of the [GENE] assemblies formed  in vitro  
2021	PMC7938805	deup1	photobleaching	Consistent with the results observed in cells, we found that turnover of mScarlet I-Deup1 was barely observed within the Deup1 assemblies  in vitro  (recovery: 1±1% t 290 s after photobleaching) ( Fig. 4 A).	 Consistent with the results observed in cells we found that turnover of mScarlet I-Deup1 was barely observed within the [GENE] assemblies  in vitro   recovery: 1±1% t 290 s after [EXPE]    Fig 4 A  
2021	PMC7938805	deup1	bleaching	In addition, internal rearrangement in Deup1 assemblies was undetectable following partial bleaching of the fluorescence of mScarlet I-Deup1 assemblies ( Fig. S4B ).	 In addition internal rearrangement in [GENE] assemblies was undetectable following partial [EXPE] of the fluorescence of mScarlet I-Deup1 assemblies   Fig S4B   
2021	PMC7938805	deup1	purified	The purified N-terminus fragment of Deup1 also showed strong self-assembly properties  in vitro  (as observed with full-length Deup1), whereas the C-terminus fragments did not ( Fig. 5 C;  Figs S4C and S5E ).	 The [EXPE] N-terminus fragment of [GENE] also showed strong self-assembly properties  in vitro   as observed with full-length Deup1  whereas the C-terminus fragments did not   Fig 5 C;  Figs S4C and S5E   
2021	PMC7938805	deup1	purified	The purified N-terminus fragment of Deup1 also showed strong self-assembly properties  in vitro  (as observed with full-length Deup1), whereas the C-terminus fragments did not ( Fig. 5 C;  Figs S4C and S5E ).	 The [EXPE] N-terminus fragment of Deup1 also showed strong self-assembly properties  in vitro   as observed with full-length [GENE]  whereas the C-terminus fragments did not   Fig 5 C;  Figs S4C and S5E   
2019	PMC6777370	plk4	inhibitor	To further verify the behavior of Plk4-mClover at centrioles, we monitored the effect of treatment with a Plk4 inhibitor, centrinone ( Wong et al., 2015 ).	 To further verify the behavior of Plk4-mClover at centrioles we monitored the effect of treatment with a [GENE] [EXPE] centrinone   Wong et al 2015   
2019	PMC6777370	plk4	imaging	 (A,B) Simultaneous imaging of endogenously tagged Plk4 and STIL (A) or HsSAS6 (B).	   AB  Simultaneous [EXPE] of endogenously tagged [GENE] and STIL  A  or HsSAS6  B  
2019	PMC6777370	stil	imaging	 (A,B) Simultaneous imaging of endogenously tagged Plk4 and STIL (A) or HsSAS6 (B).	   AB  Simultaneous [EXPE] of endogenously tagged Plk4 and [GENE]  A  or HsSAS6  B  
2019	PMC6777370	plk4	imaging	 (A,B) Simultaneous imaging of endogenously tagged Plk4 and STIL (A) or HsSAS6 (B).	   AB  Simultaneous [EXPE] of endogenously tagged [GENE] and STIL  A  or HsSAS6  B  
2019	PMC6777370	stil	imaging	 (A,B) Simultaneous imaging of endogenously tagged Plk4 and STIL (A) or HsSAS6 (B).	   AB  Simultaneous [EXPE] of endogenously tagged Plk4 and [GENE]  A  or HsSAS6  B  
2019	PMC6777370	stil	immunofluorescence	This is consistent with previous immunofluorescence observations, as well as the model in which centriolar loading of STIL promotes disassembly of the ring-like pattern of Plk4 to form the single-focus pattern ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ).	 This is consistent with previous [EXPE] observations as well as the model in which centriolar loading of [GENE] promotes disassembly of the ring-like pattern of Plk4 to form the single-focus pattern   Arquint et al 2015 ;  Ohta et al 2018   2014   
2019	PMC6777370	plk4	immunofluorescence	This is consistent with previous immunofluorescence observations, as well as the model in which centriolar loading of STIL promotes disassembly of the ring-like pattern of Plk4 to form the single-focus pattern ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ).	 This is consistent with previous [EXPE] observations as well as the model in which centriolar loading of STIL promotes disassembly of the ring-like pattern of [GENE] to form the single-focus pattern   Arquint et al 2015 ;  Ohta et al 2018   2014   
2019	PMC6777370	stil	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since [GENE] and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar Plk4 in cells [EXPE] of STIL or HsSAS6  as well as in a control culture  
2019	PMC6777370	plk4	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar [GENE]   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar Plk4 in cells [EXPE] of STIL or HsSAS6  as well as in a control culture  
2019	PMC6777370	plk4	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar [GENE] in cells [EXPE] of STIL or HsSAS6  as well as in a control culture  
2019	PMC6777370	stil	depleted	Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4 ( Arquint et al., 2015 ;  Ohta et al., 2018 ,  2014 ), we then observed the behavior of centriolar Plk4 in cells depleted of STIL or HsSAS6 (as well as in a control culture).	 Since STIL and HsSAS6 are thought to induce the spatial-pattern shift of centriolar Plk4   Arquint et al 2015 ;  Ohta et al 2018   2014   we then observed the behavior of centriolar Plk4 in cells [EXPE] of [GENE] or HsSAS6  as well as in a control culture  
2019	PMC6777370	stil	depletion	In stark contrast, upon depletion of STIL or HsSAS6, centriolar Plk4-mClover remained constant after reaching its fluorescence peak throughout the rest of the period until the next mitosis ( Fig. 3 A).	 In stark contrast upon [EXPE] of [GENE] or HsSAS6 centriolar Plk4-mClover remained constant after reaching its fluorescence peak throughout the rest of the period until the next mitosis   Fig 3 A  
2019	PMC6777370	plk4	immunofluorescence	Indeed, when observed by immunofluorescence microscopy at a higher resolution, in line with previous observations ( Ohta et al., 2014 ), centriolar Plk4 primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells ( Fig. 3 B).	 Indeed when observed by [EXPE] microscopy at a higher resolution in line with previous observations   Ohta et al 2014   centriolar [GENE] primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells   Fig 3 B  
2019	PMC6777370	plk4	microscopy	Indeed, when observed by immunofluorescence microscopy at a higher resolution, in line with previous observations ( Ohta et al., 2014 ), centriolar Plk4 primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells ( Fig. 3 B).	 Indeed when observed by immunofluorescence [EXPE] at a higher resolution in line with previous observations   Ohta et al 2014   centriolar [GENE] primarily exhibited its ring-like pattern in STIL- or HsSAS6-depleted cells   Fig 3 B  
2019	PMC6777370	stil	depletion	Effect of depletion of STIL or HsSAS6 on the behavior of centriolar Plk4.	 Effect of [EXPE] of [GENE] or HsSAS6 on the behavior of centriolar Plk4 
2019	PMC6777370	plk4	depletion	Effect of depletion of STIL or HsSAS6 on the behavior of centriolar Plk4.	 Effect of [EXPE] of STIL or HsSAS6 on the behavior of centriolar [GENE] 
2019	PMC6777370	stil	depletion	(B,C) Effect of depletion of STIL or HsSAS6 on the spatial patterning of centriolar Plk4.	  BC  Effect of [EXPE] of [GENE] or HsSAS6 on the spatial patterning of centriolar Plk4 
2019	PMC6777370	plk4	depletion	(B,C) Effect of depletion of STIL or HsSAS6 on the spatial patterning of centriolar Plk4.	  BC  Effect of [EXPE] of STIL or HsSAS6 on the spatial patterning of centriolar [GENE] 
2019	PMC6777370	plk4	high-resolution	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative [EXPE] immunofluorescence images of [GENE] with and without the centriole marker CEP152  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	plk4	immunofluorescence	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative high-resolution [EXPE] images of [GENE] with and without the centriole marker CEP152  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	cep152	high-resolution	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative [EXPE] immunofluorescence images of Plk4 with and without the centriole marker [GENE]  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	cep152	immunofluorescence	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative high-resolution [EXPE] images of Plk4 with and without the centriole marker [GENE]  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	stil	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to [GENE] or HsSAS6 and the centriole marker pericentrin  PCNT  
2019	PMC6777370	stil	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to [GENE] or HsSAS6 and the centriole marker pericentrin  PCNT  
2019	PMC6777370	pericentrin	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker [GENE]  PCNT  
2019	PMC6777370	pericentrin	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to STIL or HsSAS6 and the centriole marker [GENE]  PCNT  
2019	PMC6777370	pcnt	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin  [GENE]  
2019	PMC6777370	pcnt	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to STIL or HsSAS6 and the centriole marker pericentrin  [GENE]  
2019	PMC6777370	stil	depletion	Effect of depletion of STIL or HsSAS6 on the behavior of centriolar Plk4.	 Effect of [EXPE] of [GENE] or HsSAS6 on the behavior of centriolar Plk4 
2019	PMC6777370	plk4	depletion	Effect of depletion of STIL or HsSAS6 on the behavior of centriolar Plk4.	 Effect of [EXPE] of STIL or HsSAS6 on the behavior of centriolar [GENE] 
2019	PMC6777370	stil	depletion	(B,C) Effect of depletion of STIL or HsSAS6 on the spatial patterning of centriolar Plk4.	  BC  Effect of [EXPE] of [GENE] or HsSAS6 on the spatial patterning of centriolar Plk4 
2019	PMC6777370	plk4	depletion	(B,C) Effect of depletion of STIL or HsSAS6 on the spatial patterning of centriolar Plk4.	  BC  Effect of [EXPE] of STIL or HsSAS6 on the spatial patterning of centriolar [GENE] 
2019	PMC6777370	plk4	high-resolution	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative [EXPE] immunofluorescence images of [GENE] with and without the centriole marker CEP152  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	plk4	immunofluorescence	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative high-resolution [EXPE] images of [GENE] with and without the centriole marker CEP152  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	cep152	high-resolution	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative [EXPE] immunofluorescence images of Plk4 with and without the centriole marker [GENE]  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	cep152	immunofluorescence	Representative high-resolution immunofluorescence images of Plk4 with and without the centriole marker CEP152 (B) and the ring-filling indices (C) for the three conditions.	 Representative high-resolution [EXPE] images of Plk4 with and without the centriole marker [GENE]  B  and the ring-filling indices  C  for the three conditions 
2019	PMC6777370	stil	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to [GENE] or HsSAS6 and the centriole marker pericentrin  PCNT  
2019	PMC6777370	stil	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to [GENE] or HsSAS6 and the centriole marker pericentrin  PCNT  
2019	PMC6777370	pericentrin	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker [GENE]  PCNT  
2019	PMC6777370	pericentrin	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to STIL or HsSAS6 and the centriole marker [GENE]  PCNT  
2019	PMC6777370	pcnt	transfected	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were [EXPE] with siControl siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin  [GENE]  
2019	PMC6777370	pcnt	stained	HeLa cells were transfected with siControl, siSTIL or siHsSAS6 and then stained with antibodies to STIL or HsSAS6 and the centriole marker pericentrin (PCNT).	 HeLa cells were transfected with siControl siSTIL or siHsSAS6 and then [EXPE] with antibodies to STIL or HsSAS6 and the centriole marker pericentrin  [GENE]  
2019	PMC6777370	plk4	immunofluorescence	To quantify the spatial pattern of Plk4, we calculated ring-filling indices for centriolar Plk4 from the immunofluorescence images.	 To quantify the spatial pattern of [GENE] we calculated ring-filling indices for centriolar Plk4 from the [EXPE] images 
2019	PMC6777370	plk4	immunofluorescence	To quantify the spatial pattern of Plk4, we calculated ring-filling indices for centriolar Plk4 from the immunofluorescence images.	 To quantify the spatial pattern of Plk4 we calculated ring-filling indices for centriolar [GENE] from the [EXPE] images 
2019	PMC6777370	stil	immunofluorescence	We confirmed by using immunofluorescence microscopy that STIL is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa ( Fig. 3 D).	 We confirmed by using [EXPE] microscopy that [GENE] is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa   Fig 3 D  
2019	PMC6777370	stil	microscopy	We confirmed by using immunofluorescence microscopy that STIL is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa ( Fig. 3 D).	 We confirmed by using immunofluorescence [EXPE] that [GENE] is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa   Fig 3 D  
2019	PMC6777370	stil	depleted	We confirmed by using immunofluorescence microscopy that STIL is mostly absent from centrioles in cells that are depleted of HsSAS6 and vice versa ( Fig. 3 D).	 We confirmed by using immunofluorescence microscopy that [GENE] is mostly absent from centrioles in cells that are [EXPE] of HsSAS6 and vice versa   Fig 3 D  
2019	PMC6777370	stil	depletion	The simulation data have been plotted in the same way as in the graphs in  Fig. 2 . (D) Simulated effect of STIL or HsSAS6 depletion.	 The simulation data have been plotted in the same way as in the graphs in  Fig 2   D  Simulated effect of [GENE] or HsSAS6 [EXPE] 
2019	PMC6777370	stil	depletion	The simulation data have been plotted in the same way as in the graphs in  Fig. 2 . (D) Simulated effect of STIL or HsSAS6 depletion.	 The simulation data have been plotted in the same way as in the graphs in  Fig 2   D  Simulated effect of [GENE] or HsSAS6 [EXPE] 
2019	PMC6777370	stil	depletion	Centriolar accumulation of HsSAS6 was significantly attenuated with the depletion of STIL and vice versa ( Fig. 4 D).	 Centriolar accumulation of HsSAS6 was significantly attenuated with the [EXPE] of [GENE] and vice versa   Fig 4 D  
2019	PMC6777370	stil	live-cell	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig. 4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig 4 E Our [EXPE] imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both [GENE] and HsSAS6 is tightly associated with and indeed required for the rapid decrease in Plk4 after it has reached its fluorescence peak 
2019	PMC6777370	stil	imaging	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig. 4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig 4 E Our live-cell [EXPE] of single cells throughout the cell cycle demonstrated that the centriolar loading of both [GENE] and HsSAS6 is tightly associated with and indeed required for the rapid decrease in Plk4 after it has reached its fluorescence peak 
2019	PMC6777370	plk4	live-cell	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig. 4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig 4 E Our [EXPE] imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with and indeed required for the rapid decrease in [GENE] after it has reached its fluorescence peak 
2019	PMC6777370	plk4	imaging	Based on both experimental observations and simulations, we propose a model of procentriole formation as schematically illustrated in  Fig. 4 E. Our live-cell imaging of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with, and indeed required for, the rapid decrease in Plk4 after it has reached its fluorescence peak.	 Based on both experimental observations and simulations we propose a model of procentriole formation as schematically illustrated in  Fig 4 E Our live-cell [EXPE] of single cells throughout the cell cycle demonstrated that the centriolar loading of both STIL and HsSAS6 is tightly associated with and indeed required for the rapid decrease in [GENE] after it has reached its fluorescence peak 
2019	PMC6777370	sas6	assay	This is analogous to a previous model based on an  in vitro  reconstitution assay using  Chlamydomonas reinhardtii  SAS6 and mathematical modeling, which suggested that the cartwheel assembly mechanism was mediated by the  Chlamydomonas  protein Bld10p ( Klein et al., 2016 ;  Goldie et al., 2017 ;  Nievergelt et al., 2018 ).	 This is analogous to a previous model based on an  in vitro  reconstitution [EXPE] using  Chlamydomonas reinhardtii  [GENE] and mathematical modeling which suggested that the cartwheel assembly mechanism was mediated by the  Chlamydomonas  protein Bld10p   Klein et al 2016 ;  Goldie et al 2017 ;  Nievergelt et al 2018   
2019	PMC6777370	plk4	suppress	Concurrently, at the procentriole assembly site, this increased quantity of the protein complex may suppress the dissociation of active Plk4 from centrioles via direct interaction, while promoting the activation and subsequent dissociation of neighboring Plk4 molecules from centrioles.	 Concurrently at the procentriole assembly site this increased quantity of the protein complex may [EXPE] the dissociation of active [GENE] from centrioles via direct interaction while promoting the activation and subsequent dissociation of neighboring Plk4 molecules from centrioles 
2019	PMC6777370	plk4	suppress	Concurrently, at the procentriole assembly site, this increased quantity of the protein complex may suppress the dissociation of active Plk4 from centrioles via direct interaction, while promoting the activation and subsequent dissociation of neighboring Plk4 molecules from centrioles.	 Concurrently at the procentriole assembly site this increased quantity of the protein complex may [EXPE] the dissociation of active Plk4 from centrioles via direct interaction while promoting the activation and subsequent dissociation of neighboring [GENE] molecules from centrioles 
2019	PMC6829667	plk4	confocal	HCT116 cells, in which endogenous Plk4 was tagged with mClover, were synchronized via thymidine arrest, then observed via spinning disc confocal microscopy after thymidine release ( Fig. 1 A  and Fig. S1 A).	 HCT116 cells in which endogenous [GENE] was tagged with mClover were synchronized via thymidine arrest then observed via spinning disc [EXPE] microscopy after thymidine release   Fig 1 A  and Fig S1 A  
2019	PMC6829667	plk4	confocal microscopy	HCT116 cells, in which endogenous Plk4 was tagged with mClover, were synchronized via thymidine arrest, then observed via spinning disc confocal microscopy after thymidine release ( Fig. 1 A  and Fig. S1 A).	 HCT116 cells in which endogenous [GENE] was tagged with mClover were synchronized via thymidine arrest then observed via spinning disc [EXPE] after thymidine release   Fig 1 A  and Fig S1 A  
2019	PMC6829667	plk4	microscopy	HCT116 cells, in which endogenous Plk4 was tagged with mClover, were synchronized via thymidine arrest, then observed via spinning disc confocal microscopy after thymidine release ( Fig. 1 A  and Fig. S1 A).	 HCT116 cells in which endogenous [GENE] was tagged with mClover were synchronized via thymidine arrest then observed via spinning disc confocal [EXPE] after thymidine release   Fig 1 A  and Fig S1 A  
2019	PMC6829667	plk4	live imaging	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   [EXPE] of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc confocal microscopy 
2019	PMC6829667	plk4	imaging	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live [EXPE] of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc confocal microscopy 
2019	PMC6829667	plk4	confocal	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live imaging of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc [EXPE] microscopy 
2019	PMC6829667	plk4	confocal microscopy	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live imaging of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc [EXPE] 
2019	PMC6829667	plk4	microscopy	(A)  Live imaging of Plk4 endogenously tagged with mClover in HCT116 cells, using spinning-disc confocal microscopy.	  A   Live imaging of [GENE] endogenously tagged with mClover in HCT116 cells using spinning-disc confocal [EXPE] 
2019	PMC6829667	plk4	confocal	Scale bars, 10 µm.  (B)  Confocal immunofluorescence images of endogenous Plk4, with deconvolution.	 Scale bars 10 µm   B   [EXPE] immunofluorescence images of endogenous [GENE] with deconvolution 
2019	PMC6829667	plk4	immunofluorescence	Scale bars, 10 µm.  (B)  Confocal immunofluorescence images of endogenous Plk4, with deconvolution.	 Scale bars 10 µm   B   Confocal [EXPE] images of endogenous [GENE] with deconvolution 
2019	PMC6829667	plk4	stained	Synchronized cells were fixed at the indicated time after thymidine release and stained with antibodies against Plk4 and CEP152 (centriolar marker).	 Synchronized cells were fixed at the indicated time after thymidine release and [EXPE] with antibodies against [GENE] and CEP152  centriolar marker  
2019	PMC6829667	cep152	stained	Synchronized cells were fixed at the indicated time after thymidine release and stained with antibodies against Plk4 and CEP152 (centriolar marker).	 Synchronized cells were fixed at the indicated time after thymidine release and [EXPE] with antibodies against Plk4 and [GENE]  centriolar marker  
2019	PMC6829667	plk4	immunofluorescence	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via [EXPE] confocal microscopy the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	confocal	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via immunofluorescence [EXPE] microscopy the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	confocal microscopy	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via immunofluorescence [EXPE] the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	microscopy	Indeed, when observed at higher resolution via immunofluorescence confocal microscopy, the Plk4 ring pattern most frequently appeared 13 h after thymidine release.	 Indeed when observed at higher resolution via immunofluorescence confocal [EXPE] the [GENE] ring pattern most frequently appeared 13 h after thymidine release 
2019	PMC6829667	plk4	sted	We used STED super-resolution microscopy to further investigate the incomplete ring patterns of Plk4 at higher resolution.	 We used [EXPE] super-resolution microscopy to further investigate the incomplete ring patterns of [GENE] at higher resolution 
2019	PMC6829667	plk4	super-resolution	We used STED super-resolution microscopy to further investigate the incomplete ring patterns of Plk4 at higher resolution.	 We used STED [EXPE] microscopy to further investigate the incomplete ring patterns of [GENE] at higher resolution 
2019	PMC6829667	plk4	microscopy	We used STED super-resolution microscopy to further investigate the incomplete ring patterns of Plk4 at higher resolution.	 We used STED super-resolution [EXPE] to further investigate the incomplete ring patterns of [GENE] at higher resolution 
2019	PMC6829667	plk4	super-resolution	Discrete and periodic Plk4 ring patterns at the super-resolution scale.	 Discrete and periodic [GENE] ring patterns at the [EXPE] scale 
2019	PMC6829667	plk4	confocal	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional [EXPE] and STED images of centriolar [GENE]  from different samples  with or without deconvolution  A  and the oval profile of Plk4  B  
2019	PMC6829667	plk4	sted	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional confocal and [EXPE] images of centriolar [GENE]  from different samples  with or without deconvolution  A  and the oval profile of Plk4  B  
2019	PMC6829667	oval	confocal	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional [EXPE] and STED images of centriolar Plk4  from different samples  with or without deconvolution  A  and the [GENE] profile of Plk4  B  
2019	PMC6829667	oval	sted	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional confocal and [EXPE] images of centriolar Plk4  from different samples  with or without deconvolution  A  and the [GENE] profile of Plk4  B  
2019	PMC6829667	plk4	confocal	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional [EXPE] and STED images of centriolar Plk4  from different samples  with or without deconvolution  A  and the oval profile of [GENE]  B  
2019	PMC6829667	plk4	sted	(A and B)  Comparison of the resolution of conventional confocal and STED images of centriolar Plk4 (from different samples) with or without deconvolution (A) and the oval profile of Plk4 (B).	  A and B   Comparison of the resolution of conventional confocal and [EXPE] images of centriolar Plk4  from different samples  with or without deconvolution  A  and the oval profile of [GENE]  B  
2019	PMC6829667	plk4	sted	 (C)  An array plot of all STED profiles of Plk4 ( n  = 37 cells).	   C   An array plot of all [EXPE] profiles of [GENE]   n  = 37 cells  
2019	PMC6829667	cep152	sted	The angle shown in the inset STED image (*) corresponds to the distance indicated in yellow (*) in the profile in B.  (E)  Representative STED images and quantification of CEP152 spatial patterns.	 The angle shown in the inset [EXPE] image  *  corresponds to the distance indicated in yellow  *  in the profile in B   E   Representative STED images and quantification of [GENE] spatial patterns 
2019	PMC6829667	cep152	sted	The angle shown in the inset STED image (*) corresponds to the distance indicated in yellow (*) in the profile in B.  (E)  Representative STED images and quantification of CEP152 spatial patterns.	 The angle shown in the inset STED image  *  corresponds to the distance indicated in yellow  *  in the profile in B   E   Representative [EXPE] images and quantification of [GENE] spatial patterns 
2019	PMC6829667	cep192	sted	 (F)  Representative STED image and quantification of CEP192 spatial patterns.	   F   Representative [EXPE] image and quantification of [GENE] spatial patterns 
2019	PMC6829667	cep152	super-resolution	We applied the super-resolution analysis to CEP152, the main scaffold of centriolar Plk4, to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4.	 We applied the [EXPE] analysis to [GENE] the main scaffold of centriolar Plk4 to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4 
2019	PMC6829667	plk4	super-resolution	We applied the super-resolution analysis to CEP152, the main scaffold of centriolar Plk4, to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4.	 We applied the [EXPE] analysis to CEP152 the main scaffold of centriolar [GENE] to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4 
2019	PMC6829667	plk4	super-resolution	We applied the super-resolution analysis to CEP152, the main scaffold of centriolar Plk4, to identify the factor generating the sixfold symmetry of the discrete ring patterns of Plk4.	 We applied the [EXPE] analysis to CEP152 the main scaffold of centriolar Plk4 to identify the factor generating the sixfold symmetry of the discrete ring patterns of [GENE] 
2019	PMC6829667	cep152	sted	Via STED observations using an antibody to the N-terminal region of CEP152, we found that CEP152 also showed periodic patterns ( Fig. 2 E ).	 Via [EXPE] observations using an antibody to the N-terminal region of [GENE] we found that CEP152 also showed periodic patterns   Fig 2 E   
2019	PMC6829667	cep152	sted	Via STED observations using an antibody to the N-terminal region of CEP152, we found that CEP152 also showed periodic patterns ( Fig. 2 E ).	 Via [EXPE] observations using an antibody to the N-terminal region of CEP152 we found that [GENE] also showed periodic patterns   Fig 2 E   
2019	PMC6829667	cep192	sted	We therefore similarly quantified the spatial pattern of centriolar CEP192 by STED analysis.	 We therefore similarly quantified the spatial pattern of centriolar [GENE] by [EXPE] analysis 
2019	PMC6829667	plk4	sted	This variation in the spatial and temporal patterns simulated may explain the variety of the spatial patterns of Plk4 observed in our STED analysis.	 This variation in the spatial and temporal patterns simulated may explain the variety of the spatial patterns of [GENE] observed in our [EXPE] analysis 
2019	PMC6829667	plk4	overexpression	 (B)  Representative simulation results using overexpression of Plk4 or STIL.	   B   Representative simulation results using [EXPE] of [GENE] or STIL 
2019	PMC6829667	stil	overexpression	 (B)  Representative simulation results using overexpression of Plk4 or STIL.	   B   Representative simulation results using [EXPE] of Plk4 or [GENE] 
2019	PMC6829667	plk4	overexpression	Overexpression of Plk4, STIL, or HsSAS6 is known to induce overduplication of centrioles ( Habedanck et al., 2005 ;  Kleylein-Sohn et al., 2007 ;  Strnad et al., 2007 ;  Tang et al., 2011 ;  Arquint et al., 2012 ;  Vulprecht et al., 2012 ).	 [EXPE] of [GENE] STIL or HsSAS6 is known to induce overduplication of centrioles   Habedanck et al 2005 ;  Kleylein-Sohn et al 2007 ;  Strnad et al 2007 ;  Tang et al 2011 ;  Arquint et al 2012 ;  Vulprecht et al 2012   
2019	PMC6829667	stil	overexpression	Overexpression of Plk4, STIL, or HsSAS6 is known to induce overduplication of centrioles ( Habedanck et al., 2005 ;  Kleylein-Sohn et al., 2007 ;  Strnad et al., 2007 ;  Tang et al., 2011 ;  Arquint et al., 2012 ;  Vulprecht et al., 2012 ).	 [EXPE] of Plk4 [GENE] or HsSAS6 is known to induce overduplication of centrioles   Habedanck et al 2005 ;  Kleylein-Sohn et al 2007 ;  Strnad et al 2007 ;  Tang et al 2011 ;  Arquint et al 2012 ;  Vulprecht et al 2012   
2019	PMC6829667	plk4	overexpression	In simulations using overexpression of Plk4 (the cytosolic level of Plk4 was set five times higher), multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading.	 In simulations using [EXPE] of [GENE]  the cytosolic level of Plk4 was set five times higher  multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading 
2019	PMC6829667	plk4	overexpression	In simulations using overexpression of Plk4 (the cytosolic level of Plk4 was set five times higher), multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading.	 In simulations using [EXPE] of Plk4  the cytosolic level of [GENE] was set five times higher  multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading 
2019	PMC6829667	plk4	overexpression	In simulations using overexpression of Plk4 (the cytosolic level of Plk4 was set five times higher), multiple Plk4 foci tended to remain even after STIL–HsSAS6 loading.	 In simulations using [EXPE] of Plk4  the cytosolic level of Plk4 was set five times higher  multiple [GENE] foci tended to remain even after STIL–HsSAS6 loading 
2019	PMC6829667	plk4	overexpression	Interestingly, under overexpression of Plk4, the simulated Plk4 patterns were relatively unstable throughout the time course ( Fig. 4 B ), until they were stabilized via the entry of STIL.	 Interestingly under [EXPE] of [GENE] the simulated Plk4 patterns were relatively unstable throughout the time course   Fig 4 B   until they were stabilized via the entry of STIL 
2019	PMC6829667	plk4	overexpression	Interestingly, under overexpression of Plk4, the simulated Plk4 patterns were relatively unstable throughout the time course ( Fig. 4 B ), until they were stabilized via the entry of STIL.	 Interestingly under [EXPE] of Plk4 the simulated [GENE] patterns were relatively unstable throughout the time course   Fig 4 B   until they were stabilized via the entry of STIL 
2019	PMC6829667	stil	overexpression	Interestingly, under overexpression of Plk4, the simulated Plk4 patterns were relatively unstable throughout the time course ( Fig. 4 B ), until they were stabilized via the entry of STIL.	 Interestingly under [EXPE] of Plk4 the simulated Plk4 patterns were relatively unstable throughout the time course   Fig 4 B   until they were stabilized via the entry of [GENE] 
2019	PMC6829667	stil	overexpression	Overexpression of STIL was then simulated by setting a lower threshold (one fifth) of STIL binding to Plk4 foci.	 [EXPE] of [GENE] was then simulated by setting a lower threshold  one fifth  of STIL binding to Plk4 foci 
2019	PMC6829667	stil	overexpression	Overexpression of STIL was then simulated by setting a lower threshold (one fifth) of STIL binding to Plk4 foci.	 [EXPE] of STIL was then simulated by setting a lower threshold  one fifth  of [GENE] binding to Plk4 foci 
2019	PMC6829667	plk4	overexpression	Overexpression of STIL was then simulated by setting a lower threshold (one fifth) of STIL binding to Plk4 foci.	 [EXPE] of STIL was then simulated by setting a lower threshold  one fifth  of STIL binding to [GENE] foci 
2019	PMC6829667	plk4	overexpression	Interestingly, the numbers of stabilized Plk4 foci in the overexpression simulations did not exceed six, potentially explaining the limitation in the maximum number of overduplicated daughter centrioles.	 Interestingly the numbers of stabilized [GENE] foci in the [EXPE] simulations did not exceed six potentially explaining the limitation in the maximum number of overduplicated daughter centrioles 
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that [GENE] is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that Plk4 is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of [GENE] and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] [EXPE] centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] inhibitor centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 [EXPE] centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 inhibitor centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	cep152	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	plk4	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that [GENE] is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibition	Assuming that Plk4 is converted into its active form via autophosphorylation, inhibition of its kinase activity may decelerate the activation of Plk4 and diminishes the LI effect ( Fig. 3 A ).	 Assuming that Plk4 is converted into its active form via autophosphorylation [EXPE] of its kinase activity may decelerate the activation of [GENE] and diminishes the LI effect   Fig 3 A   
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] [EXPE] centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the [GENE] inhibitor centrinone   Wong et al 2015   Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	plk4	inhibitor	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 [EXPE] centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our STED observations  Fig S3 A  
2019	PMC6829667	plk4	sted	In contrast, upon treatment with the Plk4 inhibitor centrinone ( Wong et al., 2015 ), Plk4 exhibited ninefold rotationally symmetrical spatial patterns in our STED observations (Fig. S3 A).	 In contrast upon treatment with the Plk4 inhibitor centrinone   Wong et al 2015   [GENE] exhibited ninefold rotationally symmetrical spatial patterns in our [EXPE] observations  Fig S3 A  
2019	PMC6829667	cep152	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	cep152	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of [GENE] further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of Plk4 and its scaffold 
2019	PMC6829667	plk4	electron microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron [EXPE] or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion [EXPE]   Chen et al 2015 ;  Chang et al 2017   besides STED microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	sted	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides [EXPE] microscopy may provide more information about the relationship between the activity of [GENE] and its scaffold 
2019	PMC6829667	plk4	microscopy	Considering the somewhat unclear periodicity of CEP152, further investigation using electron microscopy or perhaps expansion microscopy ( Chen et al., 2015 ;  Chang et al., 2017 ), besides STED microscopy, may provide more information about the relationship between the activity of Plk4 and its scaffold.	 Considering the somewhat unclear periodicity of CEP152 further investigation using electron microscopy or perhaps expansion microscopy   Chen et al 2015 ;  Chang et al 2017   besides STED [EXPE] may provide more information about the relationship between the activity of [GENE] and its scaffold 
2017	PMC5509424	nek7	depletion	Depletion of NEK7 has been shown to have an effect on cell cycle progression, causing a range of phenotypes, including prometaphase arrest with spindle assembly defects ( Yissachar  et al. , 2006 ;  Kim  et al. , 2007 ;  Regan and Fry, 2009 ), delays in the cell cycle, and inhibition of cell proliferation ( Kim  et al. , 2011 ;  Saloura  et al. , 2015 ).	 [EXPE] of [GENE] has been shown to have an effect on cell cycle progression causing a range of phenotypes including prometaphase arrest with spindle assembly defects   Yissachar  et al  2006 ;  Kim  et al  2007 ;  Regan and Fry 2009   delays in the cell cycle and inhibition of cell proliferation   Kim  et al  2011 ;  Saloura  et al  2015   
2017	PMC5509424	nek7	inhibition	Depletion of NEK7 has been shown to have an effect on cell cycle progression, causing a range of phenotypes, including prometaphase arrest with spindle assembly defects ( Yissachar  et al. , 2006 ;  Kim  et al. , 2007 ;  Regan and Fry, 2009 ), delays in the cell cycle, and inhibition of cell proliferation ( Kim  et al. , 2011 ;  Saloura  et al. , 2015 ).	 Depletion of [GENE] has been shown to have an effect on cell cycle progression causing a range of phenotypes including prometaphase arrest with spindle assembly defects   Yissachar  et al  2006 ;  Kim  et al  2007 ;  Regan and Fry 2009   delays in the cell cycle and [EXPE] of cell proliferation   Kim  et al  2011 ;  Saloura  et al  2015   
2017	PMC5509424	nek7	interfering	Our initial experiments indicated that treatment with small interfering RNA (siRNA) against NEK7 in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA ( Figure 1A ).	 Our initial experiments indicated that treatment with small [EXPE] RNA  siRNA  against [GENE] in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA   Figure 1A   
2017	PMC5509424	nek7	sirna	Our initial experiments indicated that treatment with small interfering RNA (siRNA) against NEK7 in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA ( Figure 1A ).	 Our initial experiments indicated that treatment with small interfering RNA  [EXPE]  against [GENE] in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA   Figure 1A   
2017	PMC5509424	nek7	cell cultures	Our initial experiments indicated that treatment with small interfering RNA (siRNA) against NEK7 in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA ( Figure 1A ).	 Our initial experiments indicated that treatment with small interfering RNA  siRNA  against [GENE] in asynchronous U2OS [EXPE] caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA   Figure 1A   
2017	PMC5509424	nek7	sirna	Our initial experiments indicated that treatment with small interfering RNA (siRNA) against NEK7 in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control siRNA ( Figure 1A ).	 Our initial experiments indicated that treatment with small interfering RNA  siRNA  against [GENE] in asynchronous U2OS cell cultures caused a slight increase in the G0/G1 cell population compared with cells treated with control [EXPE]   Figure 1A   
2017	PMC5509424	nek7	sirnas	To confirm whether these cells indeed represent a cell cycle arrest, we arrested U2OS cells that were treated with control or NEK7 siRNAs at early mitosis using nocodazole and then released them into fresh medium ( Figure 1B ).	 To confirm whether these cells indeed represent a cell cycle arrest we arrested U2OS cells that were treated with control or [GENE] [EXPE] at early mitosis using nocodazole and then released them into fresh medium   Figure 1B   
2017	PMC5509424	nek7	depletion	Depletion of NEK7 causes a G1-phase arrest.	 [EXPE] of [GENE] causes a G1-phase arrest 
2017	PMC5509424	nek7	transfected	(A) Asynchronous U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and the cells were analyzed for their DNA content profiles.	  A  Asynchronous U2OS cells were [EXPE] with control or [GENE] siRNAs for 48 h and the cells were analyzed for their DNA content profiles 
2017	PMC5509424	nek7	sirnas	(A) Asynchronous U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and the cells were analyzed for their DNA content profiles.	  A  Asynchronous U2OS cells were transfected with control or [GENE] [EXPE] for 48 h and the cells were analyzed for their DNA content profiles 
2017	PMC5509424	nek7	transfected	(B) Schematic of the experimental conditions in C–E. U2OS cells were transfected with control or NEK7 siRNAs for 8 h and then synchronized at early mitosis with 100 ng/ml nocodazole (Noc) for 16 h. The cells were then released into fresh medium and collected at the indicated time points.	  B  Schematic of the experimental conditions in C–E U2OS cells were [EXPE] with control or [GENE] siRNAs for 8 h and then synchronized at early mitosis with 100 ng/ml nocodazole  Noc  for 16 h The cells were then released into fresh medium and collected at the indicated time points 
2017	PMC5509424	nek7	sirnas	(B) Schematic of the experimental conditions in C–E. U2OS cells were transfected with control or NEK7 siRNAs for 8 h and then synchronized at early mitosis with 100 ng/ml nocodazole (Noc) for 16 h. The cells were then released into fresh medium and collected at the indicated time points.	  B  Schematic of the experimental conditions in C–E U2OS cells were transfected with control or [GENE] [EXPE] for 8 h and then synchronized at early mitosis with 100 ng/ml nocodazole  Noc  for 16 h The cells were then released into fresh medium and collected at the indicated time points 
2017	PMC5509424	nek7	sirnas	All samples treated with control and NEK7 siRNAs were blotted on the same membrane; they have been separated for clarity.	 All samples treated with control and [GENE] [EXPE] were blotted on the same membrane; they have been separated for clarity 
2017	PMC5509424	cyclin b1	sirna	Expression levels of the mitotic cyclin B1 decreased in cells treated with NEK7 siRNA compared with control cells upon mitotic exit ( Figure 1D ).	 Expression levels of the mitotic [GENE] decreased in cells treated with NEK7 [EXPE] compared with control cells upon mitotic exit   Figure 1D   
2017	PMC5509424	nek7	sirna	Expression levels of the mitotic cyclin B1 decreased in cells treated with NEK7 siRNA compared with control cells upon mitotic exit ( Figure 1D ).	 Expression levels of the mitotic cyclin B1 decreased in cells treated with [GENE] [EXPE] compared with control cells upon mitotic exit   Figure 1D   
2017	PMC5509424	cdc20	depletion	The APC/C cofactor Cdc20, which is expressed from early S-phase to late mitosis, was also significantly down-regulated upon NEK7 depletion ( Figure 1E ).	 The APC/C cofactor [GENE] which is expressed from early S-phase to late mitosis was also significantly down-regulated upon NEK7 [EXPE]   Figure 1E   
2017	PMC5509424	nek7	depletion	The APC/C cofactor Cdc20, which is expressed from early S-phase to late mitosis, was also significantly down-regulated upon NEK7 depletion ( Figure 1E ).	 The APC/C cofactor Cdc20 which is expressed from early S-phase to late mitosis was also significantly down-regulated upon [GENE] [EXPE]   Figure 1E   
2017	PMC5509424	nek7	depletion	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that [GENE] [EXPE] induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	nek7	sirnas	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that [GENE] depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 [EXPE] for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	nek7	inhibition	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that [GENE] depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct [EXPE] of CDK2 activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	nek7	depletion	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 [EXPE] induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and [GENE] siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	nek7	sirnas	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and [GENE] [EXPE] for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	nek7	inhibition	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and [GENE] siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct [EXPE] of CDK2 activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	cdk2	depletion	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 [EXPE] induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of [GENE] activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	cdk2	sirnas	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 [EXPE] for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of [GENE] activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	cdk2	inhibition	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct [EXPE] of [GENE] activity as well as by binding proliferating cell nuclear antigen  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	proliferating cell nuclear antigen	depletion	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 [EXPE] induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding [GENE]  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	proliferating cell nuclear antigen	sirnas	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 [EXPE] for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding [GENE]  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	proliferating cell nuclear antigen	inhibition	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct [EXPE] of CDK2 activity as well as by binding [GENE]  PCNA  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	pcna	depletion	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 [EXPE] induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen  [GENE]  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	pcna	sirnas	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 [EXPE] for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen  [GENE]  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	pcna	inhibition	To further confirm that NEK7 depletion induces a G1 arrest, we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h. It is known that high levels of p21 can inhibit S-phase entry through the direct inhibition of CDK2 activity as well as by binding proliferating cell nuclear antigen (PCNA) to inhibit DNA synthesis ( Abbas and Dutta, 2009 ).	 To further confirm that NEK7 depletion induces a G1 arrest we looked at p21 levels in U2OS cells that were treated with control and NEK7 siRNAs for 48 h It is known that high levels of p21 can inhibit S-phase entry through the direct [EXPE] of CDK2 activity as well as by binding proliferating cell nuclear antigen  [GENE]  to inhibit DNA synthesis   Abbas and Dutta 2009   
2017	PMC5509424	nek7	depletion	Thus we conclude that depletion of NEK7 is sufficient to arrest or delay cells at the G1 stage of the cell cycle.	 Thus we conclude that [EXPE] of [GENE] is sufficient to arrest or delay cells at the G1 stage of the cell cycle 
2017	PMC5509424	nek7	depletion	Considering that the expression levels of several important cell cycle proteins required for proper G1 progression are affected upon depletion of NEK7 ( Figure 1, D–F ), we next investigated whether cells that are already in S-phase can complete DNA replication and undergo mitosis normally in the absence of NEK7.	 Considering that the expression levels of several important cell cycle proteins required for proper G1 progression are affected upon [EXPE] of [GENE]   Figure 1 D–F   we next investigated whether cells that are already in S-phase can complete DNA replication and undergo mitosis normally in the absence of NEK7 
2017	PMC5509424	nek7	depletion	Considering that the expression levels of several important cell cycle proteins required for proper G1 progression are affected upon depletion of NEK7 ( Figure 1, D–F ), we next investigated whether cells that are already in S-phase can complete DNA replication and undergo mitosis normally in the absence of NEK7.	 Considering that the expression levels of several important cell cycle proteins required for proper G1 progression are affected upon [EXPE] of NEK7   Figure 1 D–F   we next investigated whether cells that are already in S-phase can complete DNA replication and undergo mitosis normally in the absence of [GENE] 
2017	PMC5509424	nek7	depletion	To overcome the G1 arrest that was induced upon prolonged NEK7 depletion, we treated U2OS cells with either control or NEK7 siRNAs for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h, followed by subsequent release into fresh medium and sample collection ( Figure 2A ).	 To overcome the G1 arrest that was induced upon prolonged [GENE] [EXPE] we treated U2OS cells with either control or NEK7 siRNAs for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h followed by subsequent release into fresh medium and sample collection   Figure 2A   
2017	PMC5509424	nek7	sirnas	To overcome the G1 arrest that was induced upon prolonged NEK7 depletion, we treated U2OS cells with either control or NEK7 siRNAs for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h, followed by subsequent release into fresh medium and sample collection ( Figure 2A ).	 To overcome the G1 arrest that was induced upon prolonged [GENE] depletion we treated U2OS cells with either control or NEK7 [EXPE] for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h followed by subsequent release into fresh medium and sample collection   Figure 2A   
2017	PMC5509424	nek7	depletion	To overcome the G1 arrest that was induced upon prolonged NEK7 depletion, we treated U2OS cells with either control or NEK7 siRNAs for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h, followed by subsequent release into fresh medium and sample collection ( Figure 2A ).	 To overcome the G1 arrest that was induced upon prolonged NEK7 [EXPE] we treated U2OS cells with either control or [GENE] siRNAs for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h followed by subsequent release into fresh medium and sample collection   Figure 2A   
2017	PMC5509424	nek7	sirnas	To overcome the G1 arrest that was induced upon prolonged NEK7 depletion, we treated U2OS cells with either control or NEK7 siRNAs for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h, followed by subsequent release into fresh medium and sample collection ( Figure 2A ).	 To overcome the G1 arrest that was induced upon prolonged NEK7 depletion we treated U2OS cells with either control or [GENE] [EXPE] for 8 h and then arrested these cells at the G1/S transition or in S-phase by adding thymidine to the medium for 16 h followed by subsequent release into fresh medium and sample collection   Figure 2A   
2017	PMC5509424	cyclin a2	depletion	Depletion of cyclin A2 causes delays in the G2/M transition ( De Boer  et al. , 2008 ;  Gong and Ferrell, 2010 ;  Barr  et al. , 2016 ), and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation ( Musacchio and Salmon, 2007 ); hence low levels of cyclin A2 and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells ( Figure 2B ), as well as previously reported mitotic defects ( Yissachar  et al. , 2006 ;  Kim  et al. , 2007 ;  Regan and Fry, 2009 ;  Salem  et al. , 2010 ).	 [EXPE] of [GENE] causes delays in the G2/M transition   De Boer  et al  2008 ;  Gong and Ferrell 2010 ;  Barr  et al  2016   and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation   Musacchio and Salmon 2007  ; hence low levels of cyclin A2 and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells   Figure 2B   as well as previously reported mitotic defects   Yissachar  et al  2006 ;  Kim  et al  2007 ;  Regan and Fry 2009 ;  Salem  et al  2010   
2017	PMC5509424	cdc20	depletion	Depletion of cyclin A2 causes delays in the G2/M transition ( De Boer  et al. , 2008 ;  Gong and Ferrell, 2010 ;  Barr  et al. , 2016 ), and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation ( Musacchio and Salmon, 2007 ); hence low levels of cyclin A2 and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells ( Figure 2B ), as well as previously reported mitotic defects ( Yissachar  et al. , 2006 ;  Kim  et al. , 2007 ;  Regan and Fry, 2009 ;  Salem  et al. , 2010 ).	 [EXPE] of cyclin A2 causes delays in the G2/M transition   De Boer  et al  2008 ;  Gong and Ferrell 2010 ;  Barr  et al  2016   and [GENE] plays a crucial role in the spindle assembly checkpoint for chromosome segregation   Musacchio and Salmon 2007  ; hence low levels of cyclin A2 and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells   Figure 2B   as well as previously reported mitotic defects   Yissachar  et al  2006 ;  Kim  et al  2007 ;  Regan and Fry 2009 ;  Salem  et al  2010   
2017	PMC5509424	cyclin a2	depletion	Depletion of cyclin A2 causes delays in the G2/M transition ( De Boer  et al. , 2008 ;  Gong and Ferrell, 2010 ;  Barr  et al. , 2016 ), and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation ( Musacchio and Salmon, 2007 ); hence low levels of cyclin A2 and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells ( Figure 2B ), as well as previously reported mitotic defects ( Yissachar  et al. , 2006 ;  Kim  et al. , 2007 ;  Regan and Fry, 2009 ;  Salem  et al. , 2010 ).	 [EXPE] of cyclin A2 causes delays in the G2/M transition   De Boer  et al  2008 ;  Gong and Ferrell 2010 ;  Barr  et al  2016   and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation   Musacchio and Salmon 2007  ; hence low levels of [GENE] and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells   Figure 2B   as well as previously reported mitotic defects   Yissachar  et al  2006 ;  Kim  et al  2007 ;  Regan and Fry 2009 ;  Salem  et al  2010   
2017	PMC5509424	cdc20	depletion	Depletion of cyclin A2 causes delays in the G2/M transition ( De Boer  et al. , 2008 ;  Gong and Ferrell, 2010 ;  Barr  et al. , 2016 ), and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation ( Musacchio and Salmon, 2007 ); hence low levels of cyclin A2 and Cdc20 can largely account for the significant mitotic delays seen in these NEK7-depleted cells ( Figure 2B ), as well as previously reported mitotic defects ( Yissachar  et al. , 2006 ;  Kim  et al. , 2007 ;  Regan and Fry, 2009 ;  Salem  et al. , 2010 ).	 [EXPE] of cyclin A2 causes delays in the G2/M transition   De Boer  et al  2008 ;  Gong and Ferrell 2010 ;  Barr  et al  2016   and Cdc20 plays a crucial role in the spindle assembly checkpoint for chromosome segregation   Musacchio and Salmon 2007  ; hence low levels of cyclin A2 and [GENE] can largely account for the significant mitotic delays seen in these NEK7-depleted cells   Figure 2B   as well as previously reported mitotic defects   Yissachar  et al  2006 ;  Kim  et al  2007 ;  Regan and Fry 2009 ;  Salem  et al  2010   
2017	PMC5509424	nek7	depletion	Collectively our results suggest that the various defects in cell cycle progression observed upon depletion of NEK7 can be mostly explained by anomalous down-regulation in the expression levels of several critical cell cycle proteins.	 Collectively our results suggest that the various defects in cell cycle progression observed upon [EXPE] of [GENE] can be mostly explained by anomalous down-regulation in the expression levels of several critical cell cycle proteins 
2017	PMC5509424	nek7	transfected	(A) Schematic of the experimental conditions in B–D. U2OS cells were transfected with control or NEK7 siRNAs for 8 h and then synchronized at S-phase with 2 mM thymidine (Thy) for 16 h. The cells were then released into fresh medium and collected at the indicated time points.	  A  Schematic of the experimental conditions in B–D U2OS cells were [EXPE] with control or [GENE] siRNAs for 8 h and then synchronized at S-phase with 2 mM thymidine  Thy  for 16 h The cells were then released into fresh medium and collected at the indicated time points 
2017	PMC5509424	nek7	sirnas	(A) Schematic of the experimental conditions in B–D. U2OS cells were transfected with control or NEK7 siRNAs for 8 h and then synchronized at S-phase with 2 mM thymidine (Thy) for 16 h. The cells were then released into fresh medium and collected at the indicated time points.	  A  Schematic of the experimental conditions in B–D U2OS cells were transfected with control or [GENE] [EXPE] for 8 h and then synchronized at S-phase with 2 mM thymidine  Thy  for 16 h The cells were then released into fresh medium and collected at the indicated time points 
2017	PMC5509424	nek7	sirnas	All samples treated with control and NEK7 siRNAs were blotted on the same membrane; they have been separated for clarity.	 All samples treated with control and [GENE] [EXPE] were blotted on the same membrane; they have been separated for clarity 
2017	PMC5509424	nek7	knockdown	The knockdown of NEK7 has been reported to inhibit centriole duplication, as well as to reduce the total amount of pericentriolar material (PCM) that surrounds the centrioles and is required for the nucleation of spindle microtubules ( Kim  et al. , 2011 ).	 The [EXPE] of [GENE] has been reported to inhibit centriole duplication as well as to reduce the total amount of pericentriolar material  PCM  that surrounds the centrioles and is required for the nucleation of spindle microtubules   Kim  et al  2011   
2017	PMC5509424	nek7	inhibition	In addition, the PCM has been suggested to provide a suitable environment for centriole assembly by recruiting essential proteins ( Strnad and Gönczy, 2008 ), which was suggested to be the reason for the inhibition of centriole duplication in the absence of NEK7 ( Kim  et al. , 2011 ).	 In addition the PCM has been suggested to provide a suitable environment for centriole assembly by recruiting essential proteins   Strnad and Gönczy 2008   which was suggested to be the reason for the [EXPE] of centriole duplication in the absence of [GENE]   Kim  et al  2011   
2017	PMC5509424	nek7	depletion	Considering our results that NEK7 is required for the G1/S transition and affects the expression of various cyclin–CDK complexes, we speculated that some of the components required for the early stages of procentriole formation may also be affected upon NEK7 depletion.	 Considering our results that [GENE] is required for the G1/S transition and affects the expression of various cyclin–CDK complexes we speculated that some of the components required for the early stages of procentriole formation may also be affected upon NEK7 [EXPE] 
2017	PMC5509424	nek7	depletion	Considering our results that NEK7 is required for the G1/S transition and affects the expression of various cyclin–CDK complexes, we speculated that some of the components required for the early stages of procentriole formation may also be affected upon NEK7 depletion.	 Considering our results that NEK7 is required for the G1/S transition and affects the expression of various cyclin–CDK complexes we speculated that some of the components required for the early stages of procentriole formation may also be affected upon [GENE] [EXPE] 
2017	PMC5509424	cep192	depletion	We found that CEP192 and CEP152, which are the earliest scaffold proteins to promote procentriole assembly ( Sonnen  et al. , 2013 ), were not affected upon NEK7 depletion (see later discussion of  Figure 7, A, C, and E ).	 We found that [GENE] and CEP152 which are the earliest scaffold proteins to promote procentriole assembly   Sonnen  et al  2013   were not affected upon NEK7 [EXPE]  see later discussion of  Figure 7 A C and E   
2017	PMC5509424	cep152	depletion	We found that CEP192 and CEP152, which are the earliest scaffold proteins to promote procentriole assembly ( Sonnen  et al. , 2013 ), were not affected upon NEK7 depletion (see later discussion of  Figure 7, A, C, and E ).	 We found that CEP192 and [GENE] which are the earliest scaffold proteins to promote procentriole assembly   Sonnen  et al  2013   were not affected upon NEK7 [EXPE]  see later discussion of  Figure 7 A C and E   
2017	PMC5509424	nek7	depletion	We found that CEP192 and CEP152, which are the earliest scaffold proteins to promote procentriole assembly ( Sonnen  et al. , 2013 ), were not affected upon NEK7 depletion (see later discussion of  Figure 7, A, C, and E ).	 We found that CEP192 and CEP152 which are the earliest scaffold proteins to promote procentriole assembly   Sonnen  et al  2013   were not affected upon [GENE] [EXPE]  see later discussion of  Figure 7 A C and E   
2017	PMC5509424	nek7	depletion	Tang  et al. , 2009 ), were also absent from the centrosomes upon NEK7 depletion ( Figure 3, A–C ).	 Tang  et al  2009   were also absent from the centrosomes upon [GENE] [EXPE]   Figure 3 A–C   
2017	PMC5509424	stil	depletion	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of [GENE] SAS-6 and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 [EXPE] as determined by immunoblotting analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	stil	immunoblotting	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of [GENE] SAS-6 and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion as determined by [EXPE] analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	sas-6	depletion	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of STIL [GENE] and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 [EXPE] as determined by immunoblotting analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	sas-6	immunoblotting	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of STIL [GENE] and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion as determined by [EXPE] analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	cpap	depletion	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of STIL SAS-6 and [GENE] were low not only at the centrosomes but also in total cell lysates upon NEK7 [EXPE] as determined by immunoblotting analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	cpap	immunoblotting	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of STIL SAS-6 and [GENE] were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion as determined by [EXPE] analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	nek7	depletion	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of STIL SAS-6 and CPAP were low not only at the centrosomes but also in total cell lysates upon [GENE] [EXPE] as determined by immunoblotting analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	nek7	immunoblotting	Surprisingly, we found that the levels of STIL, SAS-6, and CPAP were low not only at the centrosomes but also in total cell lysates upon NEK7 depletion, as determined by immunoblotting analyses ( Figure 3D  and Supplemental Figure S1A).	 Surprisingly we found that the levels of STIL SAS-6 and CPAP were low not only at the centrosomes but also in total cell lysates upon [GENE] depletion as determined by [EXPE] analyses   Figure 3D  and Supplemental Figure S1A  
2017	PMC5509424	nek7	depletion	Thus it is likely that the reduction in their cytoplasmic and centrosomal levels that was observed upon NEK7 depletion is a consequence of the G1 arrest.	 Thus it is likely that the reduction in their cytoplasmic and centrosomal levels that was observed upon [GENE] [EXPE] is a consequence of the G1 arrest 
2017	PMC5509424	nek7	transfected	(A) Asynchronous U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and the cells were fixed and immunostained using the indicated antibodies.	  A  Asynchronous U2OS cells were [EXPE] with control or [GENE] siRNAs for 48 h and the cells were fixed and immunostained using the indicated antibodies 
2017	PMC5509424	nek7	sirnas	(A) Asynchronous U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and the cells were fixed and immunostained using the indicated antibodies.	  A  Asynchronous U2OS cells were transfected with control or [GENE] [EXPE] for 48 h and the cells were fixed and immunostained using the indicated antibodies 
2017	PMC5509424	nek7	immunostained	(A) Asynchronous U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and the cells were fixed and immunostained using the indicated antibodies.	  A  Asynchronous U2OS cells were transfected with control or [GENE] siRNAs for 48 h and the cells were fixed and [EXPE] using the indicated antibodies 
2017	PMC5509424	nek7	transfected	(E) U2OS cells were transfected with control or NEK7 siRNAs.	  E  U2OS cells were [EXPE] with control or [GENE] siRNAs 
2017	PMC5509424	nek7	sirnas	(E) U2OS cells were transfected with control or NEK7 siRNAs.	  E  U2OS cells were transfected with control or [GENE] [EXPE] 
2017	PMC5509424	nek7	transfected	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were [EXPE] with control or [GENE] siRNAs simultaneously induced for overexpression of GFP-STIL and fixed after 48 h Cells in E and F were immunostained with antibodies specific to STIL or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	nek7	sirnas	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were transfected with control or [GENE] [EXPE] simultaneously induced for overexpression of GFP-STIL and fixed after 48 h Cells in E and F were immunostained with antibodies specific to STIL or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	nek7	overexpression	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were transfected with control or [GENE] siRNAs simultaneously induced for [EXPE] of GFP-STIL and fixed after 48 h Cells in E and F were immunostained with antibodies specific to STIL or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	nek7	immunostained	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were transfected with control or [GENE] siRNAs simultaneously induced for overexpression of GFP-STIL and fixed after 48 h Cells in E and F were [EXPE] with antibodies specific to STIL or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	stil	transfected	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were [EXPE] with control or NEK7 siRNAs simultaneously induced for overexpression of GFP-STIL and fixed after 48 h Cells in E and F were immunostained with antibodies specific to [GENE] or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	stil	sirnas	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were transfected with control or NEK7 [EXPE] simultaneously induced for overexpression of GFP-STIL and fixed after 48 h Cells in E and F were immunostained with antibodies specific to [GENE] or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	stil	overexpression	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs simultaneously induced for [EXPE] of GFP-STIL and fixed after 48 h Cells in E and F were immunostained with antibodies specific to [GENE] or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	stil	immunostained	(F) GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs, simultaneously induced for overexpression of GFP-STIL, and fixed after 48 h. Cells in E and F were immunostained with antibodies specific to STIL or GFP (red) and Flag or Centrin (green).	  F  GFP-STIL U2OS cells were transfected with control or NEK7 siRNAs simultaneously induced for overexpression of GFP-STIL and fixed after 48 h Cells in E and F were [EXPE] with antibodies specific to [GENE] or GFP  red  and Flag or Centrin  green  
2017	PMC5509424	plk4	overexpression	Overexpression of PLK4, STIL, or SAS-6 causes amplification of centrioles independently of cell cycle–mediated regulation on the centrosomes ( Habedanck  et al. , 2005 ;  Leidel  et al. , 2005 ;  Arquint  et al. , 2012 ).	 [EXPE] of [GENE] STIL or SAS-6 causes amplification of centrioles independently of cell cycle–mediated regulation on the centrosomes   Habedanck  et al  2005 ;  Leidel  et al  2005 ;  Arquint  et al  2012   
2017	PMC5509424	stil	overexpression	Overexpression of PLK4, STIL, or SAS-6 causes amplification of centrioles independently of cell cycle–mediated regulation on the centrosomes ( Habedanck  et al. , 2005 ;  Leidel  et al. , 2005 ;  Arquint  et al. , 2012 ).	 [EXPE] of PLK4 [GENE] or SAS-6 causes amplification of centrioles independently of cell cycle–mediated regulation on the centrosomes   Habedanck  et al  2005 ;  Leidel  et al  2005 ;  Arquint  et al  2012   
2017	PMC5509424	sas-6	overexpression	Overexpression of PLK4, STIL, or SAS-6 causes amplification of centrioles independently of cell cycle–mediated regulation on the centrosomes ( Habedanck  et al. , 2005 ;  Leidel  et al. , 2005 ;  Arquint  et al. , 2012 ).	 [EXPE] of PLK4 STIL or [GENE] causes amplification of centrioles independently of cell cycle–mediated regulation on the centrosomes   Habedanck  et al  2005 ;  Leidel  et al  2005 ;  Arquint  et al  2012   
2017	PMC5509424	plk4	overexpression	Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected, in cells pretreated with NEK7 siRNA, both centriole numbers and the numbers of PLK4/STIL foci were reduced ( Figure 3, E–G ).	 Whereas [EXPE] of [GENE] and STIL induced centriole overduplication in control cells as expected in cells pretreated with NEK7 siRNA both centriole numbers and the numbers of PLK4/STIL foci were reduced   Figure 3 E–G   
2017	PMC5509424	plk4	sirna	Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected, in cells pretreated with NEK7 siRNA, both centriole numbers and the numbers of PLK4/STIL foci were reduced ( Figure 3, E–G ).	 Whereas overexpression of [GENE] and STIL induced centriole overduplication in control cells as expected in cells pretreated with NEK7 [EXPE] both centriole numbers and the numbers of PLK4/STIL foci were reduced   Figure 3 E–G   
2017	PMC5509424	stil	overexpression	Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected, in cells pretreated with NEK7 siRNA, both centriole numbers and the numbers of PLK4/STIL foci were reduced ( Figure 3, E–G ).	 Whereas [EXPE] of PLK4 and [GENE] induced centriole overduplication in control cells as expected in cells pretreated with NEK7 siRNA both centriole numbers and the numbers of PLK4/STIL foci were reduced   Figure 3 E–G   
2017	PMC5509424	stil	sirna	Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected, in cells pretreated with NEK7 siRNA, both centriole numbers and the numbers of PLK4/STIL foci were reduced ( Figure 3, E–G ).	 Whereas overexpression of PLK4 and [GENE] induced centriole overduplication in control cells as expected in cells pretreated with NEK7 [EXPE] both centriole numbers and the numbers of PLK4/STIL foci were reduced   Figure 3 E–G   
2017	PMC5509424	nek7	overexpression	Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected, in cells pretreated with NEK7 siRNA, both centriole numbers and the numbers of PLK4/STIL foci were reduced ( Figure 3, E–G ).	 Whereas [EXPE] of PLK4 and STIL induced centriole overduplication in control cells as expected in cells pretreated with [GENE] siRNA both centriole numbers and the numbers of PLK4/STIL foci were reduced   Figure 3 E–G   
2017	PMC5509424	nek7	sirna	Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected, in cells pretreated with NEK7 siRNA, both centriole numbers and the numbers of PLK4/STIL foci were reduced ( Figure 3, E–G ).	 Whereas overexpression of PLK4 and STIL induced centriole overduplication in control cells as expected in cells pretreated with [GENE] [EXPE] both centriole numbers and the numbers of PLK4/STIL foci were reduced   Figure 3 E–G   
2017	PMC5509424	nek7	depleted	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells [EXPE] of [GENE] and overexpressing PLK4 PLK4 formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the depletion of STIL   Ohta  et al  2014   
2017	PMC5509424	nek7	depletion	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells depleted of [GENE] and overexpressing PLK4 PLK4 formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the [EXPE] of STIL   Ohta  et al  2014   
2017	PMC5509424	plk4	depleted	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells [EXPE] of NEK7 and overexpressing [GENE] PLK4 formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the depletion of STIL   Ohta  et al  2014   
2017	PMC5509424	plk4	depletion	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells depleted of NEK7 and overexpressing [GENE] PLK4 formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the [EXPE] of STIL   Ohta  et al  2014   
2017	PMC5509424	plk4	depleted	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells [EXPE] of NEK7 and overexpressing PLK4 [GENE] formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the depletion of STIL   Ohta  et al  2014   
2017	PMC5509424	plk4	depletion	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells depleted of NEK7 and overexpressing PLK4 [GENE] formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the [EXPE] of STIL   Ohta  et al  2014   
2017	PMC5509424	stil	depleted	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells [EXPE] of NEK7 and overexpressing PLK4 PLK4 formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the depletion of [GENE]   Ohta  et al  2014   
2017	PMC5509424	stil	depletion	Of interest, in cells depleted of NEK7 and overexpressing PLK4, PLK4 formed ring-like foci ( Figure 3E ), which is reminiscent of the phenotype associated with the depletion of STIL ( Ohta  et al. , 2014 ).	 Of interest in cells depleted of NEK7 and overexpressing PLK4 PLK4 formed ring-like foci   Figure 3E   which is reminiscent of the phenotype associated with the [EXPE] of [GENE]   Ohta  et al  2014   
2017	PMC5509424	plk4	inhibited	This result suggests that, despite high PLK4 levels, centriole amplification was inhibited by the absence of STIL and possibly other procentriolar proteins.	 This result suggests that despite high [GENE] levels centriole amplification was [EXPE] by the absence of STIL and possibly other procentriolar proteins 
2017	PMC5509424	stil	inhibited	This result suggests that, despite high PLK4 levels, centriole amplification was inhibited by the absence of STIL and possibly other procentriolar proteins.	 This result suggests that despite high PLK4 levels centriole amplification was [EXPE] by the absence of [GENE] and possibly other procentriolar proteins 
2017	PMC5509424	stil	overexpression	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that [EXPE] of [GENE] did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells   Figure 3 F and G   NEK7 may have an additional role in the maintenance of STIL at centrioles 
2017	PMC5509424	stil	rescue	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that overexpression of [GENE] did not [EXPE] the expression levels of STIL at centrioles in NEK7-depleted cells   Figure 3 F and G   NEK7 may have an additional role in the maintenance of STIL at centrioles 
2017	PMC5509424	stil	overexpression	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that [EXPE] of STIL did not rescue the expression levels of [GENE] at centrioles in NEK7-depleted cells   Figure 3 F and G   NEK7 may have an additional role in the maintenance of STIL at centrioles 
2017	PMC5509424	stil	rescue	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that overexpression of STIL did not [EXPE] the expression levels of [GENE] at centrioles in NEK7-depleted cells   Figure 3 F and G   NEK7 may have an additional role in the maintenance of STIL at centrioles 
2017	PMC5509424	nek7	overexpression	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that [EXPE] of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells   Figure 3 F and G   [GENE] may have an additional role in the maintenance of STIL at centrioles 
2017	PMC5509424	nek7	rescue	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that overexpression of STIL did not [EXPE] the expression levels of STIL at centrioles in NEK7-depleted cells   Figure 3 F and G   [GENE] may have an additional role in the maintenance of STIL at centrioles 
2017	PMC5509424	stil	overexpression	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that [EXPE] of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells   Figure 3 F and G   NEK7 may have an additional role in the maintenance of [GENE] at centrioles 
2017	PMC5509424	stil	rescue	Furthermore, given that overexpression of STIL did not rescue the expression levels of STIL at centrioles in NEK7-depleted cells ( Figure 3, F and G ), NEK7 may have an additional role in the maintenance of STIL at centrioles.	 Furthermore given that overexpression of STIL did not [EXPE] the expression levels of STIL at centrioles in NEK7-depleted cells   Figure 3 F and G   NEK7 may have an additional role in the maintenance of [GENE] at centrioles 
2017	PMC5509424	nek7	inhibition	Taken together, these results suggest that inhibition of procentriole formation upon NEK7 depletion is due to low cytoplasmic expression levels of several important procentriole proteins, possibly caused by the G1 arrest.	 Taken together these results suggest that [EXPE] of procentriole formation upon [GENE] depletion is due to low cytoplasmic expression levels of several important procentriole proteins possibly caused by the G1 arrest 
2017	PMC5509424	nek7	depletion	Taken together, these results suggest that inhibition of procentriole formation upon NEK7 depletion is due to low cytoplasmic expression levels of several important procentriole proteins, possibly caused by the G1 arrest.	 Taken together these results suggest that inhibition of procentriole formation upon [GENE] [EXPE] is due to low cytoplasmic expression levels of several important procentriole proteins possibly caused by the G1 arrest 
2017	PMC5509424	nek7	sirna	Hence we treated RPE1 cells with NEK7 siRNA for 48 h and tested the frequency of ciliation compared with that of control cells after serum starvation for the same duration.	 Hence we treated RPE1 cells with [GENE] [EXPE] for 48 h and tested the frequency of ciliation compared with that of control cells after serum starvation for the same duration 
2017	PMC5509424	nek7	starvation	Hence we treated RPE1 cells with NEK7 siRNA for 48 h and tested the frequency of ciliation compared with that of control cells after serum starvation for the same duration.	 Hence we treated RPE1 cells with [GENE] siRNA for 48 h and tested the frequency of ciliation compared with that of control cells after serum [EXPE] for the same duration 
2017	PMC5509424	ift88	immunostained	To quantify ciliogenesis, we immunostained these cells with antibodies against acetylated tubulin (AcTub) and the intraflagellar transport protein IFT88, which mark both the cilium and centrioles ( Figure 4, A and D ).	 To quantify ciliogenesis we [EXPE] these cells with antibodies against acetylated tubulin  AcTub  and the intraflagellar transport protein [GENE] which mark both the cilium and centrioles   Figure 4 A and D   
2017	PMC5509424	mark	immunostained	To quantify ciliogenesis, we immunostained these cells with antibodies against acetylated tubulin (AcTub) and the intraflagellar transport protein IFT88, which mark both the cilium and centrioles ( Figure 4, A and D ).	 To quantify ciliogenesis we [EXPE] these cells with antibodies against acetylated tubulin  AcTub  and the intraflagellar transport protein IFT88 which [GENE] both the cilium and centrioles   Figure 4 A and D   
2017	PMC5509424	nek7	starvation	This result suggests that the G1 arrest caused in siNEK7-treated cells may be very similar to what occurs in cells that have entered G0/G1 after a prolonged serum starvation and reinforces our hypothesis that NEK7 plays an important role in G1 progression, particularly for overcoming the restriction point.	 This result suggests that the G1 arrest caused in siNEK7-treated cells may be very similar to what occurs in cells that have entered G0/G1 after a prolonged serum [EXPE] and reinforces our hypothesis that [GENE] plays an important role in G1 progression particularly for overcoming the restriction point 
2017	PMC5509424	nek7	depletion	Depletion of NEK7 induces ciliogenesis.	 [EXPE] of [GENE] induces ciliogenesis 
2017	PMC5509424	nek7	transfected	RPE1 cells were transfected with control and NEK7 siRNAs for a total of 48 h, and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h. (A) The cells were then fixed and stained with the indicated antibodies.	 RPE1 cells were [EXPE] with control and [GENE] siRNAs for a total of 48 h and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h  A  The cells were then fixed and stained with the indicated antibodies 
2017	PMC5509424	nek7	sirnas	RPE1 cells were transfected with control and NEK7 siRNAs for a total of 48 h, and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h. (A) The cells were then fixed and stained with the indicated antibodies.	 RPE1 cells were transfected with control and [GENE] [EXPE] for a total of 48 h and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h  A  The cells were then fixed and stained with the indicated antibodies 
2017	PMC5509424	nek7	sirna	RPE1 cells were transfected with control and NEK7 siRNAs for a total of 48 h, and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h. (A) The cells were then fixed and stained with the indicated antibodies.	 RPE1 cells were transfected with control and [GENE] siRNAs for a total of 48 h and additional samples were simultaneously treated with a control [EXPE] and released into serum-free medium for a total of 48 h  A  The cells were then fixed and stained with the indicated antibodies 
2017	PMC5509424	nek7	stained	RPE1 cells were transfected with control and NEK7 siRNAs for a total of 48 h, and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h. (A) The cells were then fixed and stained with the indicated antibodies.	 RPE1 cells were transfected with control and [GENE] siRNAs for a total of 48 h and additional samples were simultaneously treated with a control siRNA and released into serum-free medium for a total of 48 h  A  The cells were then fixed and [EXPE] with the indicated antibodies 
2017	PMC5509424	stil	starvation	However, in the control experiments with serum starvation, we found that both STIL and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells ( Figure 4, C and D , and Supplemental Figure S6A), and centriolar recruitment of both STIL and SAS-6 appeared to be independent of the total expression levels of these proteins ( Figure 4E ).	 However in the control experiments with serum [EXPE] we found that both [GENE] and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells   Figure 4 C and D  and Supplemental Figure S6A  and centriolar recruitment of both STIL and SAS-6 appeared to be independent of the total expression levels of these proteins   Figure 4E   
2017	PMC5509424	sas-6	starvation	However, in the control experiments with serum starvation, we found that both STIL and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells ( Figure 4, C and D , and Supplemental Figure S6A), and centriolar recruitment of both STIL and SAS-6 appeared to be independent of the total expression levels of these proteins ( Figure 4E ).	 However in the control experiments with serum [EXPE] we found that both STIL and [GENE] were present around these mother centrioles in ∼48% of all ciliated cells   Figure 4 C and D  and Supplemental Figure S6A  and centriolar recruitment of both STIL and SAS-6 appeared to be independent of the total expression levels of these proteins   Figure 4E   
2017	PMC5509424	stil	starvation	However, in the control experiments with serum starvation, we found that both STIL and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells ( Figure 4, C and D , and Supplemental Figure S6A), and centriolar recruitment of both STIL and SAS-6 appeared to be independent of the total expression levels of these proteins ( Figure 4E ).	 However in the control experiments with serum [EXPE] we found that both STIL and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells   Figure 4 C and D  and Supplemental Figure S6A  and centriolar recruitment of both [GENE] and SAS-6 appeared to be independent of the total expression levels of these proteins   Figure 4E   
2017	PMC5509424	sas-6	starvation	However, in the control experiments with serum starvation, we found that both STIL and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells ( Figure 4, C and D , and Supplemental Figure S6A), and centriolar recruitment of both STIL and SAS-6 appeared to be independent of the total expression levels of these proteins ( Figure 4E ).	 However in the control experiments with serum [EXPE] we found that both STIL and SAS-6 were present around these mother centrioles in ∼48% of all ciliated cells   Figure 4 C and D  and Supplemental Figure S6A  and centriolar recruitment of both STIL and [GENE] appeared to be independent of the total expression levels of these proteins   Figure 4E   
2017	PMC5509424	nek7	depletion	We demonstrate that the depletion of NEK7 induces a G1 arrest, and to a certain extent, this arrest explains the down-regulation of various procentriole proteins, such as STIL and SAS-6, that are expressed toward the G1/S transition ( Erez  et al. , 2008 ;  Foster  et al. , 2010 ).	 We demonstrate that the [EXPE] of [GENE] induces a G1 arrest and to a certain extent this arrest explains the down-regulation of various procentriole proteins such as STIL and SAS-6 that are expressed toward the G1/S transition   Erez  et al  2008 ;  Foster  et al  2010   
2017	PMC5509424	stil	depletion	We demonstrate that the depletion of NEK7 induces a G1 arrest, and to a certain extent, this arrest explains the down-regulation of various procentriole proteins, such as STIL and SAS-6, that are expressed toward the G1/S transition ( Erez  et al. , 2008 ;  Foster  et al. , 2010 ).	 We demonstrate that the [EXPE] of NEK7 induces a G1 arrest and to a certain extent this arrest explains the down-regulation of various procentriole proteins such as [GENE] and SAS-6 that are expressed toward the G1/S transition   Erez  et al  2008 ;  Foster  et al  2010   
2017	PMC5509424	sas-6	depletion	We demonstrate that the depletion of NEK7 induces a G1 arrest, and to a certain extent, this arrest explains the down-regulation of various procentriole proteins, such as STIL and SAS-6, that are expressed toward the G1/S transition ( Erez  et al. , 2008 ;  Foster  et al. , 2010 ).	 We demonstrate that the [EXPE] of NEK7 induces a G1 arrest and to a certain extent this arrest explains the down-regulation of various procentriole proteins such as STIL and [GENE] that are expressed toward the G1/S transition   Erez  et al  2008 ;  Foster  et al  2010   
2017	PMC5509424	nek7	transfected	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were [EXPE] with control or [GENE] siRNAs for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using STIL SAS-6 or tubulin antibodies 
2017	PMC5509424	nek7	sirnas	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or [GENE] [EXPE] for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using STIL SAS-6 or tubulin antibodies 
2017	PMC5509424	nek7	transfected	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or [GENE] siRNAs for 24 h and then [EXPE] with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using STIL SAS-6 or tubulin antibodies 
2017	PMC5509424	nek7	immunoblotting	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or [GENE] siRNAs for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by [EXPE] using STIL SAS-6 or tubulin antibodies 
2017	PMC5509424	stil	transfected	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were [EXPE] with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using [GENE] SAS-6 or tubulin antibodies 
2017	PMC5509424	stil	sirnas	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or NEK7 [EXPE] for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using [GENE] SAS-6 or tubulin antibodies 
2017	PMC5509424	stil	transfected	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then [EXPE] with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using [GENE] SAS-6 or tubulin antibodies 
2017	PMC5509424	stil	immunoblotting	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by [EXPE] using [GENE] SAS-6 or tubulin antibodies 
2017	PMC5509424	sas-6	transfected	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were [EXPE] with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using STIL [GENE] or tubulin antibodies 
2017	PMC5509424	sas-6	sirnas	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or NEK7 [EXPE] for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using STIL [GENE] or tubulin antibodies 
2017	PMC5509424	sas-6	transfected	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then [EXPE] with the indicated vectors for another 24 h Total cell lysates were analyzed by immunoblotting using STIL [GENE] or tubulin antibodies 
2017	PMC5509424	sas-6	immunoblotting	(A, C) U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h. Total cell lysates were analyzed by immunoblotting using STIL, SAS-6, or tubulin antibodies.	  A C  U2OS cells were transfected with control or NEK7 siRNAs for 24 h and then transfected with the indicated vectors for another 24 h Total cell lysates were analyzed by [EXPE] using STIL [GENE] or tubulin antibodies 
2017	PMC5509424	nek7	transfected	(D) U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and 10 μM MG132 was added for the last 6 h of the siRNA treatment.	  D  U2OS cells were [EXPE] with control or [GENE] siRNAs for 48 h and 10 μM MG132 was added for the last 6 h of the siRNA treatment 
2017	PMC5509424	nek7	sirnas	(D) U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and 10 μM MG132 was added for the last 6 h of the siRNA treatment.	  D  U2OS cells were transfected with control or [GENE] [EXPE] for 48 h and 10 μM MG132 was added for the last 6 h of the siRNA treatment 
2017	PMC5509424	nek7	sirna	(D) U2OS cells were transfected with control or NEK7 siRNAs for 48 h, and 10 μM MG132 was added for the last 6 h of the siRNA treatment.	  D  U2OS cells were transfected with control or [GENE] siRNAs for 48 h and 10 μM MG132 was added for the last 6 h of the [EXPE] treatment 
2017	PMC5509424	stil	rescued	Among these mutants, the deletion of the C-terminal region spanning residues 1001–1287 (ΔC) largely rescued the low protein levels of STIL in NEK7-depleted cells.	 Among these mutants the deletion of the C-terminal region spanning residues 1001–1287  ΔC  largely [EXPE] the low protein levels of [GENE] in NEK7-depleted cells 
2017	PMC5509424	stil	rescuing	Upon narrowing the C-terminal region of STIL even further, we discovered that a triple alanine mutation of the KEN-box (KEN/AAA) in STIL was effective in rescuing the protein expression levels of ectopically expressed STIL ( Figure 5, A and B ).	 Upon narrowing the C-terminal region of [GENE] even further we discovered that a triple alanine mutation of the KEN-box  KEN/AAA  in STIL was effective in [EXPE] the protein expression levels of ectopically expressed STIL   Figure 5 A and B   
2017	PMC5509424	stil	rescuing	Upon narrowing the C-terminal region of STIL even further, we discovered that a triple alanine mutation of the KEN-box (KEN/AAA) in STIL was effective in rescuing the protein expression levels of ectopically expressed STIL ( Figure 5, A and B ).	 Upon narrowing the C-terminal region of STIL even further we discovered that a triple alanine mutation of the KEN-box  KEN/AAA  in [GENE] was effective in [EXPE] the protein expression levels of ectopically expressed STIL   Figure 5 A and B   
2017	PMC5509424	stil	rescuing	Upon narrowing the C-terminal region of STIL even further, we discovered that a triple alanine mutation of the KEN-box (KEN/AAA) in STIL was effective in rescuing the protein expression levels of ectopically expressed STIL ( Figure 5, A and B ).	 Upon narrowing the C-terminal region of STIL even further we discovered that a triple alanine mutation of the KEN-box  KEN/AAA  in STIL was effective in [EXPE] the protein expression levels of ectopically expressed [GENE]   Figure 5 A and B   
2017	PMC5509424	sas-6	rescue	Because SAS-6 also contains a KEN-box, we also tested the stability of a KEN/AAA mutant of SAS-6 in NEK7-depleted cells but did not observe any rescue in expression (unpublished data).	 Because [GENE] also contains a KEN-box we also tested the stability of a KEN/AAA mutant of SAS-6 in NEK7-depleted cells but did not observe any [EXPE] in expression  unpublished data  
2017	PMC5509424	sas-6	rescue	Because SAS-6 also contains a KEN-box, we also tested the stability of a KEN/AAA mutant of SAS-6 in NEK7-depleted cells but did not observe any rescue in expression (unpublished data).	 Because SAS-6 also contains a KEN-box we also tested the stability of a KEN/AAA mutant of [GENE] in NEK7-depleted cells but did not observe any [EXPE] in expression  unpublished data  
2017	PMC5509424	stil	inhibitor	To examine whether STIL undergoes active degradation by the proteasome in NEK7-depleted cells, we treated these cells with the proteasome inhibitor, MG132 ( Figure 5, D and E ).	 To examine whether [GENE] undergoes active degradation by the proteasome in NEK7-depleted cells we treated these cells with the proteasome [EXPE] MG132   Figure 5 D and E   
2017	PMC5509424	stil	rescued	As expected, both endogenous and ectopically expressed STIL were partially rescued upon proteasomal inhibition, whereas the protein levels of the KEN/AAA mutant of STIL were not largely affected.	 As expected both endogenous and ectopically expressed [GENE] were partially [EXPE] upon proteasomal inhibition whereas the protein levels of the KEN/AAA mutant of STIL were not largely affected 
2017	PMC5509424	stil	inhibition	As expected, both endogenous and ectopically expressed STIL were partially rescued upon proteasomal inhibition, whereas the protein levels of the KEN/AAA mutant of STIL were not largely affected.	 As expected both endogenous and ectopically expressed [GENE] were partially rescued upon proteasomal [EXPE] whereas the protein levels of the KEN/AAA mutant of STIL were not largely affected 
2017	PMC5509424	stil	rescued	As expected, both endogenous and ectopically expressed STIL were partially rescued upon proteasomal inhibition, whereas the protein levels of the KEN/AAA mutant of STIL were not largely affected.	 As expected both endogenous and ectopically expressed STIL were partially [EXPE] upon proteasomal inhibition whereas the protein levels of the KEN/AAA mutant of [GENE] were not largely affected 
2017	PMC5509424	stil	inhibition	As expected, both endogenous and ectopically expressed STIL were partially rescued upon proteasomal inhibition, whereas the protein levels of the KEN/AAA mutant of STIL were not largely affected.	 As expected both endogenous and ectopically expressed STIL were partially rescued upon proteasomal [EXPE] whereas the protein levels of the KEN/AAA mutant of [GENE] were not largely affected 
2017	PMC5509424	cdh1	inhibitor	The APC/C Cdh1  is typically active from late mitosis to late G1 and plays a role in preventing premature DNA replication by regulating the levels of G1 cyclins as well as the CDK inhibitor p21 ( Pines, 2011 ;  Qiao  et al. , 2014 ).	 The APC/C [GENE]  is typically active from late mitosis to late G1 and plays a role in preventing premature DNA replication by regulating the levels of G1 cyclins as well as the CDK [EXPE] p21   Pines 2011 ;  Qiao  et al  2014   
2017	PMC5509424	cdh1	inactivation	Several feedback loops involving CDK-mediated phosphorylation of Cdh1 are necessary for the inactivation of APC/C Cdh1  at late G1, without which entry into the S-phase is blocked.	 Several feedback loops involving CDK-mediated phosphorylation of [GENE] are necessary for the [EXPE] of APC/C Cdh1  at late G1 without which entry into the S-phase is blocked 
2017	PMC5509424	cdh1	blocked	Several feedback loops involving CDK-mediated phosphorylation of Cdh1 are necessary for the inactivation of APC/C Cdh1  at late G1, without which entry into the S-phase is blocked.	 Several feedback loops involving CDK-mediated phosphorylation of [GENE] are necessary for the inactivation of APC/C Cdh1  at late G1 without which entry into the S-phase is [EXPE] 
2017	PMC5509424	cdh1	inactivation	Several feedback loops involving CDK-mediated phosphorylation of Cdh1 are necessary for the inactivation of APC/C Cdh1  at late G1, without which entry into the S-phase is blocked.	 Several feedback loops involving CDK-mediated phosphorylation of Cdh1 are necessary for the [EXPE] of APC/C [GENE]  at late G1 without which entry into the S-phase is blocked 
2017	PMC5509424	cdh1	blocked	Several feedback loops involving CDK-mediated phosphorylation of Cdh1 are necessary for the inactivation of APC/C Cdh1  at late G1, without which entry into the S-phase is blocked.	 Several feedback loops involving CDK-mediated phosphorylation of Cdh1 are necessary for the inactivation of APC/C [GENE]  at late G1 without which entry into the S-phase is [EXPE] 
2017	PMC5509424	cdh1	depleted	Instead, we tried to characterize whether Cdh1 might have altered expression patterns if NEK7 is depleted from cycling cells.	 Instead we tried to characterize whether [GENE] might have altered expression patterns if NEK7 is [EXPE] from cycling cells 
2017	PMC5509424	nek7	depleted	Instead, we tried to characterize whether Cdh1 might have altered expression patterns if NEK7 is depleted from cycling cells.	 Instead we tried to characterize whether Cdh1 might have altered expression patterns if [GENE] is [EXPE] from cycling cells 
2017	PMC5509424	cdh1	sirna	First, overall Cdh1 expression levels were not affected on prolonged treatment of NEK7 siRNA ( Figure 1G ), even though the expression levels Cdc20 were low, which is a target of the APC/C Cdh1 .	 First overall [GENE] expression levels were not affected on prolonged treatment of NEK7 [EXPE]   Figure 1G   even though the expression levels Cdc20 were low which is a target of the APC/C Cdh1  
2017	PMC5509424	nek7	sirna	First, overall Cdh1 expression levels were not affected on prolonged treatment of NEK7 siRNA ( Figure 1G ), even though the expression levels Cdc20 were low, which is a target of the APC/C Cdh1 .	 First overall Cdh1 expression levels were not affected on prolonged treatment of [GENE] [EXPE]   Figure 1G   even though the expression levels Cdc20 were low which is a target of the APC/C Cdh1  
2017	PMC5509424	cdc20	sirna	First, overall Cdh1 expression levels were not affected on prolonged treatment of NEK7 siRNA ( Figure 1G ), even though the expression levels Cdc20 were low, which is a target of the APC/C Cdh1 .	 First overall Cdh1 expression levels were not affected on prolonged treatment of NEK7 [EXPE]   Figure 1G   even though the expression levels [GENE] were low which is a target of the APC/C Cdh1  
2017	PMC5509424	cdh1	sirna	First, overall Cdh1 expression levels were not affected on prolonged treatment of NEK7 siRNA ( Figure 1G ), even though the expression levels Cdc20 were low, which is a target of the APC/C Cdh1 .	 First overall Cdh1 expression levels were not affected on prolonged treatment of NEK7 [EXPE]   Figure 1G   even though the expression levels Cdc20 were low which is a target of the APC/C [GENE]  
2017	PMC5509424	nek7	transfected	U2OS cells were transfected with control (A) or NEK7 (C) siRNAs for 48 h, and the cells were fixed and immunostained with antibodies specific to Cdh1 (green) and centrin (red).	 U2OS cells were [EXPE] with control  A  or [GENE]  C  siRNAs for 48 h and the cells were fixed and immunostained with antibodies specific to Cdh1  green  and centrin  red  
2017	PMC5509424	nek7	sirnas	U2OS cells were transfected with control (A) or NEK7 (C) siRNAs for 48 h, and the cells were fixed and immunostained with antibodies specific to Cdh1 (green) and centrin (red).	 U2OS cells were transfected with control  A  or [GENE]  C  [EXPE] for 48 h and the cells were fixed and immunostained with antibodies specific to Cdh1  green  and centrin  red  
2017	PMC5509424	nek7	immunostained	U2OS cells were transfected with control (A) or NEK7 (C) siRNAs for 48 h, and the cells were fixed and immunostained with antibodies specific to Cdh1 (green) and centrin (red).	 U2OS cells were transfected with control  A  or [GENE]  C  siRNAs for 48 h and the cells were fixed and [EXPE] with antibodies specific to Cdh1  green  and centrin  red  
2017	PMC5509424	cdh1	transfected	U2OS cells were transfected with control (A) or NEK7 (C) siRNAs for 48 h, and the cells were fixed and immunostained with antibodies specific to Cdh1 (green) and centrin (red).	 U2OS cells were [EXPE] with control  A  or NEK7  C  siRNAs for 48 h and the cells were fixed and immunostained with antibodies specific to [GENE]  green  and centrin  red  
2017	PMC5509424	cdh1	sirnas	U2OS cells were transfected with control (A) or NEK7 (C) siRNAs for 48 h, and the cells were fixed and immunostained with antibodies specific to Cdh1 (green) and centrin (red).	 U2OS cells were transfected with control  A  or NEK7  C  [EXPE] for 48 h and the cells were fixed and immunostained with antibodies specific to [GENE]  green  and centrin  red  
2017	PMC5509424	cdh1	immunostained	U2OS cells were transfected with control (A) or NEK7 (C) siRNAs for 48 h, and the cells were fixed and immunostained with antibodies specific to Cdh1 (green) and centrin (red).	 U2OS cells were transfected with control  A  or NEK7  C  siRNAs for 48 h and the cells were fixed and [EXPE] with antibodies specific to [GENE]  green  and centrin  red  
2017	PMC5509424	cdh1	3d-sim	(D) U2OS cells were imaged by 3D-SIM to address the localization of Cdh1 around the centrosomes.	  D  U2OS cells were imaged by [EXPE] to address the localization of [GENE] around the centrosomes 
2017	PMC5509424	cdh1	three-dimensional	Hence we further examined the finer details of Cdh1 localization using three-dimensional structured illumination microscopy (3D-SIM).	 Hence we further examined the finer details of [GENE] localization using [EXPE] structured illumination microscopy  3D-SIM  
2017	PMC5509424	cdh1	structured illumination microscopy	Hence we further examined the finer details of Cdh1 localization using three-dimensional structured illumination microscopy (3D-SIM).	 Hence we further examined the finer details of [GENE] localization using three-dimensional [EXPE]  3D-SIM  
2017	PMC5509424	cdh1	microscopy	Hence we further examined the finer details of Cdh1 localization using three-dimensional structured illumination microscopy (3D-SIM).	 Hence we further examined the finer details of [GENE] localization using three-dimensional structured illumination [EXPE]  3D-SIM  
2017	PMC5509424	cdh1	3d-sim	Hence we further examined the finer details of Cdh1 localization using three-dimensional structured illumination microscopy (3D-SIM).	 Hence we further examined the finer details of [GENE] localization using three-dimensional structured illumination microscopy  [EXPE]  
2017	PMC5509424	pcm1	depletion	Of interest, we observed that depletion of the centriolar satellite component PCM1 appeared to target high levels of Cdh1 to the centrosomes in similar patterns as seen in NEK7-depleted cells (Supplemental Figure S7, B and C), suggesting that centriolar satellites may play a role in Cdh1 localization.	 Of interest we observed that [EXPE] of the centriolar satellite component [GENE] appeared to target high levels of Cdh1 to the centrosomes in similar patterns as seen in NEK7-depleted cells  Supplemental Figure S7 B and C  suggesting that centriolar satellites may play a role in Cdh1 localization 
2017	PMC5509424	cdh1	depletion	Of interest, we observed that depletion of the centriolar satellite component PCM1 appeared to target high levels of Cdh1 to the centrosomes in similar patterns as seen in NEK7-depleted cells (Supplemental Figure S7, B and C), suggesting that centriolar satellites may play a role in Cdh1 localization.	 Of interest we observed that [EXPE] of the centriolar satellite component PCM1 appeared to target high levels of [GENE] to the centrosomes in similar patterns as seen in NEK7-depleted cells  Supplemental Figure S7 B and C  suggesting that centriolar satellites may play a role in Cdh1 localization 
2017	PMC5509424	cdh1	depletion	Of interest, we observed that depletion of the centriolar satellite component PCM1 appeared to target high levels of Cdh1 to the centrosomes in similar patterns as seen in NEK7-depleted cells (Supplemental Figure S7, B and C), suggesting that centriolar satellites may play a role in Cdh1 localization.	 Of interest we observed that [EXPE] of the centriolar satellite component PCM1 appeared to target high levels of Cdh1 to the centrosomes in similar patterns as seen in NEK7-depleted cells  Supplemental Figure S7 B and C  suggesting that centriolar satellites may play a role in [GENE] localization 
2017	PMC5509424	cep192	depletion	The core centrosomal protein CEP192 plays a major role in this process, as it is a crucial component for PCM assembly; depletion of CEP192 frequently results in the formation of disorganized spindles ( Gomez-Ferreria  et al. , 2007 ).	 The core centrosomal protein [GENE] plays a major role in this process as it is a crucial component for PCM assembly; [EXPE] of CEP192 frequently results in the formation of disorganized spindles   Gomez-Ferreria  et al  2007   
2017	PMC5509424	cep192	depletion	The core centrosomal protein CEP192 plays a major role in this process, as it is a crucial component for PCM assembly; depletion of CEP192 frequently results in the formation of disorganized spindles ( Gomez-Ferreria  et al. , 2007 ).	 The core centrosomal protein CEP192 plays a major role in this process as it is a crucial component for PCM assembly; [EXPE] of [GENE] frequently results in the formation of disorganized spindles   Gomez-Ferreria  et al  2007   
2017	PMC5509424	cep152	depletion	Although CEP152 seemingly localizes closer to the centrosomes compared to Cdh1, depletion of CEP152 had no noticeable effect on Cdh1 localization (Supplemental Figure S8).	 Although [GENE] seemingly localizes closer to the centrosomes compared to Cdh1 [EXPE] of CEP152 had no noticeable effect on Cdh1 localization  Supplemental Figure S8  
2017	PMC5509424	cdh1	depletion	Although CEP152 seemingly localizes closer to the centrosomes compared to Cdh1, depletion of CEP152 had no noticeable effect on Cdh1 localization (Supplemental Figure S8).	 Although CEP152 seemingly localizes closer to the centrosomes compared to [GENE] [EXPE] of CEP152 had no noticeable effect on Cdh1 localization  Supplemental Figure S8  
2017	PMC5509424	cep152	depletion	Although CEP152 seemingly localizes closer to the centrosomes compared to Cdh1, depletion of CEP152 had no noticeable effect on Cdh1 localization (Supplemental Figure S8).	 Although CEP152 seemingly localizes closer to the centrosomes compared to Cdh1 [EXPE] of [GENE] had no noticeable effect on Cdh1 localization  Supplemental Figure S8  
2017	PMC5509424	cdh1	depletion	Although CEP152 seemingly localizes closer to the centrosomes compared to Cdh1, depletion of CEP152 had no noticeable effect on Cdh1 localization (Supplemental Figure S8).	 Although CEP152 seemingly localizes closer to the centrosomes compared to Cdh1 [EXPE] of CEP152 had no noticeable effect on [GENE] localization  Supplemental Figure S8  
2017	PMC5509424	cdh1	depleted	To examine the PCM dependence of Cdh1 centrosomal localization, we depleted CEP192 in U2OS cells, and quantified the amount of Cdh1 present at the centrosomes in mitotic cells containing monopolar spindles, as well as in interphase cells ( Figure 7, C, D, and F ).	 To examine the PCM dependence of [GENE] centrosomal localization we [EXPE] CEP192 in U2OS cells and quantified the amount of Cdh1 present at the centrosomes in mitotic cells containing monopolar spindles as well as in interphase cells   Figure 7 C D and F   
2017	PMC5509424	cep192	depleted	To examine the PCM dependence of Cdh1 centrosomal localization, we depleted CEP192 in U2OS cells, and quantified the amount of Cdh1 present at the centrosomes in mitotic cells containing monopolar spindles, as well as in interphase cells ( Figure 7, C, D, and F ).	 To examine the PCM dependence of Cdh1 centrosomal localization we [EXPE] [GENE] in U2OS cells and quantified the amount of Cdh1 present at the centrosomes in mitotic cells containing monopolar spindles as well as in interphase cells   Figure 7 C D and F   
2017	PMC5509424	cdh1	depleted	To examine the PCM dependence of Cdh1 centrosomal localization, we depleted CEP192 in U2OS cells, and quantified the amount of Cdh1 present at the centrosomes in mitotic cells containing monopolar spindles, as well as in interphase cells ( Figure 7, C, D, and F ).	 To examine the PCM dependence of Cdh1 centrosomal localization we [EXPE] CEP192 in U2OS cells and quantified the amount of [GENE] present at the centrosomes in mitotic cells containing monopolar spindles as well as in interphase cells   Figure 7 C D and F   
2017	PMC5509424	cdh1	depletion	Of interest, we found that although centrosomal levels of Cdh1 in interphase cells were unaffected upon CEP192 depletion, most of the mitotic accumulation of centrosomal Cdh1 was lost ( Figure 7, D and F ).	 Of interest we found that although centrosomal levels of [GENE] in interphase cells were unaffected upon CEP192 [EXPE] most of the mitotic accumulation of centrosomal Cdh1 was lost   Figure 7 D and F   
2017	PMC5509424	cep192	depletion	Of interest, we found that although centrosomal levels of Cdh1 in interphase cells were unaffected upon CEP192 depletion, most of the mitotic accumulation of centrosomal Cdh1 was lost ( Figure 7, D and F ).	 Of interest we found that although centrosomal levels of Cdh1 in interphase cells were unaffected upon [GENE] [EXPE] most of the mitotic accumulation of centrosomal Cdh1 was lost   Figure 7 D and F   
2017	PMC5509424	cdh1	depletion	Of interest, we found that although centrosomal levels of Cdh1 in interphase cells were unaffected upon CEP192 depletion, most of the mitotic accumulation of centrosomal Cdh1 was lost ( Figure 7, D and F ).	 Of interest we found that although centrosomal levels of Cdh1 in interphase cells were unaffected upon CEP192 [EXPE] most of the mitotic accumulation of centrosomal [GENE] was lost   Figure 7 D and F   
2017	PMC5509424	cep192	transfected	U2OS cells were transfected with control (A, C), CEP192 (D), or NEK7 (A, E) siRNAs for 48 h, and the cells were fixed and immunostained with the indicated antibodies.	 U2OS cells were [EXPE] with control  A C  [GENE]  D  or NEK7  A E  siRNAs for 48 h and the cells were fixed and immunostained with the indicated antibodies 
2017	PMC5509424	cep192	sirnas	U2OS cells were transfected with control (A, C), CEP192 (D), or NEK7 (A, E) siRNAs for 48 h, and the cells were fixed and immunostained with the indicated antibodies.	 U2OS cells were transfected with control  A C  [GENE]  D  or NEK7  A E  [EXPE] for 48 h and the cells were fixed and immunostained with the indicated antibodies 
2017	PMC5509424	cep192	immunostained	U2OS cells were transfected with control (A, C), CEP192 (D), or NEK7 (A, E) siRNAs for 48 h, and the cells were fixed and immunostained with the indicated antibodies.	 U2OS cells were transfected with control  A C  [GENE]  D  or NEK7  A E  siRNAs for 48 h and the cells were fixed and [EXPE] with the indicated antibodies 
2017	PMC5509424	nek7	transfected	U2OS cells were transfected with control (A, C), CEP192 (D), or NEK7 (A, E) siRNAs for 48 h, and the cells were fixed and immunostained with the indicated antibodies.	 U2OS cells were [EXPE] with control  A C  CEP192  D  or [GENE]  A E  siRNAs for 48 h and the cells were fixed and immunostained with the indicated antibodies 
2017	PMC5509424	nek7	sirnas	U2OS cells were transfected with control (A, C), CEP192 (D), or NEK7 (A, E) siRNAs for 48 h, and the cells were fixed and immunostained with the indicated antibodies.	 U2OS cells were transfected with control  A C  CEP192  D  or [GENE]  A E  [EXPE] for 48 h and the cells were fixed and immunostained with the indicated antibodies 
2017	PMC5509424	nek7	immunostained	U2OS cells were transfected with control (A, C), CEP192 (D), or NEK7 (A, E) siRNAs for 48 h, and the cells were fixed and immunostained with the indicated antibodies.	 U2OS cells were transfected with control  A C  CEP192  D  or [GENE]  A E  siRNAs for 48 h and the cells were fixed and [EXPE] with the indicated antibodies 
2011	PMC3089914	sas-6	purified	We expressed and purified soluble SAS-6 full-length (ceFL), the N terminus plus the coiled coil (ceN-CC), or the coiled-coil domain alone (ceCC) ( Figure 1 A and  Figures S1 A and S1B available online) and analyzed them by biophysical and structural methods.	 We expressed and [EXPE] soluble [GENE] full-length  ceFL  the N terminus plus the coiled coil  ceN-CC  or the coiled-coil domain alone  ceCC    Figure 1 A and  Figures S1 A and S1B available online  and analyzed them by biophysical and structural methods 
2011	PMC3089914	coil	purified	We expressed and purified soluble SAS-6 full-length (ceFL), the N terminus plus the coiled coil (ceN-CC), or the coiled-coil domain alone (ceCC) ( Figure 1 A and  Figures S1 A and S1B available online) and analyzed them by biophysical and structural methods.	 We expressed and [EXPE] soluble SAS-6 full-length  ceFL  the N terminus plus the coiled [GENE]  ceN-CC  or the coiled-coil domain alone  ceCC    Figure 1 A and  Figures S1 A and S1B available online  and analyzed them by biophysical and structural methods 
2011	PMC3089914	sas-6	electron microscopy	Inspection by electron microscopy revealed an ∼35 nm elongated rod in all three constructs, which fits the predicted length of the SAS-6 coiled coil (∼220 residues × 0.1485 nm [axial raise per residue] = ∼32.7 nm) ( Figure 1 B).	 Inspection by [EXPE] revealed an ∼35 nm elongated rod in all three constructs which fits the predicted length of the [GENE] coiled coil  ∼220 residues × 01485 nm [axial raise per residue] = ∼327 nm    Figure 1 B  
2011	PMC3089914	sas-6	microscopy	Inspection by electron microscopy revealed an ∼35 nm elongated rod in all three constructs, which fits the predicted length of the SAS-6 coiled coil (∼220 residues × 0.1485 nm [axial raise per residue] = ∼32.7 nm) ( Figure 1 B).	 Inspection by electron [EXPE] revealed an ∼35 nm elongated rod in all three constructs which fits the predicted length of the [GENE] coiled coil  ∼220 residues × 01485 nm [axial raise per residue] = ∼327 nm    Figure 1 B  
2011	PMC3089914	coil	electron microscopy	Inspection by electron microscopy revealed an ∼35 nm elongated rod in all three constructs, which fits the predicted length of the SAS-6 coiled coil (∼220 residues × 0.1485 nm [axial raise per residue] = ∼32.7 nm) ( Figure 1 B).	 Inspection by [EXPE] revealed an ∼35 nm elongated rod in all three constructs which fits the predicted length of the SAS-6 coiled [GENE]  ∼220 residues × 01485 nm [axial raise per residue] = ∼327 nm    Figure 1 B  
2011	PMC3089914	coil	microscopy	Inspection by electron microscopy revealed an ∼35 nm elongated rod in all three constructs, which fits the predicted length of the SAS-6 coiled coil (∼220 residues × 0.1485 nm [axial raise per residue] = ∼32.7 nm) ( Figure 1 B).	 Inspection by electron [EXPE] revealed an ∼35 nm elongated rod in all three constructs which fits the predicted length of the SAS-6 coiled [GENE]  ∼220 residues × 01485 nm [axial raise per residue] = ∼327 nm    Figure 1 B  
2011	PMC3089914	sas-6	x-ray	Next, we determined the structure of the N-terminal globular domain of  C. elegans  SAS-6 (ceN;  Figures S1 A and S1B) by X-ray crystallography.	 Next we determined the structure of the N-terminal globular domain of  C elegans  [GENE]  ceN;  Figures S1 A and S1B  by [EXPE] crystallography 
2011	PMC3089914	sas-6	crystallography	Next, we determined the structure of the N-terminal globular domain of  C. elegans  SAS-6 (ceN;  Figures S1 A and S1B) by X-ray crystallography.	 Next we determined the structure of the N-terminal globular domain of  C elegans  [GENE]  ceN;  Figures S1 A and S1B  by X-ray [EXPE] 
2011	PMC3089914	coil	itc	Isothermal titration calorimetry (ITC) experiments yielded a K d  for the N-N interaction of ∼110 ± 30 μM ( Figure 2 E and  Figure S3 A), two orders of magnitude higher than that of the ceCC coiled coil.	 Isothermal titration calorimetry  [EXPE]  experiments yielded a K d  for the N-N interaction of ∼110 ± 30 μM   Figure 2 E and  Figure S3 A  two orders of magnitude higher than that of the ceCC coiled [GENE] 
2011	PMC3089914	sas-6	resistant	To investigate the biological significance of the oligomerization of SAS-6 homodimers mediated by the N-N interaction, we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be resistant to RNAi directed against endogenous SAS-6 (GFP-SAS-6RR[I154E]) ( Dammermann et al., 2008 ).	 To investigate the biological significance of the oligomerization of [GENE] homodimers mediated by the N-N interaction we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be [EXPE] to RNAi directed against endogenous SAS-6  GFP-SAS-6RR[I154E]    Dammermann et al 2008   
2011	PMC3089914	sas-6	rnai	To investigate the biological significance of the oligomerization of SAS-6 homodimers mediated by the N-N interaction, we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be resistant to RNAi directed against endogenous SAS-6 (GFP-SAS-6RR[I154E]) ( Dammermann et al., 2008 ).	 To investigate the biological significance of the oligomerization of [GENE] homodimers mediated by the N-N interaction we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be resistant to [EXPE] directed against endogenous SAS-6  GFP-SAS-6RR[I154E]    Dammermann et al 2008   
2011	PMC3089914	sas-6	resistant	To investigate the biological significance of the oligomerization of SAS-6 homodimers mediated by the N-N interaction, we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be resistant to RNAi directed against endogenous SAS-6 (GFP-SAS-6RR[I154E]) ( Dammermann et al., 2008 ).	 To investigate the biological significance of the oligomerization of SAS-6 homodimers mediated by the N-N interaction we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be [EXPE] to RNAi directed against endogenous [GENE]  GFP-SAS-6RR[I154E]    Dammermann et al 2008   
2011	PMC3089914	sas-6	rnai	To investigate the biological significance of the oligomerization of SAS-6 homodimers mediated by the N-N interaction, we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be resistant to RNAi directed against endogenous SAS-6 (GFP-SAS-6RR[I154E]) ( Dammermann et al., 2008 ).	 To investigate the biological significance of the oligomerization of SAS-6 homodimers mediated by the N-N interaction we generated transgenic worms expressing GFP fused to SAS-6[I154E] engineered so as to be resistant to [EXPE] directed against endogenous [GENE]  GFP-SAS-6RR[I154E]    Dammermann et al 2008   
2011	PMC3089914	sas-6	rnai	Upon  sas-6 ( RNAi ) in an otherwise wild-type background, the two paternally contributed centrioles split from one another and assembled a bipolar spindle at the end of the one-cell stage ( Movie S1 ).	 Upon  [GENE]   [EXPE]   in an otherwise wild-type background the two paternally contributed centrioles split from one another and assembled a bipolar spindle at the end of the one-cell stage   Movie S1   
2011	PMC3089914	sas-6	rnai	In  sas-6 ( RNAi ) embryos expressing RNAi-resistant wild-type SAS-6 fused to GFP (GFP-SAS-6RR), ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle ( Figures 3 A and 3G and  Movie S2 ) ( Kitagawa et al., 2009 ).	 In  [GENE]   [EXPE]   embryos expressing RNAi-resistant wild-type SAS-6 fused to GFP  GFP-SAS-6RR  ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle   Figures 3 A and 3G and  Movie S2     Kitagawa et al 2009   
2011	PMC3089914	sas-6	rnai-resistant	In  sas-6 ( RNAi ) embryos expressing RNAi-resistant wild-type SAS-6 fused to GFP (GFP-SAS-6RR), ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle ( Figures 3 A and 3G and  Movie S2 ) ( Kitagawa et al., 2009 ).	 In  [GENE]   RNAi   embryos expressing [EXPE] wild-type SAS-6 fused to GFP  GFP-SAS-6RR  ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle   Figures 3 A and 3G and  Movie S2     Kitagawa et al 2009   
2011	PMC3089914	sas-6	rnai	In  sas-6 ( RNAi ) embryos expressing RNAi-resistant wild-type SAS-6 fused to GFP (GFP-SAS-6RR), ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle ( Figures 3 A and 3G and  Movie S2 ) ( Kitagawa et al., 2009 ).	 In  sas-6   [EXPE]   embryos expressing RNAi-resistant wild-type [GENE] fused to GFP  GFP-SAS-6RR  ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle   Figures 3 A and 3G and  Movie S2     Kitagawa et al 2009   
2011	PMC3089914	sas-6	rnai-resistant	In  sas-6 ( RNAi ) embryos expressing RNAi-resistant wild-type SAS-6 fused to GFP (GFP-SAS-6RR), ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle ( Figures 3 A and 3G and  Movie S2 ) ( Kitagawa et al., 2009 ).	 In  sas-6   RNAi   embryos expressing [EXPE] wild-type [GENE] fused to GFP  GFP-SAS-6RR  ∼40% of embryos underwent bipolar spindle assembly in each blastomere at the end of the second cell cycle   Figures 3 A and 3G and  Movie S2     Kitagawa et al 2009   
2011	PMC3089914	sas-4	rescue	This reflected rescue of centriole formation, as demonstrated by the presence of the centriolar protein SAS-4 in each spindle pole ( Figure 3 D).	 This reflected [EXPE] of centriole formation as demonstrated by the presence of the centriolar protein [GENE] in each spindle pole   Figure 3 D  
2011	PMC3089914	sas-6	rescue	Partial rescue to only ∼40% is likely due to GFP at the N terminus interfering with the function of SAS-6 and to levels of the fusion protein being lower than that of the endogenous protein ( Figure 3 H) (see also  Kitagawa et al., 2009 ).	 Partial [EXPE] to only ∼40% is likely due to GFP at the N terminus interfering with the function of [GENE] and to levels of the fusion protein being lower than that of the endogenous protein   Figure 3 H   see also  Kitagawa et al 2009   
2011	PMC3089914	sas-6	interfering	Partial rescue to only ∼40% is likely due to GFP at the N terminus interfering with the function of SAS-6 and to levels of the fusion protein being lower than that of the endogenous protein ( Figure 3 H) (see also  Kitagawa et al., 2009 ).	 Partial rescue to only ∼40% is likely due to GFP at the N terminus [EXPE] with the function of [GENE] and to levels of the fusion protein being lower than that of the endogenous protein   Figure 3 H   see also  Kitagawa et al 2009   
2011	PMC3089914	sas-6	rescue	Importantly, there was no rescue of centriole formation in  sas-6 ( RNAi ) embryos expressing GFP-SAS-6RR[I154E] or GFP-SAS-6RR[I154G] ( Figures 3 B, 3C, and 3E–3G and  Movie S3 ).	 Importantly there was no [EXPE] of centriole formation in  [GENE]   RNAi   embryos expressing GFP-SAS-6RR[I154E] or GFP-SAS-6RR[I154G]   Figures 3 B 3C and 3E–3G and  Movie S3   
2011	PMC3089914	sas-6	rnai	Importantly, there was no rescue of centriole formation in  sas-6 ( RNAi ) embryos expressing GFP-SAS-6RR[I154E] or GFP-SAS-6RR[I154G] ( Figures 3 B, 3C, and 3E–3G and  Movie S3 ).	 Importantly there was no rescue of centriole formation in  [GENE]   [EXPE]   embryos expressing GFP-SAS-6RR[I154E] or GFP-SAS-6RR[I154G]   Figures 3 B 3C and 3E–3G and  Movie S3   
2011	PMC3089914	bach	doxycycline-inducible	We generated constructs in which wild-type or F131E mutant HsSAS-6 was fused to GFP and expressed from a doxycycline-inducible promoter ( Bach et al., 2007 ).	 We generated constructs in which wild-type or F131E mutant HsSAS-6 was fused to GFP and expressed from a [EXPE] promoter   [GENE] et al 2007   
2011	PMC3089914	sas-6	recombinant	By contrast, we were able to produce soluble recombinant proteins from  C. reinhardtii  Bld12p ( Nakazawa et al., 2007 ), which has the same domain organization as other SAS-6 orthologues ( Figure S4 A).	 By contrast we were able to produce soluble [EXPE] proteins from  C reinhardtii  Bld12p   Nakazawa et al 2007   which has the same domain organization as other [GENE] orthologues   Figure S4 A  
2011	PMC3089914	sas-6	x-ray	Like for  C. elegans  SAS-6, we started by producing a fragment encompassing the N-terminal domain (denoted crN;  Figures S4 A and S4B) and solved its structure to 2.1 Å resolution by X-ray crystallography ( Table S1 ).	 Like for  C elegans  [GENE] we started by producing a fragment encompassing the N-terminal domain  denoted crN;  Figures S4 A and S4B  and solved its structure to 21 Å resolution by [EXPE] crystallography   Table S1   
2011	PMC3089914	sas-6	crystallography	Like for  C. elegans  SAS-6, we started by producing a fragment encompassing the N-terminal domain (denoted crN;  Figures S4 A and S4B) and solved its structure to 2.1 Å resolution by X-ray crystallography ( Table S1 ).	 Like for  C elegans  [GENE] we started by producing a fragment encompassing the N-terminal domain  denoted crN;  Figures S4 A and S4B  and solved its structure to 21 Å resolution by X-ray [EXPE]   Table S1   
2014	PMC4220463	plk4	co-immunoprecipitation	First, to investigate the physical interactions between the three key factors for centriole assembly, we conducted co-immunoprecipitation analysis with human 293T cells expressing FLAG-tagged full-length Plk4 or Plk4ΔPEST lacking the first PEST destruction motif 25 , and tested whether the Plk4 proteins interact with endogenous STIL or HsSAS-6 proteins.	 First to investigate the physical interactions between the three key factors for centriole assembly we conducted [EXPE] analysis with human 293T cells expressing FLAG-tagged full-length [GENE] or Plk4ΔPEST lacking the first PEST destruction motif 25  and tested whether the Plk4 proteins interact with endogenous STIL or HsSAS-6 proteins 
2014	PMC4220463	plk4	co-immunoprecipitation	First, to investigate the physical interactions between the three key factors for centriole assembly, we conducted co-immunoprecipitation analysis with human 293T cells expressing FLAG-tagged full-length Plk4 or Plk4ΔPEST lacking the first PEST destruction motif 25 , and tested whether the Plk4 proteins interact with endogenous STIL or HsSAS-6 proteins.	 First to investigate the physical interactions between the three key factors for centriole assembly we conducted [EXPE] analysis with human 293T cells expressing FLAG-tagged full-length Plk4 or Plk4ΔPEST lacking the first PEST destruction motif 25  and tested whether the [GENE] proteins interact with endogenous STIL or HsSAS-6 proteins 
2014	PMC4220463	stil	co-immunoprecipitation	First, to investigate the physical interactions between the three key factors for centriole assembly, we conducted co-immunoprecipitation analysis with human 293T cells expressing FLAG-tagged full-length Plk4 or Plk4ΔPEST lacking the first PEST destruction motif 25 , and tested whether the Plk4 proteins interact with endogenous STIL or HsSAS-6 proteins.	 First to investigate the physical interactions between the three key factors for centriole assembly we conducted [EXPE] analysis with human 293T cells expressing FLAG-tagged full-length Plk4 or Plk4ΔPEST lacking the first PEST destruction motif 25  and tested whether the Plk4 proteins interact with endogenous [GENE] or HsSAS-6 proteins 
2014	PMC4220463	plk4	yeast two-hybrid	Moreover, yeast two-hybrid and  in vitro  binding assays established that Plk4 directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner ( Fig. 1e  and  Supplementary Fig. 1g,h ).	 Moreover [EXPE] and  in vitro  binding assays established that [GENE] directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner   Fig 1e  and  Supplementary Fig 1gh   
2014	PMC4220463	plk4	two-hybrid	Moreover, yeast two-hybrid and  in vitro  binding assays established that Plk4 directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner ( Fig. 1e  and  Supplementary Fig. 1g,h ).	 Moreover yeast [EXPE] and  in vitro  binding assays established that [GENE] directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner   Fig 1e  and  Supplementary Fig 1gh   
2014	PMC4220463	plk4	assays	Moreover, yeast two-hybrid and  in vitro  binding assays established that Plk4 directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner ( Fig. 1e  and  Supplementary Fig. 1g,h ).	 Moreover yeast two-hybrid and  in vitro  binding [EXPE] established that [GENE] directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner   Fig 1e  and  Supplementary Fig 1gh   
2014	PMC4220463	stil	yeast two-hybrid	Moreover, yeast two-hybrid and  in vitro  binding assays established that Plk4 directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner ( Fig. 1e  and  Supplementary Fig. 1g,h ).	 Moreover [EXPE] and  in vitro  binding assays established that Plk4 directly bound to the [GENE] fragments containing the CC domain presumably in a kinase-activity-dependent manner   Fig 1e  and  Supplementary Fig 1gh   
2014	PMC4220463	stil	two-hybrid	Moreover, yeast two-hybrid and  in vitro  binding assays established that Plk4 directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner ( Fig. 1e  and  Supplementary Fig. 1g,h ).	 Moreover yeast [EXPE] and  in vitro  binding assays established that Plk4 directly bound to the [GENE] fragments containing the CC domain presumably in a kinase-activity-dependent manner   Fig 1e  and  Supplementary Fig 1gh   
2014	PMC4220463	stil	assays	Moreover, yeast two-hybrid and  in vitro  binding assays established that Plk4 directly bound to the STIL fragments containing the CC domain presumably in a kinase-activity-dependent manner ( Fig. 1e  and  Supplementary Fig. 1g,h ).	 Moreover yeast two-hybrid and  in vitro  binding [EXPE] established that Plk4 directly bound to the [GENE] fragments containing the CC domain presumably in a kinase-activity-dependent manner   Fig 1e  and  Supplementary Fig 1gh   
2014	PMC4220463	stil	depleted	We depleted endogenous STIL using short interfering RNAs (siRNAs) against the 3′-untranslated region (3′UTR) and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells ( Supplementary Fig. 1a ).	 We [EXPE] endogenous [GENE] using short interfering RNAs  siRNAs  against the 3′-untranslated region  3′UTR  and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells   Supplementary Fig 1a   
2014	PMC4220463	stil	interfering	We depleted endogenous STIL using short interfering RNAs (siRNAs) against the 3′-untranslated region (3′UTR) and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells ( Supplementary Fig. 1a ).	 We depleted endogenous [GENE] using short [EXPE] RNAs  siRNAs  against the 3′-untranslated region  3′UTR  and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells   Supplementary Fig 1a   
2014	PMC4220463	stil	sirnas	We depleted endogenous STIL using short interfering RNAs (siRNAs) against the 3′-untranslated region (3′UTR) and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells ( Supplementary Fig. 1a ).	 We depleted endogenous [GENE] using short interfering RNAs  [EXPE]  against the 3′-untranslated region  3′UTR  and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells   Supplementary Fig 1a   
2014	PMC4220463	stil	depleted	We depleted endogenous STIL using short interfering RNAs (siRNAs) against the 3′-untranslated region (3′UTR) and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells ( Supplementary Fig. 1a ).	 We [EXPE] endogenous STIL using short interfering RNAs  siRNAs  against the 3′-untranslated region  3′UTR  and expressed [GENE] full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells   Supplementary Fig 1a   
2014	PMC4220463	stil	interfering	We depleted endogenous STIL using short interfering RNAs (siRNAs) against the 3′-untranslated region (3′UTR) and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells ( Supplementary Fig. 1a ).	 We depleted endogenous STIL using short [EXPE] RNAs  siRNAs  against the 3′-untranslated region  3′UTR  and expressed [GENE] full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells   Supplementary Fig 1a   
2014	PMC4220463	stil	sirnas	We depleted endogenous STIL using short interfering RNAs (siRNAs) against the 3′-untranslated region (3′UTR) and expressed STIL full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells ( Supplementary Fig. 1a ).	 We depleted endogenous STIL using short interfering RNAs  [EXPE]  against the 3′-untranslated region  3′UTR  and expressed [GENE] full-length or deletion constructs tagged with HA at comparable levels in human U2OS cells   Supplementary Fig 1a   
2014	PMC4220463	stil	depletion	We found that whereas centriole numbers were reduced in the majority of interphase cells upon depletion of endogenous STIL, expression of exogenous full-length STIL could functionally rescue this phenotype (~26% and ~57% of cells with ≥4 centrioles, respectively;  Fig. 1f ) and frequently induced formation of multiple procentrioles next to each pre-existing centriole.	 We found that whereas centriole numbers were reduced in the majority of interphase cells upon [EXPE] of endogenous [GENE] expression of exogenous full-length STIL could functionally rescue this phenotype  ~26% and ~57% of cells with ≥4 centrioles respectively;  Fig 1f   and frequently induced formation of multiple procentrioles next to each pre-existing centriole 
2014	PMC4220463	stil	rescue	We found that whereas centriole numbers were reduced in the majority of interphase cells upon depletion of endogenous STIL, expression of exogenous full-length STIL could functionally rescue this phenotype (~26% and ~57% of cells with ≥4 centrioles, respectively;  Fig. 1f ) and frequently induced formation of multiple procentrioles next to each pre-existing centriole.	 We found that whereas centriole numbers were reduced in the majority of interphase cells upon depletion of endogenous [GENE] expression of exogenous full-length STIL could functionally [EXPE] this phenotype  ~26% and ~57% of cells with ≥4 centrioles respectively;  Fig 1f   and frequently induced formation of multiple procentrioles next to each pre-existing centriole 
2014	PMC4220463	stil	depletion	We found that whereas centriole numbers were reduced in the majority of interphase cells upon depletion of endogenous STIL, expression of exogenous full-length STIL could functionally rescue this phenotype (~26% and ~57% of cells with ≥4 centrioles, respectively;  Fig. 1f ) and frequently induced formation of multiple procentrioles next to each pre-existing centriole.	 We found that whereas centriole numbers were reduced in the majority of interphase cells upon [EXPE] of endogenous STIL expression of exogenous full-length [GENE] could functionally rescue this phenotype  ~26% and ~57% of cells with ≥4 centrioles respectively;  Fig 1f   and frequently induced formation of multiple procentrioles next to each pre-existing centriole 
2014	PMC4220463	stil	rescue	We found that whereas centriole numbers were reduced in the majority of interphase cells upon depletion of endogenous STIL, expression of exogenous full-length STIL could functionally rescue this phenotype (~26% and ~57% of cells with ≥4 centrioles, respectively;  Fig. 1f ) and frequently induced formation of multiple procentrioles next to each pre-existing centriole.	 We found that whereas centriole numbers were reduced in the majority of interphase cells upon depletion of endogenous STIL expression of exogenous full-length [GENE] could functionally [EXPE] this phenotype  ~26% and ~57% of cells with ≥4 centrioles respectively;  Fig 1f   and frequently induced formation of multiple procentrioles next to each pre-existing centriole 
2014	PMC4220463	stil	rescued	In contrast, expression of the N-terminal fragment of STIL rescued centriole formation in only ~13% of cells ( Fig. 1f ) even though this fragment efficiently localized to the centrioles, indicating that the C-terminal region of STIL is crucial for centriole formation.	 In contrast expression of the N-terminal fragment of [GENE] [EXPE] centriole formation in only ~13% of cells   Fig 1f   even though this fragment efficiently localized to the centrioles indicating that the C-terminal region of STIL is crucial for centriole formation 
2014	PMC4220463	stil	rescued	In contrast, expression of the N-terminal fragment of STIL rescued centriole formation in only ~13% of cells ( Fig. 1f ) even though this fragment efficiently localized to the centrioles, indicating that the C-terminal region of STIL is crucial for centriole formation.	 In contrast expression of the N-terminal fragment of STIL [EXPE] centriole formation in only ~13% of cells   Fig 1f   even though this fragment efficiently localized to the centrioles indicating that the C-terminal region of [GENE] is crucial for centriole formation 
2014	PMC4220463	stil	rescue	Importantly, we determined that STIL proteins lacking the CC domain did not localize to the centrioles (~21% of cells with centriolar STILΔCC, compared with ~76% of cells with centriolar STIL FL;  Fig. 1f ) and failed to rescue centriole formation.	 Importantly we determined that [GENE] proteins lacking the CC domain did not localize to the centrioles  ~21% of cells with centriolar STILΔCC compared with ~76% of cells with centriolar STIL FL;  Fig 1f   and failed to [EXPE] centriole formation 
2014	PMC4220463	stil	rescue	Importantly, we determined that STIL proteins lacking the CC domain did not localize to the centrioles (~21% of cells with centriolar STILΔCC, compared with ~76% of cells with centriolar STIL FL;  Fig. 1f ) and failed to rescue centriole formation.	 Importantly we determined that STIL proteins lacking the CC domain did not localize to the centrioles  ~21% of cells with centriolar STILΔCC compared with ~76% of cells with centriolar [GENE] FL;  Fig 1f   and failed to [EXPE] centriole formation 
2014	PMC4220463	stil	depleted	Since centriolar loading of HsSAS-6 is dependent on STIL 8 9 10 , we monitored whether HsSAS-6 proteins are present at centrioles when the C-terminal region or the conserved STAN motif 23  of STIL was depleted.	 Since centriolar loading of HsSAS-6 is dependent on [GENE] 8 9 10  we monitored whether HsSAS-6 proteins are present at centrioles when the C-terminal region or the conserved STAN motif 23  of STIL was [EXPE] 
2014	PMC4220463	stil	depleted	Since centriolar loading of HsSAS-6 is dependent on STIL 8 9 10 , we monitored whether HsSAS-6 proteins are present at centrioles when the C-terminal region or the conserved STAN motif 23  of STIL was depleted.	 Since centriolar loading of HsSAS-6 is dependent on STIL 8 9 10  we monitored whether HsSAS-6 proteins are present at centrioles when the C-terminal region or the conserved STAN motif 23  of [GENE] was [EXPE] 
2014	PMC4220463	stil	depletion	We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon depletion of endogenous STIL, expression of STIL full length restored the localization of HsSAS-6 around the mother centriole (~40% and ~85% of cells with centriolar HsSAS-6, respectively;  Fig. 2a ).	 We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon [EXPE] of endogenous [GENE] expression of STIL full length restored the localization of HsSAS-6 around the mother centriole  ~40% and ~85% of cells with centriolar HsSAS-6 respectively;  Fig 2a   
2014	PMC4220463	stil	restored	We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon depletion of endogenous STIL, expression of STIL full length restored the localization of HsSAS-6 around the mother centriole (~40% and ~85% of cells with centriolar HsSAS-6, respectively;  Fig. 2a ).	 We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon depletion of endogenous [GENE] expression of STIL full length [EXPE] the localization of HsSAS-6 around the mother centriole  ~40% and ~85% of cells with centriolar HsSAS-6 respectively;  Fig 2a   
2014	PMC4220463	stil	depletion	We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon depletion of endogenous STIL, expression of STIL full length restored the localization of HsSAS-6 around the mother centriole (~40% and ~85% of cells with centriolar HsSAS-6, respectively;  Fig. 2a ).	 We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon [EXPE] of endogenous STIL expression of [GENE] full length restored the localization of HsSAS-6 around the mother centriole  ~40% and ~85% of cells with centriolar HsSAS-6 respectively;  Fig 2a   
2014	PMC4220463	stil	restored	We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon depletion of endogenous STIL, expression of STIL full length restored the localization of HsSAS-6 around the mother centriole (~40% and ~85% of cells with centriolar HsSAS-6, respectively;  Fig. 2a ).	 We first confirmed that whereas centriolar loading of HsSAS-6 was significantly reduced upon depletion of endogenous STIL expression of [GENE] full length [EXPE] the localization of HsSAS-6 around the mother centriole  ~40% and ~85% of cells with centriolar HsSAS-6 respectively;  Fig 2a   
2014	PMC4220463	stil	assays	To examine this, we used a combined biochemical approach using  in vitro  kinase assays with recombinant STIL N3C and Plk4ΔPEST-FLAG, followed by  in vitro  pull-down assays with recombinant maltose-binding protein (MBP) tagged HsSAS-6 ( Fig. 2c ).	 To examine this we used a combined biochemical approach using  in vitro  kinase [EXPE] with recombinant [GENE] N3C and Plk4ΔPEST-FLAG followed by  in vitro  pull-down assays with recombinant maltose-binding protein  MBP  tagged HsSAS-6   Fig 2c   
2014	PMC4220463	stil	recombinant	To examine this, we used a combined biochemical approach using  in vitro  kinase assays with recombinant STIL N3C and Plk4ΔPEST-FLAG, followed by  in vitro  pull-down assays with recombinant maltose-binding protein (MBP) tagged HsSAS-6 ( Fig. 2c ).	 To examine this we used a combined biochemical approach using  in vitro  kinase assays with [EXPE] [GENE] N3C and Plk4ΔPEST-FLAG followed by  in vitro  pull-down assays with recombinant maltose-binding protein  MBP  tagged HsSAS-6   Fig 2c   
2014	PMC4220463	stil	pull-down	To examine this, we used a combined biochemical approach using  in vitro  kinase assays with recombinant STIL N3C and Plk4ΔPEST-FLAG, followed by  in vitro  pull-down assays with recombinant maltose-binding protein (MBP) tagged HsSAS-6 ( Fig. 2c ).	 To examine this we used a combined biochemical approach using  in vitro  kinase assays with recombinant [GENE] N3C and Plk4ΔPEST-FLAG followed by  in vitro  [EXPE] assays with recombinant maltose-binding protein  MBP  tagged HsSAS-6   Fig 2c   
2014	PMC4220463	stil	assays	To examine this, we used a combined biochemical approach using  in vitro  kinase assays with recombinant STIL N3C and Plk4ΔPEST-FLAG, followed by  in vitro  pull-down assays with recombinant maltose-binding protein (MBP) tagged HsSAS-6 ( Fig. 2c ).	 To examine this we used a combined biochemical approach using  in vitro  kinase assays with recombinant [GENE] N3C and Plk4ΔPEST-FLAG followed by  in vitro  pull-down [EXPE] with recombinant maltose-binding protein  MBP  tagged HsSAS-6   Fig 2c   
2014	PMC4220463	stil	recombinant	To examine this, we used a combined biochemical approach using  in vitro  kinase assays with recombinant STIL N3C and Plk4ΔPEST-FLAG, followed by  in vitro  pull-down assays with recombinant maltose-binding protein (MBP) tagged HsSAS-6 ( Fig. 2c ).	 To examine this we used a combined biochemical approach using  in vitro  kinase assays with recombinant [GENE] N3C and Plk4ΔPEST-FLAG followed by  in vitro  pull-down assays with [EXPE] maltose-binding protein  MBP  tagged HsSAS-6   Fig 2c   
2014	PMC4220463	stil	assays	We first conducted  in vitro  kinase assays with Plk4ΔPEST-FLAG and the indicated four STIL fragments, and found that the fragments STIL N3 and C were efficiently phosphorylated by Plk4ΔPEST-FLAG  in vitro  ( Fig. 3a ).	 We first conducted  in vitro  kinase [EXPE] with Plk4ΔPEST-FLAG and the indicated four [GENE] fragments and found that the fragments STIL N3 and C were efficiently phosphorylated by Plk4ΔPEST-FLAG  in vitro    Fig 3a   
2014	PMC4220463	stil	assays	We first conducted  in vitro  kinase assays with Plk4ΔPEST-FLAG and the indicated four STIL fragments, and found that the fragments STIL N3 and C were efficiently phosphorylated by Plk4ΔPEST-FLAG  in vitro  ( Fig. 3a ).	 We first conducted  in vitro  kinase [EXPE] with Plk4ΔPEST-FLAG and the indicated four STIL fragments and found that the fragments [GENE] N3 and C were efficiently phosphorylated by Plk4ΔPEST-FLAG  in vitro    Fig 3a   
2014	PMC4220463	stil	rescue	Second, we investigated whether alanine substitution mutants of the two phosphorylation sites of STIL have the ability to rescue the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous STIL proteins are depleted.	 Second we investigated whether alanine substitution mutants of the two phosphorylation sites of [GENE] have the ability to [EXPE] the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous STIL proteins are depleted 
2014	PMC4220463	stil	depleted	Second, we investigated whether alanine substitution mutants of the two phosphorylation sites of STIL have the ability to rescue the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous STIL proteins are depleted.	 Second we investigated whether alanine substitution mutants of the two phosphorylation sites of [GENE] have the ability to rescue the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous STIL proteins are [EXPE] 
2014	PMC4220463	stil	rescue	Second, we investigated whether alanine substitution mutants of the two phosphorylation sites of STIL have the ability to rescue the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous STIL proteins are depleted.	 Second we investigated whether alanine substitution mutants of the two phosphorylation sites of STIL have the ability to [EXPE] the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous [GENE] proteins are depleted 
2014	PMC4220463	stil	depleted	Second, we investigated whether alanine substitution mutants of the two phosphorylation sites of STIL have the ability to rescue the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous STIL proteins are depleted.	 Second we investigated whether alanine substitution mutants of the two phosphorylation sites of STIL have the ability to rescue the defect in the centriolar loading of HsSAS-6 and centriole formation when endogenous [GENE] proteins are [EXPE] 
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of [GENE]   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of [GENE]   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of [GENE] failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of [GENE] failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous [GENE]  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous [GENE]  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL  centriolar HsSAS-6; ~4% for [GENE] 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous STIL  centriolar HsSAS-6; ~4% for [GENE] 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for [GENE] WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for [GENE] WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for [GENE] 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for [GENE] 2A and ~50% for STIL WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescue	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to [EXPE] centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for [GENE] WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	depleted	Strikingly, we found that although mutating both residues to alanine did not affect centriolar targeting of STIL ( Fig. 4c,d ), expression of the S1061A, S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells depleted of endogenous STIL (centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for STIL WT;  Fig. 4c,d  and  Supplementary Fig. 5b–f ).	 Strikingly we found that although mutating both residues to alanine did not affect centriolar targeting of STIL   Fig 4cd   expression of the S1061A S1116A or 2A double mutant of STIL failed to rescue centriolar loading of HsSAS-6 and centriole formation in the cells [EXPE] of endogenous STIL  centriolar HsSAS-6; ~4% for STIL 2A and ~78% for STIL WT: ≥4 centrin foci; ~2% for STIL 2A and ~50% for [GENE] WT;  Fig 4cd  and  Supplementary Fig 5b–f   
2014	PMC4220463	stil	rescued	On the other hand, expression of the STIL alanine mutants at three other MS-identified phosphorylation sites (S1181, T1238 or T1250) or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by depletion of endogenous STIL ( Supplementary Figs 4e and 5d–f ).	 On the other hand expression of the [GENE] alanine mutants at three other MS-identified phosphorylation sites  S1181 T1238 or T1250  or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly [EXPE] the phenotype provoked by depletion of endogenous STIL   Supplementary Figs 4e and 5d–f   
2014	PMC4220463	stil	depletion	On the other hand, expression of the STIL alanine mutants at three other MS-identified phosphorylation sites (S1181, T1238 or T1250) or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by depletion of endogenous STIL ( Supplementary Figs 4e and 5d–f ).	 On the other hand expression of the [GENE] alanine mutants at three other MS-identified phosphorylation sites  S1181 T1238 or T1250  or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by [EXPE] of endogenous STIL   Supplementary Figs 4e and 5d–f   
2014	PMC4220463	stil	rescued	On the other hand, expression of the STIL alanine mutants at three other MS-identified phosphorylation sites (S1181, T1238 or T1250) or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by depletion of endogenous STIL ( Supplementary Figs 4e and 5d–f ).	 On the other hand expression of the STIL alanine mutants at three other MS-identified phosphorylation sites  S1181 T1238 or T1250  or the [GENE] deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly [EXPE] the phenotype provoked by depletion of endogenous STIL   Supplementary Figs 4e and 5d–f   
2014	PMC4220463	stil	depletion	On the other hand, expression of the STIL alanine mutants at three other MS-identified phosphorylation sites (S1181, T1238 or T1250) or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by depletion of endogenous STIL ( Supplementary Figs 4e and 5d–f ).	 On the other hand expression of the STIL alanine mutants at three other MS-identified phosphorylation sites  S1181 T1238 or T1250  or the [GENE] deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by [EXPE] of endogenous STIL   Supplementary Figs 4e and 5d–f   
2014	PMC4220463	stil	rescued	On the other hand, expression of the STIL alanine mutants at three other MS-identified phosphorylation sites (S1181, T1238 or T1250) or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by depletion of endogenous STIL ( Supplementary Figs 4e and 5d–f ).	 On the other hand expression of the STIL alanine mutants at three other MS-identified phosphorylation sites  S1181 T1238 or T1250  or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly [EXPE] the phenotype provoked by depletion of endogenous [GENE]   Supplementary Figs 4e and 5d–f   
2014	PMC4220463	stil	depletion	On the other hand, expression of the STIL alanine mutants at three other MS-identified phosphorylation sites (S1181, T1238 or T1250) or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by depletion of endogenous STIL ( Supplementary Figs 4e and 5d–f ).	 On the other hand expression of the STIL alanine mutants at three other MS-identified phosphorylation sites  S1181 T1238 or T1250  or the STIL deletion mutant lacking all the seven MS-identified phosphorylation sites in the N3 region mostly rescued the phenotype provoked by [EXPE] of endogenous [GENE]   Supplementary Figs 4e and 5d–f   
2014	PMC4220463	plk4	database	Given that the MS analysis revealed that this residue was phosphorylated by Plk4  in vitro  and also that it is found to be phosphorylated in mammalian cells (PhosphoSitePlus database), we favour the possibility that substitution of S1116 to D/E could not mimic the phosphorylation state, but rather reduced the function of STIL.	 Given that the MS analysis revealed that this residue was phosphorylated by [GENE]  in vitro  and also that it is found to be phosphorylated in mammalian cells  PhosphoSitePlus [EXPE]  we favour the possibility that substitution of S1116 to D/E could not mimic the phosphorylation state but rather reduced the function of STIL 
2014	PMC4220463	stil	database	Given that the MS analysis revealed that this residue was phosphorylated by Plk4  in vitro  and also that it is found to be phosphorylated in mammalian cells (PhosphoSitePlus database), we favour the possibility that substitution of S1116 to D/E could not mimic the phosphorylation state, but rather reduced the function of STIL.	 Given that the MS analysis revealed that this residue was phosphorylated by Plk4  in vitro  and also that it is found to be phosphorylated in mammalian cells  PhosphoSitePlus [EXPE]  we favour the possibility that substitution of S1116 to D/E could not mimic the phosphorylation state but rather reduced the function of [GENE] 
2014	PMC4220463	plk4	depleted	To test this, we examined the centriolar distribution of Plk4 when STIL or HsSAS-6 was depleted from U2OS cells.	 To test this we examined the centriolar distribution of [GENE] when STIL or HsSAS-6 was [EXPE] from U2OS cells 
2014	PMC4220463	stil	depleted	To test this, we examined the centriolar distribution of Plk4 when STIL or HsSAS-6 was depleted from U2OS cells.	 To test this we examined the centriolar distribution of Plk4 when [GENE] or HsSAS-6 was [EXPE] from U2OS cells 
2014	PMC4220463	stil	depleted	Interestingly, we found that most of the interphase cells depleted of STIL or HsSAS-6 harboured the ring-like arrangement of centriolar Plk4 while the cell cycle progression was not affected (Plk4 ring; ~18% for siCnt, ~91% for siHsSAS-6 and ~71% for siSTIL;  Fig. 5d,e , and  Supplementary Figs 1a and 7c,d ).	 Interestingly we found that most of the interphase cells [EXPE] of [GENE] or HsSAS-6 harboured the ring-like arrangement of centriolar Plk4 while the cell cycle progression was not affected  Plk4 ring; ~18% for siCnt ~91% for siHsSAS-6 and ~71% for siSTIL;  Fig 5de  and  Supplementary Figs 1a and 7cd   
2014	PMC4220463	plk4	depleted	Interestingly, we found that most of the interphase cells depleted of STIL or HsSAS-6 harboured the ring-like arrangement of centriolar Plk4 while the cell cycle progression was not affected (Plk4 ring; ~18% for siCnt, ~91% for siHsSAS-6 and ~71% for siSTIL;  Fig. 5d,e , and  Supplementary Figs 1a and 7c,d ).	 Interestingly we found that most of the interphase cells [EXPE] of STIL or HsSAS-6 harboured the ring-like arrangement of centriolar [GENE] while the cell cycle progression was not affected  Plk4 ring; ~18% for siCnt ~91% for siHsSAS-6 and ~71% for siSTIL;  Fig 5de  and  Supplementary Figs 1a and 7cd   
2014	PMC4220463	plk4	depleted	Interestingly, we found that most of the interphase cells depleted of STIL or HsSAS-6 harboured the ring-like arrangement of centriolar Plk4 while the cell cycle progression was not affected (Plk4 ring; ~18% for siCnt, ~91% for siHsSAS-6 and ~71% for siSTIL;  Fig. 5d,e , and  Supplementary Figs 1a and 7c,d ).	 Interestingly we found that most of the interphase cells [EXPE] of STIL or HsSAS-6 harboured the ring-like arrangement of centriolar Plk4 while the cell cycle progression was not affected  [GENE] ring; ~18% for siCnt ~91% for siHsSAS-6 and ~71% for siSTIL;  Fig 5de  and  Supplementary Figs 1a and 7cd   
2014	PMC4220463	stil	suppress	In addition, the expression of STIL ΔCC in STIL siRNA-treated cells did not suppress the increase in the number of cells with a ring-like pattern of centriolar Plk4 (~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig. 5e  and  Supplementary Fig. 7e ), indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot.	 In addition the expression of [GENE] ΔCC in STIL siRNA-treated cells did not [EXPE] the increase in the number of cells with a ring-like pattern of centriolar Plk4  ~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig 5e  and  Supplementary Fig 7e   indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot 
2014	PMC4220463	stil	suppress	In addition, the expression of STIL ΔCC in STIL siRNA-treated cells did not suppress the increase in the number of cells with a ring-like pattern of centriolar Plk4 (~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig. 5e  and  Supplementary Fig. 7e ), indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot.	 In addition the expression of STIL ΔCC in [GENE] siRNA-treated cells did not [EXPE] the increase in the number of cells with a ring-like pattern of centriolar Plk4  ~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig 5e  and  Supplementary Fig 7e   indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot 
2014	PMC4220463	plk4	suppress	In addition, the expression of STIL ΔCC in STIL siRNA-treated cells did not suppress the increase in the number of cells with a ring-like pattern of centriolar Plk4 (~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig. 5e  and  Supplementary Fig. 7e ), indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot.	 In addition the expression of STIL ΔCC in STIL siRNA-treated cells did not [EXPE] the increase in the number of cells with a ring-like pattern of centriolar [GENE]  ~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig 5e  and  Supplementary Fig 7e   indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot 
2014	PMC4220463	stil	suppress	In addition, the expression of STIL ΔCC in STIL siRNA-treated cells did not suppress the increase in the number of cells with a ring-like pattern of centriolar Plk4 (~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig. 5e  and  Supplementary Fig. 7e ), indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot.	 In addition the expression of STIL ΔCC in STIL siRNA-treated cells did not [EXPE] the increase in the number of cells with a ring-like pattern of centriolar Plk4  ~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig 5e  and  Supplementary Fig 7e   indicating that the existence of [GENE] and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot 
2014	PMC4220463	plk4	suppress	In addition, the expression of STIL ΔCC in STIL siRNA-treated cells did not suppress the increase in the number of cells with a ring-like pattern of centriolar Plk4 (~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig. 5e  and  Supplementary Fig. 7e ), indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar Plk4 ring into a dot.	 In addition the expression of STIL ΔCC in STIL siRNA-treated cells did not [EXPE] the increase in the number of cells with a ring-like pattern of centriolar Plk4  ~59% for siSTIL+empty vector and ~60% for siSTIL+ΔCC;  Fig 5e  and  Supplementary Fig 7e   indicating that the existence of STIL and HsSAS-6 at centrioles is required for the conversion of the centriolar [GENE] ring into a dot 
2014	PMC4220463	stil	overexpression	To address this model, we next investigated whether overexpression of STIL full-length or mutant proteins stabilizes centriolar Plk4.	 To address this model we next investigated whether [EXPE] of [GENE] full-length or mutant proteins stabilizes centriolar Plk4 
2014	PMC4220463	plk4	overexpression	To address this model, we next investigated whether overexpression of STIL full-length or mutant proteins stabilizes centriolar Plk4.	 To address this model we next investigated whether [EXPE] of STIL full-length or mutant proteins stabilizes centriolar [GENE] 
2014	PMC4220463	stil	depleted	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells [EXPE] of endogenous [GENE] restored the population of cells containing Plk4 dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	stil	restored	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous [GENE] [EXPE] the population of cells containing Plk4 dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	stil	overexpression	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous [GENE] restored the population of cells containing Plk4 dots at the centrioles [EXPE] of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	plk4	depleted	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells [EXPE] of endogenous STIL restored the population of cells containing [GENE] dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	plk4	restored	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL [EXPE] the population of cells containing [GENE] dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	plk4	overexpression	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing [GENE] dots at the centrioles [EXPE] of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	plk4	depleted	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells [EXPE] of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar [GENE] as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	plk4	restored	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL [EXPE] the population of cells containing Plk4 dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar [GENE] as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	plk4	overexpression	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles [EXPE] of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar [GENE] as a ring overlapping with the STIL proteins   Fig 6c   
2014	PMC4220463	stil	depleted	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells [EXPE] of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the [GENE] proteins   Fig 6c   
2014	PMC4220463	stil	restored	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL [EXPE] the population of cells containing Plk4 dots at the centrioles overexpression of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the [GENE] proteins   Fig 6c   
2014	PMC4220463	stil	overexpression	We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles, overexpression of HA-STIL full-length, ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the STIL proteins ( Fig. 6c ).	 We found that whereas low expression of HA-STIL full length in the cells depleted of endogenous STIL restored the population of cells containing Plk4 dots at the centrioles [EXPE] of HA-STIL full-length ΔSTAN or 5A mutant proteins stabilized centriolar Plk4 as a ring overlapping with the [GENE] proteins   Fig 6c   
2014	PMC4220463	stil	inhibited	Considering that the centriolar loading of HsSAS-6 and procentriole formation were inhibited in the cells expressing HA-STIL ΔSTAN or 5A mutant, this result suggests that centriolar presence of STIL might be sufficient for stabilizing centriolar Plk4 in this situation.	 Considering that the centriolar loading of HsSAS-6 and procentriole formation were [EXPE] in the cells expressing HA-STIL ΔSTAN or 5A mutant this result suggests that centriolar presence of [GENE] might be sufficient for stabilizing centriolar Plk4 in this situation 
2014	PMC4220463	plk4	inhibited	Considering that the centriolar loading of HsSAS-6 and procentriole formation were inhibited in the cells expressing HA-STIL ΔSTAN or 5A mutant, this result suggests that centriolar presence of STIL might be sufficient for stabilizing centriolar Plk4 in this situation.	 Considering that the centriolar loading of HsSAS-6 and procentriole formation were [EXPE] in the cells expressing HA-STIL ΔSTAN or 5A mutant this result suggests that centriolar presence of STIL might be sufficient for stabilizing centriolar [GENE] in this situation 
2014	PMC4220463	stil	overexpressed	However, we cannot exclude the possibility that residual binding activity of overexpressed STIL ΔCC to Plk4 somehow managed to facilitate those events.	 However we cannot exclude the possibility that residual binding activity of [EXPE] [GENE] ΔCC to Plk4 somehow managed to facilitate those events 
2014	PMC4220463	plk4	overexpressed	However, we cannot exclude the possibility that residual binding activity of overexpressed STIL ΔCC to Plk4 somehow managed to facilitate those events.	 However we cannot exclude the possibility that residual binding activity of [EXPE] STIL ΔCC to [GENE] somehow managed to facilitate those events 
2014	PMC4220463	stil	inhibited	Importantly, we demonstrated that expression of STIL efficiently inhibited ubiquitination of Plk4ΔPEST-FLAG WT ( Fig. 6d ).	 Importantly we demonstrated that expression of [GENE] efficiently [EXPE] ubiquitination of Plk4ΔPEST-FLAG WT   Fig 6d   
2015	PMC4291483	stil	proteomic	Accordingly, we employed the mass spectrometry-based proteomic analysis to identify candidate proteins interacting with HsSAS-6 or STIL.	 Accordingly we employed the mass spectrometry-based [EXPE] analysis to identify candidate proteins interacting with HsSAS-6 or [GENE] 
2015	PMC4291483	rbm14	screening	This screening led to the identification of RNA-Binding Motif protein 14 (RBM14, also known as COAA, transcription co-activator, or PSP2, paraspeckle protein 2) (Iwasaki  et al ,  2001 ; Fox  et al ,  2002 ), a potential tumor suppressor conserved within vertebrates (Kang  et al ,  2008 ), as a STIL-interacting protein (Supplementary Table  S1 ).	 This [EXPE] led to the identification of RNA-Binding Motif protein 14  [GENE] also known as COAA transcription co-activator or PSP2 paraspeckle protein 2   Iwasaki  et al   2001 ; Fox  et al   2002   a potential tumor suppressor conserved within vertebrates  Kang  et al   2008   as a STIL-interacting protein  Supplementary Table  S1   
2015	PMC4291483	coaa	screening	This screening led to the identification of RNA-Binding Motif protein 14 (RBM14, also known as COAA, transcription co-activator, or PSP2, paraspeckle protein 2) (Iwasaki  et al ,  2001 ; Fox  et al ,  2002 ), a potential tumor suppressor conserved within vertebrates (Kang  et al ,  2008 ), as a STIL-interacting protein (Supplementary Table  S1 ).	 This [EXPE] led to the identification of RNA-Binding Motif protein 14  RBM14 also known as [GENE] transcription co-activator or PSP2 paraspeckle protein 2   Iwasaki  et al   2001 ; Fox  et al   2002   a potential tumor suppressor conserved within vertebrates  Kang  et al   2008   as a STIL-interacting protein  Supplementary Table  S1   
2015	PMC4291483	rbm14	depletion	Intriguingly, we discovered that siRNA-mediated depletion of RBM14 resulted in a significant increase of centrin foci in human U2OS (33 ± 2% compared with 7 ± 2% in control cells,  P  <   0.01,  n  = 90 in triplicate; Fig  1A  and Supplementary Fig S1A), HeLa cells (19 ± 1% compared with 1 ± 1% in control cells,  P  <   0.01,  n  = 90 in triplicate; Supplementary Fig S1B) and RPE1 cells (17 ± 4% compared with 3 ± 2% in control cells,  P  <   0.05,  n  = 90 in triplicate; Supplementary Fig S1C).	 Intriguingly we discovered that siRNA-mediated [EXPE] of [GENE] resulted in a significant increase of centrin foci in human U2OS  33 ± 2% compared with 7 ± 2% in control cells  P  <   001  n  = 90 in triplicate; Fig  1A  and Supplementary Fig S1A  HeLa cells  19 ± 1% compared with 1 ± 1% in control cells  P  <   001  n  = 90 in triplicate; Supplementary Fig S1B  and RPE1 cells  17 ± 4% compared with 3 ± 2% in control cells  P  <   005  n  = 90 in triplicate; Supplementary Fig S1C  
2015	PMC4291483	rbm14	depletion	We therefore assessed the possibility that RBM14 depletion somehow affects centriole formation through transcriptional regulation.	 We therefore assessed the possibility that [GENE] [EXPE] somehow affects centriole formation through transcriptional regulation 
2015	PMC4291483	rbm14	depletion	However, mis-localization of RBM14 from the paraspeckle caused by depletion of p54nrb/NONO, a protein essential for paraspeckle organization (Sasaki  et al ,  2009 ), did not induce amplification of centriole foci (Supplementary Fig S1H).	 However mis-localization of [GENE] from the paraspeckle caused by [EXPE] of p54nrb/NONO a protein essential for paraspeckle organization  Sasaki  et al   2009   did not induce amplification of centriole foci  Supplementary Fig S1H  
2015	PMC4291483	stil	depletion	In addition, expression levels of STIL and other centriole proteins were unaffected by RBM14 depletion (Supplementary Figs S1A, S4A, S5A, and S9B).	 In addition expression levels of [GENE] and other centriole proteins were unaffected by RBM14 [EXPE]  Supplementary Figs S1A S4A S5A and S9B  
2015	PMC4291483	rbm14	depletion	In addition, expression levels of STIL and other centriole proteins were unaffected by RBM14 depletion (Supplementary Figs S1A, S4A, S5A, and S9B).	 In addition expression levels of STIL and other centriole proteins were unaffected by [GENE] [EXPE]  Supplementary Figs S1A S4A S5A and S9B  
2015	PMC4291483	rbm14	inhibitor	Furthermore, incubation with 0.5 mM cycloheximide, a translation inhibitor, did not suppress excess formation of centrin foci by RBM14 depletion (Supplementary Fig S1G).	 Furthermore incubation with 05 mM cycloheximide a translation [EXPE] did not suppress excess formation of centrin foci by [GENE] depletion  Supplementary Fig S1G  
2015	PMC4291483	rbm14	suppress	Furthermore, incubation with 0.5 mM cycloheximide, a translation inhibitor, did not suppress excess formation of centrin foci by RBM14 depletion (Supplementary Fig S1G).	 Furthermore incubation with 05 mM cycloheximide a translation inhibitor did not [EXPE] excess formation of centrin foci by [GENE] depletion  Supplementary Fig S1G  
2015	PMC4291483	rbm14	depletion	Furthermore, incubation with 0.5 mM cycloheximide, a translation inhibitor, did not suppress excess formation of centrin foci by RBM14 depletion (Supplementary Fig S1G).	 Furthermore incubation with 05 mM cycloheximide a translation inhibitor did not suppress excess formation of centrin foci by [GENE] [EXPE]  Supplementary Fig S1G  
2015	PMC4291483	rbm14	depletion	Based on these observations, we conclude that the amplification of centrin foci by RBM14 depletion likely stems from reduction of unknown function of RBM14 rather than its known function as a component of the nuclear paraspeckle.	 Based on these observations we conclude that the amplification of centrin foci by [GENE] [EXPE] likely stems from reduction of unknown function of RBM14 rather than its known function as a component of the nuclear paraspeckle 
2015	PMC4291483	rbm14	depletion	Based on these observations, we conclude that the amplification of centrin foci by RBM14 depletion likely stems from reduction of unknown function of RBM14 rather than its known function as a component of the nuclear paraspeckle.	 Based on these observations we conclude that the amplification of centrin foci by RBM14 [EXPE] likely stems from reduction of unknown function of [GENE] rather than its known function as a component of the nuclear paraspeckle 
2015	PMC4291483	rbm14	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with [GENE] [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	rbm14	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with [GENE] siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and [GENE]  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and [GENE]  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	centrobin	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  [GENE]  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	centrobin	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  [GENE]  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and [GENE]  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and [GENE]  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cpap	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and [GENE]  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cpap	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and [GENE]  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cp110	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and [GENE]  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cp110	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and [GENE]  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	rbm14	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with [GENE] [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	rbm14	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with [GENE] siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and [GENE]  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and [GENE]  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	centrobin	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  [GENE]  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	centrobin	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  [GENE]  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and [GENE]  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	c-nap1	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and [GENE]  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cpap	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and [GENE]  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cpap	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and [GENE]  magenta   C  acetylated-tubulin  green  and CP110  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cp110	sirna	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 [EXPE] were stained with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and [GENE]  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cp110	stained	A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta) (A), Centrobin (green) and C-Nap1 (magenta) (B), centrin-2 (green) and CPAP (magenta) (C), acetylated-tubulin (green) and CP110 (magenta) (D), and centrin-2 (green) and γ-tubulin (magenta) (E).	 A–E Mitotic control U2OS cells or U2OS cells treated with RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and C-Nap1  magenta   A  Centrobin  green  and C-Nap1  magenta   B  centrin-2  green  and CPAP  magenta   C  acetylated-tubulin  green  and [GENE]  magenta   D  and centrin-2  green  and γ-tubulin  magenta   E  
2015	PMC4291483	cpap	depleted	Consistently, we found significant increase in the number of CPAP and CP110 foci in the cells depleted of RBM14 (23 ± 2% compared with 0% in control cells, 30 ± 2% compared with 6 ± 2% in control cells, respectively; for both cases,  P  <   0.01,  n  = 90 in triplicate; Fig  1C  and Supplementary Fig S1K).	 Consistently we found significant increase in the number of [GENE] and CP110 foci in the cells [EXPE] of RBM14  23 ± 2% compared with 0% in control cells 30 ± 2% compared with 6 ± 2% in control cells respectively; for both cases  P  <   001  n  = 90 in triplicate; Fig  1C  and Supplementary Fig S1K  
2015	PMC4291483	cp110	depleted	Consistently, we found significant increase in the number of CPAP and CP110 foci in the cells depleted of RBM14 (23 ± 2% compared with 0% in control cells, 30 ± 2% compared with 6 ± 2% in control cells, respectively; for both cases,  P  <   0.01,  n  = 90 in triplicate; Fig  1C  and Supplementary Fig S1K).	 Consistently we found significant increase in the number of CPAP and [GENE] foci in the cells [EXPE] of RBM14  23 ± 2% compared with 0% in control cells 30 ± 2% compared with 6 ± 2% in control cells respectively; for both cases  P  <   001  n  = 90 in triplicate; Fig  1C  and Supplementary Fig S1K  
2015	PMC4291483	rbm14	depleted	Consistently, we found significant increase in the number of CPAP and CP110 foci in the cells depleted of RBM14 (23 ± 2% compared with 0% in control cells, 30 ± 2% compared with 6 ± 2% in control cells, respectively; for both cases,  P  <   0.01,  n  = 90 in triplicate; Fig  1C  and Supplementary Fig S1K).	 Consistently we found significant increase in the number of CPAP and CP110 foci in the cells [EXPE] of [GENE]  23 ± 2% compared with 0% in control cells 30 ± 2% compared with 6 ± 2% in control cells respectively; for both cases  P  <   001  n  = 90 in triplicate; Fig  1C  and Supplementary Fig S1K  
2015	PMC4291483	rbm14	depleted	Furthermore, we observed ectopic foci of acetylated tubulin in the cells depleted of RBM14 (11 ± 1% compared with 1 ± 1% in control cells,  P  <   0.01,  n  = 90 in triplicate; Fig  1D ) and also found that some of ectopic centrin-containing structures appeared to incorporate acetylated tubulin (26 ± 2%,  n  = 150 in triplicate; Supplementary Fig S1J), suggesting that they contain the centriolar microtubules.	 Furthermore we observed ectopic foci of acetylated tubulin in the cells [EXPE] of [GENE]  11 ± 1% compared with 1 ± 1% in control cells  P  <   001  n  = 90 in triplicate; Fig  1D   and also found that some of ectopic centrin-containing structures appeared to incorporate acetylated tubulin  26 ± 2%  n  = 150 in triplicate; Supplementary Fig S1J  suggesting that they contain the centriolar microtubules 
2015	PMC4291483	rbm14	depletion	Upon depletion of endogenous RBM14, the ectopic centrin-containing structures efficiently accumulated PCM proteins such as γ-tubulin and Cep192 (Stearns  et al ,  1991 ; Zheng  et al ,  1991 ; Gomez-Ferreria  et al ,  2007 ; Zhu  et al ,  2008 ) (39 ± 2% and 41 ± 2%, respectively,  n  = 150 in triplicate; Supplementary Fig S1J).	 Upon [EXPE] of endogenous [GENE] the ectopic centrin-containing structures efficiently accumulated PCM proteins such as γ-tubulin and Cep192  Stearns  et al   1991 ; Zheng  et al   1991 ; Gomez-Ferreria  et al   2007 ; Zhu  et al   2008    39 ± 2% and 41 ± 2% respectively  n  = 150 in triplicate; Supplementary Fig S1J  
2015	PMC4291483	cep192	depletion	Upon depletion of endogenous RBM14, the ectopic centrin-containing structures efficiently accumulated PCM proteins such as γ-tubulin and Cep192 (Stearns  et al ,  1991 ; Zheng  et al ,  1991 ; Gomez-Ferreria  et al ,  2007 ; Zhu  et al ,  2008 ) (39 ± 2% and 41 ± 2%, respectively,  n  = 150 in triplicate; Supplementary Fig S1J).	 Upon [EXPE] of endogenous RBM14 the ectopic centrin-containing structures efficiently accumulated PCM proteins such as γ-tubulin and [GENE]  Stearns  et al   1991 ; Zheng  et al   1991 ; Gomez-Ferreria  et al   2007 ; Zhu  et al   2008    39 ± 2% and 41 ± 2% respectively  n  = 150 in triplicate; Supplementary Fig S1J  
2015	PMC4291483	rbm14	rescue	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of [GENE] and also to identify the region of RBM14 required for its function we tested whether full-length  FL  and/or fragments of RBM14 can [EXPE] the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14 
2015	PMC4291483	rbm14	sirna	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of [GENE] and also to identify the region of RBM14 required for its function we tested whether full-length  FL  and/or fragments of RBM14 can rescue the phenotype provoked by treatment with [EXPE] against the 3′ UTR targeting solely endogenous RBM14 
2015	PMC4291483	rbm14	rescue	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of [GENE] required for its function we tested whether full-length  FL  and/or fragments of RBM14 can [EXPE] the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14 
2015	PMC4291483	rbm14	sirna	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of [GENE] required for its function we tested whether full-length  FL  and/or fragments of RBM14 can rescue the phenotype provoked by treatment with [EXPE] against the 3′ UTR targeting solely endogenous RBM14 
2015	PMC4291483	rbm14	rescue	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function we tested whether full-length  FL  and/or fragments of [GENE] can [EXPE] the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14 
2015	PMC4291483	rbm14	sirna	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function we tested whether full-length  FL  and/or fragments of [GENE] can rescue the phenotype provoked by treatment with [EXPE] against the 3′ UTR targeting solely endogenous RBM14 
2015	PMC4291483	rbm14	rescue	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function we tested whether full-length  FL  and/or fragments of RBM14 can [EXPE] the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous [GENE] 
2015	PMC4291483	rbm14	sirna	To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function, we tested whether full-length (FL) and/or fragments of RBM14 can rescue the phenotype provoked by treatment with siRNA against the 3′ UTR targeting solely endogenous RBM14.	 To confirm that the appearance of ectopic centriolar protein complexes specifically results from loss of RBM14 and also to identify the region of RBM14 required for its function we tested whether full-length  FL  and/or fragments of RBM14 can rescue the phenotype provoked by treatment with [EXPE] against the 3′ UTR targeting solely endogenous [GENE] 
2015	PMC4291483	rbm14	depleted	We found that expression of the C-terminal half of RBM14 (RBM14[C]) lacking the RNA-recognition motif (RRM) as well as RBM14 FL markedly suppressed the amplification of centriolar protein complexes in the cells depleted of endogenous RBM14 (Fig  2A and B , and Supplementary Fig S2A).	 We found that expression of the C-terminal half of [GENE]  RBM14[C]  lacking the RNA-recognition motif  RRM  as well as RBM14 FL markedly suppressed the amplification of centriolar protein complexes in the cells [EXPE] of endogenous RBM14  Fig  2A and B  and Supplementary Fig S2A  
2015	PMC4291483	rbm14	depleted	We found that expression of the C-terminal half of RBM14 (RBM14[C]) lacking the RNA-recognition motif (RRM) as well as RBM14 FL markedly suppressed the amplification of centriolar protein complexes in the cells depleted of endogenous RBM14 (Fig  2A and B , and Supplementary Fig S2A).	 We found that expression of the C-terminal half of RBM14  RBM14[C]  lacking the RNA-recognition motif  RRM  as well as [GENE] FL markedly suppressed the amplification of centriolar protein complexes in the cells [EXPE] of endogenous RBM14  Fig  2A and B  and Supplementary Fig S2A  
2015	PMC4291483	rbm14	depleted	We found that expression of the C-terminal half of RBM14 (RBM14[C]) lacking the RNA-recognition motif (RRM) as well as RBM14 FL markedly suppressed the amplification of centriolar protein complexes in the cells depleted of endogenous RBM14 (Fig  2A and B , and Supplementary Fig S2A).	 We found that expression of the C-terminal half of RBM14  RBM14[C]  lacking the RNA-recognition motif  RRM  as well as RBM14 FL markedly suppressed the amplification of centriolar protein complexes in the cells [EXPE] of endogenous [GENE]  Fig  2A and B  and Supplementary Fig S2A  
2015	PMC4291483	rbm14	sirna	A U2OS cells or U2OS cells expressing FLAG–RBM14 full length (FL, aa1–669), N-terminal fragment (RBM14[N], aa1–150) or C-terminal fragment (RBM14[C], aa151–669) and treated with control siRNA or siRNA against 3′ UTR targeting endogenous RBM14 were stained with antibodies against FLAG as well as centrin-2.	 A U2OS cells or U2OS cells expressing FLAG–RBM14 full length  FL aa1–669  N-terminal fragment  RBM14[N] aa1–150  or C-terminal fragment  RBM14[C] aa151–669  and treated with control [EXPE] or siRNA against 3′ UTR targeting endogenous [GENE] were stained with antibodies against FLAG as well as centrin-2 
2015	PMC4291483	rbm14	sirna	A U2OS cells or U2OS cells expressing FLAG–RBM14 full length (FL, aa1–669), N-terminal fragment (RBM14[N], aa1–150) or C-terminal fragment (RBM14[C], aa151–669) and treated with control siRNA or siRNA against 3′ UTR targeting endogenous RBM14 were stained with antibodies against FLAG as well as centrin-2.	 A U2OS cells or U2OS cells expressing FLAG–RBM14 full length  FL aa1–669  N-terminal fragment  RBM14[N] aa1–150  or C-terminal fragment  RBM14[C] aa151–669  and treated with control siRNA or [EXPE] against 3′ UTR targeting endogenous [GENE] were stained with antibodies against FLAG as well as centrin-2 
2015	PMC4291483	rbm14	stained	A U2OS cells or U2OS cells expressing FLAG–RBM14 full length (FL, aa1–669), N-terminal fragment (RBM14[N], aa1–150) or C-terminal fragment (RBM14[C], aa151–669) and treated with control siRNA or siRNA against 3′ UTR targeting endogenous RBM14 were stained with antibodies against FLAG as well as centrin-2.	 A U2OS cells or U2OS cells expressing FLAG–RBM14 full length  FL aa1–669  N-terminal fragment  RBM14[N] aa1–150  or C-terminal fragment  RBM14[C] aa151–669  and treated with control siRNA or siRNA against 3′ UTR targeting endogenous [GENE] were [EXPE] with antibodies against FLAG as well as centrin-2 
2015	PMC4291483	rbm14	suppress	C, D Cytoplasmic RBM14 could suppress centriole amplification in HU-treated cells.	 C D Cytoplasmic [GENE] could [EXPE] centriole amplification in HU-treated cells 
2015	PMC4291483	rbm14	immunofluorescence	The percentages of U2OS cells with centrosomal localization of the RBM14 full-length protein or mutants are shown below the immunofluorescence images.	 The percentages of U2OS cells with centrosomal localization of the [GENE] full-length protein or mutants are shown below the [EXPE] images 
2015	PMC4291483	rbm14	sirna	A U2OS cells or U2OS cells expressing FLAG–RBM14 full length (FL, aa1–669), N-terminal fragment (RBM14[N], aa1–150) or C-terminal fragment (RBM14[C], aa151–669) and treated with control siRNA or siRNA against 3′ UTR targeting endogenous RBM14 were stained with antibodies against FLAG as well as centrin-2.	 A U2OS cells or U2OS cells expressing FLAG–RBM14 full length  FL aa1–669  N-terminal fragment  RBM14[N] aa1–150  or C-terminal fragment  RBM14[C] aa151–669  and treated with control [EXPE] or siRNA against 3′ UTR targeting endogenous [GENE] were stained with antibodies against FLAG as well as centrin-2 
2015	PMC4291483	rbm14	sirna	A U2OS cells or U2OS cells expressing FLAG–RBM14 full length (FL, aa1–669), N-terminal fragment (RBM14[N], aa1–150) or C-terminal fragment (RBM14[C], aa151–669) and treated with control siRNA or siRNA against 3′ UTR targeting endogenous RBM14 were stained with antibodies against FLAG as well as centrin-2.	 A U2OS cells or U2OS cells expressing FLAG–RBM14 full length  FL aa1–669  N-terminal fragment  RBM14[N] aa1–150  or C-terminal fragment  RBM14[C] aa151–669  and treated with control siRNA or [EXPE] against 3′ UTR targeting endogenous [GENE] were stained with antibodies against FLAG as well as centrin-2 
2015	PMC4291483	rbm14	stained	A U2OS cells or U2OS cells expressing FLAG–RBM14 full length (FL, aa1–669), N-terminal fragment (RBM14[N], aa1–150) or C-terminal fragment (RBM14[C], aa151–669) and treated with control siRNA or siRNA against 3′ UTR targeting endogenous RBM14 were stained with antibodies against FLAG as well as centrin-2.	 A U2OS cells or U2OS cells expressing FLAG–RBM14 full length  FL aa1–669  N-terminal fragment  RBM14[N] aa1–150  or C-terminal fragment  RBM14[C] aa151–669  and treated with control siRNA or siRNA against 3′ UTR targeting endogenous [GENE] were [EXPE] with antibodies against FLAG as well as centrin-2 
2015	PMC4291483	rbm14	suppress	C, D Cytoplasmic RBM14 could suppress centriole amplification in HU-treated cells.	 C D Cytoplasmic [GENE] could [EXPE] centriole amplification in HU-treated cells 
2015	PMC4291483	rbm14	immunofluorescence	The percentages of U2OS cells with centrosomal localization of the RBM14 full-length protein or mutants are shown below the immunofluorescence images.	 The percentages of U2OS cells with centrosomal localization of the [GENE] full-length protein or mutants are shown below the [EXPE] images 
2015	PMC4291483	rbm14	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although [EXPE] of [GENE] had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of Plk4 STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	rbm14	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of [GENE] had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by [EXPE] of Plk4 STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	rbm14	inhibited	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of [GENE] had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of Plk4 STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly [EXPE] centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	plk4	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although [EXPE] of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of [GENE] STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	plk4	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by [EXPE] of [GENE] STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	plk4	inhibited	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of [GENE] STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly [EXPE] centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	stil	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although [EXPE] of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of Plk4 [GENE] or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	stil	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by [EXPE] of Plk4 [GENE] or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	stil	inhibited	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of Plk4 [GENE] or HsSAS-6  Supplementary Fig S2D  we found that it significantly [EXPE] centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing RBM14 FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	rbm14	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although [EXPE] of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of Plk4 STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing [GENE] FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	rbm14	overexpression	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by [EXPE] of Plk4 STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing [GENE] FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	rbm14	inhibited	Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly (Supplementary Fig S2B and C) or formation of multiple procentrioles induced by overexpression of Plk4, STIL or HsSAS-6 (Supplementary Fig S2D), we found that it significantly inhibited centriole amplification in cells treated with hydroxyurea (HU) to prolong S phase, judged by the frequency of cells with more than 4 centrin foci (26 ± 3% in cells expressing RBM14 FL, 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells,  P  <   0.05,  n  = 90 in triplicate; Fig  2C ).	 Although overexpression of RBM14 had only a minor effect on normal centriole duplication and PCM assembly  Supplementary Fig S2B and C  or formation of multiple procentrioles induced by overexpression of Plk4 STIL or HsSAS-6  Supplementary Fig S2D  we found that it significantly [EXPE] centriole amplification in cells treated with hydroxyurea  HU  to prolong S phase judged by the frequency of cells with more than 4 centrin foci  26 ± 3% in cells expressing [GENE] FL 27 ± 2% in cells expressing RBM14[C] compared with 53 ± 4% in control cells  P  <   005  n  = 90 in triplicate; Fig  2C   
2015	PMC4291483	rbm14	overexpression	Intriguingly, we found that when overexpressing RBM14-NES which localized to the cytoplasm, but seemingly not to centrioles (only 2.2 ± 1.1% of RBM14-NES in the vicinity of centrioles during interphase,  n  = 90; Fig  2D ), HU-induced centriole amplification was efficiently suppressed as is the case for overexpression of the native full-length protein (21 ± 1% in cells expressing RBM14-NES compared with 28 ± 3% in cells expressing RBM14,  P  <   0.05,  n  = 90 in triplicate; Fig  2D ).	 Intriguingly we found that when overexpressing RBM14-NES which localized to the cytoplasm but seemingly not to centrioles  only 22 ± 11% of RBM14-NES in the vicinity of centrioles during interphase  n  = 90; Fig  2D   HU-induced centriole amplification was efficiently suppressed as is the case for [EXPE] of the native full-length protein  21 ± 1% in cells expressing RBM14-NES compared with 28 ± 3% in cells expressing [GENE]  P  <   005  n  = 90 in triplicate; Fig  2D   
2015	PMC4291483	rbm14	overexpression	On the other hand, overexpression of RBM14-PACT localizing to centrioles (33.3 ± 3.8%,  n  = 90; Fig  2D ) and in the cytoplasm also suppressed the centriole amplification, but not more effectively (34 ± 4%,  n  = 90 in triplicate; Fig  2D ), suggesting that the centriolar loading of RBM14 itself seems not to be essential for its ability to suppress centriole amplification.	 On the other hand [EXPE] of RBM14-PACT localizing to centrioles  333 ± 38%  n  = 90; Fig  2D   and in the cytoplasm also suppressed the centriole amplification but not more effectively  34 ± 4%  n  = 90 in triplicate; Fig  2D   suggesting that the centriolar loading of [GENE] itself seems not to be essential for its ability to suppress centriole amplification 
2015	PMC4291483	rbm14	suppress	On the other hand, overexpression of RBM14-PACT localizing to centrioles (33.3 ± 3.8%,  n  = 90; Fig  2D ) and in the cytoplasm also suppressed the centriole amplification, but not more effectively (34 ± 4%,  n  = 90 in triplicate; Fig  2D ), suggesting that the centriolar loading of RBM14 itself seems not to be essential for its ability to suppress centriole amplification.	 On the other hand overexpression of RBM14-PACT localizing to centrioles  333 ± 38%  n  = 90; Fig  2D   and in the cytoplasm also suppressed the centriole amplification but not more effectively  34 ± 4%  n  = 90 in triplicate; Fig  2D   suggesting that the centriolar loading of [GENE] itself seems not to be essential for its ability to [EXPE] centriole amplification 
2015	PMC4291483	rbm14	depletion	Furthermore, we established that expression of RBM14-NES suppressed the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S2G).	 Furthermore we established that expression of RBM14-NES suppressed the phenotype provoked by [EXPE] of endogenous [GENE]  Supplementary Fig S2G  
2015	PMC4291483	rbm14	suppress	Overall, these data lead us to propose that cytoplasmic localization of RBM14 is crucial for its function to suppress amplification of centrioles or ectopic centriolar protein complexes.	 Overall these data lead us to propose that cytoplasmic localization of [GENE] is crucial for its function to [EXPE] amplification of centrioles or ectopic centriolar protein complexes 
2015	PMC4291483	rbm14	co-immunoprecipitation	We next confirmed by co-immunoprecipitation experiments with the endogenous proteins that RBM14 is a  bona fide  STIL-binding protein  in vivo  (Fig  3A  and Supplementary Fig S3A).	 We next confirmed by [EXPE] experiments with the endogenous proteins that [GENE] is a  bona fide  STIL-binding protein  in vivo   Fig  3A  and Supplementary Fig S3A  
2015	PMC4291483	stil	yeast two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of [GENE] and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of [GENE] and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	pull-down	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST [EXPE] and co-immunoprecipitation assays using full-length and fragments of [GENE] and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	co-immunoprecipitation	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and [EXPE] assays using full-length and fragments of [GENE] and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	assays	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation [EXPE] using full-length and fragments of [GENE] and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	suppress	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation assays using full-length and fragments of [GENE] and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to [EXPE] the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	yeast two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and [GENE] established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and [GENE] established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	pull-down	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST [EXPE] and co-immunoprecipitation assays using full-length and fragments of STIL and [GENE] established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	co-immunoprecipitation	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and [EXPE] assays using full-length and fragments of STIL and [GENE] established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	assays	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation [EXPE] using full-length and fragments of STIL and [GENE] established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	suppress	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and [GENE] established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to [EXPE] the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	yeast two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of [GENE]  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of [GENE]  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	pull-down	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST [EXPE] and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of [GENE]  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	co-immunoprecipitation	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and [EXPE] assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of [GENE]  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	assays	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation [EXPE] using full-length and fragments of STIL and RBM14 established that the N-terminal region of [GENE]  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	stil	suppress	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of [GENE]  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of RBM14 to [EXPE] the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	yeast two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of [GENE] which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of [GENE] which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	pull-down	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST [EXPE] and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of [GENE] which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	co-immunoprecipitation	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and [EXPE] assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of [GENE] which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	assays	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation [EXPE] using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of [GENE] which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	suppress	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of [GENE] which is crucial for the ability of RBM14 to [EXPE] the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	yeast two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of [GENE] to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	two-hybrid	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast [EXPE] GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of [GENE] to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	pull-down	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST [EXPE] and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of [GENE] to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	co-immunoprecipitation	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and [EXPE] assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of [GENE] to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	assays	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation [EXPE] using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of [GENE] to suppress the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	suppress	Moreover, yeast two-hybrid, GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL (STIL[N]) directly bound to the C-terminal region of RBM14, which is crucial for the ability of RBM14 to suppress the formation of ectopic centriolar protein complexes (Fig  3B  and  C , and Supplementary Fig S3B–D).	 Moreover yeast two-hybrid GST pull-down and co-immunoprecipitation assays using full-length and fragments of STIL and RBM14 established that the N-terminal region of STIL  STIL[N]  directly bound to the C-terminal region of RBM14 which is crucial for the ability of [GENE] to [EXPE] the formation of ectopic centriolar protein complexes  Fig  3B  and  C  and Supplementary Fig S3B–D  
2015	PMC4291483	rbm14	rescue	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the [GENE] mutant proteins that lack the TRBP-interacting domain did not efficiently [EXPE] the phenotype provoked by depletion of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	depletion	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the [GENE] mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by [EXPE] of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	rescue	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently [EXPE] the phenotype provoked by depletion of endogenous [GENE]  Supplementary Fig S3G  suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	depletion	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by [EXPE] of endogenous [GENE]  Supplementary Fig S3G  suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	rescue	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently [EXPE] the phenotype provoked by depletion of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of [GENE] to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	depletion	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by [EXPE] of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of [GENE] to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	stil	rescue	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently [EXPE] the phenotype provoked by depletion of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of RBM14 to [GENE] through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	stil	depletion	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by [EXPE] of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of RBM14 to [GENE] through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	rescue	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently [EXPE] the phenotype provoked by depletion of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of [GENE] suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	rbm14	depletion	Consistently, functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by depletion of endogenous RBM14 (Supplementary Fig S3G), suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of RBM14 suppressing ectopic formation of centriolar protein complexes.	 Consistently functional analysis revealed that expression of the RBM14 mutant proteins that lack the TRBP-interacting domain did not efficiently rescue the phenotype provoked by [EXPE] of endogenous RBM14  Supplementary Fig S3G  suggesting that direct binding of RBM14 to STIL through the TRBP-interacting domain is required for the function of [GENE] suppressing ectopic formation of centriolar protein complexes 
2015	PMC4291483	stil	immunofluorescence	However, both immunofluorescence and Western blot analyses in RBM14-depleted U2OS cells showed that fluctuating expression at centrioles and total expression levels of STIL across the cell cycle (Tang  et al ,  2011 ; Arquint  et al ,  2012 ; Vulprecht  et al ,  2012 ) seemed comparable to the control (Fig  3D  and Supplementary Fig S4A).	 However both [EXPE] and Western blot analyses in RBM14-depleted U2OS cells showed that fluctuating expression at centrioles and total expression levels of [GENE] across the cell cycle  Tang  et al   2011 ; Arquint  et al   2012 ; Vulprecht  et al   2012   seemed comparable to the control  Fig  3D  and Supplementary Fig S4A  
2015	PMC4291483	stil	western blot	However, both immunofluorescence and Western blot analyses in RBM14-depleted U2OS cells showed that fluctuating expression at centrioles and total expression levels of STIL across the cell cycle (Tang  et al ,  2011 ; Arquint  et al ,  2012 ; Vulprecht  et al ,  2012 ) seemed comparable to the control (Fig  3D  and Supplementary Fig S4A).	 However both immunofluorescence and [EXPE] analyses in RBM14-depleted U2OS cells showed that fluctuating expression at centrioles and total expression levels of [GENE] across the cell cycle  Tang  et al   2011 ; Arquint  et al   2012 ; Vulprecht  et al   2012   seemed comparable to the control  Fig  3D  and Supplementary Fig S4A  
2015	PMC4291483	cpap	pull-down	To address this, we conducted  in vitro  pull-down assay to test whether RBM14[C] and the STIL-binding region of CPAP, CPAP[SBD], compete with each other for binding to STIL[N].	 To address this we conducted  in vitro  [EXPE] assay to test whether RBM14[C] and the STIL-binding region of [GENE] CPAP[SBD] compete with each other for binding to STIL[N] 
2015	PMC4291483	cpap	assay	To address this, we conducted  in vitro  pull-down assay to test whether RBM14[C] and the STIL-binding region of CPAP, CPAP[SBD], compete with each other for binding to STIL[N].	 To address this we conducted  in vitro  pull-down [EXPE] to test whether RBM14[C] and the STIL-binding region of [GENE] CPAP[SBD] compete with each other for binding to STIL[N] 
2015	PMC4291483	rbm14	knockdown	Importantly, we revealed, using siRNA-based double knockdown experiments, that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and STIL (Fig  3G ).	 Importantly we revealed using siRNA-based double [EXPE] experiments that the formation of ectopic centrin foci by [GENE] depletion depends on CPAP and STIL  Fig  3G   
2015	PMC4291483	rbm14	depletion	Importantly, we revealed, using siRNA-based double knockdown experiments, that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and STIL (Fig  3G ).	 Importantly we revealed using siRNA-based double knockdown experiments that the formation of ectopic centrin foci by [GENE] [EXPE] depends on CPAP and STIL  Fig  3G   
2015	PMC4291483	cpap	knockdown	Importantly, we revealed, using siRNA-based double knockdown experiments, that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and STIL (Fig  3G ).	 Importantly we revealed using siRNA-based double [EXPE] experiments that the formation of ectopic centrin foci by RBM14 depletion depends on [GENE] and STIL  Fig  3G   
2015	PMC4291483	cpap	depletion	Importantly, we revealed, using siRNA-based double knockdown experiments, that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and STIL (Fig  3G ).	 Importantly we revealed using siRNA-based double knockdown experiments that the formation of ectopic centrin foci by RBM14 [EXPE] depends on [GENE] and STIL  Fig  3G   
2015	PMC4291483	stil	knockdown	Importantly, we revealed, using siRNA-based double knockdown experiments, that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and STIL (Fig  3G ).	 Importantly we revealed using siRNA-based double [EXPE] experiments that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and [GENE]  Fig  3G   
2015	PMC4291483	stil	depletion	Importantly, we revealed, using siRNA-based double knockdown experiments, that the formation of ectopic centrin foci by RBM14 depletion depends on CPAP and STIL (Fig  3G ).	 Importantly we revealed using siRNA-based double knockdown experiments that the formation of ectopic centrin foci by RBM14 [EXPE] depends on CPAP and [GENE]  Fig  3G   
2015	PMC4291483	rbm14	immunoprecipitates	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and [EXPE]  IPs  were analyzed by Western blotting using [GENE] STIL or CPAP antibodies 
2015	PMC4291483	rbm14	western blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by [EXPE] using [GENE] STIL or CPAP antibodies 
2015	PMC4291483	rbm14	blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by Western [EXPE] using [GENE] STIL or CPAP antibodies 
2015	PMC4291483	stil	immunoprecipitates	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and [EXPE]  IPs  were analyzed by Western blotting using RBM14 [GENE] or CPAP antibodies 
2015	PMC4291483	stil	western blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by [EXPE] using RBM14 [GENE] or CPAP antibodies 
2015	PMC4291483	stil	blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by Western [EXPE] using RBM14 [GENE] or CPAP antibodies 
2015	PMC4291483	cpap	immunoprecipitates	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and [EXPE]  IPs  were analyzed by Western blotting using RBM14 STIL or [GENE] antibodies 
2015	PMC4291483	cpap	western blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by [EXPE] using RBM14 STIL or [GENE] antibodies 
2015	PMC4291483	cpap	blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by Western [EXPE] using RBM14 STIL or [GENE] antibodies 
2015	PMC4291483	rbm14	y2h	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of [EXPE] GST pull-down and co-immunoprecipitation of the interaction between [GENE] and STIL  see also Supplementary Fig S3  
2015	PMC4291483	rbm14	pull-down	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST [EXPE] and co-immunoprecipitation of the interaction between [GENE] and STIL  see also Supplementary Fig S3  
2015	PMC4291483	rbm14	co-immunoprecipitation	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST pull-down and [EXPE] of the interaction between [GENE] and STIL  see also Supplementary Fig S3  
2015	PMC4291483	stil	y2h	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of [EXPE] GST pull-down and co-immunoprecipitation of the interaction between RBM14 and [GENE]  see also Supplementary Fig S3  
2015	PMC4291483	stil	pull-down	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST [EXPE] and co-immunoprecipitation of the interaction between RBM14 and [GENE]  see also Supplementary Fig S3  
2015	PMC4291483	stil	co-immunoprecipitation	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST pull-down and [EXPE] of the interaction between RBM14 and [GENE]  see also Supplementary Fig S3  
2015	PMC4291483	rbm14	sirna	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or [GENE] [EXPE] were stained with antibodies against centrin-2  green  and STIL  magenta  
2015	PMC4291483	rbm14	stained	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or [GENE] siRNA were [EXPE] with antibodies against centrin-2  green  and STIL  magenta  
2015	PMC4291483	stil	sirna	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or RBM14 [EXPE] were stained with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	stil	stained	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	cpap	pull-down	GST pull-down experiment was performed as in (B), with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD], His-tagged STIL-Binding Domain of CPAP.	 GST [EXPE] experiment was performed as in  B  with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD] His-tagged STIL-Binding Domain of [GENE] 
2015	PMC4291483	cpap	purified	GST pull-down experiment was performed as in (B), with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD], His-tagged STIL-Binding Domain of CPAP.	 GST pull-down experiment was performed as in  B  with [EXPE] STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD] His-tagged STIL-Binding Domain of [GENE] 
2015	PMC4291483	cpap	purified	GST pull-down experiment was performed as in (B), with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD], His-tagged STIL-Binding Domain of CPAP.	 GST pull-down experiment was performed as in  B  with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of [EXPE] His-CPAP[SBD] His-tagged STIL-Binding Domain of [GENE] 
2015	PMC4291483	stil	western blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by [EXPE] using [GENE] antibodies which recognize the N-terminal region of STIL 
2015	PMC4291483	stil	blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western [EXPE] using [GENE] antibodies which recognize the N-terminal region of STIL 
2015	PMC4291483	stil	western blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by [EXPE] using STIL antibodies which recognize the N-terminal region of [GENE] 
2015	PMC4291483	stil	blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western [EXPE] using STIL antibodies which recognize the N-terminal region of [GENE] 
2015	PMC4291483	stil	western blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by [EXPE] using the [GENE] or CPAP antibodies 
2015	PMC4291483	stil	blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by Western [EXPE] using the [GENE] or CPAP antibodies 
2015	PMC4291483	cpap	western blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by [EXPE] using the STIL or [GENE] antibodies 
2015	PMC4291483	cpap	blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by Western [EXPE] using the STIL or [GENE] antibodies 
2015	PMC4291483	stil	transfected	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were [EXPE] with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with [GENE] antibodies and the resulting IPs were analyzed by Western blotting using STIL CPAP or FLAG antibodies 
2015	PMC4291483	stil	western blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with [GENE] antibodies and the resulting IPs were analyzed by [EXPE] using STIL CPAP or FLAG antibodies 
2015	PMC4291483	stil	blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with [GENE] antibodies and the resulting IPs were analyzed by Western [EXPE] using STIL CPAP or FLAG antibodies 
2015	PMC4291483	stil	transfected	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were [EXPE] with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western blotting using [GENE] CPAP or FLAG antibodies 
2015	PMC4291483	stil	western blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by [EXPE] using [GENE] CPAP or FLAG antibodies 
2015	PMC4291483	stil	blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western [EXPE] using [GENE] CPAP or FLAG antibodies 
2015	PMC4291483	cpap	transfected	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were [EXPE] with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western blotting using STIL [GENE] or FLAG antibodies 
2015	PMC4291483	cpap	western blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by [EXPE] using STIL [GENE] or FLAG antibodies 
2015	PMC4291483	cpap	blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western [EXPE] using STIL [GENE] or FLAG antibodies 
2015	PMC4291483	c-nap1	sirnas	G U2OS cells treated with the indicated siRNAs were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta).	 G U2OS cells treated with the indicated [EXPE] were stained with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	c-nap1	stained	G U2OS cells treated with the indicated siRNAs were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta).	 G U2OS cells treated with the indicated siRNAs were [EXPE] with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	rbm14	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against [GENE] alone RBM14 + STIL or RBM14 + CPAP are shown below 
2015	PMC4291483	rbm14	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone [GENE] + STIL or RBM14 + CPAP are shown below 
2015	PMC4291483	stil	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone RBM14 + [GENE] or RBM14 + CPAP are shown below 
2015	PMC4291483	rbm14	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone RBM14 + STIL or [GENE] + CPAP are shown below 
2015	PMC4291483	cpap	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone RBM14 + STIL or RBM14 + [GENE] are shown below 
2015	PMC4291483	rbm14	immunoprecipitates	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and [EXPE]  IPs  were analyzed by Western blotting using [GENE] STIL or CPAP antibodies 
2015	PMC4291483	rbm14	western blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by [EXPE] using [GENE] STIL or CPAP antibodies 
2015	PMC4291483	rbm14	blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by Western [EXPE] using [GENE] STIL or CPAP antibodies 
2015	PMC4291483	stil	immunoprecipitates	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and [EXPE]  IPs  were analyzed by Western blotting using RBM14 [GENE] or CPAP antibodies 
2015	PMC4291483	stil	western blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by [EXPE] using RBM14 [GENE] or CPAP antibodies 
2015	PMC4291483	stil	blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by Western [EXPE] using RBM14 [GENE] or CPAP antibodies 
2015	PMC4291483	cpap	immunoprecipitates	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and [EXPE]  IPs  were analyzed by Western blotting using RBM14 STIL or [GENE] antibodies 
2015	PMC4291483	cpap	western blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by [EXPE] using RBM14 STIL or [GENE] antibodies 
2015	PMC4291483	cpap	blotting	Soluble cytosolic fractions (input) and immunoprecipitates (IPs) were analyzed by Western blotting using RBM14, STIL or CPAP antibodies.	 Soluble cytosolic fractions  input  and immunoprecipitates  IPs  were analyzed by Western [EXPE] using RBM14 STIL or [GENE] antibodies 
2015	PMC4291483	rbm14	y2h	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of [EXPE] GST pull-down and co-immunoprecipitation of the interaction between [GENE] and STIL  see also Supplementary Fig S3  
2015	PMC4291483	rbm14	pull-down	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST [EXPE] and co-immunoprecipitation of the interaction between [GENE] and STIL  see also Supplementary Fig S3  
2015	PMC4291483	rbm14	co-immunoprecipitation	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST pull-down and [EXPE] of the interaction between [GENE] and STIL  see also Supplementary Fig S3  
2015	PMC4291483	stil	y2h	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of [EXPE] GST pull-down and co-immunoprecipitation of the interaction between RBM14 and [GENE]  see also Supplementary Fig S3  
2015	PMC4291483	stil	pull-down	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST [EXPE] and co-immunoprecipitation of the interaction between RBM14 and [GENE]  see also Supplementary Fig S3  
2015	PMC4291483	stil	co-immunoprecipitation	C Schematic of our analyses of Y2H, GST pull-down and co-immunoprecipitation of the interaction between RBM14 and STIL (see also Supplementary Fig S3).	 C Schematic of our analyses of Y2H GST pull-down and [EXPE] of the interaction between RBM14 and [GENE]  see also Supplementary Fig S3  
2015	PMC4291483	rbm14	sirna	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or [GENE] [EXPE] were stained with antibodies against centrin-2  green  and STIL  magenta  
2015	PMC4291483	rbm14	stained	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or [GENE] siRNA were [EXPE] with antibodies against centrin-2  green  and STIL  magenta  
2015	PMC4291483	stil	sirna	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or RBM14 [EXPE] were stained with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	stil	stained	D Mitotic U2OS cells treated with control or RBM14 siRNA were stained with antibodies against centrin-2 (green) and STIL (magenta).	 D Mitotic U2OS cells treated with control or RBM14 siRNA were [EXPE] with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	cpap	pull-down	GST pull-down experiment was performed as in (B), with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD], His-tagged STIL-Binding Domain of CPAP.	 GST [EXPE] experiment was performed as in  B  with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD] His-tagged STIL-Binding Domain of [GENE] 
2015	PMC4291483	cpap	purified	GST pull-down experiment was performed as in (B), with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD], His-tagged STIL-Binding Domain of CPAP.	 GST pull-down experiment was performed as in  B  with [EXPE] STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD] His-tagged STIL-Binding Domain of [GENE] 
2015	PMC4291483	cpap	purified	GST pull-down experiment was performed as in (B), with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of purified His-CPAP[SBD], His-tagged STIL-Binding Domain of CPAP.	 GST pull-down experiment was performed as in  B  with purified STIL[N] and GST-RBM14[C] in the presence of the indicated amount of [EXPE] His-CPAP[SBD] His-tagged STIL-Binding Domain of [GENE] 
2015	PMC4291483	stil	western blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by [EXPE] using [GENE] antibodies which recognize the N-terminal region of STIL 
2015	PMC4291483	stil	blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western [EXPE] using [GENE] antibodies which recognize the N-terminal region of STIL 
2015	PMC4291483	stil	western blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by [EXPE] using STIL antibodies which recognize the N-terminal region of [GENE] 
2015	PMC4291483	stil	blotting	The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western blotting using STIL antibodies which recognize the N-terminal region of STIL.	 The fraction of STIL[N] bound to GST-RBM14[C] in such conditions was monitored by Western [EXPE] using STIL antibodies which recognize the N-terminal region of [GENE] 
2015	PMC4291483	stil	western blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by [EXPE] using the [GENE] or CPAP antibodies 
2015	PMC4291483	stil	blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by Western [EXPE] using the [GENE] or CPAP antibodies 
2015	PMC4291483	cpap	western blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by [EXPE] using the STIL or [GENE] antibodies 
2015	PMC4291483	cpap	blotting	Input materials were analyzed by Western blotting using the STIL or CPAP antibodies.	 Input materials were analyzed by Western [EXPE] using the STIL or [GENE] antibodies 
2015	PMC4291483	stil	transfected	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were [EXPE] with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with [GENE] antibodies and the resulting IPs were analyzed by Western blotting using STIL CPAP or FLAG antibodies 
2015	PMC4291483	stil	western blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with [GENE] antibodies and the resulting IPs were analyzed by [EXPE] using STIL CPAP or FLAG antibodies 
2015	PMC4291483	stil	blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with [GENE] antibodies and the resulting IPs were analyzed by Western [EXPE] using STIL CPAP or FLAG antibodies 
2015	PMC4291483	stil	transfected	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were [EXPE] with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western blotting using [GENE] CPAP or FLAG antibodies 
2015	PMC4291483	stil	western blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by [EXPE] using [GENE] CPAP or FLAG antibodies 
2015	PMC4291483	stil	blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western [EXPE] using [GENE] CPAP or FLAG antibodies 
2015	PMC4291483	cpap	transfected	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were [EXPE] with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western blotting using STIL [GENE] or FLAG antibodies 
2015	PMC4291483	cpap	western blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by [EXPE] using STIL [GENE] or FLAG antibodies 
2015	PMC4291483	cpap	blotting	U2OS cells expressing GFP-CPAP were transfected with empty vector as a control, FLAG-RBM14[N], FLAG-RBM14[C] or FLAG-RBM14 FL constructs, immunoprecipitated with STIL antibodies, and the resulting IPs were analyzed by Western blotting using STIL, CPAP or FLAG antibodies.	 U2OS cells expressing GFP-CPAP were transfected with empty vector as a control FLAG-RBM14[N] FLAG-RBM14[C] or FLAG-RBM14 FL constructs immunoprecipitated with STIL antibodies and the resulting IPs were analyzed by Western [EXPE] using STIL [GENE] or FLAG antibodies 
2015	PMC4291483	c-nap1	sirnas	G U2OS cells treated with the indicated siRNAs were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta).	 G U2OS cells treated with the indicated [EXPE] were stained with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	c-nap1	stained	G U2OS cells treated with the indicated siRNAs were stained with antibodies against centrin-2 (green) and C-Nap1 (magenta).	 G U2OS cells treated with the indicated siRNAs were [EXPE] with antibodies against centrin-2  green  and [GENE]  magenta  
2015	PMC4291483	rbm14	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against [GENE] alone RBM14 + STIL or RBM14 + CPAP are shown below 
2015	PMC4291483	rbm14	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone [GENE] + STIL or RBM14 + CPAP are shown below 
2015	PMC4291483	stil	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone RBM14 + [GENE] or RBM14 + CPAP are shown below 
2015	PMC4291483	rbm14	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone RBM14 + STIL or [GENE] + CPAP are shown below 
2015	PMC4291483	cpap	sirnas	Representative mitotic cells treated with siRNAs against RBM14 alone, RBM14 + STIL or RBM14 + CPAP are shown below.	 Representative mitotic cells treated with [EXPE] against RBM14 alone RBM14 + STIL or RBM14 + [GENE] are shown below 
2015	PMC4291483	plk4	depletion	Similarly, depletion of Plk4 did not affect the amplification of centriolar protein complexes (Supplementary Fig S5C).	 Similarly [EXPE] of [GENE] did not affect the amplification of centriolar protein complexes  Supplementary Fig S5C  
2015	PMC4291483	rbm14	depletion	These results suggest that the amplification of centriolar protein complexes induced by RBM14 depletion occurs independently of HsSAS-6 and possibly of a cartwheel structure.	 These results suggest that the amplification of centriolar protein complexes induced by [GENE] [EXPE] occurs independently of HsSAS-6 and possibly of a cartwheel structure 
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control [EXPE] [GENE] siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA [GENE] [EXPE] alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirnas	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA [GENE] siRNA alone or RBM14 + HsSAS-6 [EXPE] were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	stained	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA [GENE] siRNA alone or RBM14 + HsSAS-6 siRNAs were [EXPE] with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control [EXPE] RBM14 siRNA alone or [GENE] + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA RBM14 [EXPE] alone or [GENE] + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirnas	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA RBM14 siRNA alone or [GENE] + HsSAS-6 [EXPE] were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	stained	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA RBM14 siRNA alone or [GENE] + HsSAS-6 siRNAs were [EXPE] with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	Quantification of the number and total signal intensity of centrin foci in HeLa cells treated with control or RBM14 siRNA over time.	 Quantification of the number and total signal intensity of centrin foci in HeLa cells treated with control or [GENE] [EXPE] over time 
2015	PMC4291483	rbm14	time-lapse	Time-lapse recording across the cell cycle of HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA.	 [EXPE] recording across the cell cycle of HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] siRNA 
2015	PMC4291483	rbm14	sirna	Time-lapse recording across the cell cycle of HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA.	 Time-lapse recording across the cell cycle of HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] [EXPE] 
2015	PMC4291483	rbm14	micrographs	Electron micrographs from U2OS cells depleted of RBM14.	 Electron [EXPE] from U2OS cells depleted of [GENE] 
2015	PMC4291483	rbm14	depleted	Electron micrographs from U2OS cells depleted of RBM14.	 Electron micrographs from U2OS cells [EXPE] of [GENE] 
2015	PMC4291483	rbm14	sirna	G U2OS cells expressing GFP-CPAP (green) and treated with RBM14 siRNA were analyzed using CLEM.	 G U2OS cells expressing GFP-CPAP  green  and treated with [GENE] [EXPE] were analyzed using CLEM 
2015	PMC4291483	rbm14	clem	G U2OS cells expressing GFP-CPAP (green) and treated with RBM14 siRNA were analyzed using CLEM.	 G U2OS cells expressing GFP-CPAP  green  and treated with [GENE] siRNA were analyzed using [EXPE] 
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control [EXPE] [GENE] siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA [GENE] [EXPE] alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirnas	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA [GENE] siRNA alone or RBM14 + HsSAS-6 [EXPE] were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	stained	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA [GENE] siRNA alone or RBM14 + HsSAS-6 siRNAs were [EXPE] with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control [EXPE] RBM14 siRNA alone or [GENE] + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA RBM14 [EXPE] alone or [GENE] + HsSAS-6 siRNAs were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirnas	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA RBM14 siRNA alone or [GENE] + HsSAS-6 [EXPE] were stained with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	stained	A U2OS cells treated with control siRNA, RBM14 siRNA alone or RBM14 + HsSAS-6 siRNAs were stained with antibodies against centrin-2 (green) and HsSAS-6 (magenta).	 A U2OS cells treated with control siRNA RBM14 siRNA alone or [GENE] + HsSAS-6 siRNAs were [EXPE] with antibodies against centrin-2  green  and HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	Quantification of the number and total signal intensity of centrin foci in HeLa cells treated with control or RBM14 siRNA over time.	 Quantification of the number and total signal intensity of centrin foci in HeLa cells treated with control or [GENE] [EXPE] over time 
2015	PMC4291483	rbm14	time-lapse	Time-lapse recording across the cell cycle of HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA.	 [EXPE] recording across the cell cycle of HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] siRNA 
2015	PMC4291483	rbm14	sirna	Time-lapse recording across the cell cycle of HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA.	 Time-lapse recording across the cell cycle of HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] [EXPE] 
2015	PMC4291483	rbm14	micrographs	Electron micrographs from U2OS cells depleted of RBM14.	 Electron [EXPE] from U2OS cells depleted of [GENE] 
2015	PMC4291483	rbm14	depleted	Electron micrographs from U2OS cells depleted of RBM14.	 Electron micrographs from U2OS cells [EXPE] of [GENE] 
2015	PMC4291483	rbm14	sirna	G U2OS cells expressing GFP-CPAP (green) and treated with RBM14 siRNA were analyzed using CLEM.	 G U2OS cells expressing GFP-CPAP  green  and treated with [GENE] [EXPE] were analyzed using CLEM 
2015	PMC4291483	rbm14	clem	G U2OS cells expressing GFP-CPAP (green) and treated with RBM14 siRNA were analyzed using CLEM.	 G U2OS cells expressing GFP-CPAP  green  and treated with [GENE] siRNA were analyzed using [EXPE] 
2015	PMC4291483	rbm14	time-lapse	To investigate when and how the ectopic structures are formed, we employed long-term fluorescence time-lapse recording with HeLa cells stably expressing GFP-centrin (Piel  et al ,  2000 ) and depleted of RBM14.	 To investigate when and how the ectopic structures are formed we employed long-term fluorescence [EXPE] recording with HeLa cells stably expressing GFP-centrin  Piel  et al   2000   and depleted of [GENE] 
2015	PMC4291483	rbm14	depleted	To investigate when and how the ectopic structures are formed, we employed long-term fluorescence time-lapse recording with HeLa cells stably expressing GFP-centrin (Piel  et al ,  2000 ) and depleted of RBM14.	 To investigate when and how the ectopic structures are formed we employed long-term fluorescence time-lapse recording with HeLa cells stably expressing GFP-centrin  Piel  et al   2000   and [EXPE] of [GENE] 
2015	PMC4291483	pcna	staining	Indeed, cell cycle arrest experiments and PCNA staining in RBM14-depleted U2OS cells confirmed that ectopic formation of centriolar protein complexes occurred during S phase (Fig  4D  and Supplementary Fig S5G and H).	 Indeed cell cycle arrest experiments and [GENE] [EXPE] in RBM14-depleted U2OS cells confirmed that ectopic formation of centriolar protein complexes occurred during S phase  Fig  4D  and Supplementary Fig S5G and H  
2015	PMC4291483	cpap	clem	CLEM (Correlative Light Electron Micro-scopy) analysis further confirmed that the amorphous structures contained CPAP that is a critical component of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  4F  and  G ).	 [EXPE]  Correlative Light Electron Micro-scopy  analysis further confirmed that the amorphous structures contained [GENE] that is a critical component of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  4F  and  G   
2015	PMC4291483	rbm14	depletion	Overall, these results show that, upon RBM14 depletion, the amorphous centriolar protein complexes formed in the cytoplasm during S phase in a HsSAS-6-independent manner.	 Overall these results show that upon [GENE] [EXPE] the amorphous centriolar protein complexes formed in the cytoplasm during S phase in a HsSAS-6-independent manner 
2015	PMC4291483	rbm14	depletion	Since the ectopic centriolar protein complexes induced by RBM14 depletion could recruit PCM components (Fig  1E ), we next tested whether they are potent to nucleate microtubules.	 Since the ectopic centriolar protein complexes induced by [GENE] [EXPE] could recruit PCM components  Fig  1E   we next tested whether they are potent to nucleate microtubules 
2015	PMC4291483	rbm14	depletion	Importantly, we found that, upon RBM14 depletion, the ectopic centriolar protein complexes with PCM cloud formed extra spindle poles, which often induced formation of multipolar spindles at 30 min after cold treatment (Fig  5C – E ).	 Importantly we found that upon [GENE] [EXPE] the ectopic centriolar protein complexes with PCM cloud formed extra spindle poles which often induced formation of multipolar spindles at 30 min after cold treatment  Fig  5C – E   
2015	PMC4291483	rbm14	depletion	Taken together, these results indicate that the ectopic centriolar protein complexes induced by RBM14 depletion are at least in part potent to nucleate microtubules.	 Taken together these results indicate that the ectopic centriolar protein complexes induced by [GENE] [EXPE] are at least in part potent to nucleate microtubules 
2015	PMC4291483	rbm14	sirna	B–E Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were cold-treated for 30 min, followed by 30–60 min incubation at 37°C and stained with antibodies against centrin (magenta in (B) and (D)) or γ-tubulin (magenta in (E)) as well as α-tubulin (green).	 B–E Control U2OS cells or U2OS cells treated with [EXPE] targeting [GENE] were cold-treated for 30 min followed by 30–60 min incubation at 37°C and stained with antibodies against centrin  magenta in  B  and  D   or γ-tubulin  magenta in  E   as well as α-tubulin  green  
2015	PMC4291483	rbm14	stained	B–E Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were cold-treated for 30 min, followed by 30–60 min incubation at 37°C and stained with antibodies against centrin (magenta in (B) and (D)) or γ-tubulin (magenta in (E)) as well as α-tubulin (green).	 B–E Control U2OS cells or U2OS cells treated with siRNA targeting [GENE] were cold-treated for 30 min followed by 30–60 min incubation at 37°C and [EXPE] with antibodies against centrin  magenta in  B  and  D   or γ-tubulin  magenta in  E   as well as α-tubulin  green  
2015	PMC4291483	rbm14	sirna	B–E Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were cold-treated for 30 min, followed by 30–60 min incubation at 37°C and stained with antibodies against centrin (magenta in (B) and (D)) or γ-tubulin (magenta in (E)) as well as α-tubulin (green).	 B–E Control U2OS cells or U2OS cells treated with [EXPE] targeting [GENE] were cold-treated for 30 min followed by 30–60 min incubation at 37°C and stained with antibodies against centrin  magenta in  B  and  D   or γ-tubulin  magenta in  E   as well as α-tubulin  green  
2015	PMC4291483	rbm14	stained	B–E Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were cold-treated for 30 min, followed by 30–60 min incubation at 37°C and stained with antibodies against centrin (magenta in (B) and (D)) or γ-tubulin (magenta in (E)) as well as α-tubulin (green).	 B–E Control U2OS cells or U2OS cells treated with siRNA targeting [GENE] were cold-treated for 30 min followed by 30–60 min incubation at 37°C and [EXPE] with antibodies against centrin  magenta in  B  and  D   or γ-tubulin  magenta in  E   as well as α-tubulin  green  
2015	PMC4291483	rbm14	depleted	Furthermore, we found that most of the cells depleted of RBM14 and with multipolar spindles harbored extra HsSAS-6 foci and acetylated-tubulin foci (Fig  6A  and Supplementary Fig S6C).	 Furthermore we found that most of the cells [EXPE] of [GENE] and with multipolar spindles harbored extra HsSAS-6 foci and acetylated-tubulin foci  Fig  6A  and Supplementary Fig S6C  
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with RBM14 siRNA and stained with antibodies against centrin-2 (green) as well as HsSAS-6 (magenta).	 A U2OS cells treated with [GENE] [EXPE] and stained with antibodies against centrin-2  green  as well as HsSAS-6  magenta  
2015	PMC4291483	rbm14	stained	A U2OS cells treated with RBM14 siRNA and stained with antibodies against centrin-2 (green) as well as HsSAS-6 (magenta).	 A U2OS cells treated with [GENE] siRNA and [EXPE] with antibodies against centrin-2  green  as well as HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	B Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were stained with antibodies against HsSAS-6 as well as centrin-2.	 B Control U2OS cells or U2OS cells treated with [EXPE] targeting [GENE] were stained with antibodies against HsSAS-6 as well as centrin-2 
2015	PMC4291483	rbm14	stained	B Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were stained with antibodies against HsSAS-6 as well as centrin-2.	 B Control U2OS cells or U2OS cells treated with siRNA targeting [GENE] were [EXPE] with antibodies against HsSAS-6 as well as centrin-2 
2015	PMC4291483	cp110	stained	D RBM14-depleted HeLa cells expressing GFP-centrin (green) were stained with antibodies against CP110 (magenta) and HsSAS-6 (blue).	 D RBM14-depleted HeLa cells expressing GFP-centrin  green  were [EXPE] with antibodies against [GENE]  magenta  and HsSAS-6  blue  
2015	PMC4291483	rbm14	sirna	(F) Histograms represent the percentages of ectopic DsRed-centrin-2 foci with HsSAS-6-GFP recruitment ( n  = 69 foci for control, and  n  = 67 foci for RBM14 siRNA).	  F  Histograms represent the percentages of ectopic DsRed-centrin-2 foci with HsSAS-6-GFP recruitment   n  = 69 foci for control and  n  = 67 foci for [GENE] [EXPE]  
2015	PMC4291483	rbm14	sirna	In this experiment, cells were treated with double amount of RBM14 siRNA (20 pmol) compared to that in the other experiments.	 In this experiment cells were treated with double amount of [GENE] [EXPE]  20 pmol  compared to that in the other experiments 
2015	PMC4291483	rbm14	sirna	H HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA were analyzed using Live CLEM.	 H HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] [EXPE] were analyzed using Live CLEM 
2015	PMC4291483	rbm14	clem	H HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA were analyzed using Live CLEM.	 H HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] siRNA were analyzed using Live [EXPE] 
2015	PMC4291483	rbm14	sirna	A U2OS cells treated with RBM14 siRNA and stained with antibodies against centrin-2 (green) as well as HsSAS-6 (magenta).	 A U2OS cells treated with [GENE] [EXPE] and stained with antibodies against centrin-2  green  as well as HsSAS-6  magenta  
2015	PMC4291483	rbm14	stained	A U2OS cells treated with RBM14 siRNA and stained with antibodies against centrin-2 (green) as well as HsSAS-6 (magenta).	 A U2OS cells treated with [GENE] siRNA and [EXPE] with antibodies against centrin-2  green  as well as HsSAS-6  magenta  
2015	PMC4291483	rbm14	sirna	B Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were stained with antibodies against HsSAS-6 as well as centrin-2.	 B Control U2OS cells or U2OS cells treated with [EXPE] targeting [GENE] were stained with antibodies against HsSAS-6 as well as centrin-2 
2015	PMC4291483	rbm14	stained	B Control U2OS cells or U2OS cells treated with siRNA targeting RBM14 were stained with antibodies against HsSAS-6 as well as centrin-2.	 B Control U2OS cells or U2OS cells treated with siRNA targeting [GENE] were [EXPE] with antibodies against HsSAS-6 as well as centrin-2 
2015	PMC4291483	cp110	stained	D RBM14-depleted HeLa cells expressing GFP-centrin (green) were stained with antibodies against CP110 (magenta) and HsSAS-6 (blue).	 D RBM14-depleted HeLa cells expressing GFP-centrin  green  were [EXPE] with antibodies against [GENE]  magenta  and HsSAS-6  blue  
2015	PMC4291483	rbm14	sirna	(F) Histograms represent the percentages of ectopic DsRed-centrin-2 foci with HsSAS-6-GFP recruitment ( n  = 69 foci for control, and  n  = 67 foci for RBM14 siRNA).	  F  Histograms represent the percentages of ectopic DsRed-centrin-2 foci with HsSAS-6-GFP recruitment   n  = 69 foci for control and  n  = 67 foci for [GENE] [EXPE]  
2015	PMC4291483	rbm14	sirna	In this experiment, cells were treated with double amount of RBM14 siRNA (20 pmol) compared to that in the other experiments.	 In this experiment cells were treated with double amount of [GENE] [EXPE]  20 pmol  compared to that in the other experiments 
2015	PMC4291483	rbm14	sirna	H HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA were analyzed using Live CLEM.	 H HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] [EXPE] were analyzed using Live CLEM 
2015	PMC4291483	rbm14	clem	H HeLa cells expressing GFP-centrin (green) and RFP-H2B (magenta) and treated with RBM14 siRNA were analyzed using Live CLEM.	 H HeLa cells expressing GFP-centrin  green  and RFP-H2B  magenta  and treated with [GENE] siRNA were analyzed using Live [EXPE] 
2015	PMC4291483	rbm14	overexpression	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP [EXPE] and [GENE] depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	depletion	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP overexpression and [GENE] [EXPE] synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	overexpression	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP overexpression and [GENE] depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP [EXPE] or RBM14 depletion alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	depletion	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP overexpression and [GENE] depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 [EXPE] alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	overexpression	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP [EXPE] and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or [GENE] depletion alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	depletion	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP overexpression and RBM14 [EXPE] synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or [GENE] depletion alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	overexpression	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP [EXPE] or [GENE] depletion alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	depletion	Notably, we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or RBM14 depletion alone (Supplementary Fig S7A).	 Notably we found that simultaneous HsSAS-6-GFP overexpression and RBM14 depletion synergistically enhanced the frequency of formation of the centriolar protein complexes containing HsSAS-6 foci compared with HsSAS-6-GFP overexpression or [GENE] [EXPE] alone  Supplementary Fig S7A  
2015	PMC4291483	rbm14	depletion	In fact, when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent CPAP depletion, the increase of HsSAS-6 foci was significantly suppressed, suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  6G  and Supplementary Fig S7D).	 In fact when the formation of ectopic centriolar protein complexes upon [GENE] [EXPE] was inhibited by concurrent CPAP depletion the increase of HsSAS-6 foci was significantly suppressed suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  6G  and Supplementary Fig S7D  
2015	PMC4291483	rbm14	inhibited	In fact, when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent CPAP depletion, the increase of HsSAS-6 foci was significantly suppressed, suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  6G  and Supplementary Fig S7D).	 In fact when the formation of ectopic centriolar protein complexes upon [GENE] depletion was [EXPE] by concurrent CPAP depletion the increase of HsSAS-6 foci was significantly suppressed suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  6G  and Supplementary Fig S7D  
2015	PMC4291483	rbm14	depletion	In fact, when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent CPAP depletion, the increase of HsSAS-6 foci was significantly suppressed, suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  6G  and Supplementary Fig S7D).	 In fact when the formation of ectopic centriolar protein complexes upon [GENE] depletion was inhibited by concurrent CPAP [EXPE] the increase of HsSAS-6 foci was significantly suppressed suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  6G  and Supplementary Fig S7D  
2015	PMC4291483	cpap	depletion	In fact, when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent CPAP depletion, the increase of HsSAS-6 foci was significantly suppressed, suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  6G  and Supplementary Fig S7D).	 In fact when the formation of ectopic centriolar protein complexes upon RBM14 [EXPE] was inhibited by concurrent [GENE] depletion the increase of HsSAS-6 foci was significantly suppressed suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  6G  and Supplementary Fig S7D  
2015	PMC4291483	cpap	inhibited	In fact, when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent CPAP depletion, the increase of HsSAS-6 foci was significantly suppressed, suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  6G  and Supplementary Fig S7D).	 In fact when the formation of ectopic centriolar protein complexes upon RBM14 depletion was [EXPE] by concurrent [GENE] depletion the increase of HsSAS-6 foci was significantly suppressed suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  6G  and Supplementary Fig S7D  
2015	PMC4291483	cpap	depletion	In fact, when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent CPAP depletion, the increase of HsSAS-6 foci was significantly suppressed, suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells (Fig  6G  and Supplementary Fig S7D).	 In fact when the formation of ectopic centriolar protein complexes upon RBM14 depletion was inhibited by concurrent [GENE] [EXPE] the increase of HsSAS-6 foci was significantly suppressed suggesting that formation of ectopic HsSAS-6 foci is dependent on the existence of ectopic centriolar protein complexes in RBM14-depleted cells  Fig  6G  and Supplementary Fig S7D  
2015	PMC4291483	rbm14	clem	To address this possibility, we conducted Live CLEM analysis using HeLa cells expressing GFP-centrin and depleted of RBM14 (Fig  6H , Supplementary Fig S8A–C, and Supplementary Movie S7).	 To address this possibility we conducted Live [EXPE] analysis using HeLa cells expressing GFP-centrin and depleted of [GENE]  Fig  6H  Supplementary Fig S8A–C and Supplementary Movie S7  
2015	PMC4291483	rbm14	depleted	To address this possibility, we conducted Live CLEM analysis using HeLa cells expressing GFP-centrin and depleted of RBM14 (Fig  6H , Supplementary Fig S8A–C, and Supplementary Movie S7).	 To address this possibility we conducted Live CLEM analysis using HeLa cells expressing GFP-centrin and [EXPE] of [GENE]  Fig  6H  Supplementary Fig S8A–C and Supplementary Movie S7  
2015	PMC4291483	rbm14	depleted	In the cells depleted of RBM14, we sometimes observed the pseudo-bipolar spindles in which pre-existing centriole pairs failed to separate each other and organize a single spindle pole while only ectopic GFP-centrin foci assembled the other spindle pole (Fig  6H  and Supplementary Figs S6A and S8A–C).	 In the cells [EXPE] of [GENE] we sometimes observed the pseudo-bipolar spindles in which pre-existing centriole pairs failed to separate each other and organize a single spindle pole while only ectopic GFP-centrin foci assembled the other spindle pole  Fig  6H  and Supplementary Figs S6A and S8A–C  
2015	PMC4291483	rbm14	depletion	Although the reason why pre-existing centriole pairs did not separate in mitosis in such cases remains elusive, we speculate that RBM14 depletion might somewhat disturb the separation of centrosomes.	 Although the reason why pre-existing centriole pairs did not separate in mitosis in such cases remains elusive we speculate that [GENE] [EXPE] might somewhat disturb the separation of centrosomes 
2015	PMC4291483	rbm14	depletion	Together, these results support the notion that RBM14 depletion induces ectopic formation of centriolar protein complexes, a part of which could become a procentriole-like structure even in the presence of pre-existing centrioles.	 Together these results support the notion that [GENE] [EXPE] induces ectopic formation of centriolar protein complexes a part of which could become a procentriole-like structure even in the presence of pre-existing centrioles 
2016	PMC5007451	cep295	blast	To determine whether Cep295 is a conserved factor involved in centriole formation across species, we first conducted a thorough BLAST analysis in eukaryotes.	 To determine whether [GENE] is a conserved factor involved in centriole formation across species we first conducted a thorough [EXPE] analysis in eukaryotes 
2016	PMC5007451	cep295	depletion	Next, we found that RNAi-mediated depletion of Cep295 caused abnormal spindle formation and dramatically decreased the number of centrioles during mitosis in HeLa cells, compared to control mitotic cells that had four centrioles and assembled a bipolar spindle (21±1% of cells treated with siCep295, compared with 94±1% of control cells with ⩾4 centrioles;  Fig. 1c–e ).	 Next we found that RNAi-mediated [EXPE] of [GENE] caused abnormal spindle formation and dramatically decreased the number of centrioles during mitosis in HeLa cells compared to control mitotic cells that had four centrioles and assembled a bipolar spindle  21±1% of cells treated with siCep295 compared with 94±1% of control cells with ⩾4 centrioles;  Fig 1c–e   
2016	PMC5007451	cep295	rnai	The similar defects in centriole number and mitotic spindle formation were also found when using RNAi targeting against different sequences of Cep295 ORF (Open Reading Frame) or in different human cell lines ( Supplementary Fig. 1b ).	 The similar defects in centriole number and mitotic spindle formation were also found when using [EXPE] targeting against different sequences of [GENE] ORF  Open Reading Frame  or in different human cell lines   Supplementary Fig 1b   
2016	PMC5007451	cep295	sirna	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of [GENE] [EXPE] was confirmed by using western blotting and immunofluorescence analysis and also that Cep295 depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	western blotting	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of [GENE] siRNA was confirmed by using [EXPE] and immunofluorescence analysis and also that Cep295 depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	blotting	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of [GENE] siRNA was confirmed by using western [EXPE] and immunofluorescence analysis and also that Cep295 depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	immunofluorescence	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of [GENE] siRNA was confirmed by using western blotting and [EXPE] analysis and also that Cep295 depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	depletion	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of [GENE] siRNA was confirmed by using western blotting and immunofluorescence analysis and also that Cep295 [EXPE] did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	sirna	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of Cep295 [EXPE] was confirmed by using western blotting and immunofluorescence analysis and also that [GENE] depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	western blotting	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of Cep295 siRNA was confirmed by using [EXPE] and immunofluorescence analysis and also that [GENE] depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	blotting	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of Cep295 siRNA was confirmed by using western [EXPE] and immunofluorescence analysis and also that [GENE] depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	immunofluorescence	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of Cep295 siRNA was confirmed by using western blotting and [EXPE] analysis and also that [GENE] depletion did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	depletion	Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis, and also that Cep295 depletion did not affect cell cycle progression ( Supplementary Fig. 1c,d,h ).	 Note that the specificity of Cep295 siRNA was confirmed by using western blotting and immunofluorescence analysis and also that [GENE] [EXPE] did not affect cell cycle progression   Supplementary Fig 1cdh   
2016	PMC5007451	cep295	depleted	We depleted endogenous Cep295 proteins using siRNA and expressed RNAi-resistant full-length or deletion constructs at comparable levels ( Fig. 1f–i  and  Supplementary Fig. 1e–g,j ).	 We [EXPE] endogenous [GENE] proteins using siRNA and expressed RNAi-resistant full-length or deletion constructs at comparable levels   Fig 1f–i  and  Supplementary Fig 1e–gj   
2016	PMC5007451	cep295	sirna	We depleted endogenous Cep295 proteins using siRNA and expressed RNAi-resistant full-length or deletion constructs at comparable levels ( Fig. 1f–i  and  Supplementary Fig. 1e–g,j ).	 We depleted endogenous [GENE] proteins using [EXPE] and expressed RNAi-resistant full-length or deletion constructs at comparable levels   Fig 1f–i  and  Supplementary Fig 1e–gj   
2016	PMC5007451	cep295	rnai-resistant	We depleted endogenous Cep295 proteins using siRNA and expressed RNAi-resistant full-length or deletion constructs at comparable levels ( Fig. 1f–i  and  Supplementary Fig. 1e–g,j ).	 We depleted endogenous [GENE] proteins using siRNA and expressed [EXPE] full-length or deletion constructs at comparable levels   Fig 1f–i  and  Supplementary Fig 1e–gj   
2016	PMC5007451	cep295	depletion	Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon depletion of endogenous Cep295, expression of full-length Cep295 functionally rescued this phenotype (17%±2% and 49%±4% of cells with ⩾2 centrosomes, respectively;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon [EXPE] of endogenous [GENE] expression of full-length Cep295 functionally rescued this phenotype  17%±2% and 49%±4% of cells with ⩾2 centrosomes respectively;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	rescued	Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon depletion of endogenous Cep295, expression of full-length Cep295 functionally rescued this phenotype (17%±2% and 49%±4% of cells with ⩾2 centrosomes, respectively;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon depletion of endogenous [GENE] expression of full-length Cep295 functionally [EXPE] this phenotype  17%±2% and 49%±4% of cells with ⩾2 centrosomes respectively;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	depletion	Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon depletion of endogenous Cep295, expression of full-length Cep295 functionally rescued this phenotype (17%±2% and 49%±4% of cells with ⩾2 centrosomes, respectively;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon [EXPE] of endogenous Cep295 expression of full-length [GENE] functionally rescued this phenotype  17%±2% and 49%±4% of cells with ⩾2 centrosomes respectively;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	rescued	Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon depletion of endogenous Cep295, expression of full-length Cep295 functionally rescued this phenotype (17%±2% and 49%±4% of cells with ⩾2 centrosomes, respectively;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 Whereas the number of centrosomes marked with γ-tubulin was reduced in most of the interphase cells upon depletion of endogenous Cep295 expression of full-length [GENE] functionally [EXPE] this phenotype  17%±2% and 49%±4% of cells with ⩾2 centrosomes respectively;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	rescue	In contrast, a Cep295 mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to rescue the phenotype provoked by depletion of endogenous Cep295 (21%±4% of cells with ⩾2 centrosomes;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 In contrast a [GENE] mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to [EXPE] the phenotype provoked by depletion of endogenous Cep295  21%±4% of cells with ⩾2 centrosomes;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	depletion	In contrast, a Cep295 mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to rescue the phenotype provoked by depletion of endogenous Cep295 (21%±4% of cells with ⩾2 centrosomes;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 In contrast a [GENE] mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to rescue the phenotype provoked by [EXPE] of endogenous Cep295  21%±4% of cells with ⩾2 centrosomes;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	rescue	In contrast, a Cep295 mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to rescue the phenotype provoked by depletion of endogenous Cep295 (21%±4% of cells with ⩾2 centrosomes;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 In contrast a Cep295 mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to [EXPE] the phenotype provoked by depletion of endogenous [GENE]  21%±4% of cells with ⩾2 centrosomes;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	depletion	In contrast, a Cep295 mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to rescue the phenotype provoked by depletion of endogenous Cep295 (21%±4% of cells with ⩾2 centrosomes;  Fig. 1f–i  and  Supplementary Fig. 1j ).	 In contrast a Cep295 mutant lacking the conserved DDC8-like domain did not localize to the centriole and failed to rescue the phenotype provoked by [EXPE] of endogenous [GENE]  21%±4% of cells with ⩾2 centrosomes;  Fig 1f–i  and  Supplementary Fig 1j   
2016	PMC5007451	cep295	overly expressed	We also noted that overly expressed Cep295 frequently colocalized with the microtubule networks through the C-terminal region including the ALMS domain ( Supplementary Fig. 1i ).	 We also noted that [EXPE] [GENE] frequently colocalized with the microtubule networks through the C-terminal region including the ALMS domain   Supplementary Fig 1i   
2016	PMC5007451	cep295	immunofluorescence	To investigate the precise centriolar distribution of Cep295 across the cell cycle, we performed immunofluorescence analyses using specific antibodies against endogenous Cep295 ( Supplementary Fig. 1d ).	 To investigate the precise centriolar distribution of [GENE] across the cell cycle we performed [EXPE] analyses using specific antibodies against endogenous Cep295   Supplementary Fig 1d   
2016	PMC5007451	cep295	immunofluorescence	To investigate the precise centriolar distribution of Cep295 across the cell cycle, we performed immunofluorescence analyses using specific antibodies against endogenous Cep295 ( Supplementary Fig. 1d ).	 To investigate the precise centriolar distribution of Cep295 across the cell cycle we performed [EXPE] analyses using specific antibodies against endogenous [GENE]   Supplementary Fig 1d   
2016	PMC5007451	cep295	three-dimensional	To examine the detailed distribution of Cep295 on mother or daughter centrioles, we used three-dimensional structured illumination microscopy (3D-SIM).	 To examine the detailed distribution of [GENE] on mother or daughter centrioles we used [EXPE] structured illumination microscopy  3D-SIM  
2016	PMC5007451	cep295	structured illumination microscopy	To examine the detailed distribution of Cep295 on mother or daughter centrioles, we used three-dimensional structured illumination microscopy (3D-SIM).	 To examine the detailed distribution of [GENE] on mother or daughter centrioles we used three-dimensional [EXPE]  3D-SIM  
2016	PMC5007451	cep295	microscopy	To examine the detailed distribution of Cep295 on mother or daughter centrioles, we used three-dimensional structured illumination microscopy (3D-SIM).	 To examine the detailed distribution of [GENE] on mother or daughter centrioles we used three-dimensional structured illumination [EXPE]  3D-SIM  
2016	PMC5007451	cep295	3d-sim	To examine the detailed distribution of Cep295 on mother or daughter centrioles, we used three-dimensional structured illumination microscopy (3D-SIM).	 To examine the detailed distribution of [GENE] on mother or daughter centrioles we used three-dimensional structured illumination microscopy  [EXPE]  
2016	PMC5007451	cep295	3d-sim	3D-SIM analyses revealed that Cep295 localized at the proximal end of both daughter and mother centrioles and formed ring-like structures around the centriole wall ( Fig. 2c ).	 [EXPE] analyses revealed that [GENE] localized at the proximal end of both daughter and mother centrioles and formed ring-like structures around the centriole wall   Fig 2c   
2016	PMC5007451	cep295	depletion	We also confirmed that procentriole formation at the new mother centriole was defective upon Cep295 depletion ( Fig. 3b ).	 We also confirmed that procentriole formation at the new mother centriole was defective upon [GENE] [EXPE]   Fig 3b   
2016	PMC5007451	cep295	depletion	Depletion of Cep295 affected centriolar loading of the critical factors, Plk4, STIL, HsSAS-6 and CPAP, to new mother centrioles in interphase cells, whereas that to older mother centrioles did not appear to be affected as much ( Fig. 3c,d  and  Supplementary Fig. 3a,b ).	 [EXPE] of [GENE] affected centriolar loading of the critical factors Plk4 STIL HsSAS-6 and CPAP to new mother centrioles in interphase cells whereas that to older mother centrioles did not appear to be affected as much   Fig 3cd  and  Supplementary Fig 3ab   
2016	PMC5007451	plk4	depletion	Depletion of Cep295 affected centriolar loading of the critical factors, Plk4, STIL, HsSAS-6 and CPAP, to new mother centrioles in interphase cells, whereas that to older mother centrioles did not appear to be affected as much ( Fig. 3c,d  and  Supplementary Fig. 3a,b ).	 [EXPE] of Cep295 affected centriolar loading of the critical factors [GENE] STIL HsSAS-6 and CPAP to new mother centrioles in interphase cells whereas that to older mother centrioles did not appear to be affected as much   Fig 3cd  and  Supplementary Fig 3ab   
2016	PMC5007451	stil	depletion	Depletion of Cep295 affected centriolar loading of the critical factors, Plk4, STIL, HsSAS-6 and CPAP, to new mother centrioles in interphase cells, whereas that to older mother centrioles did not appear to be affected as much ( Fig. 3c,d  and  Supplementary Fig. 3a,b ).	 [EXPE] of Cep295 affected centriolar loading of the critical factors Plk4 [GENE] HsSAS-6 and CPAP to new mother centrioles in interphase cells whereas that to older mother centrioles did not appear to be affected as much   Fig 3cd  and  Supplementary Fig 3ab   
2016	PMC5007451	cpap	depletion	Depletion of Cep295 affected centriolar loading of the critical factors, Plk4, STIL, HsSAS-6 and CPAP, to new mother centrioles in interphase cells, whereas that to older mother centrioles did not appear to be affected as much ( Fig. 3c,d  and  Supplementary Fig. 3a,b ).	 [EXPE] of Cep295 affected centriolar loading of the critical factors Plk4 STIL HsSAS-6 and [GENE] to new mother centrioles in interphase cells whereas that to older mother centrioles did not appear to be affected as much   Fig 3cd  and  Supplementary Fig 3ab   
2016	PMC5007451	plk4	depletion	Conversely, depletion of Plk4, HsSAS-6 and STIL did not affect Cep295 localization to mother centrioles, even though procentriole formation was perturbed under these conditions, suggesting that Cep295 is recruited upstream of these factors ( Supplementary Fig. 3c ).	 Conversely [EXPE] of [GENE] HsSAS-6 and STIL did not affect Cep295 localization to mother centrioles even though procentriole formation was perturbed under these conditions suggesting that Cep295 is recruited upstream of these factors   Supplementary Fig 3c   
2016	PMC5007451	stil	depletion	Conversely, depletion of Plk4, HsSAS-6 and STIL did not affect Cep295 localization to mother centrioles, even though procentriole formation was perturbed under these conditions, suggesting that Cep295 is recruited upstream of these factors ( Supplementary Fig. 3c ).	 Conversely [EXPE] of Plk4 HsSAS-6 and [GENE] did not affect Cep295 localization to mother centrioles even though procentriole formation was perturbed under these conditions suggesting that Cep295 is recruited upstream of these factors   Supplementary Fig 3c   
2016	PMC5007451	cep295	depletion	Conversely, depletion of Plk4, HsSAS-6 and STIL did not affect Cep295 localization to mother centrioles, even though procentriole formation was perturbed under these conditions, suggesting that Cep295 is recruited upstream of these factors ( Supplementary Fig. 3c ).	 Conversely [EXPE] of Plk4 HsSAS-6 and STIL did not affect [GENE] localization to mother centrioles even though procentriole formation was perturbed under these conditions suggesting that Cep295 is recruited upstream of these factors   Supplementary Fig 3c   
2016	PMC5007451	cep295	depletion	Conversely, depletion of Plk4, HsSAS-6 and STIL did not affect Cep295 localization to mother centrioles, even though procentriole formation was perturbed under these conditions, suggesting that Cep295 is recruited upstream of these factors ( Supplementary Fig. 3c ).	 Conversely [EXPE] of Plk4 HsSAS-6 and STIL did not affect Cep295 localization to mother centrioles even though procentriole formation was perturbed under these conditions suggesting that [GENE] is recruited upstream of these factors   Supplementary Fig 3c   
2016	PMC5007451	cep295	depletion	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon [GENE] [EXPE] we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells 
2016	PMC5007451	cep295	depletion	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon [GENE] depletion we tested the effects of Cep295 [EXPE] on centriole overduplication induced by Plk4 overexpression in human cells 
2016	PMC5007451	cep295	overexpression	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon [GENE] depletion we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 [EXPE] in human cells 
2016	PMC5007451	cep295	depletion	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon Cep295 [EXPE] we tested the effects of [GENE] depletion on centriole overduplication induced by Plk4 overexpression in human cells 
2016	PMC5007451	cep295	depletion	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion we tested the effects of [GENE] [EXPE] on centriole overduplication induced by Plk4 overexpression in human cells 
2016	PMC5007451	cep295	overexpression	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion we tested the effects of [GENE] depletion on centriole overduplication induced by Plk4 [EXPE] in human cells 
2016	PMC5007451	plk4	depletion	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon Cep295 [EXPE] we tested the effects of Cep295 depletion on centriole overduplication induced by [GENE] overexpression in human cells 
2016	PMC5007451	plk4	depletion	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion we tested the effects of Cep295 [EXPE] on centriole overduplication induced by [GENE] overexpression in human cells 
2016	PMC5007451	plk4	overexpression	To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion, we tested the effects of Cep295 depletion on centriole overduplication induced by Plk4 overexpression in human cells.	 To investigate further the different phenotypes at new and older mother centrioles upon Cep295 depletion we tested the effects of Cep295 depletion on centriole overduplication induced by [GENE] [EXPE] in human cells 
2016	PMC5007451	cep295	depletion	Consistently, we found that Cep295 depletion largely suppressed the formation of multiple procentrioles at new mother centrioles but not at older mother centrioles ( Fig. 3e ).	 Consistently we found that [GENE] [EXPE] largely suppressed the formation of multiple procentrioles at new mother centrioles but not at older mother centrioles   Fig 3e   
2016	PMC5007451	cep295	depletion	Interestingly, we found that depletion of Cep295 led to complete loss of Cep192 and Cep152 at only one of the two mother centrioles during interphase.	 Interestingly we found that [EXPE] of [GENE] led to complete loss of Cep192 and Cep152 at only one of the two mother centrioles during interphase 
2016	PMC5007451	cep192	depletion	Interestingly, we found that depletion of Cep295 led to complete loss of Cep192 and Cep152 at only one of the two mother centrioles during interphase.	 Interestingly we found that [EXPE] of Cep295 led to complete loss of [GENE] and Cep152 at only one of the two mother centrioles during interphase 
2016	PMC5007451	cep152	depletion	Interestingly, we found that depletion of Cep295 led to complete loss of Cep192 and Cep152 at only one of the two mother centrioles during interphase.	 Interestingly we found that [EXPE] of Cep295 led to complete loss of Cep192 and [GENE] at only one of the two mother centrioles during interphase 
2016	PMC5007451	cep295	depletion	Next, to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly, we decided to examine the phenotype evoked by Cep295 depletion at an earlier time point (∼24 h after the RNAi treatment) and observe the redistribution of Cep192 to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis.	 Next to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly we decided to examine the phenotype evoked by [GENE] [EXPE] at an earlier time point  ∼24 h after the RNAi treatment  and observe the redistribution of Cep192 to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis 
2016	PMC5007451	cep295	rnai	Next, to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly, we decided to examine the phenotype evoked by Cep295 depletion at an earlier time point (∼24 h after the RNAi treatment) and observe the redistribution of Cep192 to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis.	 Next to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly we decided to examine the phenotype evoked by [GENE] depletion at an earlier time point  ∼24 h after the [EXPE] treatment  and observe the redistribution of Cep192 to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis 
2016	PMC5007451	cep192	depletion	Next, to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly, we decided to examine the phenotype evoked by Cep295 depletion at an earlier time point (∼24 h after the RNAi treatment) and observe the redistribution of Cep192 to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis.	 Next to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly we decided to examine the phenotype evoked by Cep295 [EXPE] at an earlier time point  ∼24 h after the RNAi treatment  and observe the redistribution of [GENE] to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis 
2016	PMC5007451	cep192	rnai	Next, to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly, we decided to examine the phenotype evoked by Cep295 depletion at an earlier time point (∼24 h after the RNAi treatment) and observe the redistribution of Cep192 to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis.	 Next to identify when in the cell cycle a new mother centriole becomes defective in centrosome assembly we decided to examine the phenotype evoked by Cep295 depletion at an earlier time point  ∼24 h after the [EXPE] treatment  and observe the redistribution of [GENE] to daughter centrioles just after mother-daughter centriole disengagement 6  during the previous mitosis 
2016	PMC5007451	cep192	staining	By using triple staining analysis, we found that in control cells, Cep192 localized to both mother and daughter centrioles just after disengagement.	 By using triple [EXPE] analysis we found that in control cells [GENE] localized to both mother and daughter centrioles just after disengagement 
2016	PMC5007451	cep295	depletion	While observing centriole disengagement in Cep295-depleted cells, we found that depletion of Cep295 caused precocious mother-daughter centriole disengagement during anaphase in mitosis, which may have occurred due to PCM loss at disengaged daughter centrioles ( Supplementary Fig. 3g ).	 While observing centriole disengagement in Cep295-depleted cells we found that [EXPE] of [GENE] caused precocious mother-daughter centriole disengagement during anaphase in mitosis which may have occurred due to PCM loss at disengaged daughter centrioles   Supplementary Fig 3g   
2016	PMC5007451	cep295	depletion	Given that upon Cep295 depletion, Cep192 was not present at the daughter centrioles that had just disengaged from mother centrioles ( Fig. 3g,h ), we assumed that formation of the daughter centrioles might be already defective.	 Given that upon [GENE] [EXPE] Cep192 was not present at the daughter centrioles that had just disengaged from mother centrioles   Fig 3gh   we assumed that formation of the daughter centrioles might be already defective 
2016	PMC5007451	cep192	depletion	Given that upon Cep295 depletion, Cep192 was not present at the daughter centrioles that had just disengaged from mother centrioles ( Fig. 3g,h ), we assumed that formation of the daughter centrioles might be already defective.	 Given that upon Cep295 [EXPE] [GENE] was not present at the daughter centrioles that had just disengaged from mother centrioles   Fig 3gh   we assumed that formation of the daughter centrioles might be already defective 
2016	PMC5007451	cep295	depletion	These considerations prompted us to reexamine whether Cep295 depletion leads to defects in the formation of daughter centrioles.	 These considerations prompted us to reexamine whether [GENE] [EXPE] leads to defects in the formation of daughter centrioles 
2016	PMC5007451	cep192	3d-sim	In control cells, 3D-SIM analyses revealed that Cep192 was recruited to the wall of newly formed daughter centrioles that were engaged with mother centrioles.	 In control cells [EXPE] analyses revealed that [GENE] was recruited to the wall of newly formed daughter centrioles that were engaged with mother centrioles 
2016	PMC5007451	cep295	depletion	Next, to precisely monitor the order in which Cep295 and Cep192 are recruited to the assembly site of procentrioles, we used the gated Stimulated Emission Depletion (STED) microscopy.	 Next to precisely monitor the order in which [GENE] and Cep192 are recruited to the assembly site of procentrioles we used the gated Stimulated Emission [EXPE]  STED  microscopy 
2016	PMC5007451	cep295	sted	Next, to precisely monitor the order in which Cep295 and Cep192 are recruited to the assembly site of procentrioles, we used the gated Stimulated Emission Depletion (STED) microscopy.	 Next to precisely monitor the order in which [GENE] and Cep192 are recruited to the assembly site of procentrioles we used the gated Stimulated Emission Depletion  [EXPE]  microscopy 
2016	PMC5007451	cep295	microscopy	Next, to precisely monitor the order in which Cep295 and Cep192 are recruited to the assembly site of procentrioles, we used the gated Stimulated Emission Depletion (STED) microscopy.	 Next to precisely monitor the order in which [GENE] and Cep192 are recruited to the assembly site of procentrioles we used the gated Stimulated Emission Depletion  STED  [EXPE] 
2016	PMC5007451	cep192	depletion	Next, to precisely monitor the order in which Cep295 and Cep192 are recruited to the assembly site of procentrioles, we used the gated Stimulated Emission Depletion (STED) microscopy.	 Next to precisely monitor the order in which Cep295 and [GENE] are recruited to the assembly site of procentrioles we used the gated Stimulated Emission [EXPE]  STED  microscopy 
2016	PMC5007451	cep192	sted	Next, to precisely monitor the order in which Cep295 and Cep192 are recruited to the assembly site of procentrioles, we used the gated Stimulated Emission Depletion (STED) microscopy.	 Next to precisely monitor the order in which Cep295 and [GENE] are recruited to the assembly site of procentrioles we used the gated Stimulated Emission Depletion  [EXPE]  microscopy 
2016	PMC5007451	cep192	microscopy	Next, to precisely monitor the order in which Cep295 and Cep192 are recruited to the assembly site of procentrioles, we used the gated Stimulated Emission Depletion (STED) microscopy.	 Next to precisely monitor the order in which Cep295 and [GENE] are recruited to the assembly site of procentrioles we used the gated Stimulated Emission Depletion  STED  [EXPE] 
2016	PMC5007451	cep295	depletion	Upon depletion of HsSAS-6, an essential component of the cartwheel structure 35 36 37 38 , a portion of Cep295 appeared to be recruited onto the mother centriole wall and formed a cap-like structure, presumably at the potential assembly site of a procentriole ( Fig. 4c ).	 Upon [EXPE] of HsSAS-6 an essential component of the cartwheel structure 35 36 37 38  a portion of [GENE] appeared to be recruited onto the mother centriole wall and formed a cap-like structure presumably at the potential assembly site of a procentriole   Fig 4c   
2016	PMC5007451	gt335	sted	The gated STED microscopy analyses demonstrated that newly formed daughter centrioles exhibited a significant reduction in the number of polyglutamylated centriolar microtubules, as marked by GT335, especially at the proximal part ( Fig. 4d ).	 The gated [EXPE] microscopy analyses demonstrated that newly formed daughter centrioles exhibited a significant reduction in the number of polyglutamylated centriolar microtubules as marked by [GENE] especially at the proximal part   Fig 4d   
2016	PMC5007451	gt335	microscopy	The gated STED microscopy analyses demonstrated that newly formed daughter centrioles exhibited a significant reduction in the number of polyglutamylated centriolar microtubules, as marked by GT335, especially at the proximal part ( Fig. 4d ).	 The gated STED [EXPE] analyses demonstrated that newly formed daughter centrioles exhibited a significant reduction in the number of polyglutamylated centriolar microtubules as marked by [GENE] especially at the proximal part   Fig 4d   
2016	PMC5007451	cep295	depletion	We then tested the integrity of the cartwheel structure upon Cep295 depletion.	 We then tested the integrity of the cartwheel structure upon [GENE] [EXPE] 
2016	PMC5007451	cep135	depletion	We next looked at Cep135, a proximal centriolar component 39  and intriguingly found that depletion of Cep295 led to complete loss of Cep135 from the daughter centrioles just after centriole disengagement ( Fig. 4e,f ).	 We next looked at [GENE] a proximal centriolar component 39  and intriguingly found that [EXPE] of Cep295 led to complete loss of Cep135 from the daughter centrioles just after centriole disengagement   Fig 4ef   
2016	PMC5007451	cep295	depletion	We next looked at Cep135, a proximal centriolar component 39  and intriguingly found that depletion of Cep295 led to complete loss of Cep135 from the daughter centrioles just after centriole disengagement ( Fig. 4e,f ).	 We next looked at Cep135 a proximal centriolar component 39  and intriguingly found that [EXPE] of [GENE] led to complete loss of Cep135 from the daughter centrioles just after centriole disengagement   Fig 4ef   
2016	PMC5007451	cep135	depletion	We next looked at Cep135, a proximal centriolar component 39  and intriguingly found that depletion of Cep295 led to complete loss of Cep135 from the daughter centrioles just after centriole disengagement ( Fig. 4e,f ).	 We next looked at Cep135 a proximal centriolar component 39  and intriguingly found that [EXPE] of Cep295 led to complete loss of [GENE] from the daughter centrioles just after centriole disengagement   Fig 4ef   
2016	PMC5007451	cep135	depletion	This is in line with the previous finding that depletion of Ana-1 also affected Cep135 recruitment to daughter centrioles in  Drosophila  cells 26 .	 This is in line with the previous finding that [EXPE] of Ana-1 also affected [GENE] recruitment to daughter centrioles in  Drosophila  cells 26  
2016	PMC5007451	cep295	depletion	On the other hand, we could detect only 34% reduction of Cep295 at centrioles by Cep135 depletion in human cells ( Supplementary Fig. 4f–j ).	 On the other hand we could detect only 34% reduction of [GENE] at centrioles by Cep135 [EXPE] in human cells   Supplementary Fig 4f–j   
2016	PMC5007451	cep135	depletion	On the other hand, we could detect only 34% reduction of Cep295 at centrioles by Cep135 depletion in human cells ( Supplementary Fig. 4f–j ).	 On the other hand we could detect only 34% reduction of Cep295 at centrioles by [GENE] [EXPE] in human cells   Supplementary Fig 4f–j   
2016	PMC5007451	cep295	depletion	Given the previous study 25  and our observation ( Supplementary Fig. 4d,e ) that Cep295 regulates the stability of a new mother centriole, we speculate that incomplete daughter centriole formation by Cep295 depletion could lead to instability and defective function of the resulting new mother centriole in the next cell cycle.	 Given the previous study 25  and our observation   Supplementary Fig 4de   that [GENE] regulates the stability of a new mother centriole we speculate that incomplete daughter centriole formation by Cep295 [EXPE] could lead to instability and defective function of the resulting new mother centriole in the next cell cycle 
2016	PMC5007451	cep295	depletion	Given the previous study 25  and our observation ( Supplementary Fig. 4d,e ) that Cep295 regulates the stability of a new mother centriole, we speculate that incomplete daughter centriole formation by Cep295 depletion could lead to instability and defective function of the resulting new mother centriole in the next cell cycle.	 Given the previous study 25  and our observation   Supplementary Fig 4de   that Cep295 regulates the stability of a new mother centriole we speculate that incomplete daughter centriole formation by [GENE] [EXPE] could lead to instability and defective function of the resulting new mother centriole in the next cell cycle 
2016	PMC5007451	cep295	co-ip	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a [EXPE] assay and yeast two-hybrid analysis with deletion constructs of [GENE] we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	assay	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a co-IP [EXPE] and yeast two-hybrid analysis with deletion constructs of [GENE] we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	yeast two-hybrid	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a co-IP assay and [EXPE] analysis with deletion constructs of [GENE] we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	two-hybrid	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a co-IP assay and yeast [EXPE] analysis with deletion constructs of [GENE] we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	co-ip	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a [EXPE] assay and yeast two-hybrid analysis with deletion constructs of Cep295 we narrowed down the [GENE] region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	assay	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a co-IP [EXPE] and yeast two-hybrid analysis with deletion constructs of Cep295 we narrowed down the [GENE] region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	yeast two-hybrid	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a co-IP assay and [EXPE] analysis with deletion constructs of Cep295 we narrowed down the [GENE] region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	two-hybrid	Using a co-IP assay and yeast two-hybrid analysis with deletion constructs of Cep295, we narrowed down the Cep295 region required for Cep192-binding to the short stretch spanning aa 1942–2144 ( Fig. 5c,d  and  Supplementary Fig. 5b–d ).	 Using a co-IP assay and yeast [EXPE] analysis with deletion constructs of Cep295 we narrowed down the [GENE] region required for Cep192-binding to the short stretch spanning aa 1942–2144   Fig 5cd  and  Supplementary Fig 5b–d   
2016	PMC5007451	cep295	depleted	We depleted endogenous Cep295 using siRNAs and expressed full-length Cep295 or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells.	 We [EXPE] endogenous [GENE] using siRNAs and expressed full-length Cep295 or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells 
2016	PMC5007451	cep295	sirnas	We depleted endogenous Cep295 using siRNAs and expressed full-length Cep295 or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells.	 We depleted endogenous [GENE] using [EXPE] and expressed full-length Cep295 or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells 
2016	PMC5007451	cep295	depleted	We depleted endogenous Cep295 using siRNAs and expressed full-length Cep295 or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells.	 We [EXPE] endogenous Cep295 using siRNAs and expressed full-length [GENE] or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells 
2016	PMC5007451	cep295	sirnas	We depleted endogenous Cep295 using siRNAs and expressed full-length Cep295 or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells.	 We depleted endogenous Cep295 using [EXPE] and expressed full-length [GENE] or deletion constructs lacking the Cep192-interacting region at comparable levels in HeLa cells 
2016	PMC5007451	cep295	depletion	While depletion of endogenous Cep295 caused a significant reduction of γ-tubulin foci in most interphase cells, the expression of full-length Cep295 could functionally rescue this phenotype (15%±4% and 52%±3% of cells with ⩾2 centrosomes, respectively;  Fig. 5g ).	 While [EXPE] of endogenous [GENE] caused a significant reduction of γ-tubulin foci in most interphase cells the expression of full-length Cep295 could functionally rescue this phenotype  15%±4% and 52%±3% of cells with ⩾2 centrosomes respectively;  Fig 5g   
2016	PMC5007451	cep295	rescue	While depletion of endogenous Cep295 caused a significant reduction of γ-tubulin foci in most interphase cells, the expression of full-length Cep295 could functionally rescue this phenotype (15%±4% and 52%±3% of cells with ⩾2 centrosomes, respectively;  Fig. 5g ).	 While depletion of endogenous [GENE] caused a significant reduction of γ-tubulin foci in most interphase cells the expression of full-length Cep295 could functionally [EXPE] this phenotype  15%±4% and 52%±3% of cells with ⩾2 centrosomes respectively;  Fig 5g   
2016	PMC5007451	cep295	depletion	While depletion of endogenous Cep295 caused a significant reduction of γ-tubulin foci in most interphase cells, the expression of full-length Cep295 could functionally rescue this phenotype (15%±4% and 52%±3% of cells with ⩾2 centrosomes, respectively;  Fig. 5g ).	 While [EXPE] of endogenous Cep295 caused a significant reduction of γ-tubulin foci in most interphase cells the expression of full-length [GENE] could functionally rescue this phenotype  15%±4% and 52%±3% of cells with ⩾2 centrosomes respectively;  Fig 5g   
2016	PMC5007451	cep295	rescue	While depletion of endogenous Cep295 caused a significant reduction of γ-tubulin foci in most interphase cells, the expression of full-length Cep295 could functionally rescue this phenotype (15%±4% and 52%±3% of cells with ⩾2 centrosomes, respectively;  Fig. 5g ).	 While depletion of endogenous Cep295 caused a significant reduction of γ-tubulin foci in most interphase cells the expression of full-length [GENE] could functionally [EXPE] this phenotype  15%±4% and 52%±3% of cells with ⩾2 centrosomes respectively;  Fig 5g   
2016	PMC5007451	cep295	rescue	In contrast, a Cep295 mutant lacking the Cep192-interacting region failed to rescue the phenotype provoked by depletion of endogenous Cep295 (22%±4% of cells with ⩾2 centrosomes;  Fig. 5g ).	 In contrast a [GENE] mutant lacking the Cep192-interacting region failed to [EXPE] the phenotype provoked by depletion of endogenous Cep295  22%±4% of cells with ⩾2 centrosomes;  Fig 5g   
2016	PMC5007451	cep295	depletion	In contrast, a Cep295 mutant lacking the Cep192-interacting region failed to rescue the phenotype provoked by depletion of endogenous Cep295 (22%±4% of cells with ⩾2 centrosomes;  Fig. 5g ).	 In contrast a [GENE] mutant lacking the Cep192-interacting region failed to rescue the phenotype provoked by [EXPE] of endogenous Cep295  22%±4% of cells with ⩾2 centrosomes;  Fig 5g   
2016	PMC5007451	cep295	rescue	In contrast, a Cep295 mutant lacking the Cep192-interacting region failed to rescue the phenotype provoked by depletion of endogenous Cep295 (22%±4% of cells with ⩾2 centrosomes;  Fig. 5g ).	 In contrast a Cep295 mutant lacking the Cep192-interacting region failed to [EXPE] the phenotype provoked by depletion of endogenous [GENE]  22%±4% of cells with ⩾2 centrosomes;  Fig 5g   
2016	PMC5007451	cep295	depletion	In contrast, a Cep295 mutant lacking the Cep192-interacting region failed to rescue the phenotype provoked by depletion of endogenous Cep295 (22%±4% of cells with ⩾2 centrosomes;  Fig. 5g ).	 In contrast a Cep295 mutant lacking the Cep192-interacting region failed to rescue the phenotype provoked by [EXPE] of endogenous [GENE]  22%±4% of cells with ⩾2 centrosomes;  Fig 5g   
2016	PMC5007451	cep192	immunofluorescence	Firstly, by using immunofluorescence analyses with Cep192 deletion mutants, we found that a short fragment of Cep192 (aa 1501–1860) was sufficient for its loading to the centriole in human cells.	 Firstly by using [EXPE] analyses with [GENE] deletion mutants we found that a short fragment of Cep192  aa 1501–1860  was sufficient for its loading to the centriole in human cells 
2016	PMC5007451	cep192	immunofluorescence	Firstly, by using immunofluorescence analyses with Cep192 deletion mutants, we found that a short fragment of Cep192 (aa 1501–1860) was sufficient for its loading to the centriole in human cells.	 Firstly by using [EXPE] analyses with Cep192 deletion mutants we found that a short fragment of [GENE]  aa 1501–1860  was sufficient for its loading to the centriole in human cells 
2016	PMC5007451	cep192	co-ip	Secondly, consistent with these observations, co-IP analyses revealed that the Cep192 mutants lacking the region of aa 1501–1860 failed to interact with endogenous Cep295 ( Fig. 6a,c ).	 Secondly consistent with these observations [EXPE] analyses revealed that the [GENE] mutants lacking the region of aa 1501–1860 failed to interact with endogenous Cep295   Fig 6ac   
2016	PMC5007451	cep295	co-ip	Secondly, consistent with these observations, co-IP analyses revealed that the Cep192 mutants lacking the region of aa 1501–1860 failed to interact with endogenous Cep295 ( Fig. 6a,c ).	 Secondly consistent with these observations [EXPE] analyses revealed that the Cep192 mutants lacking the region of aa 1501–1860 failed to interact with endogenous [GENE]   Fig 6ac   
2016	PMC5007451	cep295	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially [EXPE] recombinant proteins we purified [GENE] and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep295	recombinant	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified [EXPE] proteins we purified [GENE] and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep295	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we [EXPE] [GENE] and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep295	co-ip	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we purified [GENE] and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by [EXPE] experiments 
2016	PMC5007451	cep192	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially [EXPE] recombinant proteins we purified Cep295 and [GENE] fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep192	recombinant	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified [EXPE] proteins we purified Cep295 and [GENE] fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep192	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we [EXPE] Cep295 and [GENE] fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep192	co-ip	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we purified Cep295 and [GENE] fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192  containing the interacting regions that were identified by [EXPE] experiments 
2016	PMC5007451	cep295	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially [EXPE] recombinant proteins we purified Cep295 and Cep192 fragments  aa 1727–2204 of [GENE] and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep295	recombinant	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified [EXPE] proteins we purified Cep295 and Cep192 fragments  aa 1727–2204 of [GENE] and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep295	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we [EXPE] Cep295 and Cep192 fragments  aa 1727–2204 of [GENE] and aa 1501–2040 of Cep192  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep295	co-ip	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we purified Cep295 and Cep192 fragments  aa 1727–2204 of [GENE] and aa 1501–2040 of Cep192  containing the interacting regions that were identified by [EXPE] experiments 
2016	PMC5007451	cep192	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially [EXPE] recombinant proteins we purified Cep295 and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of [GENE]  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep192	recombinant	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified [EXPE] proteins we purified Cep295 and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of [GENE]  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep192	purified	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we [EXPE] Cep295 and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of [GENE]  containing the interacting regions that were identified by co-IP experiments 
2016	PMC5007451	cep192	co-ip	Thirdly, to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins, we purified Cep295 and Cep192 fragments (aa 1727–2204 of Cep295 and aa 1501–2040 of Cep192) containing the interacting regions that were identified by co-IP experiments.	 Thirdly to confirm the Cep295-Cep192 interaction  in vitro  with the bacterially purified recombinant proteins we purified Cep295 and Cep192 fragments  aa 1727–2204 of Cep295 and aa 1501–2040 of [GENE]  containing the interacting regions that were identified by [EXPE] experiments 
2016	PMC5007451	cep295	pull-down	We demonstrated that the two proteins interact with each other by GST pull-down assays ( Fig. 6e ), suggesting the physical association between Cep295 and Cep192.	 We demonstrated that the two proteins interact with each other by GST [EXPE] assays   Fig 6e   suggesting the physical association between [GENE] and Cep192 
2016	PMC5007451	cep295	assays	We demonstrated that the two proteins interact with each other by GST pull-down assays ( Fig. 6e ), suggesting the physical association between Cep295 and Cep192.	 We demonstrated that the two proteins interact with each other by GST pull-down [EXPE]   Fig 6e   suggesting the physical association between [GENE] and Cep192 
2016	PMC5007451	cep192	pull-down	We demonstrated that the two proteins interact with each other by GST pull-down assays ( Fig. 6e ), suggesting the physical association between Cep295 and Cep192.	 We demonstrated that the two proteins interact with each other by GST [EXPE] assays   Fig 6e   suggesting the physical association between Cep295 and [GENE] 
2016	PMC5007451	cep192	assays	We demonstrated that the two proteins interact with each other by GST pull-down assays ( Fig. 6e ), suggesting the physical association between Cep295 and Cep192.	 We demonstrated that the two proteins interact with each other by GST pull-down [EXPE]   Fig 6e   suggesting the physical association between Cep295 and [GENE] 
2016	PMC5007451	cep192	rescue	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the [GENE] mutant did not [EXPE] recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192   Fig 6fg   whereas the full-length of Cep192 rescued the phenotypes 
2016	PMC5007451	cep192	depleted	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the [GENE] mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells [EXPE] of endogenous Cep192   Fig 6fg   whereas the full-length of Cep192 rescued the phenotypes 
2016	PMC5007451	cep192	rescued	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the [GENE] mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192   Fig 6fg   whereas the full-length of Cep192 [EXPE] the phenotypes 
2016	PMC5007451	cep192	rescue	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the Cep192 mutant did not [EXPE] recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous [GENE]   Fig 6fg   whereas the full-length of Cep192 rescued the phenotypes 
2016	PMC5007451	cep192	depleted	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells [EXPE] of endogenous [GENE]   Fig 6fg   whereas the full-length of Cep192 rescued the phenotypes 
2016	PMC5007451	cep192	rescued	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous [GENE]   Fig 6fg   whereas the full-length of Cep192 [EXPE] the phenotypes 
2016	PMC5007451	cep192	rescue	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the Cep192 mutant did not [EXPE] recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192   Fig 6fg   whereas the full-length of [GENE] rescued the phenotypes 
2016	PMC5007451	cep192	depleted	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells [EXPE] of endogenous Cep192   Fig 6fg   whereas the full-length of [GENE] rescued the phenotypes 
2016	PMC5007451	cep192	rescued	We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192 ( Fig. 6f,g ) whereas the full-length of Cep192 rescued the phenotypes.	 We found that the Cep192 mutant did not rescue recruitment of γ-tubulin at centrosomes and mitotic spindle formation in the cells depleted of endogenous Cep192   Fig 6fg   whereas the full-length of [GENE] [EXPE] the phenotypes 
2016	PMC5007451	cep192	inhibited	Interestingly, expression of the Cep192 fragment that localized to centrioles inhibited centrosomal recruitment of PCM components such as γ-tubulin and endogenous Cep192 ( Fig. 6h,i  and  Supplementary Fig. 6c,d ).	 Interestingly expression of the [GENE] fragment that localized to centrioles [EXPE] centrosomal recruitment of PCM components such as γ-tubulin and endogenous Cep192   Fig 6hi  and  Supplementary Fig 6cd   
2016	PMC5007451	cep192	inhibited	Interestingly, expression of the Cep192 fragment that localized to centrioles inhibited centrosomal recruitment of PCM components such as γ-tubulin and endogenous Cep192 ( Fig. 6h,i  and  Supplementary Fig. 6c,d ).	 Interestingly expression of the Cep192 fragment that localized to centrioles [EXPE] centrosomal recruitment of PCM components such as γ-tubulin and endogenous [GENE]   Fig 6hi  and  Supplementary Fig 6cd   
